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I. INTRODUCTORY CHAPTERS 
A: "War ich krank? Bin ich genesen? 
Und wer ist mein Arzt gewesen? 
Wie vergaß ich alles das!" 
B: "Jetzt erst glaub' ich dich genesen: 
Denn gesund ist, wer vergaß ." 
F. Nietzsche, Die Fröhliche Wissenschaft. (1886) 
1.1. INTRODUCTION 
Nowadays the aged people in our society are regarded as having lost a 
number of highly valued human attributes. Whereas cultural, social and psycholo-
gical variables might influence our way of judging intellectual and motor faculties 
(Bahemuka 1982), great value is given to elucidate the relationship between the 
natural process of senescence and pathological changes in the brain. Questions 
whether loss of intellectual and motor abilities are inevitable features of later life 
and whether senile changes are the result of morphological changes in the brain, 
have been quite differently answered (Critchley 1956; Roth et al. 1967;Tomlinson 
et al. 1968,1970; Comfort 1973; Jarvik 1975; Wisniewski and Iqbal 1980; Mann 
and Yates 1982; Tomlinson and Corsellis 1984; Joseph et al. 1988; Mortimer 1988; 
Woodruff-Pak 1988). An unitary nosologic tradition about mental disorders 
apparently contributed to this obscurity (Horsman and van Tilburg 1984; Berrios 
1985; Roth 1986; Beach 1987). 
First a distinction between chronological and biological aging should be made, for 
it is obvious that only a proportion of old people and an unexpected proportion of 
rather young people are afflicted by such neuropsychiatrie and physical disabilities 
(Kay et al.1964; Gottfries 1986). Nevertheless, epidemiological data indicate that 
there is a very high correlation between age and dementia (Tanja and Hofman 1985; 
Roccaetal. 1986; Henderson 1986), suchthat, at least statistically, 100 % dementia 
might be expected around the age of 105 years (Gottfries 1986). Likewise extra-
polation of the regression line for normal age-related changes in the nigrostriatal 
system suggests that a clinical syndrome of parkinsonism might be reached in 
many individuals well over age 100(McGeeretal.l977; Calne and Peppard 1987; 
Mortimer 1988). 
Alzheimer's disease (AD) and Parkinson's disease (PD) as processes of pa-
thological or degenerative involution of cognitive and motor associated structures, 
respectively, continue to be compared with physiologic, senile involution (Bar-
beau 1976; Bowen et al. 1979; Wisniewski and Iqbal 1980; Mortimer et al.1982, 
1988; Calne and Langston 1983; Mann 1984; Gottfries 1986; Riederer and Kruzik 
1987; Brayne and Calloway 1988). It is noteworthy that Alois Alzheimer (1907) 
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in his original publication "Ueber eine eigenartige Erkrankung der Hirnrinde" 
described an exclusively presenile disease and James Parkinson (1817) in his 
"Essay on the shaking palsy", explicitly excluded cognitive deterioration from its 
clinical picture. 
Since long, intellectual impairment, dementia and cortical pathology, the dominant 
features of senile dementia of Alzheimer's type (SDAT), are also reported in PD 
(Ball 1882; Pollock and Homabrook 1966; Alvord et al. 1974; Lieberaian et al. 
1979; Hakim and Mathieson 1979; Oppenheimer 1984; Yoshimura 1988; Cum-
mings 1988). On the other hand extrapyramidal clinical symptoms are also found 
in patients with SDAT (Pearce 1974; Faden and Townsend 1976; Mölsa et 
al.l984,1987;Mayeuxetal. 1985; Leverenz and Sumi 1986; Sagar 1987; Huff et 
al. 1987; Fletcher and Sharpe 1988; Bakchine et al. 1989). Apparently, there is a 
relationship between biochemical, neuropathological and quantitative morpholo-
gical changes of both cortical and subcortical areas with senile mental and motor 
deterioration (Roth et al. 1967; Bowen and Davison 1975; Mannet al. 1985; Roth 
1986; Mountjoy 1986; Hardy et al. 1986; Riederer and Kruzik 1987); but such 
correlations, though statistically significant, are far from being perfect. 
Since the finding that damage to the dopaminergic nigrostriatal tract 
accounts for many of the motor difficulties of PD (Bemheimer et al. 1973 ) and the 
successful clinical application of this concept (for reviews see Birkmayer 1987; 
Homykiewicz 1988) it has become attractive to view other degenerative disorders, 
like AD, in terms of a selective involvement of one or several functional or 
neurotransmitter specific systems (Rossor 1982; Mann and Yates 1986; Perry et al. 
1987; Van Hoesen and Damasio 1987; Koller 1987; Goldman-Rakic 1987a,b, 
1988). Although a "cholinergic hypothesis" in AD (Davies and Maloney 1976; 
Whitehouse et al. 1982; Perry 1986; Höhmann et al. 1988) has been an attractive 
analogon of the dopaminergic model in PD (Appel 1981 ), the lack of clinical phar-
macological applicability of this concept (Terry and Katzman 1983; Davies 1986; 
Sahakian 1988) stressed the need for more extensive and systematic investigation 
of the involvement of other, e.g. monoaminergic, neurotransmitter systems in AD 
related cognitive deficits (Bowen et al. 1986; Whitehouse 1986b; Rossor 1988; 
Kaye et al. 1988). From the wealth of quantitative studies of cell counts and 
biochemical assays, a consensus emerged that subcortical choünergic, noradrener-
gic, dopaminergic and serotonergic projections are all consistently damaged in AD 
(Tomlinson et al. 1981; Perry et al. 1981 ; Bondareffet al. 1982; Iversen et al. 1983; 
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Hardy et al. 1986; Mann and Yates 1986). Eventual correlations with changes in 
cortical target areas would have implications for further research into etiology 
(Mann et al. 1985, 1986; Yamamoto and Hirano 1985a; German et al. 1987; 
Jellinger 1987c; Gibb et al. 1989b). As Mann and Yates (1986) stated there is an 
anatomical "tie up" with PD in that all the transmitter systems outside the cortex 
which are consistently affected in AD (nucleus basalis of Meynert, locus cocruleus, 
ventral tegmental area, nucleus raphe dorsalis) have diffuse cortical projections 
(see also Saper 1987a). Besides, like substantia nigra neuron loss in PD, cell loss 
in the locus coeruleus and nucleus basalis of Meynert, in AD, appeared to be 
topographically arranged (Marcyniuk et al. 1986,1989) apparently associated with 
cortical projections that might account for the clinical symptomatology. 
The aim of the present study is to show the extent of degenerative changes, 
like cell loss, changes of cell size and neuropathologic findings (presence and 
distribution of senile plaques and neurofibrillary tangles) in brainstem monoami-
nergic nuclei of patients of Alzheimer's disease and Parkinson's disease, as 
compared to the normally aged brains. Furthermore, to provide a method for the 
post mortem estimation of morphometric changes in these nuclei, adding to 
detailed knowledge of neurodegenerative features in relation to clinical symptoma-
tology. In discussing general neuropathology of AD and PD (Ch. 1.2.) special 
reference will be given to monoaminergic brainstem nuclei, locus coeruleus (LC), 
nucleus raphe dorsalis (NRd), substantia nigra (SN) and ventral tegmental area 
(VTA). The monoamines already have been the subject of many aging studies and 
it even has been suggested that changes in the related projections in particular hold 
the "key" to brain senescence (Samorajski 1975; Pradhan 1980; Mann and Yates 
1982). Knowledge about the putative role of the neurotransmitters dopamine, no-
radrenaline and serotonin and their involvement in a wide variety of functions 
associated with human behaviour, has grown far beyond the possibilities to provide 
an overall review here (Homykicwicz 1966; Mendels and Frazer 1974; Lavcrty 
1974; 
Nieuwenhuys 1985; Clark et al. 1987; Weiner and Molinoff 1989). Likewise, their 
involvement in different neuropsychiatrie disorders like depression, cognitive and 
certain motor disturbances, reminiscent of the clinical signs that can be seen in age-
related disease like Parkinson's disease and Alzheimer's disease, is well documen-
ted (Homykiewicz and Kish 1986; Agid et al. 1987; Kaye et al. 1988; Chan-Palay 
and Asan 1989a). 
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Analysis of the human mesencephalic dopaminergic cell continuum, cha-
racterized by rather diffusely located neuromelanin containing neurons, served as 
a model for studying the monoaminergic brainstem nuclei in general (Ch. 1.3.)· 
Neuromelanin was used as a marker for catccholaminergic neurons, both in 
neuroanatomical and quantitative analysis (Bogerts 1981; Saper and Petito 1982; 
Bogerts et al. 1983; German et al. 1988a). Chemical characteristics of this brain 
pigment and some relevant features, like its possible involvement in age-related 
diseases, are discussed in chapterl.4. Observations on the neuromelanin pigmented 
substantia nigra complex, macroscopically distinguishable in the human mesen-
cephalon (Vicq D'Azyr 1786; Foix and Nicolesco 1925; Winkler 1929; Huber et 
al. 1943 ; Olszewski and Baxter 1954), have quite a long historical tradition (for 
discussion see Keppcl Hcsselink 1986). Hassler (1937) suggested a detailed, 
cytoarchitectonically based, subdivision of the SN, to define an exact demarcation 
of subareas involved in parkinsonian syndromes (Hassler 1938). Nowadays 
dopamine-containing neurons in the mesencephalon are mostly subdivided into 
three groups: A8 (retrorubral area), A9 (substantia nigra proper) and AIO (ventral 
tegmental area) (Dahlström and Fuxe 1964), giving rise to more or less separated 
mesoslriatal, mesolimbic and mesocortical projections (Björklund and Lindvall 
1984). Evaluation of monoaminergic projections, encompassing monoamine 
histofluorescence (Andén et al. 1964; Ungerstedt 1971a; Fallon et al. 1978a,b; 
Fallon and Moore 1978a,b), immunohistochemistry (Gerfen et al. 1982,1987a,b; 
Gcrfen 1985; Hökfelt ci al. 1980) and anterograde or retrograde tracing methods 
(e.g. Carter and Fibiger 1977; Beckstead et al. 1979; Swanson 1982) were mostly 
performed on the rat brain. Data on comparative neuroanatomy (Ch.II.2.3.) 
therefore must precede the presentation of hodological features of the nuclei under 
investigation (Ch.II.2.4.). In view of the growing knowledge of neurochemical 
changes, some data on the chemoarchitecture will be included in the anatomical 
section (Ch.II.2.5.). 
The pathophysiology of PD-behavioral manifestations (Ch.II.2.6.) and the 
localized cell loss in the SN pars compacta, have been ascribed to different 
transcortical loops (DcLong and Georgopoulos 1981; Cools et al. 1984b; Alexan-
der et al. 1986; Marsden 1986). Thus the most medial part of the SN-VTA seems 
to be related to structures associated with cognition and cognitive disorders (Fallon 
et al. 1978b; Bogerts et al. 1983; Rinne et al. 1989), whereas the more laterally 
placed part of the SN pars compacta is most clearly involved in the motor disorders 
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of PD (Oppenheimer 1984; Jellinger 1987a,b; Homykiewicz and Kish 1986; 
Hirsch et al. 1988). In studying the mesencephalic catecholaminergic nuclei it also 
seems worthwhile to pay attention to some adjacent structures in the reticular 
formation, that are reported to provide a minor cholinergic input to the cerebral 
cortex (Saper 1987a) and the possible interaction of cholinergic and catecholami-
nergic structures (Henderson 1987; Freeman and Gibson 1988). In order to relate 
neurodegenerative changes with the many available neuroanatomical data, an atlas 
of the human mesencephalon and rostral rhombencephalon was designed (Ch. 
II.2.7.2.). A brief review on the human Locus Coemleus (CH.II.3.) and nucleus 
raphe dorsahs (Ch.II.4.) may complete the neuroanatomical section. 
Although consensus has been reached on the clinical definition of the 
dementia syndrome (Consensus 1987; Schulte 1989) and AD (McKhann et al. 
1984; Khachaturian 1985),there is yet the striking continuity of symptoms within 
the field from purely motor to exclusively cognitive dysfunctioning, which can 
manifest in quite divergent disease states and even physiologic aging. Current 
evidence suggests both AD and PD dementias to be primarily progressive cortical 
diseases in which cholinergic projections are involved in an "Alzheimer-like" 
fashion (Hakim and Mathieson 1979; Arendt 1983; Perry et al. 1985; Quinn et al. 
1986; Whitchouse et al.l985,1986b). It is compelling to attend the imperfect 
correlation of atrophy of the nucleus basalis in PD with dementia or abnormal 
senile plaque formation (Candy et al. 1983; Cummings 1988; Levin et al. 1989). On 
the other hand implications of basal ganglia dysfunction in cognitive deficits 
receive a growing interest (Cools et al. 1984a; Marsden 1982,1986; Méndez et al. 
1989). Apparently, dysfunction of subcortical systems, supporting cortical struc-
tures, may lead to certain kinds of intellectual impairment (Neumann 1968; Ross 
and Stewart 1981; Katz et al. 1987; Ruberg and Agid 1988), important to 
differentiate on behalf of possible therapeutic consequences (Bowen et al. 1975; 
Fleet et al. 1987; Rossor 1988; Levin et al. 1989). 
The question arises whether PD dementia is a specific entity, determined by 
impaired recall, visuospatial disturbances, executive deficits, bradyphrenia, perso-
nality changes and depression (Brown and Marsden 1988; Cummings 1988; 
Schulte 1989). Apart from this "subcortical dementia" (see also CH. II.2.6.), as 
described in progressive supranuclear palsy (Steele et al. 1964; Albert et al. 1974, 
1978; Dubois et al. 1988; Cummings and Benson 1988) or dementias in Hunting-
ton's disease (McHugh and Folstein 1975) and vascular disease (Caplan and 
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Schoene 1978; De Reuck et al. 1980; Román 1985; Fisher 1982,1989), other 
dementia syndromes, like that observed in Guam(Hirano et al. 1961; Elizan et al. 
1966; Kwang-ming Chen and Chase 1986), MPTP-induced parkinsonism (Lang-
ston et al. 1983; Stem and Langston 1985) and those associated with prefrontal 
disorders (Rossor 1988; Neary et al. 1988; Gotham et al. 1988), might contribute 
to PD-related cognitive decline (Yoshimura 1988; Quinn et al. 1986). Such a 
subcortical dementia syndrome might as well account for the lack of the predomi-
nantly cortical triad of agnosia, apraxia and aphasia as is usually met with in AD 
(Cummings 1988; Ruberg and Agid 1988 ). 
Morphometric analysis of neuronal elements (Ch.III. 1.) variable in size and 
shape, is marked with specific problems (Coleman and Flood 1987). Highly 
variable results in cell number of e.g. human catecholaminergic brainstem nuclei 
(Chs.III.2, III.3.) have been reported (Pakkenberg and Brody 1965; McGeer et al. 
1977;Brody 1978;Tomlinsonetal. 1981; Mann et al. 1982,1983; Bondareffet al. 
1982; Iversen et al. 1983; Bogerts et al. 1983; Halliday and Törk 1986; German et 
al. 1988a), due to methodological differences and mathematical processing. 
Therefore no major conclusions will be drawn from overall cell numbers based on 
our relatively small number of cases. Rather an attempt will be made to relate 
localized cell loss and neurodegenerative changes to anatomical data of previous 
chapters (Ch. III.5, IV). Recent developments in stereology (see Gundersen 1986) 
have criticized habitual sampling strategies and counting methods that might 
introduce unacceptable bias. Methodological considerations have to account for 
such items (Ch.III.5.2.). Systematic quantitative analysis might correlate localized 
variations to neuroanatomical and neurochemical data, providing a better distinc-
tion between pathologically and normally aged brains than is possible with any 
single parameter (Brizzee 1987). Some speculations as regards pathophysiological 
manifestations in the etiology of AD may be derived from the typical distribution 
pattern of neurofibrillary tangles and senile plaques within single brains (Ch. III.4.) 
Recent investigations on mesolimbocortical projections, closely related to 
what is called the "ventral striatum" (Heimer and Wilson 1975; Alheid and Heimer 
1988) and prefrontal lobe , suggest a more specific involvement of mesostriatal 
sub-circuitry, traditionally related to the motor system, in cognitive and limbic 
circuitry (Thierry et al. 1973,1977; Nauta and Domesick 1978; Simon and LeMoal 
1988; Fibiger and Phillips 1988; Thierry et al. 1988; Mogenson et al. 1988). 
Mesolimbocortical projections, originating in the VTA, might account for 
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Parkinson's disease- related dementia (Javoy-Agjd and Agid 1980; Torack and 
Morris 1988). Although the dopamine hypothesis of schizophrenia (Stevens 1973, 
1979; Crow et al. 1978, 1982; Nemeroff 1986) and a specific VTA-syndrome 
(LeMoal et al. 1976; Galey et al. 1977; Scamati et al. 1980), still lack a firm 
pathophysiological basis, the available data stress the importance of a better 
knowledge of this dopaminergic mcsolimbocortical projection neurons and their 
possible involvement in dementias of Alzheimer's and Parkinson's disease. Like-
wise noradrenergic projections have been associated with schizophrenia (see 
Homykiewicz 1982b; Crow 1982) and various dementia syndromes (Chan-Palay 
and Asan 1989b). There is also a growing evidence of the involvement of 
monoaminergic central nervous system circuits in depressive states (Kosüé et al. 
1987; Mazure et al. 1987; Chan-Palay et al. 1989a,b). It win be of much interest 
to correlate quantitative findings of various monoaminergic nuclei, as well as those 
of other brain arcas, in AD (Ch. IV). 
This study forms part of a research program on moiphometric parameters of 
different brain areas in aging and aging diseases, especially Alzheimer's disease 
and Paricinson's disease. Parallel studies have been performed on the neocortex 
(Broere 1990) .the nucleus basalis of Meynert (Vogels 1990), the hippocampus (De 
Vries 1990) and the amygdala (Vereecken in preparation). 
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1.2. NOTES ON NEUROPATHOLOGY 
Along with amyotrophic lateral sclerosis and the PD-ALS-dementia com-
plex of Guam (Hirano et al. 1962, 1986), Alzheimer's disease (AD) and Parkin-
son's disease (PD) are prototypes of human neurological disorders characterized 
by occurrences of cytoskeletal pathology in specific populations of nerve cells 
(Wisniewski et al. 1979; Tomlinson and Corscllis 1984; Price et al. 1986). A 
tremendous amount of investigation has been directed to these structural changes, 
because they make up the essential characteristic abnormalities, and theirpresence 
serves as diagnostic criterion for these two most common types of adult-onset 
chronic degenerative disorders of the central nervous system (Tomlinson et al. 
1970; Terry and Katzman 1983; Quinn et al. 1986). Refinements in clinical 
diagnosis of the mental disorders of the aged, in recent decades had their 
counterpart in improvements of thcneuropathological classification of age-related 
disease, especially dementia (Mayeux et al. 1985; Flicker et al. 1985; Kellet 1987; 
Alafuzoffetal. 1987; Chuil987).Ontheothcrhand,overthelastdecade,anumber 
of studies have begun to address the potential overlap of neuropathological, but 
particularly neurochemical manifestations of these two disease states, as well as the 
aging process itself (for reviews Price et al. 1986; Perry et al. 1987; Hamill et al. 
1988). Macroscopic and microscopie alterations occur in the brains of many old 
people (Tomlinson et al. 1968), some of the latter being grouped under the term 
'senile changes '. It has been alleged, however, that theirpresence in small amounts 
in the brains of old people is not correlated with intellectual deterioration 
(Tomlinson et al. 1968,1970,1984). Such senile changes include (Congophilic or 
argyrophilic) plaques, with enlarged neuntes, Alzheimer's neurofibrillary tangles 
(Alzheimer 1907), granulovacuolardegeneration, Hirano bodies and Lewy bodies. 
Recent preliminary studies suggest most, if not all, of them to be more or less 
related to cytoskeletal disorganization and specific proteins normally associated 
with the microtubules that are responsible for rapid axonal transport in the healthy 
brain (Price et al. 1986; Anderton 1987; Selkoe 1989). 
As regards these neuropathological changes, quantitative rather than quali-
tative changes form the major differentiating feature between the morphology of 
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the brains of normal and many demented old people (Gibson 1983; Tomlinson and 
Corsellis 1984; Hardy et al 1986). We are still uncertain, whether AD is a specific, 
discrete, qualitative disorder such as an infectious process, endogenous or exoge-
nous toxic disorder, or biochemical deficiency, or whether it is a quantitative 
disorder, in which an exaggeration and acceleration of the normal aging processes 
occur and dementia appears when neural reserves are exhausted and compensatory 
mechanisms fail. Vascular lesions also play an important role in the dementing 
process and in some instances significant ischaemic destruction accompanies 
severe senile changes (Fisher 1982,1989; Terry and Katzman 1983; Hardy et al. 
1986). Evidence exists on neuronal loss throughout life and it has always been 
stated, on subjective assessment, that neuronal loss is severe in 'senile dementia' 
(for reviews see Haug 1985; Coleman and Flood 1987). Likewise, the lesions in 
parkinsonism arc multifocal, show a significant overlap with age-related changes 
in nigro-striatal circuitry (McGeer et al. 1977; Joseph et al. 1978; Calne and 
Peppard 1987) and with Alzheimer neurofibrillary changes, especially as regards 
postencephalitic paikinsonism (Hassler 1938; Oppenheimer 1984) the Guam 
Parkinson-dementia-complex (Hirano et al. 1961, 1986) and the Stecle-Richard-
son-Olszewski syndrome (Tellez-Nagel and Wisniewski 1973; Agid et al. 1986). 
Even less specific for these neurodegenerative diseases are the age-related changes 
of accumulation of lipofuscin (Mann and Yates 1974a,b) and the decrease in the 
arborization of dendritic trees (see Coleman and Flood 1987). Major weight loss 
of the brain is usually seen only in younger patients. Because of the age 
dependency, most surveys of overall brain weight based on patient groups, 
consisting largely of elderly persons with AD (Tomlinson et al. 1980; Terry et al. 
1981; Mann et al. 1985), have shown only a slight (less than 10%) but significant 
or a nonsignificant change in brain weight, when compared with nondemented 
patients of that age. 
The site of predominant pathologic findings as well as their exaggeration are 
leading principles in neuropathological diagnosis of both AD and PD (Hirano and 
Zimmerman 1962; Terry and Katzman 1983; Oppenheimer 1984; Hardy et al. 
1986; Quinn et al. 1986; Perry et al. 1987). In the SN of patients dying with PD 
gross depigmentation and microscopic depigmentation of neurons, loss of neurons, 
extracellular neuromelanin, 'tombstone' formation (foci of macrophages contai-
ning the rather indigestible neuromelanin pigment) and the appearance of Lewy 
bodies in the remaining neurons, but also in the locus coeruleus and nucleus basalis 
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of Meynert, are the characteristic findings (Greenfield and Bosanquet 1953; 
Oppenheimer 1984; Forno 1986). In idiopathic parkinsonism the loss of neurons 
occurs in a reasonable stereotyped pattern, with the medial cell groups being rela-
tively spared (Oppenheimer 1984; Jellinger 1986b; Homykiewicz 1988). Morpho-
logical changes in AD, that is, the presence of plaques and tangles, are widely 
distributed in neocortex, allocortex and many deep gray areas down through the 
pontine tegmentum, but largely exclude the basal ganglia, thalamus and substantia 
nigra (Terry and Katzman 1983; Tomlinson and Corsellis 1984; Ball 1982,1984). 
The temporal lobe cortex and hippocampus are the areas most severely affected by 
the increased neurofibrillary tangle formation in serale dementia due to Alzhei-
mer's disease (Terry et al. 1981; Wilcock and Esiri 1982; Mann 1985; Hardy et al. 
1986). A severe loss of the large neocortical neurons is also characteristic of the 
disease but few attempts have been made to exactly substantiate this (Haug 1986; 
Coleman and Flood 1987; Broere 1990). In demented patients without evidence of 
cerebrovascular disease, a highly significant correlation was found between the 
presence and severity of dementia and the number of neurofibrillary tangles in the 
cerebral cortex (Wilcock and Esiri 1982; Pearson et al. 1985). A significant but 
much weaker and inconstant correlation was found for the presence and severity of 
dementia and the number of argyrophilic plaques present in the cortex (Wilcock 
andEsiri 1982; Gibson 1983; Mann 1985; Pearson et al. 1985). The neurofibrillary 
changes are much more severe in Alzheimer's disease (usually with a younger age 
of onset) than in serale dementia of the Alzheimer type (SDAT), whilst senne 
(neuriüc) plaques are most prominent in SDAT (Wisniewski and Iqbal 1980). 
Autopsy criteria for the diagnosis of AD are given by Khachaturian (1985). 
In any cortical microscopic field encompassing 1 sq. mm (microscopic magnifica-
tion x200) the number of senile or neuritic plaques and of neurofibrillary tangles 
should exceed two to five per field. Frontal, temporal and parietal lobes, as well as 
the amygdala and hippocampal formation are always sampled. For any patient 
between 66 and 75 years of age, the number of serale plaques (Bielschowsky silver, 
thioflavin S or Congo Red staining technique) must be greater than ten per field 
(Khachaturian 1985). In patients older than 75 years, neurofibrillary tangles may 
sometimes not be found in the neocortex, but the number of senile plaques should 
exceed 15 per microscopic field. In Parkinson's disease the autopsy criteria for the 
diagnosis were less strictly quantified, but the findings mentioned before, with 
special emphasis on the appearance of Lewy bodies in the SN and LC, served as 
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a safe guide for pathological diagnosis (Oppenheimer 1984). The neuropathology 
of parkinsonism differs from that of normal aging in being more severe (especially 
in the SN) and also by showing much more frequent Lewy bodies (Greenfield and 
bosanquet 1953; Ohama and Ikuta 1976; Forno 1986). 
In 1912 Lewy described peculiar inclusions that were spherical or elongated 
in shape, in the dorsal motor nucleus of the vagus and the nucleus basalis of 
Meyncrt. The term "Lewy bodies" usually implies acidophilic (occasionally poly-
chromatophilic), single or multiple, most often spherical inclusions in the nerve 
cell cytoplasm of neuromelanin pigmented nerve cells. They contain mainly 
protein, but not carbohydrate and are therefore not stained with the periodic acid 
Schiff reagent, a feature that makes it easy to tell them apart from the many corpora 
amylacea that can be seen in the aged brain (Greenfield and Bosanquet 1953; Forno 
1969,1986). Lewy bodies are found either near the nucleus (perikaryal) or within 
dendrites (intraneuritic) and are easily recognizable by light microscopic examina-
tion of ordinary chromatically stained sections (e.g. hematoxylin and eosin, 
trichrome), as intracytoplasmic, single or multiple, spherical, acidophilic or 
polychromatophilic masses with a dense core and a peripheral halo (Oppenheimer 
1984). By electron microscopy (Duffy and Tennyson 1965) the pattern resembles 
a sunflower. 
There is an extensive literature on the composition and meaning of Alzhei-
mer neurofibrillary tangles (see Tomlinson and Corsellis 1984; Selkoe 1986; Iqbal 
et al. 1986). The aggregates may be demonstrated by various staining techniques 
and immunohistochemical techniques, but are not easy to see in preparations 
stained with heamatoxylin and eosin or in Nissl (Alzheimer 1907; Brun 1983; 
Tomlinson and Corsellis 1984; Price et al. 1986; Anderton et al. 1987; Défossez 
and Delacourte 1987). The essential change consists of the thickening and 
tortuosity of fibrils within the neuronal cytoplasm. The aggregates comprise 
double helical stacks of subunits shaped like a C, surrounded by a fuzzy coat, which 
can be stripped of by protease treatment. Protein sequencing and molecular cloning 
showed that the fragment was part of 'tau', a protein normally associated with the 
microtubules (Selkoe 1986,1989; Kowall and Kosik 1987). The paired helical 
filaments (PHF), formed by these proteins, together with non-neurofilament 
proteins (Selkoe 1986,1989), form highly insoluble cross-linked polymers (Tomlinson 
and Corsellis 1984). The configuration of the aggregates may vary according to the 
site and the type of nerve cell afffected, being pyramid- shaped in cortical neurons, 
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but more often round in subcortical nuclei (Fig.III. 1 .a). Pigments, such as neuro-
melanin or Upofuscin may also be present. Neurons in the subcortical regions are 
less often affected (see Chs. III. and IV.). Ishii (1966) studied the distribution in the 
hypothalamus (see also Saper and German 1987) and brainstem and pointed out 
that the vulnerable nuclear groups showed certain metabolic features in common, 
including a high content of monoamines and an early accumulation of brain 
pigments. 
Senile (neuritic) plaques are discrete structures in the neuropil (see Fig.III.l.b) 
with an average diameter of 70 microns (Wisniewski and Terry 1973) that occur 
in largest numbers in the neocortex and amygdala (Wisniewski and Iqbal 1980; 
Tomlinson and Corsellis 1984). They were first described by Blocq and Marinesco 
(1892) as sclerotic plaques of microglia, but in order to emphasize degenerating 
small axons and dendrites noted in electron microscopic studies (Wisniewski and 
Terry 1973) the name neuritic plaque (NP) is more appropriate. The smallest type 
consists of a sharply circumscribed granular deposit of amyloid strongly fluores-
cent in Congo-red staining (Puchtler and Sweat 1965; Selkoe 1989). Extracellular 
amyloid fibrils are composed of a 4-kd peptide termed the ß-amyloid protein 
(A4 protein), of which the coding gene is located on human chromosome 21 
(Anderton 1987; Hardy 1988). The axons and myelinated fibers in the surrounding 
tissue are displaced, but show little or no evidence of abnormality. The other two 
types of plaques are larger and are usually referred to as typical (or classical) 
plaques andprimitive plaques (Mann 1985). The typical plaque consists of a central 
core of amyloid surrounded by a corona of reactive astroglial cells, microglia, ma-
crophages, degenerative axons and occasional dendrites (Tomlinson and Corsellis 
1984; Isekietal. 1989).The primitive plaque lacks the central coreof amyloid. The 
presence of various forms of plaques suggests that these forms represent different 
stages in evolution (Wisniewski and Terry 1973; Selkoe 1986; Défossez and De-
lacourte 1987). Plaques have also been described in animals in relation to 
spongiform encephalopathy, aging and viral encephalitis (see Wisniewski and 
Terry 1973; Pearson 1985), but they differ from those described in man by the 
absence of the paired helical filaments (Wisniewski and Terry 1973). In some cases 
of AD, as well as in individuals of advanced age, amyloid may be conspicuous in 
small leptomeningeal and intracortical blood vessels and stain densely with dyes 
such as Congo-red (Tomlinson and Corsellis 1984; Mann 1985; Bergeron et al. 
1987; Yamada et al. 1988). Ultrastructurally these deposits are associated with 
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perithelial cells of the basal lamina and are referred to as Congophilic angiopathy. 
The capillaries with plaque-like degeneration were not infrequently observed in the 
brain stem of patients with AD (Rudelli et al. 1984; Iseki et al. 1989). Although 
Hirano bodies and granulovacuolar degeneration have not been searched forin our 
study, they also form part of the neuropathological phenomena in degenerative 
diseases of the aging brain, that are almost exclusively restricted to the hippocam-
pus (Tomlinson and Corsellis 1984: Mann 1985). Hirano bodies are rod-shaped 
eosinophilic intra-cytoplasmic inclusions, commonly seen in the pyramidal cell 
layer and the stratum lacunosum of hippocampi in patients with AD (Tomlinson 
and Corsellis 1984; Mann 1985). Granulovacuolar degeneration refers to cytoplas-
mic inclusions, which consists of an electron-dense granule surrounded by a 
membrane-bound vacuole (Tomlinson et al. 1970; Wisniewski and Terry 1973; 
Mann 1985). They might also contain tubulin-like immunoreactivity (Price et al. 
1986). 
In neuronal perikarya, neurofibrillary tangles (NFT) consist of three popu-
lations (Défossez and Delacourte 1987): firstly strongly immunolabeled tangles, 
with a specific antiserum raised against PHF. Secondly, less dense tangles were 
weakly immunolabeled, but strongly thioflavine-stained. Thirdly "ghost tangles" 
which correspond to extracellular NFT, were exclusively thioflavin-stained (Défossez 
and Delacourte 1987). Likewise in our Congo-red histofluorescence microscopy 
weakly stained extracellular fibrils contrasted with well-shaped intracellular 
tangles. Immunolabeled neuntes, thioflavin-(or Congo-red) stained neuntes and 
transition figures can also be observed around neurilic plaques and some vessels 
with amyloid angiopathy (Tomlinson and Corsellis 1984; Selkoe 1986, 1989; 
Anderton 1987; Défossez and Delacourte 1987). But generally the cerebral 
amyloid of senile plaques is ultrastructurally distinct from PHF, consisting 4- 8 nm 
wide filaments that are not wound together in pairs (Änderten 1987; Selkoe 1986, 
1989). The immunohistochemical localization of immunoglobulins and other 
serum proteins within senile plaques, neuronal perikarya and astrocytes, suggested 
a leakage of blood vessels (Wisniewsky and Iqbal 1980; Mann et al. 1982;Davies 
1988). Neuropeptidergic systems form another component of plaques in AD (e.g. 
Struble et al. 1987). 
A major question for further study concerns the cellular origin and role of 
microvascular amyloid in the degeneration of neuntes of multiple neurotransmitter 
specificities in AD cortex (Davies 1988). Current molecular research on 
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Alzheimer's disease is focussed on two major goals: identifying the locus and 
nature of the genetic defect or defects causing familial forms of the disease, and 
studying the genesis of the earliest and most specific phenotypic abnormalities in 
a retrograde fashion, in the hopes of arriving at a molecular alteration that is directly 
linked to genetic defect (for review see Kay 1986; Hardy 1988; Tanzi et al. 1989; 
Selkoe 1989). One of the leading hypotheses that attempts to explain the pathoge-
nesis and progression of AD suggests a primary defect in blood brain barrier 
function and/or structure within the cerebral cortex, which may be the cause of the 
cerebral vessel amyloidosis common in many patients with AD (for review Hardy 
et al. 1986; Kozlowski and Nilaver 1988; Toledano-Gasea 1988) and be related to 
aging (Mooradian 1988). It is of interest to know that both noradrenergic (locus 
coeruleus) and serotonergic (raphe dorsahs) projections have been shown to be 
involved in the regulation of the integrity of the blood brain barrier (Chan-Palay 
1976; Mann et al. 1983; Mann 1985). Neurotoxins as a possible mediator between 
widespread cerebral nuclei that degenerate in both AD and PD, and other 
neurodegenerative disorders, have been shown to provide an acceptable explana-
tion for various manifestations as regards the pathological changes of the aged brain 
(Hardy et al. 1986; Saper et al. 1987; Längsten 1988; Gajdusek 1988). The 
suspicions that NP's and NFT's must in some way be responsible for the clinical 
expression of AD began to give way when it was discovered that the cortex from 
patients with AD was severely depleted in markers for cholinergic neurons (Davies 
and Maloney 1976; Terry et al. 1978; Bowen and Davison 1980; Perry 1986), an 
observation later equated with atrophy, neurofibrillary degeneration and loss of 
parent cell bodies in the nucleus basalisofMeynert(Whitehouse et al. 1981). These 
findings were soon followed by more extensive studies on neurochemical changes 
(see Terry et al. 1978; Rossor 1980, 1988; Mann and Yates 1986; Procter et al. 
1988). This again tempted investigators to speculate on a mono-transmitter deficit 
in AD (the cholinergic hypothesis) following the dopaminergic model in PD (Perry 
1986; Homykiewicz 1988). Nevertheless, the core-defect in AD remains an 
abnormally high degree of neurofibrillary degeneration, just like the Lewy body 
remains the key finding in PD brains. Integrative views on age-related neuropatho-
logical decrement of the central nervous system nuclei nowadays have to incorpo-
rate compiled data of specific genetic programs, functional roles and/or morpho-
logical connections as well as neuropathological findings within a particular area. 
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1.3. MATERIALS AND TECHNIQUES 
1.3.1 Cytoarchitectonic analysis 
For defining subareas in the substantia nigra and ventral tegmental area, and 
the boundaries of the locus coeruleus and nucleus raphe dorsalis as well as their 
topographical relationship to surrounding structures, brain stems of patients with 
no history of neurological disorders, varying in age between 60 years and 80 years 
(Table 1.1.). were used. The brain material was obtained at routine autopsy and 
fixed by immersion in 4% buffered formaldehyde for several months. On gross 
examination the brains did not show major abnormalities. The brain stems (from 
the middle of the mamillary body through the pons) were embedded in paraffin and 
cut transversely, i.e. pcipendicular to the longitudinal axis of the brainstem, into 
sections of 20 μτη with a Reichert-Jung 2050 microtome. The sections were stained 
according to Nissl (crcsylccht violet) and Kliiver-Barrera (1953). In addition a 
horizontally sectioned brain stem was available. 
As an aid for the cytoarchitectonic analysis based on the Nissl-stained 
sections, two brain stems were used for apigmentoarchitectonic analysis (Braak 
1978,1980; Braak and Braak 1986). Sections of 800 μτη were cut perpendicular to 
the brain stem axis with the aid of a freezing microtome. The sections were oxidized 
with performic acid and stained with aldehydcfuchsin for demonstration of 
lipofuscin pigment (Braak 1978). An additional, unstained, brain stem sectioned 
serially at 800 μτη was available, in which the pattern of neuromelanin containing 
cells is particularly well visible. These thick sections greatly facilitate the recog­
nition of nuclear borders and internal configuration of the substantia nigra and 
VTA. 
The topographical relationship of the various nuclei and subnuclei in the 
SN,VTA, locus coeruleus and nucleus raphe dorsalis are illustrated with camera 
lucida drawings of eight representative sections through the human mesencephalon 
and three representative sections through the dorsal part of the rostral rhombencep­
halon (see Ch. II.2.7.). For an analysis of fiber bundles adjacent Kliiver-Barrera 
stained sections were used. Delineation of the cell masses was performed using the 
following cytoarchitectural criteria: a) density and arrangement of the neuronal 
elements; b) size and shape of the cell bodies (see II.2.2.and table ILL); c) aspect 
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and distribution of the Nissl substance, and d) presence and distribution of 
neuromelanin for nigral and locus cocruleus neurons, or lipofuscin for dorsal raphe 
neurons. Cell sizes were measured with a Zeiss-Kontron MOP-Videoplan. As no-
menclature for the mesencephalic nuclei Braak and Braak's (1986) subdivision of 
the SN into subnuclei, and Halliday and Törk's (1986) subdivision for the VTA 
nuclei, were used. 
Table 1.1.: Data on the brains used for quantitative morphometric analysis 
Nr. 
87029 
87177 
86179 
88269 
88184 
87068 
87395 
88177 
87368 
88221 
89142 
89141 
87377 
86204 
87062 
Age 
60 
62 
69 
80 
91 
65 
69 
76 
82 
93 
68 
69 
74 
79 
66 
Sex 
F 
M 
M 
M 
M 
F 
M 
F 
M 
F 
M 
F 
F 
M 
M 
Diagnosis 
Normal 
Normal 
Normal 
Normal 
Normal 
AD 
SDAT 
SDAT 
MID 
SDAT 
PD 
PD 
PD 
PD 
AD+PD 
Cause of death / Clinical details P-M-delay 
hr. 
Sepsis / Decompcnsalio cordis 
Aorta rupture / Aorto-bifurc bypass 
Trauma / Myocard infarct 
Myocard infarc / Rheum arthnlis 
Carcinoma/ No dementia 
Sepsis/ 3 yrs progressively dementing 
Cachexia/ Dementia for 12 yrs ( N I H ) 
Cachexia/ Dementia for 14 yrs 
Circ insuff/Dementia for 6 yrs 
(only available for LC counting) 
Pneumonia/ Dementia for 16 yrs 
Circ insuff/Imbecility juvenile epilepsia*) 
Circ insuff/Cachexia.Depression,*) 
Diabetes.Hypertension 
Myocard infarc /2 yrs PD 
Cachexia/ Osteoporosis 
Sepsis/Rectal care,4 yrs dementia 
( N I H ) 
14 
<24 
50 
48 
36 
<12 
<12 
6 
<14 
<12 
-
32 
8 
50 
<24 
Brain weight 
1162 
1351 
1200 
1475 
1288 
865 
1077 
970 
1353 
842 
1300 
1370 
1370 
1210 
1136 
*) Prof dr D J Ruiter, Pathological Anatomical Institute, Nijmegen 
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1.3.2. Quantitative analysis 
For quantitative analysis of the number of neurons in the SN and VTA in 
aging and aging diseases both sides of the mesencephalon of 15 human brains were 
analysed; five control brains, four brains of patients with Alzheimer's disease (and 
one MID brain, only for LC countings), four brains of patients with Parkinson's 
disease and one brain of a patient in whom both Alzheimer's and Paiicinson's 
disease were diagnosed (Table 1.1.). Paraffin sections of 20 |im, cut perpendicular 
to the longitudinal axis of the brain stem were examined, from a level through the 
middle of the mamillary body through the caudal pole of the pons, to include the 
locus coeruleus. The neuropathological diagnosis was performed on paraffin 
embedded sections stained for Nissl, Bodian, Yamamoto and Congo red and 
thioflavin-S. (Puchtler and Sweat 1965; Yamamoto and Hirano 1986). 
Figi ι 
Schematic representation of the plotting equipment 
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The following sampling procedure was used: 
1) outlines of the sections as well as of the areas containing neuromelanin 
pigmented neurons, or the dorsal raphe neurons, equidistant at 800 μπι (each 40th 
section of 20 urn) were drawn with an X-Y plotter (Kipp Instruments) attached to 
a Zeiss Standard microscope (for schematic representation of plotting equipment 
(Fig.I.l.)· 
2) in these outlines cells can be plotted in relation to a point of reference, i.e. the 
bottom of the cerebral aquaduct (see Fig. I.2.). The X-Y plotter is tuned in such a 
way that displacement of the plotter-pen across one square (1 cm of the plotter 
table) corresponds to a displacement of the microscope stage of 1 mm 2 ; 
3) in each square of the plotting table one counting is performed; cells were counted 
via an ocular grid (1x1 cm2). In the magnification used (40x10) the counting grid 
corresponds to a 0,25x0,25 mm2 fraction of a plotter section. Profiles dissected by 
the right and the bottom line of this grid were included, those dissected in the left/ 
upper part were not. So a 1/16 fraction of a plotter square is counted; 
4) sampling is done in a systematic random way (Gundersen and Jensen 1987) so 
that no bias is introduced because of random clustering of cells. Data on the actual 
position of the sample studied can be obtained from the outlines on the plotting 
table. A comparable approach was used by Agnati and co-workers (Agnati et al. 
1984a,b) and German et al. (1983); 
5) according to stereological principles (Cavalieri's principle; see Mattfeldt 1987; 
Vogels 1990) only 8 equidistant sections of a given structure, selected randomly, 
provide a counted cell number with a reliability of 95 %; 
6) the following elements were counted: neuromelanin-containing cells, neurons 
without neuromelanin, but within the same outlines, dorsal raphe neurons contai­
ning lipofuscin or those within these outlines with a visible nucleolus, and 
neurofibrillary tangles and senile plaques within the sections analyzed. Identifica­
tion and counting of such elements was done using a X 400 magnification. Melanin 
deposits without cell boundaries (free neuromelanin, frequently present in aging 
diseases) may contribute in defining nuclear outlines, but were not counted as 
neurons; 
7) the so counted number of neurons or other elements, e.g. senile plaques, has to 
be multiplied by 16 for extrapolation to the real cell number in that section and by 
40 because of the fraction of sections analyzed (Fig. I.3.); 
8) Correction formula: the identification and quantification of neural elements, 
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POSITION OF 
POINT OF REFERENCE 
_L i_. L i ^ ^0 
PART OF EACH FIELD IS COUNTED AT MAGNIFICATION 400 χ 
Fig 12 
Projection of the counting grid on microscopical slides 
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variable in size and shape, is marked with specific problems ( Haug 1986; 
Gundersen 1986; Coleman and Flood 1987), that often introduce unacceptable 
bias. The actual counted cell number, multiplied with the number of sections 
represented as well as the fraction of the counted area (Fig. I.3.), actually is an 
overestimation of the real cell number. In order to correct for this bias the most used 
correction formula is that of Abercrombie (1946). Correction is perfomied by the 
following calculation: 
Nr = Np χ Τ (Abercrombie 1946) 
Dm + T 
In this formula: 
Nr =the real cell number in the (sub)nucleus studied. 
Np =the counted number. 
Dm =the mean profile diameter of the counted elements. 
Τ =the section thickness. 
In orderto correct forthe "lost caps", not counted in routinely performed countings, 
Floderus (1944) suggested an adjustment to this formula, preventing an overcor­
rection: 
Nr = Np χ Τ in which: 
Dm + Τ - 2 h 
2h =the diameter of the smallest detectable element ("lost cap"). 
This formula was used in some cases, in order to get an estimation of the real cell 
number of the given structure. 
Profile (smallest and largest) diameters were measured for each separately quan­
tified area (the pars compacta and the pars reticulata of the substantia nigra, ventral 
tegmental area and area retrorubralis, rostral and caudal locus coeruleus neurons) 
with the aid of a Zeiss-Kontron MOP-Videoplan. A mean cellular diameter was 
calculated from 25 samples of these areas. In this way possible variation due to 
shrinkage in different disease states or differences in tissue processing are also 
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corrected for these cellular elements that had to be identified by their contours. The 
mean cellular diameter here is calculated for an analogous spherical contour that 
could represent the actual profile area (D-circle). Cells without neuromelanin and 
thus comprising a visible nucleolus, but within the confines of the typical 
neuromelanin-countaining structures, were counted in the same way for optimal 
comparability. 
The shape and size of neuropathologic findings identified in Congo red fluorescen-
ce (Puchtler 1962; Puchtler and Sweat 1965) is highly variable, to such a degree that 
only semiquantitative estimation is possible. Thus, no correction formula was used 
to calculate the "exact" number of neurofibrillary tangles and senile plaques. 
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Schematic representation for the calculation of real cell numbers 
extrapolated from factors of magnification (see text) 
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1.3.3. Immunohistochemical procedures 
For immunohistochemical studies brain stems were obtained between two 
and five hours after death in cases of Alzheimer's and Parkinson's disease, and 
between three and 60 hours post mortem in control cases. At first, the brain stem 
was immediately removed, cut into slices of three to five mm and fixed in either 
buffered 4 % formaldehyde or formaldehyde-sublimate at 4° С for 24 hours. After 
dehydration the slices were embedded in paraffin wax and cut serially into sections 
of 10 μιη on a Reichert-Jung 2050 microtome. Standard immunohistochemical 
procedures as described by Pearson and со-workers (Pearson et al. 1983) were used. 
A tyrosine hydroxylase antiserum of Bugene Technics (Allendale, USA) was used 
in a delution of 1/500. 
More recently, however, anothjer fixative was used and the brain was 
perfused (see Beach et al. 1987) through the internal carotids and basilar artery (or 
vertebral arteries). Immediately after removal, the brain was put on crushed ice and 
perfused with 0.5-1 liter of buffered saline, followed by two liters of Somogyi's 
fixative (see Somogyi and Takagi 1982) using a peristaltic pump (Gibson; 25 
r.p.m.). But also without prior perfusion-fixation better results were obtained than 
in the above mentioned series. After perfusion, the brain stem as a whole was fixed 
for a few hours in Somogyi's fixative, then cut into slices of 3-5 mm. These slices 
were further fixed overnight and then cut into sections of 30 μτη on a freezing 
microtome. Standard immunohistochemical procedures using a monoclonal anti­
body against tyrosine hydroxylase (INC-STAR, Stillwater, Minneapolis, USA) 
were employed: after washing for three times 15 minutes in 0.05 M TBS (0.05M 
Tris with 0.7 % NaCl) at room temperature, free floating sections were immersed 
in 0.05 M TBS containing 1 % normal rabbit serum (NRS), 0.5 % bovine serum 
albumin and 0.5 % Triton X-100 for one to two hours, incubated overnight with a 
monoclonal antibody against TH (1:1000 in NRS), again washed for three times 
30 minutes in 0.05 M TBS and then incubated for 90 minutes with the second 
antibody, RAM/PO (Rabbit anti-Mouse peroxidase, Dakopatts P260 Denmark) 
1:90. After rinsing for three times 30 minutes in TBS the sections were stained with 
0.02 % DAB, containing 0.6 % nickel-ammoniumsulphate as intensifyer (see 
Adams 1981) and H202. Sections were washed in TBS, mounted on gelatin-coated 
slides, dried overnight, and counterstained with Cresylviolet. In figure 1.4. an 
example is shown of a case (a male who died of a heart attack, 81 years old) with 
a post mortem delay of 25.5 hours. 
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Fig. 1.4 
Tyrosine hydroxylase staining of the human mesencephalon (xA) 
1.3.4. Neuropathological procedures 
The histological diagnosis of idiopathic Parkinson's disease was established 
on the basis of severe depletion of pigmented neurons in the SNc and the occurence 
of several hyaline inclusion bodies (Lewy 1913) in the remaining pigmented cells 
of this nucleus and the nucleus coeruleus (Oppenheimer 1984; see Ch. 1.2). The 
diagnosis Alzheimer's disease was made on the basis of the recently formulated 
criteria by McKhann et al. (1984) and Khachaturian (1985). Paraffin embedded 
sections were stained for Nissl, hematoxylin eosin, a modified Bielschowsky stain 
(Yamamoto and Hirano 1986) and Congo red (Puchtler and Sweat 1965). 
25 
Fig 15 
Neuromelanin containing cell bodies as found in the 
whole rostral to caudal extent of the human 
mesencephalon (d", 69yrs), plotted in one section 
Each point represents 500 perikaryae Brain nr. 86179 
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1.4. NEUROMELANIN (AS A MARKER FOR 
CATECHOLAMINERGIC NEURONS) 
Melanin granules can be defined as complex aggregates of quinoid poly-
mers, with several enzymes in a protein matrix (Cotzias et al. 1964; Marsden 1969; 
Graham 1978). There is no specific chemical test for directly demonstrating 
melanin (Greincr and Nicolson 1965; Lillie 1969), but it has a typical appearance, 
at least in the neural elements in the brain stem (Bogerts 1981), and certain 
histochemical criteria have been suggested (Cotzias et al. 1964; Lillie 1969; Barden 
1981). The term melanin, however, is used to denote various brown and black 
pigments found in mammals, amphibians and plants (Cotzias et al. 1964; Greiner 
and Nicolson 1965; Lillie 1969; Marsden 1969; Kömer and Pawelek 1982). It 
embraces a variety of pigments, as can be found in hair, feathers, skin, tumors, 
meninges and certain brainstem nuclei (Cotzias et al. 1964; Bazelon et al. 1967). 
The neural melanin has some features in common, but differs in some essential 
aspects (Lillie 1969; Marsden 1969,1983), especially with regard to its dependence 
on catecholamines as precursor (Van den Wende and Spoerlein 1963), the capacity 
to reduce silver solutions (Lillie 1969) and spectroscopic features (Pakkenberg 
1966; Graham 1978; Marsden 1983). 
Neuromelanin resembles lipofuscin (Mann and Yates 1974,b) and electron-
microscopic studies suggest that neuromelanin is a partially melanized lipofuscin 
granule (Duffy and Tennyson 1965), whereas lipofuscin exhibited the properties 
of bleached neuromelanin (Marsden 1983). This last author suggested that neuro-
melanin consists of a core of lipofuscin, upon which melanin substances are 
deposited. Both pigments, like other lipopigments formed by peroxidation of 
polyunsaturated fatty acids and their interaction with biologically useful molecules 
and structures, are strongly associated with aging (Mann and Yates 1974 a; Graham 
1979; Barden 1981 ). In contrast to lipofuscin, however, neuromelanin is restricted 
to a number of cell types and is suggested to have some positive, or even toxic, 
function (Mann and Yates 1974b; Marsden 1981). Another feature of neuromela-
nin, as opposed to other melanins, is that the greatest amounts are found in the 
primates, where more nigral cells contain a greater number of larger and darker 
granules than in other mammals (Scherer 1939; Marsden 1961; Barden 1981). The 
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size of the granules and the amount of pigment in the neurons of the substantia nigra 
and locus coerulcus in the adult gorilla, are about identical to those of the 
corresponding regions in a 4-year-old child (Scherer 1939). The pigment, however, 
is dark gray-black in the child, as it is in the adult human, whereas in the gorilla it 
is brown (Adler 1942). Often the smallest amounts of pigment are masked in Nissl 
preparations by the dark color of the cytoplasm. Kastinet al. (1976) suggested that 
a "melanin-like" substance, similar to sepia melanin, is present in the rat brainstem, 
although not visible in fresh or silver-stained sections light microscopically. But, 
as Barden (1981) stated: "Neuromelanin granules, as they are known by the usual 
light and electron microscopic criteria, do not occur in rodent brain". In primates, 
the intensity of pigmentation increases as the relationship to man becomes closer 
(Marsden 1961). Mann and Yates (1974b) demonstrated that neuromelanin granu-
les first appear in the human locus coeruleus at birth and in the substantia nigra 
some 18 months later. Beheim-Schwarzbach (1954) described the melanogenesis 
of locus coeruleus cells in comparison to other cytological features. A slower me-
lanogenesis for the caudal part of the locus coeruleus was demonstrated, whereas 
in the involutionary phase free neuromelanin can be found after neuronal loss. 
Depigmentation, however, is typical for both the substantia nigra and locus 
coeruleus at old age, for the dopaminergic neurons of the substantia nigra 
somewhat earlier than for the noradrenergic neurons of the locus coeruleus (Mann 
and Yates 1974b; Graham 1979; Marsden 1983). 
There is a striking resemblance in the distribution pattern of neuromelanin 
containing neurons and the catecholaminergic cell bodies described by Dahlström 
and Fuxe (1964) in the rat, as well as tyrosine hydroxylase immunoreactive 
neurons, as described by Pearson et al. (1983) and catecholaminergic cell bodies 
in the human fetus (Nobin and Björklund 1973). Therefore melanin was used as a 
natural marker for catecholaminergic neurons in previous studies (Bogerts 1981; 
Saper and Petito 1982) and may also indicate dopaminergic neurons of the 
mesencephalon (Van der Wende and Spoerlcin 1963; Cotzias et al. 1964; Marsden 
1969; Das et al. 1978). Besides, the loss of neuromelanin containing, pigmented 
neurons in Parkinson's disease, noted since long (Trétiakoff 1919; Foix and 
Nicolesco 1925; Hassler 1938) appeared to be closely related to the loss of 
dopamine in the striatum (Cotzias et al. 1964; Homykiewicz 1966). 
Although the correlation of neuromelanin pigmented cell bodies with tyrosine 
hydroxylase immunoreactive elements (Gaspar et al. 1983; Pearson et al. 1983) 
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may not be absolute (Barden 1971,1981; Marsden 1983) there is enough evidence 
that at least the demarcation of mesencephalic catecholaminergic nuclei, and 
especially the dopaminergic part of the substantia nigra, can be based on the 
presence of neuromelanin (for reviews sec Bogerts 1981 ; Saper and Petito 1982). 
Neuromelanin containing catecholaminergic neurons, that also may develop Lewy 
bodies in Parkinson's disease, are the substantia nigra, the nucleus paranigralis, the 
nucleus parabrachialis pigmentosis, the nucleus tegmenti pedunculopontinus, the 
locus coeruleus and subcoeruleus and sympathetic ganglia (Marsden 1983; Jellin-
ger 1987a). Othernuclci, described as neuromelanin pigmented, without however 
observed Lewy bodies, are: the nucleus arcuatus and the nucleus periventricularis 
hypothalami, the nucleus intracapsularis, the nucleus ponüs centralis oralis and the 
nucleus retroambigualis (Barden 1981, Marsden 1983), as well as dopaminergic 
neurons in the retina (Cohen 1983) and area postrema (Barden 1981). Foix and 
Nicolesco (1925) already noted the gradual extent of neuromelanin containing 
neurons in the surroundings of substantia nigra and ventral tegmental area; Bazelon 
et al.(1967) described a column of neurons containing pigment (based on a 
modified Lillie silver technique), extending the entire length of the brain stem, until 
it ends in direct continuity with the intermcdiolateral gray of the spinal cord. It 
closely followed the course of the general visceral efferent column of the brain stem 
(Bannister 1971). 
The potential toxicity of neuromelanin and its precursors seems to be closely 
related to the biochemical processes in which it is involved (Graham 1978,1979; 
Marsden 1983). Enzymes associated with neuromelanogenesis are: lysosomal 
hydrolase, tyrosinase, peroxidase, monoaminoperoxidase and enzymes of autoo-
xidative pathways (Barden 1981). Early investigators concentrated on the conver-
sion of tyrosine to dihydroxyphenylalanine (DOPA) and of DOPA to the colored 
dopaquinone, from which polymers are formed, leading to the melanochromes of 
the skin (and equivalents) or synthetic melanin (Kömer and Pawelek 1982). The 
(copper dependent) enzyme tyrosinase is essential in this pathway (Lillie 1969; 
В azelon et al. 1967; Graham 1978,1979). (It is of intern to know that melanotropin 
(MSH) causes an increase in tyrosinase activity, whereas melatonin inhibits this 
reaction (Cotzias et al. 1964; Greiner and Nicolson 1965; Körner and Pawelek 
1982). Rainera et al.( 1988) measured increased levels of oMSH-like immunoreac-
tivity in cerebrospinal fluid of patients with Parkinson's disease). Neural melanin, 
however, probably is generated by auto-oxidation of catecholamines, that is their 
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non-enzymatic oxidation by molecular oxygen (Graham 1978; Barden 1981). 
Although there is little doubt that tyrosine is the precursor amino acid for the 
catecholamines, the intermediate stages and the enzymes responsible for the 
formation of neuromelanin, are different from that of other melanins (Marsden 
1969). Barden (1975,1981) devised a model system to test for the possibility that 
neuromelanin is formed from catecholamine derived precursors. Lipofuscin beca-
me pseudoperoxidatively melanized following its impregnation with a catalyst, 
iron sulfide, and its exposure to a solution of DOPA and hydrogen peroxide. He 
commented however, that the application of metal compounds was not necessarily 
in correspondence with the natural situation. The same author also demonstrated 
neuromelanin and catecholamine in the same neuron (Barden 1975). Again, from 
investigations of dog hypothalamus it appeared that there was an age correlated, 
inverse relationship within neurons in which catecholamine histofluorescence is 
gradually replaced by increasing quantities of accumulation of neuromelanin. In 
brain tissue the enzyme tyrosine hydroxylase (TH) is responsible for L-DOPA 
formation, from which the catecholamines are derived, also explaining the fact that 
albino patients have a normally pigmented substantia nigra without skin melanin. 
Besides skin pigmentation does not alter in patients with Parkinson's disease, 
whereas substantia nigra pigmentation decreases (Barden 1981). Unless its physi-
cochemical difference from tyrosinase (Marsden 1969) both enzymes (TH and 
tyrosinase) depend on the presence of metal ions for their effect (Cotzias et al. 
1964). As a consequence of these biochemical pathways, several mechanisms for 
the typical pathophysiology of age dependent degeneration of pigmented brain-
stem nuclei have been proposed (Cotzias et al. 1964; Mann et al. 1977; Graham 
1979; Cohen 1983; Hirsch et al. 1988). 
Mann and co-workers (Mann et al. 1977; Mann and Yates 1982) suggested 
amechanical disruption of cellular elements by the accumulation of neuromelanin, 
based on the observation of "cell growth" and RNA loss with increasing neurome-
lanin. According to these authors, the nerve cell apparently can accommodate a 
certain amount of melanin but when a "saturation level" is exceeded, at about the 
age of 60 years, atrophy and cellular death result. The most plausible characteriza-
tion of the granules then, is that of a waste product (Graham 1979). The 
observations of Beheim-Schwarzbach (1954) about the evolution of locus coeru-
leus neurons throughout the human life-cycle and the increase of neural volume 
noted by Graham (1979), fit well in this theory. Cell countings of Vijayashankar 
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and Brody (1979) in the locus coeruleus showed a maximal declination at above 
60 years, corresponding with the period of depigmentation (Mann et al. 1974a,b, 
1977). But apart from mechanically induced cellular damage neuromelanin and 
associated waste products could have cytotoxic properties (Graham 1979, Barden 
1981). Cotzias et al. (1964) stressed the binding capacities of melanin granules, 
which accounts for the presence of metals and other toxic substances. 
In line with such a proposal is the high affinity binding of N-Methyl-4-phenylpy-
ridine (MPP+) to neuromelanin, as described by D'Amato et al. (1986,1987a), 
resulting in the well-known nigrostriatal degeneration caused by N-Methyl-4-
phenyl-1,2,3,6-tetrahydropyridine: MPTP (Calne and Längsten 1983). The other 
remarkable, related phenomenon is the apparent relation of "the intensity of 
pigmentation to the degree of evolution of the brain" (Marsden 1969). The unique 
characteristic of the human brain, in this respect, apparently leads to maximal 
accumulation of neuromelanin, in a life span of seven decades, after which it 
decreases (Mann and Yates 1974b; Graham 1979) and could partly explain the 
specific vulnerability of the human brainstem catecholaminergic neurons to age 
related degeneration (Hirsch et al. 1988). As Graham (1979) stated, however, rather 
the by-products of catecholamine oxidation than neuromelanin itself, would be 
toxic. This also would explain why the dopaminergic neurons, with slower 
melanogenesis, would be more vulnerable than the more rapidly pigmented 
noradrenergic neurons of the locus coeruleus (Graham 1979; Mann and Yates 
1974b). 
Dopamine is present in different forms (Cohen 1983); most of the intracel-
lular dopamine is stored within vesicles, but a considerable amount is also present 
in the cell cytoplasm and in the synaptic cleft, where it is catabolized by oxidative 
deamination by monoamineoxidase (MAO) and O-methylation by catechol-O-
methyltransferase (COMT) (Graham 1978, Souikes 1989). Apart from the accu-
mulation of neuromelanin, such pathways lead to formation of hyperreactive free 
radicals (Cohen 1983,1984). A by-product of oxidative deamination is hydrogen 
peroxide, a cellular toxin, often accompanied by generation of superoxide free 
radicals and hydroxyl free radicals, which are also cytotoxic (Cohen 1983,1984). 
Normally, a variety of scavenger systems, among which the catecholamines 
themselves are counted (Cohen 1983, 1984), serve to prevent the excessive 
accumulation of these toxic agents (Perry et al.1982; Marsden 1983). Free radical 
products resulting from dopamine catabolism, occur more rapidly and dopamine 
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o-quinone is more likely to react with cellular elements than other qumones 
(Graham 1979), explaining why dopamine is more cytotoxic than the other amines 
(Graham 1978). Based on these presumptions, therapy with L-DOPA in Parkin-
son's disease, has a dual effect. By increasing intracellular dopamine, L-DOPA 
will protect against superoxide-mediated damage. But increased cellular dopamine 
may also spur hydrogen peroxide formation via MAO-activity (Cohen 1983, 
1984). 
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II. NEURO ANATOMICAL SECTION 
"The royal road of the sensations of the body to the 
soid is through the corpora striata, and all determi-
nations of the will also descend by that road ; 
the Mercury of the Olympus, it announces to the 
soul what is happening to the body, and it bears the 
mandate of the soul to the body." 
E. Swedenborg, Oeconomia Regni Animalis, 1740 
Transi. Prof. Ramström, 1910 
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ILI. INTRODUCTION 
The aim of this chapter is to provide a schematic view on the neuroanatomi-
cal organization of the human mesencephalon and rostral rhombencephalon, with 
emphasis on the monoaminergic nuclei: the substantia nigra (SN), the ventral 
tegmental area (VTA), the nucleus raphe dorsalis (NRd) and the locus coeruleus 
(LC). Monoaminergic brainstem nuclei are characterized, among others, by their 
intermingling and intercormectivity as regards nuclear organization (Moore 1980; 
Steinbusch 1981) and fiber trajectories (Lindvall and Björklund 1974; Feiten and 
Sladek 1983). The acceptance of the monoamines as neurotransmitters in the 
central nervous system was a slow process (for review see Björklund and Lindvall 
1984; Carlsson 1987), the real breakthrough coming with the histochemical 
techniques visualizing the cellular localization of the monoamines by means of the 
fluorescence microscope (Falck et al. 1962; Dahlström and Fuxe 1964). Similar 
techniques provided a means of studying ascending monoaminergic pathways of 
which the nigrostriatal projection (Andén et al. 1964) nowadays might be the most 
studied pathway in the brain (Graybiel and Ragsdale 1983). Other studies on 
mesotelencephalic projection systems soon followed (Andén et al. 1966a,b; 
Ungerstedt 1971a; Lindvall and Björklund 1974) and still form the basis of our 
understanding of central nervous system monoaminergic systems. 
The successful application of immunohistochemistry to neurotransmitter 
specific systems was largely based on the fact that certain enzymes (like tyrosine 
hydroxylase and dopamine-ß-hydroxylase), present in the catecholaminergic neu-
rons, are also found in the glandular cells of the adrenal medulla (Pickel et al. 1975; 
Hökfelt et al. 1975,1976). Because adrenaline and noradrenaline are synthesized 
from dopamine, various catecholaminergic neurons might share certain enzymatic 
features and the differentiation of noradrenergic elements from dopaminergic cells 
and processes is still a controversial subject. This problem was partly solved by 
proper lesion experiments, combined with formaldehyde fluorescence studies or 
identification of transmitter specific elements by their morphologic features 
directly studied in the microscope (see Lindvall and Björklund 1974; Berger 1977; 
Levitt et al. 1984; Lewis et al. 1987). 
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The functions of the central monoaminergic neurons and their role in 
neurologic and psychiatric disorders are less well understood than the morphology 
and synaptology of these systems. The remarkable exception of the nigrostriatal-
cortical dopaminergic system, involved in extrapyramidal function and disorders, 
especially Parkinson's disease, might serve as a model system in studying 
monoaminergic brainstem nuclei in aging and aging diseases. The concept of the 
mesotelencephalic projection system is based on its extensively studied counter-
part in the rat brain (Björklund and Lindvall 1984). Another, more recently 
developing, aspect is the compound organization as regards various neurochemical 
substances throughout the brainstem monoaminergic nuclei (for review Nieuwen-
huys 1985). As a highly convergent output system (Szabo 1980a; Nauta 1986) of 
motor function, closely related to structures that have widespread projections to the 
cortex and might be involved in general levels of consciousness (Moore 1980), the 
anatomy of human brainstem monoaminergic nuclei deserves a thoroughly exami-
nation, for the interpretation of quantitative changes in the aged or those with 
neurodegenerative disease. 
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IL2. THE MAMMALIAN SUBSTANTIA NIGRA AND 
VENTRAL TEGMENTAL AREA 
П.2.1. General organizational principles 
Mesencephalic catecholaminergic nuclei form a rather uniformly composed 
cell continuüm in different mammalian species, with clusters sometimes only 
separated by fiber tracts (Schwyn and Fox 1974; Moore and Bloom 1978) in this 
overall 'reticular' brain region (Divac et al. 1978; Moore 1980; Köhler and 
Goldstein 1984; Fallon and Loughlin 1985). Whereas the pattern of distribution of 
dopaminergic (DAergic) nerve-cell bodies in the rat is rather clearly organized, in 
cats DAergic cells arc more uniformly distributed throughout the SN (Wiklund et 
al. 1981; Poirier et al. 1983; Parent 1986). In monkeys the pattern is even more 
complex and compartmentalized, such that, e.g., it is hard to distinguish DAergic 
from nonDAergic projection neurons, especially in ventral nigral parts (Garver and 
Sladek 1975; Nauta and Cole 1978; Feiten and Sladek 1983; Satoh and Fibiger 
1985; Arsenault et al. 1988). There is general agreement, however, in following 
Dahlström andFuxe's (1964) subdivision in A9,A8 and AIO for the SN proper, the 
retrorubral area and the ventral tegmental area dorsomedially adjacent to the SN, 
respectively, defined in rats. 
Different cytologic criteria lead to considerable disagreement in defining 
cytoarchitcctural boundaries (see also Table II. 1.). Apparently the spread of 
dopaminergic neurons into many adjacent nuclei (Dahlström and Fuxe 1964; 
Swanson 1982; Köhler and Goldstein 1984; Fallon and Loughlin 1985) particular-
ly interfered with the demarcation of so-called "out-lying neurons" (Nauta et al. 
1978) of the SN, predominantly found rostromedial, medial and caudal to the SN 
proper (Dahlström and Fuxe 1964; Feiten and Sladek 1983; Parent 1986; Halliday 
and Törk 1986). Therefore this area dorsomedially from the SN, corresponding 
with Tsai's (1925) original description of the nucleus tegmentalis ventralis in the 
opossum, usually is referred to as ventral tegmental area (VTA). The nucleus 
linearis rostralis, linearis caudalis (or centralis) and nucleus interfascicularis 
mostly are included (Phillipson 1979a; Halliday and Törk 1986), although projec-
tions of midline structures are sometimes dealt with separately (Swanson 1982; 
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Fallon and Loughlin 1985). Thus the VTA, as originally defined, may be 
subdivided into a midline, a medial and a lateral part (Simon et al. 1976; Fallon and 
Moore 1978b), the latter two corresponding to nucleus paranigralis and nucleus 
parabrachialis pigmentosus, respectively. The nucleus parabrachialis pigmentosis 
originally was identified in the human brain by its neuromelanin content (Olszews-
ki and Baxter 1954) and described in the cat by Taber (1961). Other, cytological 
as well as hodological data contribute to its identification in the rodent brain as well 
(Halliday and Törk 1986). The nucleus parabrachialis pigmentosus blends into the 
pars compacta of the substantia nigra and actually often is referred to as "dorsal pars 
compacta" (Moore and Bloom 1978; Fallon et al. 1978a,c; Hökfelt et al. 1980; 
Loughlin and Fallon 1984; Gerfenetal. 1987a). Szabo( 1980a) identified the dorsal 
pars compacta with the retrorubral area A8. The nucleus paranigralis in the rat 
brain, together with the most medial part of the SN, is separated by its lateral 
counterpart by the accessory optic tract and its nucleus, more clearly developed in 
therodentbrain(Winklerl929; Crosby and Woodbume 1943; Paxinos and Watson 
1986). 
Caudally from the nucleus ruber, dorsolaterally continuous with the SN, the area 
A8 is defined as a retrorubral extent of catecholaminergic neurons, continuous also 
with the VTA (Dahlström and Fuxe 1964; Köhler and Goldstein 1984; Fallon and 
Loughlin 1985; Deutch et al. 1988). The different component nuclei of A8,A9 and 
AlOhave now also beenidentified in primates and m an (Francois et al. 1985; Parent 
1986; Arsenault et al. 1988), although there is substantial variation in their 
volumes and cell densities (Halliday and Törk 1986). 
In rats the neurons of the pars compacta form a rather thin horizontal layer 
that is clearly distinguishable from the more diffusely organized reticular part 
(Poirier et al. 1983; Fallon and Loughlin 1985). In cats, Jimenez-Castcllanos and 
Graybiel (1987) identified two zones within the pars compacta: a caudal densocel-
lular zone with closely packed tyrosine hydroxylase (TH)-positive neurons and 
neuropil and a more rostrally located nigral zone in which TH-positive neurons are 
loosely arranged. Although horizontal layers and mediolateral subdivisions of the 
pars compacta are readily demonstrable with acetylcholinesterase histochemical 
staining (Jiménez-Castellanos and Graybiel 1987,1989) there is no clear overlap 
with the distribution pattern of tyrosine hydroxylasc-immunoreactive neurons. 
From the pictures, based on a highly specific polyclonal antibody raised 
against dopamine-glutaraldehyde-lysyl protein conjugate, presented by Arsenault 
37 
et al. ( 1988), it may be concluded that the topographic distribution of SN DAergic 
neurons does not principally differ from that in various monkey species (see Feiten 
and Sladek 1983; Francois et al. 1985; Satoh and Fibiger 1985) and from that in TH 
immunohistochemistry or the distribution pattern of neuromelanin in humans 
(Gaspar et al. 1983; Pearson et al. 1983). Areas of the SN similar in size and 
configuration have also been visualized in a horseradish peroxidase study of 
striatonigral connections (Smith and Parent 1986). These large oval sectors, 
delimitated by the DAergic cell-trabeculae in monkeys are more pronounced than 
in the human brain. At rostral levels the medial SN pars compacta is particularly 
well developed and the ventral displacement of the caudolateral pars compacta also 
is remarkably constant. 
The VTA is much less well developed in primates and its boundaries are less 
well defined than in rodents (Francois et al. 1985; Arsenault et al. 1988), but these 
authors apparently do not include the few DAergic neurons at more dorsal levels, 
adjacent to the periaqueductal gray, which would greatly expand the VTA 
(Halliday and Törk 1986). Besides, TH immunoreacüvity seems more widely 
distributed than the neuromelanin pigmented neurons in dorsal and lateral VTA 
groups in humans (Gaspar et al. 1983). The retrorubral area in the squirrel monkey 
does not extend as far caudally as in other primates (Tanaka et al. 1982; Arsenault 
et al. 1988), but it can be distinguished from the dorsal SN on cytologic grounds 
(Arsenault et al. 1988). 
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Table Π.Ι: Cytologic characteristics used in cytoarchitecture of SN 
Explanation of symbols: ++ used as criterion for classification by these authon 
+ some remarks without classification 
с comparable to the classification proposed here 
Aulhon 
Olszewski and 
Baxter 1954 
(human) 
Rinvik and 
Grofova 1970 
(cat) 
Gulley and Wood 
1971 
(rat) 
Schwyn and 
Fox 1974 
(monkey) 
Marchandetal. 
1979 
(monkey) 
Beckstead et al. 
1982 
(cat) 
Poirier et al. 
1983 
(monkey) 
Feiten and 
Sladek 1983 
(monkey) 
Francois et al. 
1979,1984,1985 
(monkey) 
Halliday and Törk 
1986 
(human) 
Braak and Braak 
1986 
(human) 
Parent 1986 
(human) 
Yelnik and Francois 
1987 
(monkey) 
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+ 
+ 
с 
E.M. 
lyniplk 
•pcclflcation 
++ 
++ 
++ 
++ 
+ 
dcnlrltk 
morphologie 
С 
++ 
с 
с 
+ 
+ 
с 
+ 
+ 
++ 
+ 
с 
neuro­
ni danln 
content 
с 
+ 
+ 
с 
++ 
с 
Nbal 
•ututance 
+ 
+ 
++ 
+ 
++ 
с 
++ 
+ 
с 
deUlls of 
nuckiu 
++ 
+ 
+ 
+ + 
++ 
cell 
shape 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
++ 
+ 
с 
с 
+ 
++ 
cell 
size 
+ 
+ 
++ 
+ 
++ 
++ 
++ 
++ 
++ 
+ 
+ 
+ 
++ 
39 
11.2.2. Cytology 
The pars reticulata of the SNris generally considered as the receptive field, 
wilh a neuropil rich in fine unmyelinated fibers, whereas DAergic pars compacta 
neurons are the principal source of nigrostriatal projections (Poirier et al. 1983; 
Parent 1986). Golgi studies (Rinvik and Grofova 1970; Schwyn and Fox 1974; 
Juruska et al. 1977; Danner and Pfister 1982; Yelnik et al. 1987; Francois et al. 
1987) show that nigral neurons give rise to long radiating dendrites with few 
branches. Small neurons, of whichmost are found in the pars reticulata (Gullcy and 
Wood 1971), most likely are intemeurons (Francois et al. 1979). Largerneurons 
generally have abundant cytoplasmalic organelles (Rinvik and Grofova 1970), but 
variations in Nissl staining pattern, size and shape are considerable. At present 
there is still no general consensus regarding classification of neurons of the 
mammalian SN (Parent 1986). In a comparative study of the substantia nigrain rats, 
cats and rhesus monkeys. Poirier et al.( 1983) identified four types of nigral neurons 
with distinct cytological features: 1) compacla-type neurons, the most abundant 
type, characterized by large cell bodies containing unevenly distributed and 
intensely stained Nissl substance; 2) rcticulala-type neurons with discrete Nissl 
bodies are triangular or round; 3) intermediary-type fusiform or triangular neurons, 
containing less intensely stained but more diffusely distributed Nissl substance, 
and 4) globular-type neurons, characterized by a high nuclear/cytoplasmic ratio, 
that are much smaller than the other three types. According to Domesick et 
al.(1983) DAergic cells are distinguishable from non-DAergic cells in non-
primates by their dark appearance in Nissl preparations. In primates this DAergic 
character might be derived by the appearance of ncuromelanin (See Ch. I.4.). 
In Golgi preparations (see above), the dendritic fields of the pars compacta 
neurons arc oriented primarily in a dorsoventral direction, while those of the pars 
reticulata have a rostrocaudal orientation. The most ventral region of the pars 
reticulata contains inverted pyramid-shaped DAergic neurons with dendritic disc-
like formations oriented mostly parallel to the crus cerebri (Grofova et al. 
1982(cal); Fallon and Loughlin 1985(rat)). Together with the mediolateral orien-
tation of the most dorsal compacta and the VTA neurons, these morphological 
features are suggestive of a laminar organization, based on fiber orientation (Fallon 
et al. 1978a; Grofová et al. 1982). A similarlaminarpattem on hodological grounds, 
was suggested for rats (Gerfen et al. 1987a). 
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Close dendrodendritic appositions might be associated with non-synaptic 
dendritic release of DA (Chéramy et al. 1981; Wassef et al. 1981). Golgi electron 
microscopy also revealed direct synaptic contacts of striatonigral axons, suggestive 
of a feedback information system to the pars compacta neurons (Somogyi and 
Smith 1979; see also Percheron et al. 1989). Dendrites ensheathed in a meshwork 
of thin, beaded fibers of striatal origin, are termed "woolly fibers", as was described 
for ventral pallidal dendrites (Haber and Nauta 1983). The cell types, connections 
and neurotransmitter relationships within the SNr have led to the conclusion that 
it is a pallidal structure (Nauta 1979; Switzer et al. 1982; Poirier et al. 1983; Beach 
and McGeer 1984; Parent 1986). The tendency of dendritic processes to form long 
and thick bundles appears to be another characteristic of the mammalian SN 
(Gulley and Wood 1971; Arsenault et al. 1988). 
Axons of the medial pars compacta neurons are directed dorsomedially 
towards the hypothalamic area of the medial forebrain bundle, whereas those 
located laterally were preferentially directed towards ansa lenticularis on their way 
to the striatum (Preston et al. 1981; Feiten and Sladck 1983; Giguère et al. 1984; 
Fallon and Loughlin 1985). A substantial part of nigral efferente in primates is 
composed of myelinated fibers (Arsenault et al. 1988), whereas fine unmyelinated 
axons characterize DAergic and serotonergic ascending projections within the 
median forebrain bundle of rats. Non-DAergic, presumably GABAergic, projec-
tions stem from pars reticulata neurons and from the pars lateralis. Neurons of the 
"reticulata" and "lateral" types are mainly located in the ventromedial and 
rostrolateral parts, respectively (Giguère et al. 1984). The pars lateralis of the SN, 
on cytoarchitectonic, immonohistochemical and hodological grounds might be a 
distinct subdivision, with some "reticulata" features (Chesselet and Graybiel 1983; 
Francois et al. 1985; May and Hall 1986), extending in the peripeduncular nucleus. 
A morphologic distinct subset of nigrotectal projection neurons, apart from the 
general reticulata nigrotectal and nigrothalamic projection neurons, might define 
this area as a distinct nigral subdivision (May and Hall 1986). 
In cats and monkeys, the intermingling of pars compacta neurons with those 
of the pars reticulata mimics a clear laminar pattern (Poirier et al.l983; Giguère et 
al. 1984; Francois et al. 1985; Arsenault et al. 1988). Projection neurons might also 
be distinguished by their pattern of collateralization, i.e. sparsely for VTA neurons 
and adjacent dorsal pars compacta neurons, whereas medial pars compacta neurons 
and pars reticulata cells might have widely branched axons (Parent 1986; Fallon 
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1988). Apart from differences in collateralization also electrophysiological eviden-
ce of subpopulations within the nigral projection system exists (Deniau et al. 1979; 
Shepard and German 1988). Nigrostriatal dopaminergic neurons display a high 
degree of plasticity and the capacity for regeneration (Dunnettetal.1983; Schultz-
berg et al. 1984; Won et al. 1989). Such discoveries have opened a new and 
promising field of investigation that could eventually lead to the development of 
new treatment strategies for severe motor disorders, resulting from the specific loss 
of striatal dopaminergic innervation. 
A Golgi study of the VTA in rats (Phillipson 1979b) revealed that each 
cytoarchitectural subdivision of the VTA is characterized by differences in cell type 
and dendritic organization, (see also Köhler and Goldstein 19 84; Halliday and Törk 
1986). In general, VTA neurons tend to fall into one of two cell types (with 
intermediate forms): type 1 neurons, small to medium sized, with two or four 
primary dendrites, dividing into varicose spiny secondary dendrites, and type 2 
more common laterally and having many local circuit connections. A major 
difference with neurons in SN compacta (see Juraska et al. 1977) appears to be that, 
whereas SN compacta dendrites are organized in vertical as well as horizontal 
planes, in the VTA no long ventrally directed dendrites were observed. Besides, 
according to Domesick et al. (1983) dark-staining dopaminergic cells and light-
staining non-dopaminergic cells were intermingled in the VTA, rather than 
grouped in separate strata as they are in the SN. 
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11.2.3. Fiber connections of the rat substantia nigra and ventral teg-
mental area 
Topographical principles of the mesotelencephalic projections are formula-
ted by most authors who studied SN and VTA hodology in the rat (Ungerstedt 
197 la; Carter and Fibiger 1977; Moore and Bloom 1978;FallonandMoore 1978b; 
Becksteadetal. 1979; Swanson 1982), but controversion exists as to the correspon-
dence with nigral and ventral tegmental subnuclei (for review Fallon 1988). 
Fig.II.l. gives a general impression, summarizing the available data in the rat brain. 
Fig II. 1 
General topographic principles of mesencephalic dopaminergic 
projections to forebrain structures in rats 
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Generally, VTA projection neurons overlap with the most medial and dorsal 
SN compacta (SNc) neurons, providing a continous "mesolimbic projection" 
(Björklund and Lindvall 1984; Fallon and Loughlin 1985). Mcsocortical projec-
tions originate from different subnuclei, and are closely associated with the 
mesolimbic system (Björklund anfi Lmdvall 1984). Thus, the mesotelencephalic 
fiber system generally is subdivided in a mesostriatal (Andén et al. 1964,1966) 
and mesolimbocortical (Ungerstedt 1971a; Thierry et al. 1973) projection. The 
"limbic" ventral striatum (Heimcrand Wilson 1975) exhibits a greater intensity of 
CA fluorescence in rats than the caudatoputamen (Graybiel and Ragsdale 1983). 
Projections from A8 are included and continuous with the other mesotelencephalic 
projections (Deutch et al. 1988), whereas the SN pars reticulata (SNr) has its own 
characteristic efferent organization to thalamus, tectum and tegmentum. 
The medial forcbrain bundle (mfb) is the main trajectory connecting 
brainstem (monoaminergic) reticular formation structures with diencephalic and 
telencephalic regions (Andén et al. 1966; Nieuwenhuys et al. 1982; Björklund and 
Lindvall 1984; Oades and Halliday 1987). The nigrostriatal pathway is located dor-
solaterally from and in close association with the mfb. Diverging DA and NA 
pathways mostly follow classical routes to their targets, like fasciculus retroflexus, 
ansa peduncularis, fornix, stria tcrminalis and capsula externa (Nieuwenhuys et al. 
1988). Within the major systems topographical principles imply an inversed dorsal 
to ventral relationship of projection neurons with their striatal and limbic targets; 
a general medial-to-lateral topography (Björklund and Lindvall 1984) and an 
anterior to posterior topography (see also Fallon and Moore 1978b; Beckstcad et 
al. 1979; Gcrfen et al. 1987a). Afférents connecting the limbic forebrain and 
midbrain follow two primary routes, a dorsal one in which the lateral habenula is 
an important relay (Nauta 1958; Sutherland 1982) and the vcntrally located mfb. 
Thus, DAcrgic cells of the ventral tegmentum may receive converging limbic and 
striatal input. 
Striatomesencephalic projections 
The main part of the nigral afferent projections is the striatonigral projection, well 
established in rats, passing mainly through the comb bundle (or pencils of Wilson) 
towards the pars reticulata (Gerfen 1985; Fallon and Loughlin 1985). Within this 
projection (see also Ch. II.2.5) an inhibitory part, originating from GABAergic 
neurons, mainly from the lateral caudate-putamen (Araki et al. 1985), may be 
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Fig II 2 
The stnatomesencephalic projections and their 
topography in rats 
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distinguished from an excitatory part containing substance P. The latter arises 
mainly from cells rostrally in the caudate-putamen and cell bodies surrounding the 
globus pallidus. The topographic organization of these projections (Fig.II.2.) is 
presumably a consequence of the differential association with neocortìcal and me-
socorücal/allocortical afférents. E.g., a caudatoputamen patch ("striosomal") and 
matrix compartment receive a prelimbic cortical and neocortìcal input, respective-
ly (Gerfen et al. 1987b). More diffuse projections of some associational cortical 
areas (Heimeretal. 1982;DeLongetal. 1983a; Gerfen 1985; McGeorge andFaull 
1989) might be reflected in an additional non-topographic strionigral projection 
(Gerfen 1985). The "striosomes", from which the latter originates, arc neuroche-
mically defined compartments, comprising an essential feature in the striatum 
(Graybiel and Ragsdale 1983; Graybiel 1986). In rats these patches are characte-
rized by their richness in substance P, enkephalin-like immunoreactivity and opiate 
receptors, whereas the striatal matrix distinguishes itself by AChE-positive stai-
ning and also contains many somatostatin fibers (Gerfen 1985). Somatostatin-im-
munoreactive neurons may provide an intrinsic system linking the patch and matrix 
compartments (Gerfen 1985). 
Dorsal matrix regions of the striatum, receiving visual cortical input, project 
to the ventral "nigrotectal" region of the SNr (McGeorge and Faull 1989); the 
lateral and central regions, related to motor cortices, project in tum to that region 
of the SN that gives rise to the nigrothalamic projection (Faull and Mehler 1978). 
Target sites are non-dopaminergic neurons and also Dl-type (i.e. adenylate 
cyclase-linked) receptors of pars compacta dendrites (Altar and Hauser 1987). 
Rostrally and caudally located patches to the SN DA neurons (dotted area in 
Fig.II.2.) appear to converge on a single nigral locus (Gerfen 1985). 
The striatonigral projection from the dorsal striatum has a counterpart in the 
ventral striatal complex and its distinct projections to the SN dorsal pars reticulata 
and medial pars compacta, VTA and A8 (Nauta et al. 1978; Haber et al. 1985; 
Domesick 1988). Terminals on dopaminergic nigrostriatal projection neurons have 
also been described (Somogyi et al. 1981a). They provide a major link between 
dorsal (motor) and ventral (limbic) striatum (Swanson and Cowan 1979; Nauta et 
al. І978; Alexanderand DeLongl985;Gerfenl985;Parent 1986). The uninterrup­
ted continuum of subcortical grey matter that stretches in a paramedian zone 
caudalward from the septum, over the preoptic region and hypothalamus, with 
reciprocal ascending and descending projections within the mfb, has been named 
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"limbic forebrain-midbrain circuit" (Domesick 1988). The VTA belongs to the 
limbic midbrain area as defined by Nauta (1958), together with the ventral half of 
the central grey substance, dorsal and median raphe nuclei and dorsal tegmental 
nucleus of Gudden (see also Nauta and Haymaker 1969; Simon 1981). 
Non-striatal afférents to the substantia nigra and ventral tegmental area 
Apart from the massive striatonigral projections to both the SN and VTA, these 
structures receive a variety of non-striatal afférents, summarized in Fig. Π.3. and 
11.4. (based mainly on data by PhiUipson 1979c; Swanson 1982; Gerfenetal. 1982; 
Fallon and Loughlin 1985). Cortical projections, from neocortical, mesocortical 
and allocortical structures, innervate the VTA. Cortical projections to the SNr, are 
restricted to projections from prefrontal (area 32 of Brodmann) and motor cortices. 
Non - striatal afférents of the substantia nigra in rats 
Dorsal pallidomgral, most likely G AB Aergic, fibers terminate in the pars reticulata 
and pars compacta of the SN. Ventral pallidomgral fibers, i.e. those of the 
substantia innominata and so-called "ventral pallidum" (Heimerand Wilson 1975; 
Alheid and Heimer 1988; Grove 1988b) together with projections from other basal 
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Non-striatal afférents of the ventral tegmental area in rats 
forebrain structures, such as the lateral septum, Broca's diagonal band nuclei and 
bed nucleus of the stria tcrminalis, appear to end mainly in the rostrovcntral part 
of the VTA (Swanson and Cowan 1979; Grove 1988b). Dorsal substantia innomi-
nata efferents have more widely distributed projections throughout the SNc and 
VTA, whereas more ventrally located cells mainly project on VTA and dorsal layer 
of the substantia nigra pars compacta (Grove 1988b). The central nucleus of the 
amygdala projects to the pars lateralis and the nucleus peripeduncularis; more 
sparsely to the VTA (Maeda and Mogenson 1981). 
Diencephalic projections to the SN and VTA arise from the lateral habenula 
(Herkenham and Nauta 1979), subthalamic nucleus, anterior hypothalamus and 
medial and lateral preoptic areas (see also Simon et al. 1979). Afférents originating 
in several hypothalamic nuclei, follow a trajectory immediately dorsal to the SN 
(Nauta 1969; Nauta and Domesick 1978). Brain stem projections are found from 
the deep layers of the colliculus superior to the SN and serotonergic fibers from the 
nucleus raphe dorsalis (Dray et al. 1978); noradrenergic fibers from the locus 
coeruleus and cholinergic fibers from the nucleus tegmertli pedunculopontinus 
(Ch. II.3). Projections from parabrachial nuclei were demonstrated by Saper and 
Locwy (1980) and Spann and Grofova (1989). To a lesser extent, the nuclei raphe 
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magnus, raphe médius and raphe pontis connections with the VTA further 
characterize the hardly accessible interconnections of the monoaminergic systems 
(Pasquier et al. 1977; Phillipson 1979c; Feiten and Sladek 1983; Björklund and 
Lindvall 1984). 
Mesostriatal projections 
Current knowledge on the organization of the mesostriatal projection system in 
rats is summarized in Fig. II.5. (based on data by Fallon and Moore 1978b; 
Beckstead et al. 1979; Veening et al. 1980; Swanson 1982; Fallon and Loughlin 
1985; Gerfenet al. 1987a). Mesostriatal projections arising from neurons in the SN, 
VTA and retrorubral area, of which 95 % is dopaminergic, arc compartmentally 
organized in the striatum (Gcrfen et al. 1987b)·. 1) the ventral part of the pars 
compacta projects to striosomes or patches. In this projection an oblique medial-
to-lateral topography (Veening et al. 1980) is found: medial projection neurons are 
located more rostrally, lateral projection neurons more caudally in the SN; 2) the 
dorsal tier of DAcrgic neurons in the pars compacta, continuous with DAergic 
neurons in the VTA project to more ventral parts of the dorsal striatal matrix and 
to the ventral striatum; 3) neurons of the pars reticulata project to the striatal matrix 
in a medial-to-lateral and an anterior-to-posterior topography. Many SNc neurons 
project throughout the whole rostrocaudal extent (Moore and Bloom 1978; Beck-
stead et al. 1979); 4) DAergic neurons from the retrorubral area ( A8) project mainly 
to the dorsolateral part of the caudate-putamen. Thus, distinct dorsal and ventral 
sets of midbrain DAergic neurons project, respectively, to striatal matrix and 
patches and there is a nonDAergic mesostriatal projection to the matrix (Gerfcn et 
al. 1987a). These patch-matrix mesostriatal DAcrgic systems are biochemically 
and developmentally distinct (Gerfen et al. 1987b). A calcium-binding protein 
(CaBP) is expressed in dorsal tier mesostriatal DAergic neurons, matching 
DAergic neurons directed to the striatal matrix. Dopaminergic neurons that do not 
express CaBP (in the ventral tier of the pars compacta as well as in the pars 
reticulata) are distributed in a pattern that matches the origin of the DAcrgic 
projections to the striatal patches. Nigrostriatal projections partly supply local 
collaterals to SNr, SNc and retrorubral area, whereas meso-accumbens projections 
likewise have a tendency to collateralize to other forebrain structures (Albanese and 
Minciacchi 1983 ; Fallon 1988). The highest DA content is found in the septal pole 
of the nucleus accumbens (Voorn et al. 1986; Groenewcgen et al.l989) whereas 
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adjacent olfactory nuclei and islands of Calleja receive a dense plexus of DAergic 
tenninals (Fallon et al. 1978,1983)(Fig. II.7.). 
Fig II 5 
Nigrostriatal projections and their topographical 
organization in rats 
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Mesolimbocortical projections 
The nonDAergic component in the mesolimbocortical system is substantially 
larger, up to 72 % of the VTA projections to the lateral septum (Swanson 1982). 
The ascending projections from AIO cells are organized in a topographic fashion 
(Fig.n.6.), such that the neurons in the midline nuclei, nucleus linearis rostralis, 
nucleus linearis centralis/caudalis and nucleus interfascicularis preferentially 
project to the prefrontal cortex, lateral septum, lateral habenula and diagonal band 
of Broca, while neurons in the nuclei paranigralis and parabrachialis pigmentosis 
(and adjacent dorsomedial substantia nigra) project more heavily to the piriform 
cortex, entorhinal cortex, nucleus accumbens, olfactory tubercle and nuclei, and 
amygdala (Carter and Fibiger 1977; Moore and Bloom 1978; Fallon and Moore 
1978b; Beckstead et al. 1979; Swanson 1982; Oades and Halliday 1987; Fallon 
1988). More specific limbic projections are directed to the lateral septal nucleus 
(Deniau et al. 1980; Vertes 1988) and central and basolateral amygdaloid nuclei. 
Continuous with the DAergic projections to the amygdala arc those to allocortical 
structures, including anterior entorhinal and piriform cortex, the formerin a typical 
clustered pattern. Controversial hippocampal projections might stem from rostral 
(Segal and Landis 1974; Swanson 1982) and caudal (Simonetal. 1979) extensions 
of the VTA. Vemey et al. (1985) described DAergic terminals ventrally in the deep 
layers of the subiculum. 
More recently, adjuvant details on basal forebrain afférents of В roca's 
diagonal band/septal area (Vertes 1988) and substantia innominata, including bed 
nucleus of the stria terminalis (Grove 1988a) have been established. DAergic 
afférents of the nucleus basalis of Meynert have their origin mainly in the most 
lateral part of the SN (Martinez-Murillo et al. 1988). 
A, partly DAergic, mesohabenular pathway (Phillipson and Griffith 1980; 
Simon 1981 ; Albanese and Minciacchi 1983) has been suggested to be an important 
link between limbic and extrapyramidal circuitry (Hericenham and Nauta 1977; Su-
therland 1982). Minor projections to hypothalamic nuclei might be provided by 
branching fibers along the medial forebrain bundle (Kizcr et al. 1976; Nauta and 
Domesick 1978; Simon et al. 1979; Lindvall and Björklund 1983). The main 
targets are the nuclei supraopticus and suprachiasmaticus, innervated by nonDAer-
gic projections from the caudal VTA. DA in the nucleus subthalamicus probably 
stems from ascending collaterals of SNc axons that also branch to GP, on their way 
to the striatum (Fallon et al. 1978 ;Lindvall and Bjöiklund 1983; Fuxe 1985). 
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Fig. П.6 
Topographical organization of ventral tegmental 
area efferents in rats 
Mesolimbocortical projections 
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NeocoTtical projections from the mesencephalic DAergic cell continuum, first 
suggested by biochemical studies of Thierry et al. (1973), are now well established 
(for reviews see Björklund and Lindvall 1984; Oades and Halliday 1987). The 
DAergic innervation of the frontal neocortex comprises three different projection 
systems: 
1) anteromedial.i.e. to medial prefrontal cortex (including Brodmann's area 32 in 
primates), and the basal layers of the supragenual part, predominantly arising in the 
medial part of AIO (Emson and Koob 1978; Lindvall et al. 1978; Beckstead et al. 
1979). These projections have their origin in the VTA and the most medial SNc of 
which 3(M0 % is DAergic (Swanson 1982). 
2) suprarhinal; DAergic projections from the dorsolateral part of Al 0 to the deep 
cortical layers, dorsal to the rhinal sulcus. 
3) the supragenual system, giving rise to a dense innervation of the superficial 
layers of the anterior cingulate cortex, arises primarely from the SN (Carter and 
Fibiger 1977; Lindvall et al. 1978; Emson and Koob 1978; Van Eden et al. 1987). 
The projection fields of DAergic afférents to the frontal neocortex coincide very 
closely with the areas of termination of the mediodorsal thalamic nuclear projec-
tions (Divac et al. 1978; Schmidt et al. 1982; Berger et al. 1985; Van Eden et al. 
1987), usually defined as prefrontal cortex in various mammalian species (Divac 
et al. 1978). The cingulate part of the prefrontal cortex (comparable to Brodmann's 
area 24) is subdivided in a supragenual part (area 24a ventrally and area 24b 
dorsally) and a pregenual part (above area 32; Berger et al. 1985). At the level of 
the hippocampal commissure it adjoins the rctrosplenial cortex (comparable to area 
29). Projections to these areas have their origin in more laterally located cells in the 
SN/VTA at progressively more caudal levels (Sobel and Corbett 1984). The 
highest densities of cortical DAergic terminals are foundin prelimbic and agranular 
insular areas (Van Eden et al. 1987), the lowest in the medial precentrai area. 
Additional projections, suggestive of a columnarorganization, were demon-
strated to sensorimotor area 29b,c,d and to the anterior part of area 18b i.e. 
secondary visual cortex (Berger et al. 1985). Terminals with a typical varicose 
aspect in this regions are located in superficial layers I-III and show a postnatal 
ingrowth later than those to some prefrontal areas (Vemey et al. 1982; Kalsbcek. et 
al. 1988). Although Loughlin and Fallon (1985) suggested that the rctrosplenial 
terminals originate from collaterals of those projecting to area 24, Berger et al. 
(1985) stress the different location of mesencephalic neurons projecting to prefron-
tal and other cortical areas. 
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Nigrothalamic, nigrotectal and nigrotegmental projections 
The SNr gives rise to major nonDAergic projections to the thalamus, superior 
colliculus and mesencephalic tegmentum (Fig.II.7.)· The nigrotectal, nigrothala­
mic and nigrostriatal cells in rats are segregated into complementary longitudinal 
regions of the SN and each of these populations of nigrofugal neurons have somata 
exhibiting a different size distribution (Faull and Mehler 1978). Nigrotectal and 
nigrothalamic projection neurons are generally slightly larger than DA neurons 
projecting to the striatum. The nigrothalamic projections arise from large (20-25 
цт) multipolar cells in the rostrolateral and central parts of the SNr (Faull and 
Mehler 1978). Such nigrothalamic neurons first distribute local collaterals to both 
the pars reticulata and the pars compacta as well as to the midbrain reticular 
formation (Grofová et al. 1982; Parent 1986). Their GAB Aergic axons run dorsally 
and rostrally to reach the thalamus and topographically innervate the ventromedial 
nucleus. Other projections from the SNr and the VTA to the thalamus include the 
mediodorsal nucleus and intralaminar nuclei 
Fig. II 7 
Non-striatal efferents of the rat substantia nigra 
The nigrotectal projection arises from medium-sized cells in the ventrome-
dial (rostrally) and ventrolateral (caudally) part of the SNr (Faull and Mehler 1978) 
to innervate deep layers of the superior colliculus on both sides of the brain (Wright 
and Arbuthnott 1980; Gerfen et al. 1982). Williams and Faull (1985) showed a 
more extensive distribution of nigrotectal neurons including more dorsal regions 
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of the rostral pars reticulata, known to contain large numbers of nigrothalamic 
neurons (see also Bentivoglio et al. 1979). The nigrotectal axons are thin and 
unmyelinated and fonn symmetric synapses in the superior colliculus with GAB A 
as the inhibitory neurotransmitter (Chevalier et al. 1981; Arakietal. 1984). Of the 
numerous GABAergic neurons in the SNr at least some have axons which 
collateralize to innervate both thalamus and superior colliculus (Bentivoglio et al. 
1979; Parent 1986). 
Nigrotegmental projections arise throughout the SNr and the VTA and 
innervate the nucleus tegmenü pedunculoponünus, central grey, parabrachial 
nuclei, raphe nuclei, locus coemleus and adjacent area of nucleus tegmentalis 
dorsalis (Simon et al. 1979; Wright and Arbuthnott 1980; Swanson 1982; Gerfen 
et al. 1982; Fuxe 1985). Locus coemleus afférents might originate in the VTA and 
are difficult to separate from adjacent projections (Ch. II.3). The projection to the 
mesencephalic locomotor region (Saper and Loewy 1982; Rye et al. 1987) 
overlapping the nucleus tegmenü pedunculoponünus (Moon Edley and Graybiel 
1983; Scamati et al. 1989) is one possible route for the extrapyramidal motor 
system to influence reticulospinal neurons, innervating the spinal cord (for review 
Rye et al. 1987). 
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11.2.4. Fiber connections of the primate substantia nigra and ventral 
tegmental area 
The more complex cellular distribution in the SN of higher mammals first 
of all reflects a clear separation of the striatum in nucleus caudatus and putamen, 
whereas these nuclei are not separated in rodents. Furthermore, patch and matrix 
components of the neostriatum might be reflected in nigro-striato-nigral connec-
tions differently in various species, like they are in ontogenesis (Jimenez-Caslel-
lanos and Graybiel 1987,1989). This mosaic architecture of the striatum has been 
most thoroughly studied in the cat, where initially retrogradely labeled strionigral 
projection neurons appeared as geometrically complex fields interrupted by 
distinct zones of sparse labeling (Graybiel et al. 1979; Desban et al. 1989). The 
zones of poor labeling appear to correspond to the striosomes, striatal areas where 
AChE staining is characteristically weak in contrast to the AChE positive staining 
of the striatal matrix (Graybiel and Ragsdale 1979,1983). Such striatal zones, poor 
or rich in AChE activity have also been observed in the rhesus monkey and the 
human striatum (Graybiel and Ragsdale 1978; Smith and Parent 1986). AChE-
poor zones can also be distinguished within the DAcrgic part of the primate SN, 
surrounded by an AChE-rich matrix (Jiménez-Castellanos and Graybiel 1987). 
Although horizontal zonations and mediolatcral subdivisions of the pars compacta 
are readily demonstrable with AChE histochemical staining there was no clear 
overlap with tyrosine hydroxylase-immunoreactive neurons. Such nigral patches 
form only one of different mosaic-like patterns of which the typical striosomes 
form the most outstanding example (Malach and Graybiel 1986; Jimenez-Castel-
lanos and Graybiel 1989). The combination of tracer and immunohistochemical 
studies suggests an extremely complex conceptual circuitry, hardly visualizable 
unless schematized. 
As regards the general organizational principles of mesotelencephalic pro-
jections no major species differences could be derived from literature. Therefore 
many of the data presented for rats might be applicable to primates also. Supple-
mentary details, based mainly on studies in different monkey species, will be given 
here followed by schematized representations for the human brain. The arrows in 
hodological presentations represent trends in topographical principles without 
claiming completeness. 
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Stnatomesencephalic projections (Fig. Π.8.) 
Whereas the motor cortex mainly projects to the putamen, (Kiinzle 1975) associa­
tive areas of the prefrontal, temporal, parietal and anterior cingulate cortices 
project, in the form of patches, almost exclusively to the caudate nucleus in cats and 
monkeys (Divac et al. 1967;Goldman-Rakic 1983;DeLongetal. 1983a; Smith and 
Parent 1986; Malach and Graybiel 1986). This dichotomy is reflected in striato-
mesencephalic projections: putamenal neurons project massively to the globus 
pallidus and much less to the SN, whereas the reverse is true for the caudate nucleus 
(Parent et al. 1984). A third component of striatal effercnts projects to both 
substantia nigra and globus pallidus (Féger and Grossman 1984). The caudatoni-
gral fibers, arising mainly in the striatal matrix (sec also Besson et al. 1988), form 
a highly complex terminal plexus covering the cnlire rostral two-thirds of the pars 
reticulata, preferentially in its medial subdivision (Smith and Parent 1986). The 
extraslriosomal matrix also has efferents to the globus pallidus and pars lateralis 
of the substantia nigra. The putamenonigral fibers occur as more discrete fascicles 
confined to the dorsolateral caudal SNr. As a whole the pattern of anterograde and 
retrograde labeling observed in the SN after caudate injections is largely comple-
mentary to that seen after putamen injections (Parent 1986). Strionigral projections 
to the pars compacta terminate on clusters that constitute nigrostriatal projection 
neurons, suggesting a reciprocal link at this level (Smith and Parent 1986; see also 
Jiménez-Castellanos and Graybiel 1989). But it is unclear how the nigro-striato-
nigral circuit is exactly closed at the nigral end, especially with the complexity of 
the pars compacta dendrites in mind (Nauta and Domesick 1979; Percheron et al. 
1989; Haber and Groenewegen 1989). 
Comparison of data obtained in several animals suggests a consistent topo-
graphical localization of striosomes, i.e. : more numerous rostrally than caudally in 
the nucleus caudatus, and preferentially located more medially than in the 
dorsolateral quadrant (Desban et al. 1989). Striatal cell populations that innervate 
the SNrin cats were mainly found in clusters of thelateral two-thirds of the caudate 
matrix, in a rostral-to-caudal topographic relationship, partly overlapping the dor-
solateral somatosensory cortical target area as described by Malach and Graybiel 
(1986). The intermediate SNr receives projections that originate in the entire 
rostrocaudal extent of the caudate nucleus; the anterior part projecting to more 
ventrally located SNr neurons and the posterior caudate projecting to more dorsally 
located SNr neurons. It will be of particular interest to determine whether patches 
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labeled retrogradely from the SNr are in register or not with those labeled 
anterogradely by injections of tracers into the sensori and motor cortex (see also 
Somogyi et al. 1981a,b; Freund et al. 1984). Besson et al. (1988) suggested a 
relative separation, based on (striosomal) DI and (matrix) D2 receptor containing 
striatal neurons projecting to medial SNc and SNr, respectively. 
Data obtained from cats suggest some topographic ordening in efferents 
from the nucleus accumbens (Groenewegen and Russchen 1984). A medial and 
lateral subdivision of this ventral striatal nucleus project to VTA and SN, 
respectively. The retrorubral area and adjacent nucleus tegmenti pedunculoponti-
nus are innervated by both parts of the nucleus accumbens (Groenewegen and 
Russchen 1984). Their findings correspond also with the inversed dorsal-to-ventral 
topographic relationship as described in rats (Nauta and Domesick 1979), sugges-
tive for a limbic input via the ventral striatum and subsequently through the 
mesencephalic DAergic cell groups A8 and A9 to the dorsal striatum (Nauta 1978; 
Groenewegen and Russchen 1984). 
Non-striatal afférents to the primate substantia nigra and ventral tegmental 
area (FigJI.9) 
The substantia nigra and adjacent tegmental pedunculopontine nucleus have 
traditionally been considered as final relays in descending projections of the 
extrapyramidal motor system, providing their input almost exclusively from the 
striatum, including globus pallidus, by way of the ansa lenticularis (Wilson 1914; 
Winkler 1929; Nauta and Mehler 1966; Nauta and Domesick 1979). A close 
connection of the substantia nigra with the midbrain reticular formation also was 
suggestedforthe human brainin the beginning ofthecentury (Sano 1910, Winkler 
1929). As has been demonstrated both for rats and cats, a substantial ascending 
input to the SN and VTA stems mainly from raphe nuclei, nucleus tegmenti 
pedunculoponünus and, less significant, from the locus coeruleus (see Ch.II.3 and 
II.4). Projections from the (cholinergic) nucleus tegmenti pedunculopontinus have 
been confirmed by Moon Edley and Graybiel (1983) in cats, whereas Parent and 
deBellefeuille (1983) noted retrograde labeling after nigral injections in monkeys, 
both in the (serotonergic) dorsal raphe nucleus and the tegmental pedunculopontine 
nucleus of primates. The latter projects to pars compacta neurons, whereas 
serotonergic terminals are mainly found in the pars reticulata (for review see Parent 
1986). The VTA seems more specifically related to the other catecholaminergic 
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brainstem nuclei and the cerebellum (Oades and Halliday 1987), but inlcrfercnce 
with locus coerulcus projections to the cholinergic nucleus interpeduncularis is 
likely. 
A substantial afferent projection to the primate SN is provided by the 
nucleus subthalamicus (Winkler 1929; Nauta and Cole 1978; Carpenter et al. 
1981a,b; Parent and Smith 1987). The distribution of terminals favors the more 
ventral strata of the SNr, near the cerebral peduncle, avoiding regions with 
neuromelanin pigmented neurons (Nauta and Cole 1978; Parent et al. 1984). 
Similarities between the pars reticulata and the internal pallidal segment (see also 
Schwyn and Fox 1974; Marchand et al. 1979; Nauta 1979; Yclnik et al. 1987) are 
in accord with a projection of the subthalamic nucleus to both structures as well as 
comparable efferents of SNr and internal pallidal segment to thalamic nuclei 
(Parent and de Bellefcuille 1983). Whereas both globus pallidus and nucleus 
entopeduncularis in rats and cats project to the SN, such afférents in the primate SN 
exclusively stem from the external pallidal segment (Parent and dcBcUefeuille 
1983; Percheron et al. 1984b). Furthermore, pallidonigral and sublhalamonigral 
projections are more clearly separated in monkeys than in rats (Carpenter et al. 
1981a). 
It would be of interest to know more about possible diencephalic and basal 
forebrain projections to the VTA, as they were described in rats (Ch. II.2.3). Given 
the numerous retrogradely labeled neurons of large size in the substantia innomi-
nata of the monkey brain after large tracer injections in the SN (Parent and 
deBellefeuille 1983; see also Jones et al. 1976) a substantial afferent projection 
from basal forebrain structures to the "limbic midbrain area" (Nauta 1958) in 
primates has to be considered. This limbic midbrain area was defined in the cat as 
the region that has its rostral beginning in the VTA, extends caudalward along the 
base of the mesencephalon where it includes the interpeduncular nucleus and than 
arches dorsalward along the caudal aspect of the decussation of the brachium 
conjunctivum as the nucleus centralis superior, which in tum becomes continuous 
with the central grey caudal to the trochlear nucleus, including the dorsal tegmental 
nucleus of Gudden (Nauta 1958; see also Ch. II.3). Numerous fibers of the medial 
forebrain bundle, mamillo-tegmental tract and fasciculus retroflexus distribute to 
this area, providing at least indirect connections with limbic structures, particularly 
the septal-hippocampal system (see also Nieuwenhuys et al. 1982,1988). There is 
evidence of lateral preoptic, lateral hypothalamic and habenular projections to the 
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cat VTA (Nauta 1958, Swanson 1982; Oades and Halliday 1987) although such 
feedback connections of the VTA might be of minor importance in higher 
mammals according to Oadcs and Halliday (1987). In his onginal description of 
these limbic-midbrain connections in cats, Nauta (1958) suggested already possi-
ble species differences primarily in the numberof synaptic interruptions rather than 
the ultimate distribution pathways, which might explain the relative lack of such 
connections in tracing experiments. 
Fig 119 
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Autoradiographic silver-grains where distributed throughout the neurome-
lanin-containing midbrain cell-continuum, with greatest density dorsolateral to the 
SNc, after central amygdaloid injection of anterograde tracer (Price and Amarai 
1981). Labeling of the peripeduncular nucleus suggests a reciprocal connection 
with the amygdala as was also described for the extreme pole of the rat SN 
(Ch.II.2.3). Likewise, Hopkins and Holstege (1978) found retrogradely labeled 
cells both in the magnoceUular basal nucleus and the amygdala of cats after 
injections in the dorsolateral nigral complex. Direct corticonigral projections 
generally have been considered to be of minor importance (Parent 1986). Apart 
from the observations in rats, corticonigral projections have been demonstrated in 
cats, based on structural changes after frontal lobe ablation (Usunoff et al. 1982), 
which remind of similar observations in the human brain (Winkler 1929). Projec-
tions from area 6 and 9 of the prefrontal cortex in monkeys (Macaca fascicularis) 
were suggested by Kiinzle (1978) but no afférents from similar cortical areas have 
been observed in the rhesus monkey (Selemon and Goldman-Rakic 1988). Indeed 
Kiinzle (1978) noted that labeling of the SN might originate from passing fibers to 
structures in the more caudali y located reticular formation. 
Mesostriatal projection in primates (FigJI.lO.) 
Mesostriatal projections in primates, like those in rats, have their origin mainly in 
the DAergic pars compacta of the SN 
and may be divided in dorsal-to-ventral and anterior-to-posterior subdivisions 
(Langer and Graybiel 1989). Although the ventral striatum, including nucleus 
accumbens and olfactory tubercle, is less well defined in primates (see Heimer and 
Wilson 1975; Alheid and Heimer 1988), the concept ofits striatal characteris partly 
based on its connectivity comprising the triad of cortical, thalamic and mesencep-
halic dopaminergic afferent projections (see also Heimer et al. 1982; Young et 
al. 1984; Berendse et al. 1988). Different histochemical features are comparable to 
those of the dorsal striatum (Graybiel and Ragsdale 1983; Kwak et al. 1984; Haber 
and Watson 1985; Alheid and Heimer 1988; Groenewegen et al. 1989) and are in 
concordance with the pattern of DAergic terminals, although the latter proposition 
is mainly based on data in rats (Herkenham et al. 1984; Voom et al. 1986; Gerfen 
et al. 1987a,b; Berendse et al. 1988; Groenewegen et al. 1989) and cats (Graybiel 
and Ragsdale 1979; 1983; Giguère et al. 1984). The VTA and A8 projections to the 
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anterodorsal matrix compartment in primates, associated with Dl receptors (see 
also Ch. II.2.5.), are opposed to nigral projections of the main horizontal band of 
the pars compacta mainly directed to striosomes, associated with D2 receptors 
(Camps et al. 1989; Langer and Graybiel 1989) particularly in the rostromedial 
caudate nucleus (for review see Cools et al. 1989). Comparisons among Dl 
receptor binding site distribution, AChE staining and TH-immunoreactivity 
suggest similar compartmentalization principles for cats, monkeys and human 
brains (Besson et al. 1988; Camps et al. 1989). 
Generally the rostral parts of the SN pars compacta project to the striosomes 
of the caput nucleus caudati in a medial-to-lateral topographic pattern (Szabo 1979; 
Parent et al. 1983; François et al. 1984; Jiménez-Castellanos and Graybiel 1987). 
More caudally located nigral cells contribute to this rostral caudate innervation in 
its dorsolateral extension, as might be derived from studies in both monkeys and 
cats (Szabo 1980a,b; Beckstead 1987). These projections are directed to the 
striosomal system (Jiménez-Castellanos and Graybiel 1985,1987). The latter part 
of the caudate nucleus corresponds with the area of substance Ρ positive neuron 
clusters, described in cats (Beckstead 1987) and monkeys (Beach and McGeer 
1984; Graybiel and Chesselet 1984), which also has been shown to be sensitive to 
D2 specific dopamine receptor ligands (Beckstead 1987; Camps et al. 1989). 
Axons from this caudal SN pars compacta also project densely to the caudal part 
of striatal patches in cats (Beckstead 1987). 
The primate putamen is mainly projected on by posterior nigral regions, but 
clusters of caudate related nigral neurons are closely intermingled with putamen 
associated cells (Parent et al. 1983b). A dopaminergic projection from the internal 
part of the caudolateral SNc (the part most severely and consistently affected in 
PD), to the putamen was suggested by the preferential loss of catecholamines from 
the putamen in PD (Waters et al. 1988). Sometimes also pars reticulata neurons 
participate in this nigrostriatal projection (François et al. 1984). Ventral parts of the 
dorsal striatum are projected on by medially located pars compacta neurons, 
continuous with those of the VTA. At more caudal levels this medial part of the SN 
also reaches the medioventral putamen and most caudal extension of the caudate 
nucleus (Szabo 1980a,b; Parent et al. 1983a; François et al. 1984; Besson et al. 
1988). A striking inconsistency concerning striosomal directed DAergic neurons 
is the fact that, generally TH-slaining in the striatum is most developed in the matrix 
compartment (Beckstead 1987; Graybiel et al.1987; Besson et al. 1988). In 
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summary, these data agree with the medial-to-lateral and inversed dorsal-to-ventral 
topography described in rats (Ch.II.2.3.). 
The patches of high density nigral terminations within the caudate nucleus 
interdigitate with those of thalamic afférents in cats (Beckstead 1985). Nigrostria-
tal projection neurons also have a complex relationship to AChE-poor zones within 
the SN that extend in a finger-like pattern into an AChE-rich matrix (Jimenez-
Castellanos and Graybiel 1989). This latter nigral mosaic-like pattern might be 
related to AChE staining of different nigral afférents, added to the overall AChE 
immunoreactivity of nigrostriatal projection neurons. There was no overlap with 
the differential distribution of projections to cither the caudate nucleus or putamen, 
like those described by Parent et al. (1983b). Thus the significance of this nigral 
compartmentalization and its relation to striatal inhomogenities has to be elucida-
ted yet (Jimencz-Castellanos and Graybiel 1987, 1989). 
Mesolimbocortical projections and substantia nigra efferente (Fig.n.ll.) 
Apart from the mesostriatal projection a significant part of DAergic axons, directed 
to various basal forebrain, cortical, diencephalic and brainstem structures has been 
demonstrated also in primates. Fig. II. 11. presents an account of these projections. 
Like in rodents (see Swanson 1982) in primates a substantial part of the non-striatal 
efferents of the mesencephalic DAergic cell continuum might be nonDAergic 
(Björidund and Lindvall 1984; Parent 1986; Saper 1987a; Lewis et al. 1988b). It 
is hard to say if these projections have their origin either in the SNr or the VTA. 
One possibility in distinguishing these subsets is to consider the pattern of 
collateralization, being a typical feature of pars reticulata axons (Parent 1986) and 
only exceptional for VTA projections, at least in rats (Deniau et al. 1980; Swanson 
1982; Sobel and Coibett 1984). 
The number of nigrothalamic projection neurons, intermingling with nigro-
tectal neurons in primates, decreases from rostral to caudal within the pars 
reticulata of the SN. The reverse is true for the less abundant nigrotcgmental 
projection neurons (for review see Parent 1986). Differences in number, intranigral 
distribution and somatodendritic size and shape of these projection neurons in 
monkeys have been suggested (Beckstead and Frankfurter 1982; Beckstead 1983; 
Parent et al.l983b; François et al. 1984). Projections to the medial magnocellular 
part of the nucleus ventralis anterior and the mediodorsal thalamic nucleus have 
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their origin more medially in the SN, whereas lateral parts project on remaining 
parts of the magnocellular portion of the ventral anterior nucleus and paralaminar, 
parvicellular and densoccllular parts of the mediodorsal thalamic nucleus (Ilinsky 
et al. 198S). A topographical organization is maintained throughout the nigrotha-
lamocortical system in primates, in such a way that lateral parts of the SN are 
indirectly related to more posterior regiems of the frontal lobe, and the medial part 
of the nigrothalamocortical system is more selectively related to anterior regions 
of the frontal lobe (Ilinsky et al. 1985). Thus the nigral input to the various 
subdivisions of the mediodorsal nucleus may be organized in a manner similar to 
the distribution pattern of different cortical afferent systems in the striatum 
(Goldman-Rakic and Brown 1981; Goldman-Rakic 1983). 
The source of nigrotcctal projections to the intermediate gray layer of the 
monkey colliculus superior is a heterogenous population of pars reticulata neurons 
(May and Hall 1986). No distinct longitudinal zones of nigrotectal and nigrotha-
lamic projection neurons, as have been described in rats, are found in monkeys. 
Retrograde tracer studies in primates (Beckstead and Frankfurter 1982; Parent et 
al. 1983b; François et al. 1984; May and Hall 1986) have demonstrated that 
nigrotectal cells generally tend to occupy a somewhat more ventrolateral position 
as compared to nigrothalamic and nigrotegmental projection cells. Besides, these 
presumed GABAergic, neurons are believed to represent a morphological distinct 
subpopulalion (Beckstead and Frankfurter 1982; François et al. 1984; May and 
Hall 1986), particularly as regards the pars lateralis substantiae nigrae (see also 
Winkler 1929), with its typical, multi-dendritic large neurons (François et al. 
1984,1987; May and Hall 1986; Yelnik et al. 1987). Species differences, between 
monkey and rat regarding the arrangement of dendrites within the pars reticulata 
have been noted. The almost exclusively projection of the pars lateralis to the 
colliculus superior, might have caused a more restricted definition of topographic 
patterns of SNr neurons in rodents and cats (Faull and Mehler 1978; Beckstead et 
al. 1979,1982). A projection to the amygdala from this pars lateralis in cats 
(Meibach and Katzman 1981) might as well originate from the peripeduncular 
nucleus, which has been noted to receive afférents from the amygdaloid complex 
in the monkey (Jones et al. 1976; Price and Amarai 1981). The demarcation 
problem of the pars lateralis in the human brain is dealt with in Ch. II. 2.7. 
Although a direct inhibitory (GAB Aergic) SNr influence on neurons of the 
nucleus tegmenü pedunculopontinus has been disputed in rats (Rye et al. 1987), 
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there is much evidence for such a projection, at least as regards terminals within the 
traditionally defined boundaries of the tegmental pedunculopontine nucleus in 
different species (for review see Parent 1986). More caudal regions of the brainstem 
reticular formation also receive some input from the pars reticulata, but projections 
to the locus coemleus, parabrachial regions, nucleus raphe dorsalis, cerebellum and 
spinal cord arise preferentially from the VTA and A8 (Oades and Halliday 1987). 
There is a growing evidence of mesencephalic dopaminergic basal forebrain 
projections, particularly from VTA neurons, in the primates, similar to that in non-
primates, but many details are lacking yet (Nobin and Björklund 1973; Russchen 
étal. 1985; Gaspar et al. 1985; Oades and Halliday 1987). ìlie main terminal area 
of these projections is the nucleus accumbens, the only basal forebrain area 
containing high concentrations of all three monoamines (Gasparetal. 1985; Garcia-
Rill 1986). The "striatal" character of this projection might be reflected by its 
relatively high collateralization, providing branches also to lateral septum and 
prefrontal cortex (Oades et al. 1986). The patchy terminals in the ventral striatum 
are continuous with those to the bed nucleus of the stria terminalis. Likewise, they 
accompany the pathway through the stria terminalis (see Nobin and Björklund 
1973;Felten and Sladek 1983) and many terminals in the substantia perforata 
anterior (Gaspar et al. 1985). Tyrosine hydroxylase immunoreactivity in the human 
olfactory tubercle, continuous with the islands of Calleja, nucleus olfactorius 
anterior and parolfactory cortex (area 25), might be more extensive in the human 
brain than in rodents (Gaspar et al. 1985). Part of this tyrosine hydroxylase 
immunoreactivity might stem, however, from a supplementary DAcrgic cell 
cluster described by Köhler et al.(1983), containing particularly local projection 
neurons. The typical terminal distribution pattern of granular cells, surrounded by 
a network of DAergic terminals (Björklund and Lindvall 1984; Gaspare! al. 1985) 
is similar in both rodents and primates. 
Projections to the lateral septal nucleus, continuous with those of the bed 
nucleus of the stria terminalis, likewise might be more extensive than those 
described in rats (Gaspar et al. 1985). They most likely stem from midline VTA 
nuclei, as described in rats, but could also be collaterals of mesothalamic or 
mesohabenular projections (see Fuxe 1985). More diffusely spread afférents to the 
substantia innominata, extending in the area of the ventral pallidum and magnocel-
lularnucleus of Meynert, have been found by Russchen et al.(1985). The functional 
implications of these rather ill-defined basal forebrain projections in the human 
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brain, including also the presumed scptofimbrial nucleus (Gaspar et al. 1985), 
medial preoptic area,i.e. horizontal limb of Broca's diagonal band, and amygdaloid 
complex, have recently been reviewed by Alheid and Heimer (1988). Like in the 
prefrontal cortex, dopamine turnover might be particularly high here (Barmon and 
Roth 1983), implicating a possible underestimation of D Α-like immunoreactivity 
in post- mortem analysis. 
Fig II 12 
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Sagittal view 
Mesocortical projections of the human substantia nigra were suggested 
already by Winkler ( 1929), based on observations in neuropathology in which loss 
of temporal and parietofrontal cortical grisea led to degeneration of specific parts 
of the SN complex. Degeneration of the temporal lobe led to loss of a 'pars 
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lateralis', whereas medial parts of the SN were lost following parieto-frontal 
cortical destruction. 
Recent studies in cats (Scheibner and Törk 1987) and monkeys (Levitt et al. 1984; 
Lewis et al. 1987,1988b) as well as the human brain (Gaspar et al. 1989) 
demonstrated a dopaminergic input to most, if not all, cortical areas. The elabora-
tion and specialization of the primate neocortex, as compared to that of rodents, led 
to a significant expansion and differentiation of monoaminergic projections, 
greatly exaggerating those of the medial frontal, the cingulate, insular and temporal 
cortical areas found in rats. Different levels of evidence, as regards dopaminergic 
terminals in the primate cortex, however, depend on the kind of characterization of 
dopamine-like elements, like the radioenzymatic determination of DA and DA/NA 
ratios (Björklund et al. 1978), the appearance of TH-immunoreactivity (Levitt et 
al. 1984; Lewis et al. 1987,1988b) or the less ambiguously radiotopographic de-
monstration of various dopaminergic neuronal processes (Berger et al. 1988). 
Several lines of evidence indicated, however, that a highly specific anti-TH 
antiserum can select dopaminergic structures as well (Lewis et al. 1987). Thus, TH 
immunoreactivity was complementary to NA-specific dopamine-ß-hydroxylase 
immunoreactivity, rather than overlapping with this marker, whereas lesions of 
ascending NAergic fibers in the brainstem did not alter TH immunoreactivity 
significantly. 
In contrast to the distinct TH-labeling of locus coeruleus neurons, cortical NA 
processes seem to have TH concentrations or TH characteristics that make them 
hardly recognizable in such TH immunoreacüve preparations (Lewis et al. 1987; 
Gasparetal. 1989). 
In contrast to the rat (Björklund and Lindvall 1984; Berger et al. 1985; 
Descarries et al. 1987) much information is still lacking in monkeys regarding the 
exact mesencephalic origin and collateralization patterns of DAergic mesocortical 
systems. Retrograde transport studies combined with CA histofiuorescence in 
monkeys and cats, demonstrated that the mesocortical projection arises primarily 
from DAergic and nonDAergic (see also Swanson 1982) neurons in the VTA and 
medial pars compacta (Markowitsch and Irle 1981; Porrino and Goldman-Rakic 
1982; Scheibner and Törk 1987; Lewis et al. 1988a). Those of the medial SNc 
actually might stem from collaterals to other forebrain structures, such as striatum 
or septum, as was demonstrated in rats (Fallon et al. 1978b). 
Following Berger et al.'s (1988) suggestion cortical DAergic innervation in 
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primates might be subdivided in those to granular and those to agranular cortical 
areas. Those granular cortical regions, in which layer Г is most prominent 
(primary sensory areas), had the lowest density of labeled fibers, whereas agranu­
lar cortical regions, such as anterior cingulate (area 24),insula and motor 
cortices (area 4,6, including supplementary motor area), were most densely 
innervated, both in monkeys and humans (Lewis et al. 1987; 1988b; Berger et al. 
1988; Gaspar et al. 1989). The approximate twofold denser innervation in the 
agranular cortices as compared with the granular prefrontal, parietal and 
posterior cingulate, appears to be at variance with previous biochemical data 
(Björklund et al. 1978; Levitt et al. 1984). There is general agreement as regards 
cortical zones that receive very few DAergic projections, including area 1,2,3, and 
the peristriate area 18, primary visual and auditory cortices. The distribution to such 
areas is limited to lamina I (Lewis et al. 1987; Bergeret al. 1988). Generally, the 
distribution pattern coincides with cytoarchitectonic and functional boundaries. A 
rostrocaudal gradient might characterize the distribution of fiber density in the 
prefrontal cortex, increasing from area 10,9,8b and 6 to 4 (Lewis et al. 1987). In 
medial to lateral direction, over area 25 to area 24, and orbitof rontally from 10 over 
11-13 to area 12 a similar gradient was noted (Levitt et al. 1984; Lewis et al. 1988b). 
Within the parietal lobe, again, there is roughly an increase in TH- immunoreac-
tivity notable from the somatosensory areas to area 5 and area 7, respectively, 
ccmiplementary to the dopamine-ß-hydroxylase decrease over this trajectory (Moniscm 
et al. 1982b; Lewis et al. 1987). 
Although the densest DAergic innervation is observed in the motor cortex 
of primates, the projection-systems to the prefrontal cortical areas were most ex-
tensively studied (Goldman-Rakic and Brown 1981 ; Porrino and Goldman-Rakic 
1982; Levitt et al. 1984). Unlike the correspondence of this area with the target area 
of the mediodorsal thalamic nucleus in rodents (Divac et al. 1978), such a definition 
would be too narrow in primates (Goldman-Rakic and Porrino 1985). Actually, 
DAergic projections to the prefrontal region in primates seem to parallel more 
closely afférents from the ventral anterior thalamic nucleus than those from the 
mediodorsal nucleus (Lewis et al. 1988b). Like in primates, TH- immunoreactivity 
in the human prefrontal cortex is generally lower than that in other cortical areas, 
but minor differences, like the TH optimum in area 9 of monkeys, which seems only 
moderately innervated in humans (Lewis et al. 1988b; Gaspar et al. 1989) might 
be attributable to methodological variation. The lowest levels of 
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TH- immunoreactivity in the prefrontal cortex were observed in areas 10 and 46, 
the latter including the fundus of the (monkey) sulcus principalis, similar to the 
pattern as regards NAergic fibers. In comparison to DAergic processes, NAergic 
fibers have a substantially lower overall density, exhibit less marked regional 
variation and have a complementary laminar pattern of distribution (Lewis et al. 
1988b; Pamavelas and Papadopoulos 1989). Serotonin projections differ substan-
tially from DAergic projections on both regional and laminar base (Lewis et al. 
1987; Berger et al. 1988). 
Throughout the neocortex layer IV has the lowest density of DA-like immu-
noreactivity. The most densely innervated areas display fibers in all laminae, 
whereas the moderately innervated granular cortices have a bilaminar pattern, 
avoiding the granular layer IV (Lewis et al. 1988b; Berger et al. 1988; Gaspar et 
al. 1989). In frontal and cingulate cortices most of the DAergic fibers were present 
in layers II and superficial III (Levitt et al. 1984) but also coursed through deep 
layers V and VI, thus converging with amygdaloid projections (Lewis et al;. 
1988b). In very sparsely innervated regions, DAergic fibers are limited to layer I. 
Differences in the amount of TH immunoreactivity of layers II-IV may reflect 
species differences (Gaspar et al. 1989). A functional specialization is suggestive 
than, such that fibers preferentially innervate motor relative to sensory regions and 
sensory association relative to primary sensory areas (for review see Foote and 
Morrison 1987). 
Retrograde labeling studies of the parietal (area 7,5) and primary sensory 
cortex (Lewis et al. 1988a) and various prefrontal cortical areas (Porrino and 
Goldman-Rakic 1982) revealed the origin of DAergic projections to be the 
mesencephalic VTA, A8 and medial SNc. Such preliminary data could not 
establish a clear topographical organization of the mesocortical projection system. 
Such a topographical organization is suggested, however, by detailed studies in 
cats (Markowitsch and Irle 1981; Scheibner and Törk 1987). VTA nuclei contri-
bute differentially to various cortical projections, the nucleus paranigralis being a 
remarkable exception. The latter might be more specifically involved in mesolim-
bic projections to the ventral striatum (Szabo 1979; Scheibner and Törk 1987). 
Projections to the entorhinal cortex and hippocampus mainly stem from the nuclei 
interfascicularis, linearis centralis and parabrachialis pigmentosis. The nucleus 
linearis rostralis, particularly well identifiable in cats (see also Halliday and Törk 
1986), has the best developed cortical projections, especially to dorsolateral and 
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cortical areas. The nucleus interf ascicularis might be related to the lateral habenula 
(Scheibner and Törk 1987), although a "contamination" with the projection of the 
nucleus interpeduncularis is likely. 
Similarly as in rats, the most densely innervated cortical area in cats is the 
prefrontal cortex, converging with projections of the mediodorsal thalamic nucleus 
(Markowitsch and Irle 1981). This might explain the more widespread retrograde 
labeling observed by Porrino and Goldman-Rakic (1982) in monkeys, including 
the paranigral nucleus and medial SN. The contribution of SN cells to the 
mesocortical projection, thus particularly is directed to prefrontal and anterior 
cingulate cortices, as might be derived from various animal experiments (Carter 
and Fibiger 1977; Björklund et al. 1978; Porrino and Goldman-Rakic 1982; 
Bannon and Roth 1983). Apart from the well established nigral pars lateralis 
projections to the amygdala, dopaminergic projections to the primate temporal lobe 
(Björklund et al. 1978) are controversial yet, especially as regards a hippocampal 
innervation. 
73 
II.2.5. Chemoarchitecture of the substantia nigra and ventral 
tegmental area 
The distribution pattern of dopamine in the ventral mesencephalon was first 
studied in the rat (Baertler and Rosengren 1959) as was its relation to nigro-
neostriatal projections (Andén et al. 1964,1966a,b). Stepwise the knowledge on 
dopaminergic projections evolved and ten years later Berger (1977) examined the 
catecholaminergic innervation pattern in adult human cortex. This search was 
stimulated by the current hypothesis concerning the role of dopaminergic mecha-
nisms in complex behaviour patterns in the rat as well as in certain human 
psychiatric disorders such as schizophrenia and some forms of dementia (Kety 
1959; Berger 1977) and by the exciting demonstration of the close correlation of 
nigrostnatal dopaminergic dysfunction with Parkinsons's disease (Bemheimer et 
al. 1973). Nobin and Bjöiidund's (1973) histofluorescence findings on the topo-
graphy of monoamine neuron systems, including mesencephalic catecholaminer-
gic neurons in 3-4 month old fetuses were for a long time the only reliable data 
available on the DAergic mesencephalic cell continuum in the human brain. 
Usually central monoamine neurons were identified at the light microscopic level 
with the formaldehyde fluorescence technique of Falck and Hillarp (Carlsson et al. 
1962; Falck et al. 1962) by which the putative monoamine transmitters themselves, 
i.e. dopamine, noradrenaline and 5-hydroxytryptamine, were directly visualized in 
the microscope. Immunohistochemistry utilizing antibodies to tyrosine hydroxy-
lase (TH) in conjuction with the peroxidase-antiperoxidase technique can now be 
successfully applied to identify catecholaminergic neurons, not only in frozen 
sections (Gaspar et al. 1983; Waters et al. 1988) but also in formalin fixed, paraffin 
embedded human adult postmortem brain (Pearson et al. 1979,1983a). The same 
holds true for peptides, as will be reviewed briefly here. 
Even dopamine receptors can now be reliably studied in the human brain 
(Camps et al. 1989; Cortés et al. 1989). The two types of dopamine receptors Dl 
and D2 (the main binding site for neuroleptics) mediate different responses to 
dopaminergic action in the striatum (Seeman and Grigoriadis 1980; Niznik 1987; 
Cools et al. 1989). The patchy distribution of receptor binding both in cats and 
human striatum, is reminiscent of the uneven terminal pattern of the nigrostriatal 
projections (Besson et al. 1988; Camps et al. 1989; Langer and Graybiel 1989). 
Nevertheless, the vast majority of both Dl and D2 receptore, most thoroughly 
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studied in cats (see Beckstead 1988), was located on intrinsic striatal neurons. 
Indeed, in Parkinson's disease as well after experimental selective destruction of 
DAergic neurons, the densities of both types of receptors were unchanged (Pierot 
et al. 1988; Beckstead 1988), which might explain the response to dopamine 
(agonist) therapy. Within the SN D2 receptors are primarily located on DAergic 
neurons of the lateral pars compacta and their dendrites, whereas Dl receptors, 
predominant in the medial pars reticulata, might be associated with striatonigral 
neurons (Beckstead 1988; Camps et al. 1989). Relatively low levels of both 
receptor subtypes were present in the VTA, unlike the situation in rats (Dubois et 
al. 1986). The ventral striatum, particularly the islands of Calleja, present another 
important binding site for dopamine (Camps et al. 1989). The rostro-dorsal part of 
the caudate nucleus, in which the matrix compartment and Dl receptors are 
relatively abundant, corresponds to a substance P-rich area both in cats and 
primates (see Beckstead 1987,1988) which has been shown to be responsible for 
a dense substance Ρ innervation of the internal part of the globus pallidus and SN 
(see also Fig.II.13.). Met-enkephalin cell bodies have a minor predominance in 
central and ventral portions of the caput nucleus caudales (Beckstead and Kersey 
1985), a region that is characterized by the highest density of striosomes (Graybiel 
and Ragsdale 1983) and somewhat more D2 receptors (Camus et al. 1986; Cools 
et al. 1989). This region projects to the ventral pallidum and ventral parts of the SN 
pars reticulata (Beckstead and Cruz 1986). Dopamine may exert its influence at 
various sites with different functional consequences. Dopamine is also released 
within the SN from dendrites, influencing neighbouring DAergic cells as well as 
GABAergic nigrothalamic and nigrotectal neurons, by means of dendrodendritic 
and dendro-axonic contacts (Ruffieux and Schultz 1980; Wassef et al. 1981). In 
contrast to dendritic DA of the SN, vesicular DA represents the functional part in 
the nigrostriatal axons. DA autoreceptors within the SN are of the D2-type, i.e. 
those not linked to adenylate cyclase or adenylate cyclase inhibiting (Morelli et al. 
1988). As yet there is no general consensus even as to wether DA is excitatory or 
inhibitory active in the human striatum, nor do we fully understand the mechanisms 
through which L-DOPA produces benefit in patients afflicted with Parkinson's 
disease (Graybiel and Ragsdale 1983; Homykiewicz and Kish 1987). 
γ-Aininobutyric acid (GABA), mostly indicated by its metabolic enzyme 
immunoreactive glutamic acid decarboxylase (GAD), is the neurotransmittor of 
the pars reticulata projection neurons (Dichiara et al. 1979; Chevaher et al. 1981 ; 
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Araki et al. 1984) and recently specifically has been demonstrated to be involved 
in the nigrotectal projection in cats (Ficalora and Mize 1989). GAD immunoreac-
tive cells in the monkey SN are particularly abundant in the dorsolateral part of the 
pars reticulata, where they lie within a dense neuropil of GABA-containing striatal 
axon terminals (Parent 1986). GABAergic neurons from the nucleus accumbens 
project to the rostromcdial part of the SN and possibly also the VTA (Walaas and 
Fonnum 1980). 
The appearance of substance Ρ in the human SN has been thoroughly 
studied (Emson et al. 1980; Cuello et al. 1981; Del Fiacco et al. 1984; Beach and 
McGeer 1984; Mai ct al. 1986). The SNr contains the highest concentration of 
GAB A and substance Ρ in the brain, which attests to the density of these parallel 
striatonigral pathways. A comparative study of Inagaki and Parent ( 1984) showed 
differences in the distribution pattern of substance Р-Ике immunoreacüvity, which 
might reflect the increasing complexity of the striatonigral teiminal fields in 
primates relative to non-primates. Because substance Ρ antigenicity is preserved in 
routinely fixed, paraffine embedded archival materials, Mai et al. (1986) succeeded 
in tracing substance Ρ pathways also. It has become clear that the striopallidal and 
strionigral tracts, carrying the majority of substance Ρ fibers, give rise to a dense 
plexus of "woolly fibers" throughout the pars reticulata (Beach and McGeer 1984), 
confirming the "pallidal" character of this nigral part. The cells of origin are 
preferentially located anterolaterally in the striatum (Cuello et al. 1981 ; Glowinski 
et al. 1982), exerting a tonic facilitatory influence on DAergic neurons. In the 
human substantia nigra substance P-like material within the pars compacta appears 
to be arranged in strands, often parallel to blood vessels, most apparently in the 
subnucleus anteromedialis and posterolateralis (Mai et al. 1986). In the dorsal tier 
both substance P-like immunoreacüvity and enkephalin-positivity are conspiciou-
sly lacking (Haber and Groenewegen 1989). 
Like substance P, the distribution pattern of enkephalin-like immunoreac-
üvity in the human substanüa nigra complex is well established now (Emson et al. 
1980; Cuello et al. 1981; Gaspar et al. 1983; Bouras et al. 1984; Haber and 
Groenewegen 1989). Both these peptides .most likely are associated with striato-
nigral projections (Cuello et al. 1981; Sandyk 1985). Fibres with enkephalin-like 
immunoreactive varicosities were observed in m any areas of the human mesencep-
halon (Bouras et al. 1984) and sometimes in the direct vicinity of neuromelanin 
pigmented cells. In the pars reticulata the terminal pattern resembles that of 
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substance Ρ, i.e. boutons all over perikarya and along dendrites; but the distribution 
pattern is less uniformely (Gaspar et al. 1983), with a maximal density of 
enkephalin-like immunoreactivity in the medial part (Haber and Groenewegen 
1989), covering also the area of the nucleus paranigralis. There appears to be an 
increasing overlap between peptidergic afférents and TH-positive elements along 
the evolutionary lines (Inagaki and Parent 1984; Haber and Eide 1982; Waters et 
al. 1988), but TH-positive clusters, although keeping with peptidergic boundaries, 
do not overlap unequivocally (Haber and Groenewegen 1989). 
A third strionigral pathway, supplying the pars reticulata with dynorphin 
has been described in rats (Fallon and Loughlin 1985) and cats (Chesselet and 
Graybiel 1983), suggesting again an evolutionary trend. The differential distribu-
tions of enkephalin and dynorphin in the SN of cats might underline the identity 
of a separate pars lateralis, corresponding with low dynorphin-like immunoreac-
tivity in the most rostro-lateral part of the SN (Chesselet and Graybiel 1983). In 
humans the substance P, met-enkephalin and dynorphin fibers largely avoided the 
region of the caudolateral pigmented cells but also the nucleus paranigralis (Waters 
et al. 1988). 
Neurons containing both DA and cholecystokinin (CCK) have been 
associated primarily with VTA effcrents of the midline structures and the rostro-
lateral part of the rat SN (Hökfelt et al. 1980). These areas are known to contain 
projection neurons to the caudal-medial nucleus accumbens and central amygda-
loid nucleus, respectively. Other basal forebrain structures that received such 
combined CCK-DA input were the bed nucleus of the stria tcrminalis, the lateral 
septal nucleus, olfactory tubercle, ventral thalamus, diagonal band of Broca and 
basal lateral hypothalamus. Thus CCK seems more specifically related to mesolim-
bic projections, whereas neostrialal CCK might originate mainly from descending 
cortical projections (Zaborski et al. 1985). Seroogy et al. (1988) described a 
population of TH-immunorcactive neurons that contained both CCK and neurotensin. 
Neurotensin might be found in VTA D Aergic neurons, but more often in fibers, like 
those ascending from locus cocrulcus, nucleus raphe dorsalis and parabrachial 
nuclei (Kalivas 1985). The same counts for somatostatin-immunoreactivity 
detected in these mesencephalic areas (Beai and Martin 1984). The facilitatory 
effect of neurotensin on DAergic neurons is opposite to the effect of DA on its 
autoreceptors (Kalivas 1985). 
Serotonergic perikaryae have been described in the VTA nuclei surrounding 
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the inteipeduncularnucleus, oriented perpendicular to the midline and cytological-
ly different from those of the B9 raphe group (Steinbusch 1981). Serotonin immu-
noreactive fibers and terminals are abundant in the rostral part of the SNr and the 
pars lateralis of rats. Likewise both choline-acetyltransferase-positive (choliner-
gic) cells and fibers are present, the former probably ectopically located neurons 
of the pontomesencephalic tegmental cholinergic system (Gould and Butcher 
1986; Henderson et al. 1987). These projections particularly provide the medial 
third of the SN with a cholinergic input Beninato et al. 1988). Acetylcholinesterase 
in the SN of rats (Lehmann and Fibiger 1978) and cats (Jimenez-Castellanos and 
Graybiel 1985) is a less specific marker, the exact meaning of which has to be 
elucidated yet. Noradrenaline-like (dopamine-ß-hydroxylase) immunoreactivity is 
restricted to fibers passing the VTA on their way to the medial forebrain bundle 
(Fallon and Loughlin 1985). 
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11.2.6. A model of nigral organization. 
Functional and pathophysiological considerations of basal ganglia 
dysfunction. 
П.2.6.1. The complex relationship of the substantia nigra with the striatum 
(fig 11.13) 
From previous chapters it will be clear that the dopaminergic cell continuum in the 
mesencephalon has extensive reciprocal connections with the striatal complex, its 
medial and dorsal part also with the prefrontal cortex and basal forebrain structures. 
A dense dopaminergic innervation, i.e. the mesostriatal projection, is characteristic 
for the entire striatal complex including the caudate nucleus, the putamen, the 
nucleus accumbens and the olfactory tubercle. This mesostriatal projection is 
compartmcntally organized with distinct sets of DAergic neurons projecting to 
striosomes and matrix, respectively, suggesting specialized channels directed at 
dopaminergic modulation of sensorimotor and integrative processing in the striatal 
matrix and limbic-relatcd mechanisms represented in the süosomal system (Langer 
and Graybiel 1989). The exact functional significance of the mosaic-like organi-
zation of both SN and striatum and their complex interrelationship is an important 
topic of present-day investigations (Jiménez-Castellanos and Graybiel 1989; Albin 
et al. 1989; Graybiel 1989). Part of the mechanism provided by this neurochemi-
cally defined differentiation may involve presynaptic variation in enzymatic 
regulation of dopamine content in and out of striosomes (Graybiel et al. 1987). 
Apart from this chemical compartmentalizaüon, caudate-related, putamen and 
ventral striatum-related projections appear to be partly separated in primates and 
cats (Smith and Parent 1986; Beckstead and Cruz 1986). This has partly been 
explained because of the caudate nucleus and putamen being transected by the 
internal capsule and the dorsal striatum being separated from its ventral counterpart 
by the deep olfactory radiation (Nauta 1979, 1986). Within the dorsal striatum 
nigral axons synapse with dendritic spines and cell bodies of spiny, mostly 
cholinergic and GABAergic, neurons (Graybiel and Ragdsdale 1979; Carpenter 
1986; Gerfen 1988), preferentially inhibitory (see Marsden 1982) but possibly 
partly excitatory (see Carpenter 1986). The idea that DA has variable effects is 
supported by clinical experience with DA antagonists and agonists and their effects 
(Clark et al. 1985; Bunney 1988; Albin et al. 1989). Spiny target neurons are the 
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constituent of the two striatal compartments: striosomes and matrix (Bolam et al. 
1988). Tyrosine hydroxylase positive fibers within the striatum are mainly found 
in the matrix compartment. More proximal non-immunoreaclive boutons on 
dendritic spines of striatal cells probably originate from cortico-striate glutamate 
terminals, suggesting a modulatory role of dopamine on the flow of corticostrio-
nigral information (Bolam ctal. 1981,1988;Penney and Young 1983; Parent 1986; 
Gerfen 1988). 
Fig H 13 
Relationship of the substantia nigra to the basal ganglia 
Extrapyramidal circuitry 
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Striatal projections to the SN/globus pallidus internus (or entopeduncular 
nucleus in rodents) can be distinguished from striatal projections to the globus 
pallidus extemus (Fig.II. 13), on anatomical, immunohistochemical and functional 
grounds (Beach and McGeer 1984; Féger and Grossman 1984; Beckstead and Cruz 
1986; Parent et al. 1984). This subdivision is supported by autoradiographic 
binding studies of dopamine receptors (Beckstead 1988; Camps et al. 1989; Cortés 
et al. 1989). Projections from the striosomes go mainly back to the SN pars 
compacta. Matrix neurons containing substance Ρ mainly project upon the globus 
pallidus internus and SN pars reticulata, while those containing enkephalins project 
mainly upon the globus pallidus extemus (Graybiel and Ragsdale 1983; Beckstead 
and Kersey 1985; Haberand Watson 1985). Both segments of the globus pallidus 
also receive GABAergic fibers and co-localization of transmitters has been 
described (Graybiel and Ragsdale 1983; Carpenter 1986). Dynorphin projections 
seem to be directed to the internal segment (nucleus entopeduncularis) in cats and 
rats (Beckstead and Cruz 1986) butin the human GP to the external segment (Haber 
and Watson 1985). The two striatal compartments may be linked functionally by 
intemcurons that contain both somatostatin and neuropeptide Y ( Gerfen 1984; 
Chesselet and Graybiel 1986) and possibly also by dendrites that cross the borders 
between striosomes and matrix (Bolam et al. 1988). Whereas substance Ρ 
concentration in the SN pars reticulata has been shown to be decreased in 
Parkinson's disease (Waters et al. 1988) no changes in the external part of the 
globus pallidus levels of enkephalin have been reported. Projections of the globus 
pallidus pars extemus only reach the SN and globus pallidus internus via the 
subthalamic nucleus, where glutamate might also be a neurotransmitter (Carpenter 
1986; Beckstead and Cruz 1986). 
Within the SN striatal afférents largely terminate on dendrites and neurons 
in the pars rclicula transforming information to thalamic nuclei, the superior col-
liculus and the mesencephalic reticular formation, including the nucleus tegmenti 
pcdunculopontinus (Fig.II.13.). The main function of the striatal efferent activity 
appears to be inhibition of tonically active GABAergic neurons in the pars 
reticulata and globus pallidus internus. Thus, the net effect of cortical excitation is 
disinhibition of structures innervated by globus pallidus and SN (Graybiel 1986; 
Swerdlow and Koob 1987). Restricted lesions of areas of the striatum win lead to 
behavioral deficits similar to those produced by damage to the areas of cerebral 
cortex projections to that region of the striatum (Marsden 1982). 
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The multipotential, collateralized, output organization of the SN pars 
reticulata (see Ch.II.2.4.) appears to differmarkedly from that of the pars compacta, 
but is remarkably similar to that of the internal pallidum, which is the other major 
output structure of the basal ganglia (Graybiel and Ragsdale 1979; Parent et al. 
1983b; Nauta 1986; Yelnik et al. 1987). Presumed GABAergic projections from 
the primate SNr to the thalamus, are organized in such a way that the medial SN 
projects to the medial magnocellular subdivision of the nucleus ventralis anterior 
and nucleus mediodorsalis thalami, projecting in tum to the most anterior regions 
of the frontal lobe (Ilinsky et al. 1985; Giguère and Goldman-Rakic 1988). The 
lateral SN pars retícula projects to the more lateral and more posterior parts of the 
ventral anterior magnocellular nucleus and paralaminar, parvicellular and denso-
cellular subdivisions of the mediodorsal nucleus and intermediate layers of the 
colliculus superior (Graybiel 1978; Beckstead 1983; Francois et al. 1984; Ilinsky 
et al. 1985). The latter thalamic nuclei also project back to more posterior regions 
of the frontal lobe, like frontal eye fields and areas of the premotor cortex (Ilinsky 
et al. 1985; Goldman-Rakic and Porrino 1985). 
Hypokinesia and rigidity, such as in Parkinson's disease, are hypothesized 
to result from a complex series of changes resulting in an increase in basal ganglia 
output, particularly to the ventrolateral thalamic nucleus (Narabayashi 1983). The 
ventrolateral thalamic nucleus has been known since long to be related to tremor 
generation (Lee 1987). Hyperkinetic disorders generally are postulated to result 
from impairment of striatal neurons projecting to the lateral globus pallidus and 
related subthalamic nucleus dysfunction (Wilson 1925; Marsden andFahn 1987). 
AU these abnormal movements share some common pharmacology in that the 
abnormal movements are suppressed by the administration of dopamine D2 
receptor antagonists and exacerbated by DA agonists. D2 receptor antagonists 
seem to potentiate the activity of striatal neurons projecting to the globus pallidus 
extemus, asmeasured by an increase in enkephalinlevels, whereas anticholinergics 
antagonize this DAergic effect (for review see Albin et al. 1989). 
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Π.2.6.2. Functional aspects of mesencephalic dopaminergic projections. 
A key role played by the nigrostriatal projection is shown indirectly after 
unilateral 6-hydroxydopamine induced destruction of this dopaminergic pathway 
in rodents, with resulting biochemical asymmetry of the striatum (Ungerstedt 
1971b). Within one to two days after lesioning, administration of DA agonist 
drugs, such as apomorphine, provoke circling behavior away from the side of 
lesion. This circling is prevented by lesions of the SN pars reticulata (Leigh et al. 
1983). The GABAergic striatonigral projection appears to be critical for the 
mediation of this circling and GAB A agonists, such as muscimol or baclofen, cause 
contralateral circling (for review see DeLong and Georgopoulos 1981). This 
circling comprises a purely (locomotor) activation component, mediated mainly 
via the nucleus accumbens (Reavill et al. 1981; Oades et al. 1986; Cools 1986), 
whereas postural asymmetry (i.e. stereotypic head and tail deviation to the side of 
injection) is predominantly a function of striatal asymmetry and its output. The 
nigro-tegmental projection, directed to the so-called "angular-complex", a reticu­
lar formation structure adjacent to the periaquaductal gray (Reavill et al. 1981; 
Leigh et al. 1983) is crucial in the mediation of this effect. This projection is very 
likely to be involved also in muscular rigidity or stereotyped behaviour, as can be 
seen in Parkinson's disease (Narabayashi 1983; Leigh et al. 1983;Ellenbroeketal. 
1984). Rotational behaviour might be conditioned to environmental stimuli 
(Fibiger and Phillips 1974; Carey 1986; Casas et al. 1989) suggesting a role of the 
nigrostriatal projection in the generation of movements in the absence of sensory 
or mnemonic guidance (Cools et al. 1984b; Vrijmoed-De Vries and Cools 1986). 
The nigrostriatal dopamine system, rather than conveying highly specific informa­
tion about movement in the striatum, seems to exert a more tonic modulatory effect 
upon the striatum (DeLong and Georgopoulos 1981; Marsden 1982; Cools et al. 
1984b). Likewise, the VTA seems to modify (primarily inhibit) nucleus accum­
bens mediated activity, depending on environmental circumstances, like time of 
day and novelty of perception (Galey et al. 1977; Oades et al. 1986; Cools 1986; 
Van den Bos and Cools 1989). It has been known for a long time that different DA-
antagonist sensitive mechanisms in the nucleus accumbens and caudate-putamen 
may mediate hyperactivity and stereotyped behaviour, respectively, in rats (Costali 
et al. 1977). In the lateral part of the VTA projection neurons, adjoining the very 
medial part of the dorsal SN pars compacta, somewhat more non-DA cells have 
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been found (Wang 1981a), together with a somewhat lower DA turnover in 
comparison with its medial counterpart projection (Agnati et al. 1980). Besides, 
based on electrophysiological experiments (Wang 1981 a,b), type I DA neurons 
with fine unmyelinated axons can be distinguished from non-DA, more heteroge­
neous, type II cells. Type I neurons show a markedly reduced firing rate following 
intravenous injection of apomorphine, amphetamine or the iontophoretic applica­
tion of DA and GABA (Fuxe et al. 1977; Wang 1981 b; Bannon and Roth 1983). 
A depressant effect of systematical administration of amphetamine at low 
doses on DA neurons of the SNc and VTA is primarily mediated through the 
striatonigral feedback pathway; at high doses its effect may be mediated by DA 
autoreceptors as well (Aghajanian et al. 1977; Bannon and Roth 1983; Thierry et 
al. 1988). Apart from its effect on the nigrostriatal and mesolimbic projections 
(Iversen and Koob 1977), amphetamine might also influence norepinephrine 
projections (Aghajanian et al. 1977; Fuxe et al. 1977; Wangetal. 198 la,b; Thierry 
et al. 1988) for the induction of stereotyped behavior in animals. Stressful 
situations were found to activate selectively the mesocortical DA neurons as 
indicated by the enhanced rate of DA utilization (Thierry et al. 1976; Antelman et 
al. 1988; Dunn 1988; Roth et al. 1988). Delineation of the various output links 
subserving elements of circling behaviour and stereotypy could throw light upon 
clinical observations which indicate that different symptoms and signs in Parkin­
son's disease are related to different basal ganglia output pathways. 
Π.2.6.3. The extrapyramidal system (Fig.II.13.) 
It is clear then, that nigral organization as well as the effects of dopaminergic 
substances are essentially determined by a close relationship of the SN to the basal 
ganglia, the organization of which is primarily determined by cortical afférents. 
The definition of the basal ganglia is more extensive on anatomical grounds as is 
usually adopted clinically. But much about basal ganglia circuitry remains 
unknown yet and some of the results obtained in primate experiments are 
inconsistent with findings in rats and cats. As proposed by Nauta (1979, 1986), 
referring to Heimer and Wilson's (1985) study, a striatal input zone nowadays can 
be expanded to include the nucleus accumbens sepü and parts of the olfactory 
tubercle. The classical output zone, including external and internal pallidal 
segment, can now be expanded to include the nondopaminergic part of the SN and 
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a part of the globus pallidus, extending ventral to the anterior commissure and into 
the olfactory tubercle (see also Young et al. 1984; Parent 1986). Whereas the 
ventral striatum is continuous with the amygdaloid complex (Alheid and Heimer 
1988), this "ventral pallidum" is part of the substantia innominata, including the 
nucleus basahs magnocellularis of Meynert (Hedreen et al. 1984; Carpenter 1986; 
McGeer and McGeer 1987). The cholinergic neurons of the nucleus basalis are 
much more intimately intermingled with neurons of the globus pallidus in rats and 
cats than in primates (Mesulam et al. 1983a, 1984; Parent 1986). The functional 
significance of such intermingling and possible connectivity of limbic and basal 
ganglia neuronal elements at pallidal levels remains to be investigated. The 
subthalamic nucleus, globus pallidus and SNr all send fibers to the nucleus 
tegmcnü pedunculopontinus, as one of the major final output nuclei (Garcia-Rill 
1986; Nieuwenhuys et al. 1988). Adjuvant sub-circuits apparently play a key role 
in the regulation of motor function (Armstrong 1986; Jellinger 1988; Albin et al. 
1989). 
The first evidence of striatal function was obtained after bilateral destruction 
in rabbits, resulting in an irresistible drive to run forward, whereas electrical stimu-
lation of the corpus striatum elicited tonic-clonic movements of the contralateral 
extremities, even after the motor cortex had been destroyed (for reviews see Wilson 
1914; Hassler 1979). Because animals were able to run, even after bilateral 
interruption of the pyramidal tract, the name 'extrapyramidal motor pathways' was 
introduced and made very nearly synonymous with the basal ganglia and their 
efferent connections by convention (Nauta and Domesick 1979). Whereas unila-
teral limited acute pallidal lesions have no clear effects on untrained monkeys 
(DeLong and Georgopoulos 1981), bilateral extensive lesions in monkeys (Denny-
Brown and Yanagisawa 1976) and humans (Jellinger 1986a; Laplane et al. 1989) 
resulted in global akinesia, inactive posture and emotional stolidity. 
Marsden (1982) formulated the hypothesis that the basal ganglia are 
responsible for the automatic execution of learned motor plan, restricting basal 
ganglia function exclusively to motor control. His attention was mainly directed to 
basal ganglia output, in which the striatum might 'call-up' standard motor 
programs, like postural reflexes, whereas the perceptual processes involved in the 
decision to move might be independent of striatal function (see also Sheridan et al. 
1987). But the lesion studies of Denny-Brown and Yanagisawa (1976) and Hassler 
(1978) had already shown that the basal ganglia not only directed attention to a 
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particular object in the environment, but also inhibit other distracting sensory input 
(Penney and Young 1983). Likewise, proprioceptive feedback is not normal in 
Parkinson's disease (Marsden 1982), which made Cools et al. (1984a,b), mainly 
based on pharmacologic animal experiments, suggest a role of the basal ganglia in 
esthablishing new programs appropriate to available stimuli. According to these 
authors (for review see Cools et al. 1989) the SN pars reticulata transfoims the 
striatonigral information stream, reducing the degree of freedom in programming 
motor behaviour by adding information from proprioceptive, exteroceptive and in-
teroceptive input. Confirmation of a SN gating mechanism has been gained 
recently in rats (Schneider 1984; Cools et al. 1984b; Gale 1985; Baumeister et al. 
1988). Dopaminergic output of both SN and VTA might influence the cortico-
striato-nigral information stream both at striatal and subcortical level, without 
altering essentially the function of the neuronal system (loop) that is regulated 
(Penney and Young 1983; Simon and LeMoal 1988; Miller and DeLong 1988; 
Weinberger et al. 1988). Evidence for processing of sensory information by the 
basal ganglia has been reviewed by Schneider (1984) and Swerdlow and Koob 
(1987). The dependence of motor function on the behavioral and environmental set 
in patients with Parkinson's disease is very well in accordance with clinical 
experience (Marsden 1982; Evarts et al. 1984). 
Both anatomical organization and clinical evidence in Parkinson's disease 
and Huntington's disease (Penney and Young 1983; Schneider 1984; Mayeux et 
al. 1984; Cummings and Benson 1984; Phillips and Carr 1987) support views that 
the dorsal striatum is also involved in several types of cognitive activities. In such 
cases all subdivisions of the caudate nucleus are more affected than the putamen, 
suggesting that also the pattern of SN cell loss might differ according to prevailing 
motor or cognitive symptomatology (Kish et al. 1988; Homykiewicz and Kish 
1986; Gilbert et al. 1988). The indisputable effectiveness of DA blocking agents 
in schizophrenia (Sayed and Garrison 1983; Nemeroff 1986; Bunney 1988) and of 
catecholamine potentiating drugs in depression (Frazer and Mendels 1977; Swerd-
low and Koob 1987; Taylor et al. 1988) not only represents over- and underactivity 
of the target amines, but could also reflect the absence of opposing or potentiating 
elements (Clark et al. 1985). E.g. the many similarities in the actions of neurotensin 
and neuroleptic drugs (Nemeroff 1986; Bisette and Nemeroff 1988) and the 
presumed role of CCK in their therapeutic effect (Wang 1988) raised the question 
of their potential involvement in schizophrenia. Likewise, the relative overactivity 
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of dopamine in the striatum in Huntington's chorea might result from atrophy of 
opposing systems, like GABAergic (Bruyn and Went 1986). Cognitive deficits 
characteristically found in this illness are of the prefrontal type, suggesting 
secondary effects of caudate degeneration on prefrontal function (Taylor et al. 
1988; Weinberger et al. 1988). Likewise, abnormally high levels of DA transmis-
sion or DA receptor overactivity in the striatum, nowadays measurable by positron 
emission tomography (Wang et al. 1986; Laplane et al. 1989) may be involved in 
schizophrenia (Matthysse 1977; Crow et al. 1978; Nemeroff 1986; Swerdlow and 
Koob 1987; Weinberger et al. 1988). 
Nowadays basal ganglia disorders should better be understood as the result of 
deficiency of several neurotransmittermetabolites due to chains of enzymatic error 
in transstriatal circuitry and not only of dopamine deficiency. The highly variable 
symptomatology in parkinsonian syndromes of all etiologies might be determined 
by the degree and pattern of nigral cell loss, determining the degree and pattern of 
DA loss in striatal nuclei and changes in the interacting non-DA systems (Homy-
kiewicz and Kish 1986; Lee 1987). Cholinergic neurons promote the positive 
feedback loops, whereas dopaminergic neurons inhibit the circuit The traditional 
"cholinergic-dopaminergic balance" of the clinical and pharmacological literature 
wUl be found to subsume a variety of systems (Graybiel 1989). Cholinergic 
mechanisms of the basal ganglia are not any longer confined to intrinsic striatal 
neurons. Other cholinergic systems, including those originating in the midbrain 
and basal forebrain, may influence striatal mechanisms indirectly (Garcia-Rill 
1986; Lee et al. 1988; Graybiel 1989). Because of differences in the DA-related and 
ACh-related activities in the striosomal and matrix system, it should be possible 
for target drugs to influence selectively specific D Aergic or cholinergic subsystems 
(Fuxe et al. 1977; Besson et aL. 1988; Graybiel 1989).As regards responses to DA 
agonists and antagonists the two types of receptors, Dl and D2 (Seeman and 
Grigoriadis 1980; Niznik 1987), show a patchy distribution both in cats (Beckstead 
1988; Langer and Graybiel 1989) and human (Besson et al. 1988; Camps et al. 
1989; Cortés et al. 1989), reminiscent of the uneven nigrostriatal terminal pattern. 
Whereas, D2 receptors are the main binding site for neuroleptics, the existence of 
both types of DA receptors in limbic structures and the prefrontal cortex (Thierry 
et al. 1988) may account formany of the newly found "basal ganglia"-symptoma-
tology after pharmacologic manipulation of DAergic projections. 
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Π.2.6.4. Functionally segregated extrapyramidal circuits. 
Based on older silver impregnation studies (see Nauta and Domesick 1979 
for review), it was generally believed that the basal ganglia integrated inputs from 
widespread cortical areas funneling this information to the motor cortex via the 
ventrolateral thalamus. The extrapyramidal motor function of the basal ganglia was 
supposed to be determined by several minor feedback circuits such as: Striatum-
globus pallidus-thalamus-striatum, globus pallidus-nuclcus subthalamicus-glo-
bus pallidus, striatum-substantia nigra-striatum and cortex-striatum-substantia 
nigra-thalamus-cortex (Graybiel and Ragsdale 1979; Carpenter 1981; Jellinger 
1986a, 1988; Nieuwenhuys et al. 1988). More recent data, mainly based on 
autoradiographic tracing methods, however, suggest the existence of several 
parallel, but segregated, cortico-subcortical circuits in which inputs to the basal 
ganglia tend to remain anatomically and functionally segregated throughout the 
basal ganglia-thalamocortical circuitry (Alexander et al. 1986). As Kemp and 
Powell (1970) proposed, any subdivision of corticostriate projections is related to 
the functions of the cortical area under consideration and not upon their size. 
Despite morphological characteristics suggesting anatomical convergence 
from cortex to striatum to the successively smaller regions of pallidum and SN 
(Percheron et al. 1984a,b, 1989), single cell recording studies (DeLong et al. 
1983b, 1985) show that there is relatively little physiological convergence between 
inputs from various cortical areas. In a sense, the concept of funneling is retained, 
because a single cortical area receives information derived from the processing of 
inputs from several cortical areas through the basal ganglia, whereas connected 
associational cortex areas may project to one similar striatal area (Selemon and 
Goldman-Rakic 1988; Goldman-Rakic 1987). Besides, apart from such feedback 
loops, the existence of feedforward circuitry also has to be kept in mind (Groves 
1983; Cools et al. 1984a,b; Armstrong 1986) especially as regards pathophysiolo­
gical manifestations in various defect states, like motor (Garcia-Rill 1986), 
cognitive (Simon et al. 1980; Schneider 1984; Agid et al. 1987) affective (Stevens 
1973; Swerdlow and Koobl987;Tayloret al. 1988)and oculomotor (Hikosaka and 
Wurtz 1983a,b; Scheel-Kriiger 1983,1986; Wise 1984; Faull et al. 1986) distur­
bances. The general view emerging from these findings is that transstriatal 
processing permits neurochemically specialized channels to be established in the 
basal ganglia. This parallel circuitry offers another framework for the interpretation 
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of such complicated adverse effects of anti-dopaminergic medication like tardive 
dyskinesia (e.g. Baldessarini 1980; Groves 1983; Fibiger and Lloyd 1984), 
presumed cognitive changes after dopaminergic medication (Fibiger and Phillips 
1974; Blin et al. 1988; Hietanen and Teräväinen 1988) and dyskinesias following 
treatment of Parkinson's disease (Chase et al. 1973; 1988). 
The entire cerebral cortex projects onto the striatum in a highly ordered 
arrangement, of which figure 11.14. gives an account. 
Corticostriatal projections and their presumed topography in the 
human brain 
89 
Somatosensory and motor cortices of various species innervate specific dorsolate-
ral and central parts of the nucleus caudatus and putamen matrix, respectively 
(Kemp and Powell 1970; Selemon and Goldman-Rakic 1985; Malach and Graybiel 
1986; McGeorge and Faull 1989), which in tum project preferentially to that region 
of the SN giving rise to the nigrothalamic projection. In primates the dorsolateral 
part of the caudate nucleus matrix is a typical somatosensory recipient area, related 
to areas 1,2 and 3 of Brodmann (Kemp and Powell 1970; Kiinzle 1977), whereas 
the putamenal matrix is particularly projected on by the motor cortex in a 
somatotopic order (Kiinzle 1975;DeLongetal. 1983;Percheronetal. 1984). These 
target areas are continuous, or rather interdigitating, with those of the posterior 
parietal cortex (area 7 and 5 of Brodmann) and the premotor area 6 (Kiinzle 1978; 
Ragsdale and Graybiel 1981; Selemon and Goldman-Rakic 1985). Terminals of 
the posterior parietal cortex are also observed in ventral parts of the caudal putamen 
(Selemon and Goldman-Rakic 1985). Projections of the supplementary motor 
cortex (area 9) have been described to terminate both in patch and matrix 
compartments (Ragsdale and Graybiel 1984; Selemon and Goldman-Rakic 1985; 
1988). Indeed, part of Brodmann's area 9 has been indicated as typical prefrontal 
(Goldman and Nauta 1977; Kiinzle 1978) related to somewhat more medially 
placed caudate striosomes (Graybiel 1984). More frontally located cortical areas 
(dorsomedial and dorsolateral prefrontal areas i.e. parts of area 9 and 10 of 
Brodmann) have their target sites on progressively more medially located strioso-
mes of the caudate nucleus (Goldman and Nauta 1977; Kiinzle 1978; Selemon and 
Goldman-Rakic 1985). These projections are continuous with those of areas 8 
(frontal eye fields) and 6 of Brodmann (Kiinzle 1978; Selemon and Goldman-Rakic 
1985). Projections of cortical areas 6 (premotor), 7, 8 (frontal eye fields) and 9 
(supplementary motor) apparently are convergent and project to adjacent longitu-
dinal domains of the neostriatum mediating many aspects of spatial function 
(Selemon and Goldman-Rakic 1988). They are terminated on themselves by the 
mediodorsal thalamic nucleus (Goldman-Rakic 1985). Medial and lateral orbito-
frontal cortices (belonging to areas 10,11 and 12 of Brodmann) project to central 
regions of the caudate matrix (Graybiel 1984, Selemon and Goldman-Rakic 1985), 
together with projections of the anterior cingulate cortex (area 24) and a minor 
basomedial amygdaloid projection (Ragsdale and Graybiel 1988). Limbic regions, 
particulary the basolateral amygdaloid nuclear complex, allocortical (entorhinal 
and piriform) and archicortical (hippocampal) areas project to striosomes of the 
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ventromedial caudate nucleus and to the ventral striatum, particularly the medial 
pan of the nucleus accumbens (mainly based on data fron rats, see: Swanson and 
Cowan 1979; Graybiel 1984; Nauta 1986; McGeorge and Faull 1989). Thus, the 
basolateral amygdala, like the hippocampus, serves as the hub of a circuit that 
constitutes the limbic system at the level ofcortex and thalamus (Nauta 1958,1986; 
Ragsdale and Graybiel 1988). The principal of ventral prefrontal areas projecting 
to more medial parts of the caudate nucleus than do dorsal prefrontal areas is also 
reflected in the topography of temporal lobe projections to the striatum (Van 
Hoesenetal. 1981). 
In conclusion, these findings seem to implicate the matrix in functions related to 
somatosensory and motor processing, whereas the striosomal system seems more 
closely related to conditional and affective components of behaviour (see also 
McGeorge and Faull 1989). The matrix might also be expected to be the primary 
target-site of visual and auditory cortices projecting to dorsomedial parts of the 
striatum in rats and cats (Faull et al. 1986; McGeorge and Faull 1989; Graybiel 
1989). 
The largest flow of information through the basal ganglia is comprised by 
the 'motor loop', which is the circuit most directly involved in the control of 
movement (Penney and Young 1983). Related basal ganglia inputs are derived 
from precentral motor, premotor, supplementary motor and postcentral somato-
sensory areas (including area 5) defined in the human cortex. Striatal terminations 
are mainly directed to the matrix of the dorsolateral caudate nucleus and putamen 
in a somatotopical way, such that the 'face' area has a terminal labeling located 
mainly within the ventromedial putamen (Fig.II. 14.) Likewise in rats, ventrolateral 
striatal ('putamen' in higher mammals) lesions increased the reaction times and 
produced impairments in the execution of both orofacial and forelimb movements 
(Pisa 1988) and putamenal neurons, but not caudate neurons (in primates) fire in 
relation to specific physical parameters of movement (Crutcher and DeLong 1984). 
Outputs from the striatum group together in the bundles known as Wilson's pencils 
and project topographically to the caudo-ventral part of both segments of the globus 
pallidus (mainly related to limb movement) and caudolateral SN pars reticulata 
associated with orofacial movements. Neuronal activity in the putamen and globus 
pallidus has been shown to be related to specific aspects of limb movements, 
including direction amplitude (or velocity) and load (Alexanderet al. 1986). Cells 
of the centrolateral SN pars reticulata were related to licking and chewing (DeLong 
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et al. 1983, 1985); those of the lateral portions were related to eye movements 
(Hikosaka and Wurtz 1983b), whereas the internal segment of the globus pallidus, 
mainly contains cells related to movements of extremities and other body parts 
(Evarts et al. 1984; DeLong et al. 1985). The final stage is from the internal segment 
of the globus pallidus and the SNr to the ventrolateral thalamus, closely associated 
with fiber bundles of the capsula interna. The major output of these thalamic nuclei 
is to the supplementary motor area (Schcll and Strick 1984), which apparently is 
the final destination of this extrapyramidal motor loop (fig.II.15.). 
Fig. II. 15 
Four main "loops" composing basal ganglia circuitry 
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The phenomenon of most basal ganglia cells with sensory input responding also 
electrophysiologically to movement, implies a convergence of sensory and motor 
inputfrom different cortical areas (DcLong et al. 1985; Malach andGraybiel 1986) 
An Oculomotor loop' is associated with cortical areas known tobe involved 
in the control of eye movements, i.e. area 8 (frontal eye fields), dorsolateral 
prefrontal areas 9 and 10 and posterior parietal cortex 7. Related projections from 
the body of the caudate nucleus (fïg.II.15.) are mainly directed to the most ventral 
and rostrolateral parts of the SN pars reticulata, which in tum send collaterals to 
thalamus and colliculus superior. (Scheel-Kriiger 1983, 1986; François et al. 
1984). This loop is closed by projections from the ventral anterior thalamic nucleus 
onto the frontal eye fields (Alexander et al. 1986), focussing inputs from several 
areas back onto a more limited region of the cerebral cortex. Alterations in part of 
this circuit produce saccadic distractability (Bruce and Goldberg 1984) a symptom 
which is gaining growing interest in the study of basal ganglia dysfunction, like 
Parkinson's disease and Huntington's disease (Evarts et al. 1984; Albin et al. 
1989). Various 'association' circuits, originating in prefrontal areas 9,10,11,12 
and posterior parietal cortex, with feedback projections to prefrontal, particularly 
orbitofrontal, areas m ay play a role in the mediation of behaviours other than simple 
motor (Alexander et al. 1986). A final loop running parallel to these motor loops 
is the 'limbic loop' of the ventral striatopallidal pathway. Although anatomical and 
physiological substrates of this limbic loop have been extensively studied in non-
primate mammals (Haberet al. 1985; Oades and Halliday 1987) the functional role 
of this circuitry in human clinical conditions is clearly speculative. 
Π.2.6.5. Mesolimbocortical circuitry. 
Whereas the SN and dorsal striatum are relatively large and differentiated in 
man, the nucleus accumbens and limbic midbrain area are large in rats and cats but 
small in man (Nauta 1958; Heimer and Wilson 1975; Carpenter 1981; see Fig 
II. 16.) The meaning of this evolutionary trend in terms of the importance of DA for 
cortical function is unknown (Weinbergeret al. 1988). The vast majority of cortical 
efferents received by the ventral striatum orginates from allocortical (including 
hippocampus, amygdala, entorhinal and perirtünal cortices) structures (Heimer 
andWilsonl975;SwansonandCowanl979;Nautaetal. 1978;Kelleyetal. 1982; 
Haber et al. 1985; Voorn et al. 1986) continuous with projections from other 
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associaüonal cortical arcas. Just as the major efferent projection from the dorsal 
striatum is to the dorsal pallidum so the nucleus accumbens sends a majority of its 
GABAergic containing spiny efferents into the ventral pallidum, as demonstrated 
for rats and cats (Mogenson 1983; Young et al. 1984) continuous with projections 
to VTA, medial SN, A8, 
hypothalamic areas, cen-
tral grey and nucleus teg-
menti pedunculopontinus 
(Heimer et al. 1982; 
Mogenson 1983; Groe-
newegen and Russchen 
1984). More differentia-
ted presumed projections 
of enkephalin-, dynorp-
hyn- and substance P-
containing fibers from the 
stnatum to the globus 
Fig иле pallidus and adjacent 
Comparison of basal forebrain structu-
the olfactory projection area and ventral res of the human brain 
striatal region between rats and human have been described by 
Heimer 78 (modified) 
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Haber and Watson (1985), raising the question of which area in the primate 
forebrain is homologous with the ventral pallidum in rats. Projections from the 
ventral pallidum and rostrodorsal part of the SN pars reticulata reach the mediodor-
sal thalamic nucleus in different species (Carpenter et al. 1976; Beckstead and 
Frankfurter 1982; Young et al. 1984), which in turn maintains reciprocal excitatory 
connections with the cingulate (area 24), frontal principal sulcal (in monkeys) and 
medial prefrontal cortices (Giguère and Goldman-Rakic 1988). This positive 
feedback circuit, much like that proposed for the striatum- SNr- ventral thalamus-
neocortex interactions, receives modifying DAergic midbrain influence from VTA 
projections (see also Penney and Young 1983). Ithas become clearthat this system 
is in many ways qualitatively distinct from the better-characterized nigrostriatal 
dopamine system. The mesolimbic projection is characterized by co-localization 
of dopamine with neurotransmitter substances like CCK and neurotensin (Hökfelt 
et al. 1980,1984; Zaborsky et al. 1985; Nemeroff 1988; Phillips et al. 1988) that 
might have important implications for human pathophysiology at the interface 
between the limbic (motivation) and motor system (Mogenson et al. 1988; Wang 
1988; Alhcid and Heimer 1988). A dorsal-ventral "switch", based on limbic and 
non-limbic portions and dorsoventral topography of DAergic mesostriatal projec-
tion systems suggests a limbic-to-motor polarity in the striato-nigral-striatal 
circuitry (Nauta and Domesick 1978; Groenewegen and Russchen 1984; Carpenter 
1986; Nauta 1986; see also Fig. III.15). 
Whereas the ventral pallidum and adjacent substantia innominata cells are 
under inhibitory control of striatal GAB Aergic output cells, a sequential GAB A-
to-GABA (ventral) striatal - ventral pallidal - dorsomedial thalamic circuit is also 
capable of exciting the corticothalamic circuitry through disinhibition, promoted 
by limbic cortical and VTA afférents (see van Rossum et al. 1977; Penney and 
Young 1983; Swerdlow and Koob 1987; Mogenson et al. 1988). These afférents 
provide a means to disrupt or change ongoing informational cognitive and 
emotional processes, thereby allowing for the initiation of new processes (Groves 
1983; Rowers and Robertson 1985; Oades 1985). But the complexity of these 
interactions is raised by the finding of more differentiated presumed peptidergic 
(particularly enkephalin-, dynorphin- and substance P) mediated influences within 
the human brain (Kalivas 1985; Haber and Watson 1985; Swerdlow and Koob 
1987; Kalivas et al. 1988). Likewise the uneven distribution of dopaminergic 
terminals in the ventral striatum has been shown to be parallelled by the uneven 
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parallelled by the uneven distribution of the neuropeptides enkephalin, substance 
Ρ and dynorphin, as well as ChAT and GABA-like immunoreactivity (Graybiel 
and Ragsdale 1983; Kwak et al. 1984; Voom et al. 1986; Bisctte and Nemeroff 
1988; Groenewegcn et al. 1989). Considering the extent of experimentation on 
mesencephalic dopaminergic systems in recent years and the complexity of their 
interactions with telencephalic structures it is not surprising that they have been 
focussed as a 'final common pathway' for a wide variety of psychiatric disorders 
(Stevens 1973; Tassin et al. 1977; Bunney 1977; Javoy-Agid and Agid 1980; 
Bannon and Roth 1983; Hardy et al. 1986; Sandyk 1986; Swcrdlow and Koob 
1987; Kalivas and Nemeroff 1988; Thierry et al. 1988; Rinne et al. 1989). 
Characteristic of this "final common pathway" is the regulation of DA receptors in 
the nucleus accumbens and dorsal striatum through its effects on the cortico-
subcortical glutamatergic pathways (Penney and Young 1983; Bannon and Roth 
1983; Glowinsky et al. 1984,1988), crucial for the passage of properly delimited 
limbic-cortical information (Glowinsky et al. 1984; Homykiewicz and Kish 1986; 
Mogenson et al. 1988). Much like traditional "motor-output" of the striatum, this 
information might be transformed at each hierarchically lower output level into 
information that becomes more and more related to the presence and context of 
environmental and internal stimuli (Cools et al. 1984b; Gelissen and Cools 1986). 
Just like parkinsonian hypokinesia, due to the consistently impaired execu­
tion phase of movements (Marsden 1982) and rigidity (Narabayashi 1983) was as­
sociated with nigrostriatal destruction (Bemheimer et al. 1973), there is a growing 
clinical evidence now of characteristic changes in cognitive processing associated 
with impairment of presumed mesolimbic projections (Tassin et al. 1977; LeMoal 
et al. 1977; Crow et al. 1978; Schneider 1984; Swerdlow and Koob 1987; Alheid 
and Heimer 1988; Glowinsky et al. 1988). As Birkmayer et al. (1983) stated: 
"В radyphrenia is the psychic correlate to akinesia". It is most thoroughly documen­
ted in progressive supranuclear palsy and Parkinson's disease (Taylor et al. 1988; 
Dubois et al. 1988), in which cognitive processing is slower than in control 
subjects, matched for the speed of motor activity (Rogers 1986).Bradyphrenia is 
uncharacteristic of cortical dysfunction and is to be distinguished from organic 
dementia (Rogers 1986; Cummings and Benson 1988). There is no deficit in the 
cristalline intelligence, but the patient is more easily distracted and his mental 
performance is very dependant on mood (Birkmayer et al. 1983). This association 
of motor-related and motivational or attention-directing ascending projections 
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through mesostnatal circuitry is also consolidated by the close relationship of these 
ascending dopaminergic projections to the isodendritic core of the reticular 
formation (Ramón-Moliner and Nauta 1966; Matthyse 1977; Hassler 1978; Moore 
1980; Rossor 1981; Agid et al. 1986; Nieuwenhuys et al. 1988). The interaction 
between motor-related and motivational (mesolimbic) ascending basal ganglia 
modifying projections has been suggested especially as regards certain nodal 
points, like the VTA, nucleus accumbens, lateral habenula and possibly nucleus 
tegmcnti pedunculopontinus (Iversen and Koob 1977; Nauta 1979,1986; Mogen-
sonet al. 1988; Sutherland 1982; Armstrong 1986; Parent 1986; Garcia-Rill 1986; 
Oades and Halliday 1987). 
The second important target site of VTA projections is the prefrontal cortex 
(Thierry et al. 1976,1988; Divac et al. 1978; Bannon and Roth 1983; Weinberger 
et al. 1988). Characteristically the mesocortical projection is less sensitive to DA 
synthesis inhibition through autoreceptor stimulation (Bannon and Roth 1983; 
Sayed and Garrison 1983; Glowinskyetal. 1988) and has been reported to develop 
less tolerance to chronic neuroleptic administration (Glowir ' , et al. 1984; 
Bunney 1988; Huntetal. 1988). Several preclinical studies underline the influence 
of the prefrontal cortex on subcortical systems (for reviews see Nauta 1971; Levici 
et al. 1984; Goldman-Rakic 1987). Frontal lobe dysfunction in patients with 
Parkinson's disease has gained much interest (Taylor et al. 1986,1988; Miller and 
DeLong 1988; Weinberger et al. 1988). One of the most consistent deficits 
observed in parkinsonian subjects is a failure to perform card sorting tasks, such 
as the Wisconsin Card Sorting Task, normally (Taylor et al. 1986), reflecting a 
deficit in the manipulation of mental sets (Growdon and Corkin 1986; Phillips and 
Carr 1987; Cummings and Benson 1988). The presence of various frontal-lobe 
related deficits in both Parkinson's disease and Schizophrenia (Matthysse 1977; 
Crow et al. 1978; Lees 1985; Taylor et al. 1986, 1988; Weinberger et al. 1988) 
reminiscent of disturbances found in dysregulaüon of mesolimbocortical circuitry 
in animal experiments, are most satisfactorily explained by abnormal activity 
within the association circuits of the basal ganglia (Crow et al. 1976; Miller and 
DeLong 1988; Laplanc et al. 1989; Rinne et al. 1989). The notion that thesemainly 
attention-related cognitive deficits might arise from a dysruption of dynamic 
interactions between DAergic terminal regions in the nucleus accumbens, prefron-
tal cortex and amygdala is a particularly evolving concept and deserves proper 
study (Clark et al. 1985; Sandyk 1986; Swerdlow and Koob 1987). 
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A core clinical syndrome of parkinsonian symptomatology, progressive 
dementia and behavioral disturbances (especially depression and mutism) has been 
suggested to be associated with the specific mesolimbocortical circuitry (Torack 
andMorris 1986,1988). Such a 'mesolimbocortical dementia' is strongly reminis-
cent of the controversial 'subcortical dementia'. Subcortical dementia is a clinical 
syndrome -the cardinal features of which are those identified by Albert et al. 
(1974)- characterized by slowness of mental processing, forgetfulness, impaired 
cognition, apathy and disturbances of mood (Cummings and Benson 1984,1988; 
Freedman and Albert 1985 ; Brown and Marsden 1988). Similar to motor disturban-
ces in Parkinson's disease, neuropsychological mechanisms of subcortical demen-
tia were thought to involve deficits in timing and activation (Freedman and Albert 
1985; Cummings and Benson 1988). Essentially this can be considered as an 
impaired ability to manipulate acquired knowledge. The syndrome contrasts with 
dementia of the Alzheimer type in which primary cortical involvement produces 
aphasia, combined recall and recognition deficits. The most typical disorder in 
which this subcortical dementia syndrome has been described is progressive 
supranuclear palsy (Steele et al. 1964; Albert 1974,1978; Agid el al. 1986; Dubois 
et al. 1988; Goulding et al. 1989) in which the primary site of lesion is still 
controversial. Similarities with the characteristic slowing of cognitive processing, 
mentioned before (see also Habib and Poncet 1988), are significant. The pathologic 
changes are concentrated in the globus pallidus, subthalamic nucleus, red nucleus, 
SN and rostral brainstem (Steele et al. 1964,1988). At the actual state of knowledge 
it is not possible to relate these changes to one of the specific loops described before, 
but it is tempting to speculate on the possible involvement of the oculomotor and 
closely related limbic loop. But 'subcortical dementia' is primarily a clinical and 
not an anatomical concept (Cummings and Benson 1984; Freedman and Albert 
1985; Schulte 1989). Retrospectively it occurs in diseases where various patholo-
gical changes involve primarily deep gray matter structures, like thalamus, basal 
ganglia and related brainstem nuclei, but also hemispheric white matter tracts 
(Cummings and Benson 1988). Whereas subcortical dementia primarily is a 
disease of ascending subcortical projections, with relative sparing of the cerebral 
cortex, dementia of the Alzheimer's type only secondary seems to affect subcor-
tical structures like nucleus basalis (Vogels 1990) and VTA (this thesis). The 
development of neurofibrillary tangles in the perforant pathway, in the absence of 
senile plaques, as described by Torack and Morris (1986,1988) in their 'mesolim-
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bocortical dementia' cases, might be related to diminished dopaminergic input. 
The VTA abnormalities are always associated with similar cell loss and gliosis in 
other subcortical nuclei, notably the LC, NRd, basal ganglia and nucleus basalis. 
Disorders manifesting subcortical dementia are progressive supranuclear palsy, 
Huntington's disease, Parkinson's disease, Wilson's disease, spinocerebellar 
degeneration, idiopathic basal ganglia calcifications, the lacunar state and the 
dementia syndrome of depression (Cummings and Benson 1984,1988). Various 
vascular and inflammatory conditions involving the basal ganglia and thalamus, 
like multiple sclerosis and the AIDS-dementia complex (Nielsen et al. 1984; 
Navia et al. 1986; Diederich et al. 1988; Brew et al. 1988a,b) may lead to a 
comparable dementia syndrome. Whitehouse (1986b), reviewing clinical neuropa-
thological and neurochemical studies, found little support for classifying demen-
tias into "cortical" and "subcortical" types. 
Phillips et al. (1987) described a patient with apathy and loss of volition, 
anterograde amnesia and altered arousal after repair of a ruptured anterior commu-
nicating aneurysm. Postmortem examination of the brain revealed bilateral de-
struction of the septal gray, nucleus accumbens and of the nucleus of Broca's 
diagonal band, inferior portions of the anterior limb of the internal capsule and 
globus pallidus. This patient's septal lesion might have destroyed many connec-
tions of the medial forebrain bundle, contributing to the altered state of arousal 
(Phillips et al. 1987). Similar case studies have recently been provided by LaPlane 
et al. (1989) and Katz et al. (1989). Infarcts due to disruption of the perforating 
branches of the proximal anterior cerebral and communicating arteries might 
underly some cases of the subcortical arteriosclerotic encephalopathy of Binswan-
ger's diseases (Caplan 1978,1985; Zeumeretal. 1982; Fisher 1982,1989) in which 
slowness of mental processing is the predominant sign (Cummings and Benson 
1984) and frontal lobe symptômes seem to predominate (Ishii et al. 1986). Ross and 
Stewart(1981) described a patient with devastating akinesia after surgical removal 
of a tumor from the anterior hypothalamic area, who lacked other parkinsonism 
features like tremor and rigidity, and who improved on treatment with lergotrile 
and bromocriptine. They concluded that akinetic mutism, which is distinct from 
rigidity and tremor of parkinsonian patients, may relate to a loss of dopamine 
modulation of the anterior cingulate cortex or other corticolimbic structures. Such 
reports are reminiscent of those in older literature referring to defects in the 
ascending reticular activating system (Dale and Lowe 1958; Neumann and Cohn 
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1967; Neumann 1968; Fisman 1975). Selective involvement of the nucleus basalis 
of Meynert may cause disturbances in memory and arousal, with otherwise 
preserved intellect (Mcsulam et al. 1983b; Phillips et al. 1987). Indeed the basal 
nucleus also has been suggested to represent a tclencephalic extension of the 
reticular formation of the brainstem (Mesulam et al. 1983a,b, 1984; Mann et al. 
1984a; Parent et al. 1986). 
Compared with other diseases in which dementia occurs, Parkinson's is 
distinct because of the lack of significant language impairment or agnosia 
(Freedman and Albert 1985; Lees 1985). Since the strongest predictors of the 
overall performance on the mini-mental state evolution in Parkinson's disease were 
bradykinesia and rigidity (see Ball 1984) a distinct parallel between clinical 
indications of dysfunction of the basal ganglia and the intellectual impairment 
might be drawn (Mortimer et al. 1982; Girotti et al. 1988). No association has been 
observed between the presence of cortical atrophy and the mental function, whereas 
ventricular enlargement on CT scans is no unusual finding (Growdon and Gorkin 
1986). The degenerating neurons in AD often contain neurofibrillary tangles 
(Ch.III.), whereas those in Parkinson's disease or 'mesolimbocortical demenlia' 
contain Lewy bodies (Greenfield and Bosanquet 1953; Forno 1986; Sima et al. 
1986; Gibb 1989a). Although the same structures appear to be involved in both 
diseases, the varying pattern of neuronal degeneration suggest that their pathoge-
nesis is not the same. Future studies must confimi the presumptive dopaminergic 
deficit and examine other terminal sites, including nucleus accumbens, septal 
nuclei and the olfactory tubercle, for their association with clinical manifestations. 
In Parkinson's disease the VTAmay be ovcrlookedbecause the usual pattemof cell 
loss involves the dorsolateral rather than the ventromedial region of the SN (see 
Morphometric section, Ch.III.). Neuron loss in the VTA and medial SN could be 
primary in Parkinson's disease and 'mesolimbocortical dementia', and secondary 
in AD (Hardy et al. 1986; Mann et al. 1987). 
The general view evolving from this chapter might be summarized as follows: 
1. Basal ganglia circuitry, or the extrapyramidal system, is composed of several 
'loops' in relative balance and with opposing neurochemical forces including 
hyper or hypo-activity. 
2. Whereas different circuits are closely related to different functional aspects of 
striatal function, ascending (reciprocal) dopaminergic projections serve to modify 
a descending cortico-striato-thalamic information stream. 
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3. Although a clear overlap within these anatomical trajectories is stressed by most 
authors, generally medially placed SN and VTA projections are characteristically 
connected with cognition and motivational aspects, whereas laterally placed 
dopaminergic neurons of the SNc are characteristically involved in the extrapyramidal 
motor circuit. 
4. Because of its involvement in cognitive and emotional processing, the mesolim-
bocortical projection is very likely to be associated with the typical ' subcortical ' 
type of dementia, the features of which mainly concern attention deficits and 
manipulation of available knowledge. 
5. It is tempting to speculate on dementia of the Alzheimer type to be primarily a 
cortical disease (with secondary involvement of subcortical structures, including 
eventually mesolimbocortical structures) and of subcortical dementia being prima-
rily caused by dysfunction of basal forebrain, basal ganglia and thalamic nuclei and 
their projections, with only secondary cortical involvement. 
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II.2.7. An atlas of the human mesencephalon and rostral 
rhombencephalon 
П.2.7.1. Introduction 
Based on the visualization of neuromelanin-containing neurons, the sub­
stantia nigra can easily be distinguished macroscopically in the human brainstem 
in its rostral part (locus niger crurum cerebri, Vicq d'Azyr 1786). The substantia 
nigra is generally subdivided into a cell-dense pars compacta and a cell-sparse pars 
reticulata, as first described by Cajal( 1909), based on Nissl-stained sections. A pars 
lateralis extends from the lateral border of A9 towards the dorsolaterally situated 
corpus geniculatum mediale (Bauer 1909),described as area M by Sano (1910). 
Various subdivisions for the human substantia nigra as well as adjacent structures, 
such as the ventral tegmental area, have been suggested. The historically grown 
differences in nomenclature are shown in table II.2.a,b. Criteria used for subdivi­
sion variably stressed cytological (Poirier et al. 1983; Braak and Braak 1986), 
hodological (Francois et al. 1985; Parent 1986) and biochemical (Wassef et 
al.1981; Waters et al.1988) data, leading to a sometimes rather confusing nomen­
clature. Several allasses with subdivisions of mesencephalic catecholaminergic 
grísea in the human brain are available (Foix and Nicolesco 1925; Winkler 1929; 
Hassler 1937; Olszewski and Baxter 1954; Riley 1943; Crosby et al. 1962; 
Nieuwenhuys et al. 1988). The classic woric of Foix and Nicolesco (1925) is of 
special value, because it includes the situation in aging and Parkinson's disease. 
The same holds for the detailed studies of Hassler (1937,1938), although his 
extensive description of pars compacta subnuclei is hardly applicable. Olszewski 
and Baxter's atlas (1954) gives a clear view of Nissl-stained sections, mostly 
referred to in literature. Riley's atlas (1943), based on Klüver-Ваігега stained 
sections presents additional information on fiber tracts, also in horizontal and 
transversal sections. The terminology used for (sub)nuclei in the human substantia 
nigra and the ventral tegmental area, basically follows Braak and Braak's (1986) 
and Halliday and Törk's (1986) studies, respectively. Neuromelanin containing 
neurons can be found throughout the mesencephalon (Foix and Nicolesco 1925; 
Feiten and Sladek 1983; Bogerts 1981; Saper and Petito 1982), dorsally bordering 
the deep layers of the superior colliculus and medially through different midline 
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structures. There is a continuity with pigmented neurons in the locus coeruleus and 
subcoeruleus caudally and the nucleus raphe dorsalis medially (Bogerts 1981). 
Because of the close association with nucleus ruber neurons, Foix and Nicolesco 
(1925) introduced the term "formation cupuliforme peri-retro-rubrique" which 
reaches its greatest extension at the caudal pole of the nucleus ruber. 
Dahlström and Fuxe's (1964) terminology in the rat brain for this cell con-
tinuum, based on the Falck and Hillarp histofluorescence technique: i.e. A9 for the 
substantia nigra, AIO for adjacent neurons mainly related to the nucleus tegmen-
talis ventralis of Tsai (1925) and A8 for a retrorubral cell cluster, is generally 
accepted and overlaps with the topography of melanin-containing cells and 
catecholaminergic cells in the human brain (Nobin and Björklund 1973). Closely 
related are various structures/nuclei of the "deep tegmental gray" (Crosby et 
al. 1962), such as the nucleus tegmenti pedunculopontinus, the nucleus centralis 
superior and the nucleus tegmentalis laterodorsalis (Gudden), structures that also 
could be involved in Alzheimer's disease and Parkinson's disease (Ishii 1966; 
Yamada and Mchraein 1977; German et al.1987; Jellinger 1988; Ohm and Braak 
1988; Zweig et al. 1988). A functional relationship with concepts as that of the 
formatio reticularis is considered since long, in spite of the limited knowledge 
about such an entity (Winkler 1929; Crosby et al. 1962; Nauta 1979; Moore 1980). 
From a pathophysiologic point of view it would be important to know if neuropa-
thological findings really spread through these subcortical nuclei (Neumann 1968; 
Saper et al. 1987) on which some etiological considerations about Alzheimer's 
disease are based (Rossor 1981). 
There is no general consensus concerning cytological criteria on which a 
cytoarchitectonic subdivision could be based in the human substantia nigra (Parent 
1986). In their fundamental work, Foix and Nicolesco (1925) presented general 
characteristics of cell body and neural processes, concerning nigral as well as 
perirubral pigmented neurons. For subdivisions, however, they only referred to 
other classical studies. On the other extreme, Hassler(1937) gave a detailed 
subdivision of the substantia nigra, without describing cytological details (only 
naming some differences in cell size). Olszewski and Baxter (1954) paired 
topographical data with cytological details. Hassler's approach was followed and 
extended with neuropathological data, by e.g. Beheim-Schwarzbach (1956) and 
Bemheimeret al. (1973). Al though these authors gaveimportant information about 
localized cell-loss and pathologic changes, they do not provide cytological 
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information on which a subdivision of nigral cells could be based. 
More recently, Braak and Braak (1986) made an attempt to correlate 
cytological features to a cytoarchitonic subdivision of the substantia nigra. The 
subdivision of the ventral tegmental area as proposed by Halliday and Törk (1986), 
offers less details about cytologic features, although some typical aspects are 
referred to. A subdivision in nigro-slriatal projection neurons is mainly based on 
functional considerations (Shephard and German 1988). Within the substantia 
nigra pars reticulata nerve cells are of different size and shape and are often devoid 
of neuromelanin granules, but may contain considerable amounts of lipofuscin 
pigment (Barden 1981). They are scattered among dendritic processes (Braak and 
Braak 1986), probably originating from pars compacta neurons (Rinvik and 
Grofova 1970). A further subdivision of the pars reticulata cannot be proposed on 
the basis of pigmentoarchitectonic analyses (Braak and Braak 1986). The same 
authors further distinguish three general types of nerve cells on the basis of soma 
size and shape, features of the cellular processes and the pigmentation. Type I 
neurons are mainly found in the pars compacta and pars diffusa. Their mean 
greatest diameter is about 50 μτη. This medium-sized to large cell body, fusiform 
or less often polygonal, gives rise to two to six radiating dendrites, which 
occasionally branch off, one of the dendrites extending into the pars reticulata. 
Only neurons of the "pars diffusa" portion may send dendrites into the perirubral 
formation. Thorny appendages are richly present, but only a sparse number of 
spines are generally encountered along the dendrites. The axon arises from cell 
bodies or from proximal portions of primary dendrites, devoid of melanin granules. 
Type I neurons contain numerous elongated patches of intensely stained Nissl 
bodies and various amounts of neuromelanin granules. Nissl bodies as well as the 
nucleus are usually eccentrically located (Braak and Braak 1986). In literature the 
typical pars compacta projection neurons are generally identified, in different 
species, as medium sized neurons with long, relatively unbranched dendrites. 
Apart from their spread in the pars compacta, portions of at least one dendritic 
process extend ventrally among the fibers of the cerebral peduncle (Winkler 1929). 
Otherportions may spread medially into the ventral tegmental area, or dorsally into 
the retrorubral area. Their axons may ascend laterally towards the corpus striatum 
or medially into the median forebrain bundle ( Cajal 1909; Winkler 1929). 
Type II neuron, with mean maximal diameter about 34 (im., are mainly 
found within the pars reticulata and pars diffusa. These cells can be either 
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multipolar or typical elongated, depending on the number of primary dendrites. 
Only the distant portion of these may bear some clusters of spines. Transparant 
Golgi impregnations counterstained for pigment showed the type II neurons to be 
devoid of neuromelanin deposits and often even devoid of lipofuscin pigment. In 
the Nissl stained material this aspect is less well clear, because of the intensely 
stained Nissl substance sharply contrasting to the pallid ground cytoplasm. 
Probably these cells correspond with the subclass С1 of Marchand et al. (1979) in 
which they described the typical "Tigroid " in the monkey substantia nigra. These 
basophilic patches, more uniformly distributed around the nucleus, do not extend 
into the dendrites, a feature that helps to distinguish between type I and type II 
neurons (Braak and Braak 1986). The nuclear membrane shows numerous small 
infoldings, as were also described in the rat (Schwyn and Fox 1974) and the monkey 
(Poirier et al. 1983; see also table II. 1). Not all pars reticulata neurons comply with 
these features and details on the pars lateralis neurons are not given, in contrast to 
the clearly defined subset of pars lateralis neurons in the monkey (Marchand et al. 
1979; Poirier et al. 1983; Francois et al.1984,1985). 
Type III neurons, probably intemeurons (Francois et al. 1979), are generally 
smaller, with mean diameter about 16 μτη. The few dendrites arc devoid of spiny 
appendages and have only few branches, contrary to the axon. Several filiform 
processes are described with small varicose swellings. Type III neurons contain 
lipofuscin granules that arc smaller than neuromelanin granules and stain intensely 
with aldehydefuchscin. Intemeurons are more thoroughly described in animal 
species (Francois et al. 1979; Braak and Braak 1986). 
Because of the greatvariaüonin soma size, also stressed in literature (Rinvik 
and Grofova 1970; Schwyn and Fox 1974; Domcsick et al.1983; Parent 1986; 
Halliday and Törk 1986; Braak and Braak 1986) cell body size is not a reliable 
criterion for subdivision. Neurons of various subnuclei of the pars compacta have 
many features in common and are considered local variations of a single neuronal 
type (Braak and Braak 1986). Other characteristics have to be used (see table II. 1). 
The nucleus parabrachialis pigmentosis, e.g., is hard to distinguish from the 
substantia nigra pars compacta dorsally unless special attention is paid to the 
mediolaterally orientation of these relatively small neurons (see also Olszewski 
and Baxter 1954; Halliday and Törk 1986). The nucleus paranigralis is continuous 
with the subnucleus anteromedialis but its neurons are more stellate, smaller and 
directed towards the more dorsomedially located inteipeduncular nucleus. The 
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nucleus interfascicularis contains small round cells (Halliday and Törk 1986). 
Neuromelanin containing neurons of the midline structures (nucleus linearis 
rostralis and caudalis) are often oriented ventrodorsally and are topographically 
clearly isolated from other ventral tegmental nuclei. They are the most variable in 
size and shape (Halliday and Törk 1986). Generally the ventral tegmental area, like 
the pars reticulata, contains relatively more neurons without neuromelanin pig-
ment, and catecholaminergic cells may be underestimated relative to TH-immuno-
reactivity especially in its lateral and dorsal parts (Gaspar et al. 1983). Variouscell 
types can be found here (Olszewski and Baxter 1954; Halliday and Törk 1986), 
manyof which contain considerable amounts of lipofuscin (Barden 1981). Cellular 
orientation generally follows morphological characteristics of surrounding struc-
tures, like the lemniscus medialis, root of the oculomotor nerve, fasciculus 
rctroflexus and nucleus ruber. The distinction between dopaminergic and non-
dopaminergic neurons as proposed for the non-human substantia nigra (Poirier et 
al. 1983; Domesick et al. 1983) finds its counterpart in the human brain in 
neuromelanin containing neurons (Type I of Braak and Braak 1986) vs. unpigmen-
ted neurons (Homykiewicz 1966; Bogcrts 1981; Saper and Perito 1982). Morpho-
metric analysis of different pigmento-architectonic areas might correspond with 
that of TH-studies (Pearson et al. 1979,1983a; Hirsch et al. 1988). Another 
important correspondence with studies on different non-primate species (see 
Ch.II.2.2.) is the similarity of pars reticulata neurons with those of the globus 
pallidus internus (Marchand et al. 1979; Nauta et al. 1978; Nauta 1979; Yelnik et al. 
1984,1987; Huber 1985; Parent 1986). A complementary association between 
substantia nigra pars compacta and external pallidum is only hypothetical (Nauta 
1979; Alexander et al. ^Só^dorsal pallidum"). 
II.2.7.2. Cytoarchitectomc subdivisions 
The human substantia nigra and ventral tegmental area cover the entire 
length of the mesencephalon. Their rostral border is found at a plane connecting 
commissura posterior dorsally, and corpus mamillarc, ventrally (see Fig.II.17.). 
The caudal border is present at a plane, parallel to the former, right behind the 
colliculus inferior, passing through the pons. In defining subnuclei, as well as area-
size, comparison with data in literature (Winkler 1929; Hassler 1937; Braak and 
Braak 1986) is often difficult, because of the varying plane of section and of the 
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arbitrarily way of taking subdivisions from various allasses. The use of "frontal" 
sections (e.g. Hassler 1937) i.e. perpendicular to the intercommissural axis (the line 
connecting commissura posterior and commissura anterior) resulted in a termino-
logy in which rather anteriorly located subnuclei arc named "postero" - lateral, 
which we will nevertheless follow for reasons of consistency. The description of 
a substantia nigra in an arca as given by Braak and Braak (1986): "...from the 
latitude of the oculomotor nucleus to the caudal pole of the mamillary bodies" can 
also be explained in this way. Our sections were chosen perpendicular to the axis 
Level of transection and angle of transection compared with 
similar studies in literature 
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of the brainstem, as is usually done in an atlas of the human brainstem (Olszewski 
and Baxter 1954; Nicuwenhuys et al.1988). Following François et al.(1985) we 
chose eight levels, which will be discussed subsequently. Because of the slanting 
position of the substantia nigra in relation to the intercommissural line, the crossing 
points of their transections with the substantia nigra can also be used in chosing our 
levels of transverse sections (Fig.II.17.). 
Some variation exists in the position of different nuclei in relation to each 
other. Together with only seemingly subdivisions due to fiber course (Rinvik and 
Grofová 1970) these facts prompt to limited classi fication into subnuclei, contrary 
to Hassler's (1937)approach (Braak and Braak 1986). For the same reason itis hard 
to define whether the most rostral extension of the neuromelanin containing cell 
clusters is occupied by the ventral tegmental area (Crosby et al. 1943,1962), the 
substantia nigra pars reticulata (Hasslcr 1937; Berman 1968; Schwyn and Fox 
1974; François et al. 1984) or the substantia nigra pars compacta. 
An atlas of the human mesencephalon and rostral rhombencephalon 
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F.gs II 18-25 
Transections through the human mesencephalon from rostral to 
caudal, based on Nissl and Klüver - Barrera stained sections of 
brains of people >60yrs 
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Following François et al.'s (1985) description for the monkey brain, eight 
levels through the human brainstem will be discussed, (for reference in the human 
brain: Talairach and Toumoux 1988). In the first section (Fig.II.18.), through the 
commissura posterior and the corpus mamillare, a small cluster of neuromelanin 
containing cells is found at the ventromedial border of the nucleus subthalamicus, 
surrounded by neuromclanin-sparse neurons of the pars reticulata (rab, Hassler 
1937). This cluster represents the rostral tip of the subnucleus anteromedialis 
(Sam, Hassler 1937) of the parí compacta. Between this cell group and the corpus 
mamillare some, densely stained, neuron clusters can be seen. Because of the 
presence of neurofibrillary degeneration here (see Ch.III) in Alzheimer's disease 
brains, it seems worthwile to define these nuclei. Crosby et al.( 1962) noted that the 
nucleus lateralis of the corpus mamillare often is not well developed in man, just 
like the nucleus of the tractus pcduncularis transversus (Riley 1943). The latter 
nucleus is comparable to the nucleus of the accessory optic tract (Sano 1910; Poirier 
et al. 1983) and nucleus opticus tegmenti as defined in the opossum (Tsai 1925). 
Hassler (1937) defined a nucleus intercalatus of Ingram, apparently as part of the 
nucleus lateralis of the corpus mamillare (Crosby et al. 1962). Likewise ill-defined 
are the supramamillary and the interstitial nucleus of the pedunculus mamillare 
(Crosby et al.1962; Poirier et al.l983), at the place where Tsai (1925) defined his 
nucleus tegmentalis ventralis. Actually, the dorsal part of this area is considered 
as a transition zone between the caudal hypothalamic border and the ventral 
tegmental area, part of Nauta's (1958) "limbic midbrain area" (extending upto the 
nucleus centralis superior,more caudally) and "area densa" in the atlas of Riley 
(1943). 
At slightly more caudal levels (Section II, Fig.II.19.),a nucleus linearis 
rostralis can be distinguished, based on the presence of neuromelanin in the 
midline. From this level on, such pigmented neurons are rather diffusely spread 
throughout the midline structures, up to the raphe nuclei at the pontine level. From 
here on a rather well developed substantia nigra can be observed. Hassler(1937) 
divided the anteromedial pars compacta (Sam) into four subdivisions (α, β, γ, δ) 
of which γ probably is identical with the nucleus paranigralis. Again, his antero-
intermediary nucleus is subdivided into three divisions (πι,ζ,Ι) and laterally 
bordered by the anterolateral nucleus (Sai,SaI). At this rostral level we define two 
clearly distinguishable subnuclei of the anterior pars compacta: subnucleus ante­
romedialis (Am) and subnucleus anterolateralis, or anterointermediolateralis, 
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Fig II 20b 
Microscopical section similar to Fig.20a (Klüver-Barrera(x9) 
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(Ai-1). A subnucleus anterolateralis is particularly distinct in horizontal sections. 
Following Braak and Braak's (1986) description the latter subnucleus can be 
divided in an intermediary and a lateral part. A further subdivision, based on the 
flnger-likc extensions in ventral direction, does not seem practical. The ventral 
tegmental area is well developed now, constituted by the nuclei linearis rostralis, 
paranigralis and parabrachialis pigmentosus (Halliday and Törk 1986), taken 
together by Hassler (1937) as the putamen nuclei rubri ("Ruberschalc"). 
The nigral subnuclei are surrounded by neurons and fibers of the pari reticulata, 
mainly between the densely neuromelanin containing compacta neurons and 
pedunculus cerebri. Laterally the pars reticulata contains the pari lateralis, the 
latter showing slightly more pigmented and some larger neurons. The pars lateralis 
extends into the nucleus peripeduncularis (Olszewski and Baxter 1954). 
At the level of the rostral border of the oculomotornerve, about 1 mm. behind 
the caudal pole of the corpus mamillare (section III,Fig.II.20.) the ventral tegmen-
tal area is penetrated by oculomotor nerve fibers, partly masking its existence. A 
separate nucleus linearis intermedius (Crosby et al. 1943) could therefore not be 
demarcated, although some neuromelanin containing neurons can be found. The 
substantia nigra pars compacta now clearly can be divided into a subnucleus 
anter omedialis, antero(intermedio) lateralis (part of pars γ of Olszewski and 
Baxter 1954) and posterolateralis. The latter subnucleus (pars α of Olszewski and 
Baxter 1954) is located more ventrolaterally (Braak and Braak 1986) The pars 
lateralis is well developed now in the most fibrous region bordering the pars 
reticulata (Poirier et al.1983; Giguèrc and Marchand 1983; Francois et al.l985). 
The impression based on our material confirms that of Yelnik and co-workers 
(1987), based on dendritic arborizations, that this part actually belongs to the pars 
reticulata (see also Schwyn and Fox 1974). 
In older comparative studies it was already noted that this extension, between the 
cerebral peduncle and the corpus gcniculatum mediale, is particularly well-
developed in the primate brain (Crosby et al.1943; Francois et al. 1984). Part 
of the posterolateral and especially posterosuperior subnuclei represent the "in-
termediate" cell group, as described by several authors (Bauer 1909; Winkler 1929; 
Crosby et al.l943; Riley 1943; Poirier et al. 1983). They correspond to pars α and 
β as distinguished by Olszewski and Baxter (1954). 
Hassler (1937) defined various parts of the posterolateral subnucleus: Spz and Spe, 
the latter being subdivided again in parts v,z,d. His Spd with its two parts, 
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corresponds to our subnucleus posterosuperior. 
At the caudal pole of the nucleus ruber (section IV,Fig.II.21.) fibers of the 
oculomotor nerve leave the bulk of the midbrain tegmentum. Oculomotor nerve 
fibers pass through the most medial part of the pars compacta, while the lateral parts 
of the pars compacta (subnucleus posterolateralis and posterosuperior) are shifted 
to a more ventral position. The pars lateralis is well developed now. A separate 
subnucleus, like Braak and Braak's (1986) nucleus magnoccllularis, correspon-
ding to Sped of Hassler (1937) can not be defined because of the rather diffusely 
spread neurons in this fibrous area (Schwyn and Fox 1974). 
The subnucleus posterosuperior occupies part of, what Braak and Braak 
(1986) called "pars diffusa", and Francois et al. (1984) the "pars mixta". Like the 
"stratum intermedium" (Sano 1910) such names provide no furtherinformation on 
the reticulata-like surroundings of the pars compacta subnuclei. Therefore the 
whole nigral extension surrounding pars compacta subnuclei is termed pars 
reticulata in our investigation. The dorsally adjoining nucleus parabrachialis 
pigmentosus, however, should be distinguished from this nigral extension, since 
it belongs to the ventral tegmental area (Halliday and Törk 1986), and not to a 
"pars dorsalis of the substantia nigra" (Poirier et al. 1983). At this level, however, 
a clear border between substantia nigra and ventral tegmental area is hard to define, 
unless an imaginary connection line between the more clearly demarcated medial 
and lateral parts is supposed. Ventral tegmental and midline nuclei are largely 
replaced by descending oculomotor fibers. 
About one millimeter behind the nucleus ruber (section V, Fig.II.22) the ventral 
tegmental area shows its most typical configuration (Halliday and Törk 1986). In 
the midline neuromelanin-containing neurons are still sparse and a separate 
nucleus linearis intermedius (Crosby et al. 1962) or linearis centralis (Berman 
1968; Halliday and Tork 1986) is hardly distinguishable in our material. 
Following Phülipson ( 1979a,b), who m ade a detailed study of this region in the rat 
(see also Ch.II.3), the cell cluster dorsally adjacent to the nucleus interpeduncularis 
is named nucleus interfascicularis. In sections cut perpendicular to the axis of the 
brainstem, however, this nucleus is found somewhat more caudally than between 
both fasciculi retroflexi. This area is continuous with the nucleus paranigralis 
(Hassler's Sam, γ) and the medial parts of the pars compacta. At this level still an 
anteromedial subnucleus can be distinguished, but also the beginning of the 
subnucleus posteromedialis. 
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The subnucleus posteromedialis is composed of here by less densely packed 
neurons in the ventral part of the pars compacta, again subdivided by Hassler 
(1937) in three parts: Spvm, Spvi and Spvl. 
Well over one millimeter behind the caudal pole of the nucleus ruber a 
subdivision of the pars compacta into a posteromedial and a posterolateral 
subnucleus becomes more pronounced (sections VI and VII, Figs.II.23 and 24). 
At this level the nucleus paranigralis is well developed, forming a continuum of 
substantia nigra and ventral tegmental area, but clearly distinguishable on cytolo-
gic grounds. Its perikarya are smaller, mostly oriented in dorsomedial direction and 
with somewhat less neuromelanin granules. Hassler (1937) defined an area mH 
here, also describing the continuity of midline structures, substantia nigra and the 
retrorubral extension of neuromelanin containing nerve cells. The latter area sill 
or suboculomolor part of nigral cells (Hassler 1937) represents area A8, (Table I) 
following the generally accepted nomenclature of Dahlström and Fuxe (1964). 
Bordering, and slightly overlapping, the lateral extension of the substantia nigra the 
nucleus tegmenti pedunculopontinus is found (Olszewski and Baxter 1954; 
Beckstead and Frankfurter 1982; Nieuwenhuys et al. 1988). 
In the midline the nucleus linearis caudalis (Halliday and Törk 1986) can 
be distinguished, continuous with the nucleus interfascicularis. There is a marked 
spread of neuromelanin containing nerve cells into surrounding nuclei. Thus, 
pigmented neurons also can be found in the nucleus raphe dorsalis, the nucleus 
tegmenti pedunculopontinus and the nucleus laterodorsalis tegmenti of Gudden 
(Bazelon et al. 1967). 
At the level of the colliculus inferior the nucleus raphe dorsalis is well developed 
and typically wing-shaped, hooking around the nucleus nervi trochlearis (section 
VII, Fig.II.24). It displaces the ventral tegmental area in the midline, whereas more 
laterally area A8 is expanding. Actually, at this level, apart from the nigral 
subnucleus posteromedialis and posterolateralis, hardly any demarcated subnu-
cleus within the neuromelanin containing cell continuum can be defined. Hassler 
(1937) described distinct paralemniscal subnuclei (hj) not distinguishable in our 
material. Possibly his paralemniscal nuclei are represented by the nucleus parabra-
chialis medialis, described by Olszewski and Baxter (1954) and the pigmented 
nucleus subpeduncularis, described by Ohm and Braak (1988:see also Table II.2b) 
Because of the growing interest on the mesencephalic locomotor region 
(Armstrong 1986; Garcia-Rill 1986,Garcia-Rill and Skinner 1988) and the lack of 
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detailed anatomical demarcation of this area (Nieuwenhuys et al. 1988) a more 
detailed cytoarchictectorüc map of the mesenccphalic-pontine transition area 
would be of need for defining various structures in this region. Itis remarkable that 
catecholaminergic neurons seem to spread throughout the grisea that form part of 
the ill-defined centrencephalic system (Crosby et al. 1962) or reticular formation 
(Rámon-Moliner 1975) as well as to the mesencephalic cholinergic nuclei as 
defined in the rat (Mesulam et al. 1989). 
In the most caudal section (section VIII, Fig.II.25), about ten millimeters caudal to 
the mamillary bodies, four main clusters of pigmented neurons can generally be 
distinguished: the caudal tip of the nucleus linearis caudalis, the nucleus parabra-
chialis pigmentosus and the subnucleus posteromedialis and posterolateralis of the 
pars compacta. Only a few intermingling pars reticulata neurons can be seen. 
Hassler (1937) distinguished a separated medial part (Spcg), which in our 
classification is part of the subnucleus posteromedialis. The nucleus linearis 
caudalis is bordered dorsally by the nucleus centralis superior (Olszewski and 
В axter 1954; Nieuwenhuys et al. 1988). The nucleus raphe dorsalis extends towards 
the other, pontine, raphe nuclei. The nucleus tegmenü pcdunculopontimis can be 
divided in a pars compacta and a pars dissipatus. The most rostrally situated 
neurons of the locus coeruleus can sometimes be seen at this level, continuous with 
the mesencephalic catecholaminergic grisea. In the Yakovlev collection, studied 
by Bogerts (1981) this area is clearly defined as A7, likewise extending into the 
pedunculopontine nucleus and the nucleus cuneiformis. 
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IL 2.7.3. Discussion 
Although an extensive literature on neuroanatomical and comparative 
aspects of the substantia nigra, ventral tegmental area and adjacent catechol aminer-
gic structures exists, many topographical inconsistencies nowadays lead to con-
fusion about new histochemical, function^ and pathophysiological concepts. Our 
purpose is to relate quantitative and neuropathologic findings to well-defined 
subnuclei. The nomenclature is primarily based on recent studies by Braak and 
Braak (1986) and Halliday andTörk (1986), whereas references to older literature 
are necessary to resolve inconsistencies originating from the use of different 
standard drawings, based on different planes of section (François et al. 1984). 
Apart from the variation among the smallest of Hassler's (1937) subareas, not 
consistent in localization (Braak and Braak 1986), some general topographical 
principles can be defined. In the broadest sense there is a border-line between two 
parts of the pars compacta, running diagonally from rostro- ventro-medial to caudo-
dorso-lateral (Hassler 1937). 
This dual subdivision seems to be confirmed also by hodological principles 
(Ch.Il.2.4.) and histochemical data (Ch.II.2.5). The medial pars compacta, again, 
can be subdivided in a medial to lateral direction, whereas the lateral pars compacta 
roughly tends to a composition in dorsal and ventral layers. The cell-sparse pars 
reticulata is not subdivided, unless different suggestions in literature (Winkler 
1929; Hassler 1937; Poirieretal.1983; Table II.2a). Winkler's (1929) intermediate 
nucleus corresponds to most of our antero-intermedio-lateral and posterosuperior 
subnuclei.partly extending into the pars reticulata, His medial nucleus also covers 
the area of the nucleus paranigralis. The stratum intermedium (Meynert 1874; Foix 
and Nicolesco 1925) however, belongs to the fibrous pars reticulata, which has led 
to some confusion about the indication "intermediate part" (François et al. 1985), 
sometimes defined as a separate nucleus intermedius (Riley 1943). The pars 
lateralis substantiae nigrae (Sano 1910) is the most fibrous part (Poirier et al. 1983), 
with neurons provided with a dendritic pattern like the pars reticulata (Rinvik and 
Grofová 1970; Schwyn and Fox 1974; Yelnik et al. 1987). It therefore can be 
considered as a lateral extension of the pars reticulata. In primates this lateral part 
is an important source of nigrotectal projection neurons (François et al. 1984), 
somewhat larger in size and often rather heavily pigmented. The nucleus magno-
cellularis (Braak and Braak 1986) is included in our nucleus posterolateralis, but 
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it is not ruled out that the larger pars lateralis cell bodies also raised the suggestion 
of a separated entity. Different cell types are intermingled here, however, and the 
smaller ones extend towards the rostro-dorsally located corpus geniculatum 
mediale (Crosby and Woodbume 1943; Crosby et al. 1962). More caudally such 
neurons are scattered into the region of the nucleus paralemniscalis and the nucleus 
tegmenti pedunculoponünus. Following Fix (1980) a separate nucleus subpedun-
cularis was distinguished here by Ohm and Braak (1988). 
Another nigral part, in which different neural types are intermingled ( pars mixta 
of François et al. 1985) is located dorsally of our subnucleus postcrolateralis, 
surrounding the subnucleus posterosuperior (Braak and Braak 1986). It was 
defined as compacta like (or "dorsal pars compacta") by several authors (Crosby 
and Woodbume 1943; Poirier et al. 1983; Graybicl and Ragsdale 1983; François et 
al. 1984,1985; Gerfen 1987a). 
Several less dense cell-clusters of which the subnucleus posterosuperior is the best 
recognizable are intermingled here with afferent and efferent fibers (Sano 1910; 
Crosby and Woodbume 1943; Nauta and Cole 1978; Parent 1986). 
Therefore, we considered the most cell-sparse part (pars difftisaof Braak andBraak 
1986) as part of the pars reticulata. It is continuous with the nucleus parabrachialis 
pigmentosus and this part of the ventral tegmental area probably has been misin-
terpreted as part of the substantia nigra by several authors (for discussion: François 
et al.l985).Diffcrent descriptions of the area of maximal cell loss in Paridnson's 
disease, like the "lateral portion" (Bogerts et al. 1983; Homykiewicz and Kish 
1986), a "mid-portion" (Bcheim-Schwarzbach 1956; Forno 1966 ), the "caudal 
portion" (Forno 1966) and the "ventral portion" (Foix and Nicolesco 1925; German 
et al. 1988b), and the "neonigrum" (Winkler 1929; Riley 1943), all refer to what we 
call the subnucleus postcrolateralis and posterosuperior of the pars compacta. 
The midline structures, or linear nuclei, seem to be the most variable in size 
and shape,whereas packing density and other criteria (including cell number, see 
table III. 17) sometimes show marked variation among different species (Halliday 
and Törk 1986). On the other hand a medial part of the ventral tegmental area is 
most consistently included in the ventral tegmental area in studies on the pathology 
of this entity (Bogerts et al. 1983; Oades and Halliday 1987; German et al. 1987; 
Gibb et al. 1989b). A subnucleus linearis centralis, or intermedius, often defined 
to indicate the transition zone between the nucleus linearis rostralis and nucleus 
linearis caudalis, could not be distinguished as a separate entity in our material. 
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Since this nucleus is well developed in the cat (Tabcr 1961, Berman 1968), this 
probably made Poirier et al. (1983) state that the "rostral linear" nucleus is unique 
for the cat brain. Rather the nucleus linearis rostralis is defined from the area 
between the nuclei of the oculomotor nerve and the nucleus ruber along its medial 
border in a dorsal to ventral extent. Only few pigmented neurons spread caudally 
into the area of the nucleus interfascicularis. Based on the appearance of neurome-
lanin containing cells, our subdivision seems to be most appropriate, also avoiding 
ill-defined entities like "pars vcnlralis of the nucleus supratrochlcaris" (Olszewski 
and Baxter 1954; Bogerts et al. 1983) and "nucleus niger suboculomotorius" 
(Hassler 1937; Bogerts et al. 1983). It may be concluded than that Tsai's original 
nucleus tegmentalis ventralis mainly covers our nucleus linearis rostralis, whereas 
A10, as defined by Dahlslröm and Fuxe ( 1964) mostly is represented by the nucleus 
paranigralis and nucleus interfascicularis. These subdivisions are separated by 
fibers of the oculomotor nerve, passing partly through the midline structures. In its 
largest extent, however, the medial part of the ventral tegmental area seems to be 
differently developed in the human brain in comparison to other species (Crosby 
and Woodbume 1943; Halliday and Törk 1986; sec also Rinne et al. 1989). 
There is general agreement about the subdivision of the whole mesencepha-
lic catecholaminergic, neuromelanin containing, cell continuum into three parts, 
A8, A9 and AIO, according to Dahlström and Fuxe (1964). This entity, again, 
forms part of the monoamine neuron system (Hillarp et al.1966), of which Moore 
(1980), referring to the concept of the reticular formation, stated: "These are neuron 
systems not classified by the conventional criteria.that is nuclear organization, 
neuronal morphology and differential connections, but rather on the basis of the 
neurotransmitter produced by neurons comprising them". Neuromelanin contai-
ning cells spread into surrounding regions, like cholinergic nuclei tegmentalis 
laterodorsalis of Gudden and tegmenti pcdunculopontinus, as well as pontine pa-
rabrachial nuclei (Olszewski and Baxter 1954; Bazelon et al. 1967; Marsden 1983). 
Next there is a continuity with the neuromelanin containing noradrenergic cells of 
locus coeruleus and subcoeruleus, as well as a spread into the serotonergic nuclei 
centralis superior and raphe dorsalis. Rostrally, neuromelanin containing neurons 
spread into the lateral hypothalamic zone, zona incerta and the nucleus pcripedun-
cularis. Of particular interest is the localization of pathologic findings in these 
transition areas (see Ch.III). In view of our findings, the substantia nigra and, more 
particularly, the ventral tegmental area, have a more diffuse topography than 
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generally assumed. The remarkable continuity with such entities as the ascending 
cholinergic reticular system (Shute and Lewis 1967), the isodendriüc core of the 
brainstem (Ramón-Moliner 1975) or the reticular formation (Hobson 1980), as 
well as the more recently proposed "paracores" (Nieuwenhuys 1985) are worth 
considering. 
The overlap in distribution of cholinergic and catecholaminergic neurons 
has been described in the ferret (Henderson 1987) and cat (Jones and Beaudet 
1987). ChAT-positive cells were described in the caudal pars reticulata in the rat, 
possibly of ponto-mesencephalo-tegmental origin (Gould and Butcher 1986). 
There has even been proposed a functional opposition of these neurochemical 
defined systems at ponto-mesencephalic level (Garcia-Rill and Skinner 1988). 
Interaction of dopaminergic and cholinergic signals (see McGeer and McGeer 
1984; Niijima and Yoshida 1988), as has been proposed since long for the striatum 
(Glowinski et al. 1980), may well have implications for pathophysiological 
concepts (McGeer and McGeer 1984; Jellinger 1988b; Freeman and Gibson 1988). 
Future research will deliver many more details on hodological, histochemical, 
cytological (dendritic patterns) and functional aspects of the overlap of catechola-
minergic neuromelanin containing nuclei with surrounding structures. 
130 
II.3. NEUROANATOMY OF THE LOCUS COERULEUS 
11.3.1. General morphology 
The largest accumulation of noradrenergic neurons in the human brainstem 
is a small cluster of blue-black stained cells in the dorsolateral pontine tegmentum, 
close to the fourth ventricle, surrounding the mesencephalic tract of the nervus 
trigeminus (Kemper et al. 1987; Nieuwenhuys et al. 1988). Because of its typical 
appearance caused by neuromelanin pigment, it was first identified in the human 
brainstem and named "locus coemleus" (for review see Russell 1955). In non-
primate species, where neuromelanin either is not present or can not be seen light 
microscopically, it was often considered as part of the adjacent trigeminal nuclear 
complex or related to the nucleus tegmentalis dorsalis (Crosby and Woodbume 
1943 ; Russell 1955). Identification as one of the main catecholaminergic brainstem 
areas followed with the formaldehyde induced fluorescence technique of Falck et 
al.(1962). The initial rat brain mapping studies were done in rats by Dahlström and 
Fuxe (1964), referring to the locus coemleus (LC) as area A6. Ungerstedt (1971a) 
provided data on the most important projections in his classic paper on monoami-
nergic projections. Similar studies on catecholaminergic neurons in the human 
fetal brain were done by Nobin and Björklund (1973) and Olson et al. (1973), 
whereas Hubbard and DiCarlo (1973) mapped these fluorescent structures in the 
monkey brain and Jones and Moore (1974), among others, in the cat 
After an initial spectrofluorimetric study by Farley and Homykiewicz (1977), 
the noradrenergic character of the locus coemleus is well-established now, by 
immunohistochemical staining of the rate-limiting enzyme dopamine-ß-hydroxyla-
se (DBH), in the rodent (Swanson 1976; Grzanna and Molliver 1980; Vincent 
1988) and human (Hartman 1974; Kemper et al. 1987; Chan-Palay and Asan 
1989a) brain stem. Several authors also reported acetylcholinesterase (AChE) 
containing perikarya in the LC (Palkovits and Jacobowitz 1974; Albanese and 
Butcher 1980; Satoh and Fibiger 1985), morphologically indistinguishable from 
noradrenergic cells. It even has been stated that all noradrenergic cells also are 
AChE-immunoreactive (Kimura and Maeda 1982). A cholinergic input, similar to 
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that of the nigral CA neurons (Lehman and Fibiger 1978; Satoh andFibiger 1985) 
is likely therefore. Indolamin neurons within or adjacent to the LC have been 
observed in the monkey brain (Schofield and Everitt 1981; Sladek et al. 1982; 
Feiten and Sladek 1983) and cat (Léger and Hemandez-Nicaise 1980). Further 
histochemical characteristics of this particular histochemically heterogenous area 
were reviewed by Nieuwenhuys (1985). Although lacking light microscopically 
visible pigment in most non-primate species, perikarya are always identifiable in 
routinely stained preparations, whereas its dense vascularization is another out-
standing uniform feature (Russell 1955;Footeetal. 1983). Bloodvessels appeared 
directly appositted to perikarya and dendrites in the monkey brain (Amarai and 
Sinnamon 1977; Foote et al 1983; Feiten and Sladek 1983). The close proximity 
of noradrenergic dendrites to the ependym led Demirjian et al.(1976) to suggest a 
possible neurosecretory or cerebrospinal fluid sensing function. A related noradre-
naline cell cluster in the area postrema of the human brain (Kemper et al. 1987) 
likewise is located strategically. Feiten and Sladek (1983) noted that zones of direct 
neuronal-vascular apposition without astrocyte interposition in monoaminergic 
nuclei appear to be a primate phenomenon. 
In their paper on LC functions, Amarai and Sinnamon ( 1977) concluded that 
there are important parallels with the functions of the sympathetic ganglia. 
Generally noradrenaline projections have been implicated in a number of physio-
logical and behavioral functions, as well as in neurological disorders (Van Dongen 
1980; Foote et al. 1983; Iversen et al. 1983; Tomonaga 1983; Mann étal 1983). The 
traditional view of a "pneumotaxic centre" (Russell 1955) certainly is outdated now 
and might eventually be applied to the adjacent parabrachial region with the 
nucleus of Kölliker-Fuse (Nieuwenhuys et al. 1988). Variable results from 
physiologic experiments at least partly were due to inconsistencies of demarcation. 
Similar inconsistencies might lead to variable results in quantitative studies (Swan-
son 1976). Cell-countings concerning the LC in aging and aging diseases are 
mostly restricted to the neuromelanin-containing neurons (Brody 1978; Vijayas-
hankar and Brody 1979; Bondareff et al. 1982;1986; Mann et al. 1982; 1983; 
Iversen et al.l983; Marcyniuk et al. 1986a,b; 1989). As regards the possibility of 
selective loss of melanin-containing neurons with aging (Mann and Yates 1974a,b; 
German et al. 1988a; Chan-Palay and Asanl989a; Marcyniuk et al. 1989) attention 
must be paid also to the less well defined unpigmented neurons within the 
pigmento-architectonically or immunohistochemically defined borders. Topo-
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graphie principles, mainly derived from animal studies, might account for the 
distribution of neuropathologic findings and cell loss (Marcyniuk et al. 1986a,b,1989; 
German et al. 1988a; Chan-Palay and Asan 1989a,b), but interspecies differences 
of the general distribution of the catecholaminergic neurons in the pontine tegmen-
tum caution for oversimplification of conclusions. 
The phylogenetic development of the LC, like that of the catecholamine 
nuclei in general, is proposed to parallel the elaboration of its cortical target areas, 
providing a remaricable low number of neurons innervating the extensive cortical 
and subcortical areas (Moore and Bloom 1978; Foote et al. 1983; Satoh andFibiger 
1985). A distinct LC, which projects to the forebrain, is not found until the reptilian 
and avian classes and Crosby and Woodbume ( 1943) continued to reduce both the 
nucleus LC and the nucleus laterodorsalis tegmenti to one common nucleus, even 
in man. Whereas the avian LC contains few hundreds of neurons, the LC in rats is 
composed of about 1600 cells (Swanson 1976; Loughlinet al. 1986a), in cats about 
9150 (Foote et al. 1983), the monkey (subspecies Macaca) about 6500-8250 and the 
human with counted numbers between 10.000 to 65.000 cells (Brody 1978; 
VijayashankarandBrodyl979;Bondareffetal. 1982,1986; German et al. 1988a; 
Baker et al. 1988, 1989; Chan-Palay and Asan 1989a). General organizational 
principles are recognizable in different species, but the merging of ventrolateral CA 
clusters with each other and with those of dorsal groups (especially LC) may reflect 
a more specific primate organizational feature (Feiten and Sladek 1983). 
Three groups, described separately by Dahlström and Fuxe (1964) in the rat 
(areas A4, A6 and A7) were therefore considered together as one group in both 
monkey (Hubbard and DiCarlo 1973) and cat (Jones and Moore 1974), where they 
are most loosely arranged (Berman 1968). Otherwise areas A4 and A7 are dealt 
with separately in primates (Feiten and Sladek 1983; Demirjian et al. 1976) and 
human brain (Braak 1970; Bogerts 1981; Saper and Petito 1982; Pearson et al. 
1983a). These areas also seem to have increased in relative size as compared to 
other mammals (Demirjian et al. 1976; Feiten and Sladek 1983). The most compact 
appearance of LC (A6) cells is seen in the rat brain, consisting of a dense 
accumulation of uniform appearance, ventrally bordered by a less dense smaller 
"subcoeruleus" area, of slightly larger cells (Swanson 1976; Grzanna and Molliver 
1980; Loughlin et al. 1986b). This A6 complex is easily distinguishable from the 
more caudoventrally located area A7 of Dahlström and Fuxe (1964). In all species 
the LC has its largest dorsal-to-ventral extension in the middle one-third, diminis-
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hing in size again caudally (Russell 1955; Jones and Moore 1974; Demirjian et 
al. 1976; Loughlin et al. 1986; Fig.II.26). 
Confusion exists, however, as regards the identification of the nucleus sub-
coeruleus. In the human brain it was often situated where Dahlström and Fuxe 
(1964) defined A7 (Olszewski and Baxter 1954; Russell 1955; Taber 1961; 
Berman 1968; Nobin and Björklund 1973; Bogerts 1981; Kemper et al. 1987), 
whereas "A7" was ascribed to the sparse rostroventral extension, continuous with 
A8 (Amarai and Sinnamon 1977; Léger and Hemandez-Nicaise 1980; Bogerts 
1981; Nieuwenhuys et al. 1988). Mapping studies in primates (Bogerts 1981; 
Tanakaetal. 1982; Feiten and Sladek 1983; SatohandFibiger 1985) arcoftenbased 
on frontal sections, in which the primate brainstem is cut obliquely (see also 
Fig.II.17). This explains, at least partly, the seemingly rostral localization of A7, 
originally described "....at a level of the caudal third of the griseum pontis..." 
(Dahlström and Fuxe 1964). Indeed, CA labeling in the rostral deep tegmentum of 
the primate brain is confined to fibers and only sparsely distributed neuromelanin-
containing neurons can be seen here (Pearson et al. 1983a; Kemper et al. 1987). 
Because the distribution pattern of CA neurons in the primate brain is best compa-
rable to that in the rat in comparison to other non-primates (Tanaka et al. 1982) it 
seems appropriate to follow Dahlström andFuxe's (1964) momenclaturc. Thus the 
term "subcoeruleus" is applied to the ventrally extending, slightly larger neurons 
of the LC, throughout its rostral-to-caudal extent (Taber 1961; German and 
Bowden 1975; Schofield andEveritt 1981; Pearson et al. 1983a; Feiten and Sladek 
1983). Area A7 is continous with the caudal extent of subcoeruleus neurons, but 
its smaller cells are identifiable by their ventrolateral-to-dorsomedial orientation, 
partly interspersed between fibers of the pedunculus cerebellaris superior (Taber 
1961; Garver and Sladek 1975; Saper and Perito 1982; Feiten and Sladek 1983; 
Pearson et al. 1983a). In the cat brain (Léger and Hemandez-Nicaise 1980) the 
LC-a corresponds with the subcoeruleus described here. An overlap with parabra-
chial nuclei has been described in several species (Russell 1955; Jones and Moore 
1974; German and Bowden 1975; Demirjian et al. 1976; Tanaka et al. 1982; Feiten 
and Sladek 1983; Satoh and Fibiger 1985). Other parabrachial nuclei (Fix 1980; 
Saper and Loewy 1980; Ohm and Braak 1988) are less well distinguishable from 
the reticular formation as discussed in the next section. 
LC neurons are mostly described as oval or spindle shaped, with cytoplasm 
rich in organelles, the larger neurons having a somewhat more rounded appearance. 
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Several attemps to classify cellular subtypes have been performed, but only 
Loughlin et al. (1986) gave data on correlations with other topographic principles. 
Summarizing the literature on cytologic features of non-primate LC (Taber 1961; 
Jones and Moore 1974; Swanson 1976; Léger and Herdandez-Nicaise 1980; 
Groves and Wilson 1980; Loughlin et al. 1986) medium-sized multipolar and 
fusiform cells may be distinguished from small, stellate, neurons. Of the former 
90% are catecholaminergic (Swanson 1976), with typical fluorescent appearance; 
the latter are probably intemeurons as described by Gulley and Wood (1971), with 
an "isodendriüc" appearance (Ramón-Moliner and Nauta 1966; Groves and 
Wilson 1980). In Golgi impregnated material, medium-to-large sized cells have 
long dendrites, that branch once or twice and extend outside the nucleus proper 
(Swanson 1976; Léger and Hemandez-Nicaise 1980). The same authors describe 
appendages on both dendrites and somata, in the rat and the cat. The orientation of 
dendritic fields is maximally developed in medioventral direction, reaching into 
the adjacent pontine central gray. Disc-shaped dendritic fields, parallel to the 
anterior-posterior axis of the brainstem, with predominantly longitudinal axo-
dendritic synaptic configuration are described in the rat brain (Groves and Wilson 
1980). Together with the subdivision in a "compacta" and a "reticulata" part 
(Russell 1955) and the evidence of dendrodendritic and dendrosomatic contacts 
between LC neurons (Groves and Wilson 1980; Foote et al. 1983; Feiten and 
Sladek 1983) such characteristics remind us of those described in the SN (Ch.II.2; 
Yelnik et al. 1987). 
The existence of NA "autoreceptors" on LC perikarya may be one mechanism by 
which adjacent regions interact (Mason and Fibiger 1979). There is substantial 
evidence that noradrenaline as well as the enzyme required for its manifacture, 
reside in LC dendrites, and is released there as a consequence of impuls activity 
(Groves and Wilson 1980; Foote et al. 1983). 
The LC noradrenergic neurons in the human brain are less densely packed 
than in other species and oriented more along a horizontal plane (see Chan-Palay 
and Asan 1989a; Baker et al. 1989). Like in the rat, in the rostral pole of the LC 
larger neurons predominate, round to oval multipolar with radiating dendrites and, 
relatively small, eccentric nucleus. From ourNissl-stained sections (Fig.ll.26.) the 
spread of melanin-containing neurons into adjacent nuclei is obvious. Rostrally, in 
the deep tegmentum, the caudal extension of AIO midline structures can be seen, 
whereas ventrolaterally small neurons of area A8 provide a continuity of dopami-
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nergic and noradrenergic structures. The nucleus subcoeruleus, with slightly larger 
neurons, mainly developed from halfway to caudal, is continuous with A7 and A5, 
the latter adjacent to the olivary complex. Like in the animal brain, area A7 is 
located at caudal levels, latero-ventrally, showing its typical neuronal orientation. 
For the purpose of counting, neuromelanin can be used as a marker of noradrena-
line, as was demonstrated quantitatively by Iversen et al. (1983) and Baker et al. 
(1989), but critized by others (Chan-Palay and Asan 1989a,b). 
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Transections of the human rhombencephalon (dorsal 
part), demonstrating cytoarchitecture of the locus coeruleus 
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II.3.2. Adjacent reticular formation structures 
Because of the close approximation of different rather ill-defined nuclei in 
the pontine tegmentum and the spread of neuropathological changes in AD and PD 
in this area (Ch.III), some notes on these reticular formation structures are of need. 
Both cholinergic and monoaminergic structures have been brought in relation to 
such psychologically defined phenomena, like affecting the cortical EEG and 
levels of consciousness and the induction of locomotion in decerebrate animals 
(e.g. Armstrong 1986; Leichnetz et al. 1989). Historically the problem is reflected 
by the search for a brainstem "relay" centre in descending motor-projections of the 
basal ganglia (Wilson 1914,1925; Nauta andMehler 1966) and, otherwise, the need 
of a chemoarchitectonically defined substrate for the "ascending reticular activa-
ting system" (ARAS; Shute and Lewis 1967; Neumann 1968; Moore 1980; 
Robbins 1984). 
The reticular formation is characterized by neurons of uniform morphology 
with extensive dendritic overlapping (Ramón-Moliner and Nauta 1966; Ramón-
Moliner 1975; Hobson 1980) taking part in an "isodendrilic core" which displays 
very little histological variation throughout the whole extent of the brainstem and 
basal forebrain (Ramón-Moliner 1975; Jones and Yang 1985). This core was more 
specifically associated with ascending cholinergic projections from the pontine 
tegmentum by Shute and Lewis (1967) and more recently with AD pathophysio-
logy (Rossor 1981; McGeer and McGeer 1987). Remaining uncertainties about the 
organization of the reticular formation, and more particularly with the brainstem 
pontine tegmentum, have to do with its possible ties to the corpus striatum and 
monoaminergic nuclei, with unconventional nuclear organization, neural morpho-
logy and connections (Pasquier et al. 1977; Nauta 1979; Butcher and Woolf 1984; 
Newman 1985; Garcia-RiU 1986; Rye et al. 1987; Mori et al. 1987). 
Cholinergic structures of the pontine reticular formation were separately 
analysed by Mesulam and coworkers in the rat and monkey (1983a, 1984) and 
subdivided in two main groups, Ch5 and Ch6. Cytoarchitectonic demarcation of 
the main related nuclei, nucleus laterodorsalis tegmenti (NTld; Ch6) and nucleus 
tegmenti pedunculopontinus (NTPP; Ch5), however, stems from early work on the 
human brain (Jacobsohn 1909; Crosby and Woodbume 1943; Olszewski and 
Baxter 1954). Overlap with the adjacent nuclei cuneiformis, parabrachiales and 
monoaminergic nuclei, particularly noted in the non-human brain, has led to a 
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confusing terminology (Palkovits and Jacobowitz 1974; Saper and Loewy 1980; 
Moon-Edley andGraybiel 1983;Ryeetal. 1987). Combined studies on cholinergic 
and catecholaminergic markers solved many of the demarcation problems in 
different animal species (Palkovits and Jacobowitz 1974; KimuraandMaeda 1982; 
Satoh and Fibiger 1985; Jones and Beaudet 1987; Henderson 1987; DeLima and 
Singer 1987; Vincent 1988) and, more recently, also in the human brain (Mesulam 
et al. 1989). The distribution of reticular formation cholinergic systems in the 
human brain follows a general plan of organization similar to that described in 
various animal species (Mizukawa et al. 1986; Mesulam et al. 1989). The 
cytoarchitectonic subdivision of the human pontine tegmental cholinergic neurons 
in a limbic-associated part (Ch6) and an extrapyramidal part (Ch5) has no firm 
hodological basis in the primate yet (Satoh and Fibiger 1986). 
A continuous band of choline-acetyltransferase (ChAT)- positive neurons 
extends from the caudolateral part of the SN to midpontine levels, adjacent to the 
LC complex. ChAT-positive, large, multipolar neurons of the NTPP present them-
selves within cross-sections that also include the A6 through A9 CA cell groups in 
the rat (Rye et al. 1987) and are traversed by CA axons. In agreement with the 
traditional view of the isodendritic core (Ramón-Moliner 1975) the dendritic 
arborization of NTPP neurons are comparable in moiphology to the majority of 
reticular neurons (Rye et al. 1987). Projections on the SNr, although disputed in the 
rat (Rye et al. 1987), have a firm physiologic as well as neuroanatomical basis 
(Carter and Fibiger 1977; McGcer and McGeer 1984; Moon-Edley and Graybiel 
1983; Clarke et al. 1987; Niijama and Yoshida 1988; Scamati et al 1989). Based 
on connections as analysed in cats, Moon-Edley and Graybiel (1983), concluded 
that efferents of the NTPP that follow the pattern characteristic of a wider 
"extrapyramidal" region (Rye et al. 1987) of the midbrain tegmentum confirm the 
concept of combined reticular and basal ganglia-like structures. 
In Nissl stained sections of the human brain, multipolar and darkly stained 
neurons of the NTPP can be seen, extending from the caudal pole of the SN 
subnucleus posterolateralis, in close association with the ascending limb of the 
superior cerebellar peduncle (Fig.II.26). Neuromelanin containing neurons are 
scattered through this cholinergic area (Ch5) of the NTPP (Foix and Nicolesco 
1925; Olszewski and Baxter 1954), mostly belonging to the adjacent area A8. A 
pars compacta of the NTPP is situated at more caudal levels, dorsomedially 
(Olszewski and Baxter 1954), corresponding to the compact sector of Ch5 as 
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described by Mesulam et al. (1989). An accumulation of caudolaterally placed 
neuromelanin containing neurons, ventrolaterally bordering the pedunculus cere-
bellaris superior, was named nucleus subpeduncularis by Ohm and Braak (1988), 
probably corresponding to the nucleus X of Fix (1980). No clear accumulation of 
pigmented neurons could be identified here in ourmaterial, but small darkly stained 
neurons in this region, intermingled with some small pigmented neurons, might 
correspond with this nucleus subpeduncularis (Fig.II.26). The scattered neurome-
lanin containing neurons might be derived from the adjacent subcoeruleus and area 
A7. Remarkably enough again a cholinergic structure is identified here, slightly 
rostrally from this area, indicated Ch8 by Mesulam et al. (1989), mainly confined 
to the corpus parabigcminum. The latter can be identified as a lenticular collection 
of relatively small and hyperchronic neurons, flanked medially by the lateral 
lemniscus and dorsally by the inferior colliculus (Nieuwenhuys et al. 1988). 
Although Ch5 and Ch6 are only relatively separated by the fasciculus lon-
gitudinalis medialis, a separate laterodorsal tegmental nucleus (NTld) is separately 
defined in the ventrolateral part of the pontine periventricular gray, immediately 
rostral to the locus coeruleus and lateral to the dorsal tegmental nucleus of Gudden. 
The location of this nucleus in the human brain (Crosby and Woodbume 1943; 
Nieuwenhuys et al. 1988) corresponds with that in the monkey (Mesulam et al. 
1984; Satoh and Fibiger 1985,1986), the rat (Kimura and Maeda 1982; Mesulam 
et al. 1983a; Vincent et al. 1983; Newman 1985) and the cat (Jones and Beaudet 
1987; Leichnetz et al. 1989). In the latter it might be homologous with the nucleus 
annularis of Taber (1961). In Nissl stained sections it can be distinguished from the 
surrounding grey matter by the presence of roundish relatively hyperchromic cells 
that are scattered among smaller cells of the periaqueductal and periventricular 
system (Fig.II.26), resembling the multipolar neurons of the NTPP pars compacta. 
Because the central grey caudal to the trochlear nucleus becomes an exceedingly 
complex region (Mesulam et al. 1989), it is hard to define exact boundaries of this 
nucleus and the neighbouring dorsal tegmental nucleus of Gudden. Not only 
intermingling with locus coeruleus neurons occurs, but also with the medial 
longitudinal fasciculus and rostrally with NRd neurons. Olszewski and Baxter 
(1954) do not indicate a separate nucleus within the boundaries of the nucleus 
supratrochlearis, where Riley (1943) located the nucleus tegmentalis dorsalis 
accessorius. In the alias of Nieuwenhuys et al. (1988) it is primarily functionally 
defined, in relation to visceral afferent pathways. The cell number is relatively low 
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in comparison to the findings of ChAT-positive cells as described in the cat 
(Kimura and Maeda 1982; Jones and Beaudet 1987) and monkey (Mesulam et al. 
1984; Satoh and Fibiger 1985, 1986). In their immunohistochemical study on 
cholinergic neurons in the human brainstem Mizukawa et al (1986) do not mention 
a clearly developed nucleus at this site. But their material was mainly based on 
patients dying with AD and a possible cell-lose can not be ruled out. 
In the rat brain noradrenergic projections of the LC and cholinergic projec-
tions of the NTld to forebrain structures arc closely related (Shute and Lewis 1967; 
Jones and Yang 1985; Satoh and Fibiger 1986) making the interpretation of the 
many related physiologic findings rather difficult (Nieuwenhuys et al. 1988; 
Leichnetz et al. 1989). Of particular interest are direct projections to the cerebral 
cortex and limbic structures (Vincent et al. 1983; Jones and Beaudet 1987; 
Nieuwenhuys et al. 1988; Mesulam et al. 1984, 1989). Apart from this common 
feature with basal forbrain cholinergic nuclei, Mesulam et al. (1989) discuss 
differences in cytochemical features and the marked heterogeneity of prima'y 
transmitter in these areas, as was also suggested for the rat by Nieuwenhuys (1985). 
In contrast to e.g. striatal cholinergic perikarya, which are predominantly local 
circuit neurons (Graybiel and Ragsdale 1983; Graybiel 1989) the cholinergic 
neurons of the isodendritic core, like the noradrenergic projections, bridge long 
distances to thalamus and cortex. Both cholinergic and catecholaminergic neurons 
of the dorsolateral pontine tegmentum may be among the mostimportant brainstem 
influence on forebrain and cortical activity (Jones and Yang 1985). The presence 
of varicosities in the ascent of cholinergic fibers through the midbrain tegmentum 
is suggestive of synaptic termination (Jones and Friedman 1983; Rye et al. 1987). 
Besides, by combined AChE and fluorescence histochemistry, it has been demon-
strated that the AChE-positive neurons that have no CHAT immunoreactivity, are 
mostly, if not exclusively catecholaminergic (Satoh and Fibiger 1985), suggestive 
of cholinoception of CA neurons (Kimura and Maeda 1982). An interaction of 
these systems, both at the level of the brainstem (Henderson 1987) and Cortex 
(Oades 1985 ; Pamavelas and Papadopoulos 1989) might be an important factor in 
the influence on cortical activity. 
141 
II.3.3. Fiber connections of the locus coeruleus 
Given the extensive distribution of LC projections (Fig.II.27), it is not 
surprising that the literature on this subject is massive. As techniques for visuali-
zing NA efferents became more sensitive and specific, the impression of a single 
CA projection bundle and scattered CA terminals in the lisencephalic rat neocortex 
(Fuxe et al. 1965; Andén et al. 1966) evolved to the separation of three different 
ascending NA tracts, with much more dense and specifically organized dopamine-
ß-hydroxylase (DBH) immunoreactìvity throughout the six layers of the entire 
primate cortex (Morrison et al. 1982a; Levitt et al. 1984; Saper 1987a). The data 
available now, about cortical terminal patterns, effects of localized lesions (Mor-
rison et al. 1981) and possible topographical organization of LC projection 
neurons, might well contribute to the interpretation of ncuropathological findings 
of this nucleus in aging diseases. 
The extensive phylogenetic development of the neocortex strongly suggests 
that, apart from general principles, specific anatomical and functional features of 
the coeruleo-cortical projections may have also become increasingly specialized 
(Amarai and Sinnamon 1977; Clark 1979; Morrison et al. 1982a;Footeetal. 1983; 
Saper 1987a). Presumably, each LC neuron sustains a highly divergent axon that 
innervates a large terminal field, e.g. from the entire frontal to occipital neocortex 
(Morrison et al. 1981 ; Foote et al. 1983). NA projections are similar to cholinergic 
cortical projections therefore, in providing diffuse cortical influence with wide-
spread axonal distribution, contrary to DA neurons constituting but discrete 
systems (Moore and Bloom 1979; Satoh and Fibiger 1986; Lewis et al. 1987). 
Generally speaking, the ascending and descending NA projection neurons are 
comprised by two major subdivisions, originally defined in the rat, where they are 
most clearly separated (Ungerstedt 1971a; Lindvall and Björklund 1974; Moore 
and Card 1984). An application of this subdivision to the cat (Jones and Friedman 
1983; Nakazato 1987) and primate brain (Tanaka et al. 1982; Feiten and Sladek 
1983; Kitahamaetal. 1988) historically led to confusing nomenclature (Moore and 
Bloom 1979; Jones and Friedman 1983). The LC system (A6 and A4) projects 
mainly to spinal cord, cerebellum, thalamus and cerebral cortex with few reciprocal 
cortical afférents ("open loops"; Segal 1980a,b), whereas the lateral tegmental 
system (Al, A2, A3, A5, A7) projects reciprocally to the spinal cord, brainstem, 
hypothalamus and basal forebrain (Clark 1979; Moore and Card 1984). As unique 
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component of the lateral reticular formation the long catecholaminergic bundle 
serves to interconnect the multiple adjacent CA neurons along its course, especially 
in the mammalian brain (Levitt and Moore 1980a; Jones and Friedman 1983; 
Feiten and Sladek 1983; Nieuwenhuys et al. 1988) Thus, e.g., somatomotor or 
discrete visceromotor nuclei are innervated by lateral tegmental NA groups, 
suggesting that these adjuvant NA cells may have a general function in regulation 
of autonomic, visceral and neuroendocrine activity (Levitt and Moore 1980a). 
Otherwise, the LC, including subcoeruleus, also innervates primary sensory areas, 
such as the cochlear nuclei, and pontine reticular formation nuclei. 
Summarizing the literature a schematic representation of pathways and terminal 
areas is given in Fig.II.27, indicating the most likely situation in the human brain. 
Ascending LC axons have their initial course in three major pathways, that appear 
to be rather uniform in different species: 
1. The dorsal noradrenergic bundle (dnb) travelling ventrolaterally from the 
periventricular/aquaductal grey, originating mainly from the locus coeruleus. This 
appears to be a rather universal tract phylogenetically, branching to numerous 
mesenphalic and diencephalic grísea, following the dorsal part of the mfb (Unger-
stedt 1971a; Lindvall and Björidund 1974; Garver and Sladek 1976; Nieuwenhuys 
et al. 1982; Jones and Friedman 1983; Jones and Yang 1985; Astier et al. 1987; 
Kitahama et al. 1988). LC fibers projecting to the cerebellum frequently send 
collaterals to the forebrain via this dorsal noradrenergic bundle (Saper 1987a). 
Authors studying monoamine histofluorescence (Nobin and Bjorklund 1973; 
Garver and Sladek 1976; Feiten and Sladek 1983) observed a higher amount of 
monoamines prenatally, which apparently disappeared with age. This projection is 
also associated with the "Acg" (that is the nucleus linearis rostralis in our 
nomenclature) as described in the monkey (Garver and Sladek 1976; Feiten and 
Sladek 1983). 
2. The ventral noradrenergic pathway 
According to Ungerstedt (1971a) the cell groups Al, A2, A5 and A7 (Dahlström 
and Fuxe 1964) give rise to this ascending fiber system, ascending through the 
reticular core (see above). The terminal areas of this bundle include: the ventrola-
teral part of the periaqueductal grey in the mesencephalon and the hypothalamus, 
especially periventricular, infundibular, supraoptic and paraventricular nuclei. 
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Telencephalic terminal areas include the area preopüca and bed nucleus of the stria 
terminalis (Nieuwenhuys et al. 1988). Descending bulbospinal fibers terminate in 
the ventral horn, intermediolateral nucleus and substantia gelatinosa. 
3. The dorsal longitudinal fasciculus of Schütz is, much like the mfb, a 
composite system consisting of thin ascending and descending fibers. It occupies 
over its entire length a periventricular position and synapücal interruption may 
occure at e.g. the dorsolateral tegmental nucleus of Gudden. LC projections 
provide only a minor contribution to this fiber system, interconnecting important 
autonomic centers of the hypothalamus and lower medulla oblongata. 
Fig 11.27 — — — - ^ 
Efferent projections of the human locus coeruleus, rostral and 
caudal parts 
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Unlike their absence in reviews mentioned before, projections to the rostral 
caudate-putamen in the rat (Mason and Fibigcr 1979) and primate (Parent et al. 
1983) suggestive of NA-DA interaction at this level, are included here. The 
coemleo-cortical system in the primate brain embodies organizational principles 
that contrast with those of the classical thalamocortical or cortico-cortical systems, 
which are primarily organized in a modular fashion and terminate in narrow radial 
columns with minimal arborization in the horizontal plane (Momson et al. 1981, 
1982a; Levitt et al. 1984; Saper 1987a). The highest NA concentrations have been 
observed in the cingulate, frontal and insular cortices, followed by visual, auditory 
and sensorimotor cortices respectively (Moore and Card 1984; Saper 1987a). The 
dorsolateral prefrontal cortex of the primate brain, however, shows a relatively 
sparse innervation as compared to other cortical areas (Momson et al. 1982a; Levitt 
et al. 1984; Lewis and Morrison 1989). Regional differences in the prefrontal 
cortex of monkey species were demonstrated by Lewis and Morrison (1989). 
Unless regional variation in density, the laminar pattern was rather similar across 
cytoarchitectonic areas. The particular dense CA innervation around sulcal inva­
ginations in all cerebral lobes might reflect a specialization in gyrencephalic brains 
(Levitt et al. 1984). 
Differences between rat and monkey also exist as regards an additional lateral 
trajectory in the latter, following the amygdalofugal pathway to the temporal lobe 
and possibly also innervating more posterior cortical regions (Morrison et al. 
1982a; Levitt et al. 1984). Whereas the cingulum bundle, mainly provides the 
medial cortex, a third route follows the ventral caudate and capsula externa, through 
the cortex in an anteroposterior direction (Momson et al. 1981; Saper 1987a) in 
different species. Axons course through cortical layer VI, until reaching the 
terminal field where they tum to the pial surface and branche in a grid-like pattern. 
In rats they mainly innervate layers I-V, in a laminar configuration consistent 
especially throughout the lateral neocortex (Saper 1987a). The density of NA ter­
minals is greatest in layers I,IV and VI (Moore and Card 1984). 
In cats and monkeys axons aremainly directed towards layer II and ΙΠ (Levitt 
et al. 1984), but substantial regional variation exists in terminal pattern as well as 
fiber orientation, especially in the medial cortex (Morrison et al. 1982a; Foote et 
al. 1983; Lewis and Momson 1989). Thus, DBH-immunoreacüve synaptic 
junctions in dorsolateral prefrontal and somatosensory cortices were mainly found 
in layers IV and V, whereas DBH immunoreactivity in layers I, II, III and VI stem 
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from passing fibers, running paralell to the pial surface in layer VI (Morrison et al. 
1982a). The innervation pattern of the primary visual cortex differs fundamentally 
in that layer IV is the least densely innervated and the NA innervation is primarily 
directed towards the pyramidal cells of layer V and VI (Morrison et al. 1982a). The 
highest density of NA innervation surrounding the central sulcus of the primate has 
a less clear geometric pattern, although some laminar complementarity with 
dopamine projections might be expected (Morrison et al. 1982a). 
A striking complementrary relationship of NA and serotonin innervation 
patterns of the primary visual cortex in the monkey brain (Morrison et al. 1982b) 
suggests a high degree of specificity of both monoamine projections. A similar 
complementary laminar distribution of DA and NA patterns, hardly distinguisha-
ble in histofluoresccnce preparations, has been demonstrated in the anterior 
dngulate cortex (Lewis et al. 1988b; Lewis and Morrison 1989). Such cortical 
areas apparently show more marked laminar differentiation, in comparison to the 
lateral neocortex. The small cortical field that lies at the juncture of cingulate and 
prefrontal cortex shows a confluence of DA, NA and serotonin projections, 
suggesting a key role in the convergence of subcortical inputs to both limbic and 
frontal cortices (Porrino and Goldman-Rakic 1982; Levitt et al. 1984). The exact 
meaning of these divergent monoamine projections remains to be elucidated yet 
(Saper 1987a). 
Like other cortical NA afférents, hippocampal NA by far mostly stems from 
LC projections, as demonstrated both neuroanatomically and electrophysiologi-
cally (Moore and Bloom 1979; Segal 1980a,b; Foote et al. 1983). The densest pro-
jections are directed to the Mlus of the fascia dentata, stratum lucidum of С A3 and 
the molecular layer of the subiculum, close to the entorhinal cortex. This innerva­
tion reaches the hippocampal formation from the ansa peduncularis-ventral amyg­
daloid bundle, the fornix and the cingulum, especüvely (Segal 1980a,b; Moore and 
Card 1984; Nieuwenhuys et al. 1988). 
The question whether LC neurons are spatially clustered according to their 
targets (and possibly reciprocal afférents) can only be answered according to the 
most rudimentary principles. Apparent discrepancies in the literature are partly due 
to differences in terminology and methods (Loughlin et al. 1986a). Ascending LC 
projections might interfere also with cholinergic projections, as has been described 
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for the cat (Nakazato 1987) and more caudoventrally placed parabrachial projec-
tions in the rat (Saper and Loewy 1980). Besides many LC cells can be doubly 
labelled after injections at widespread target sites (Waterhouse et al. 1983; Foote 
et al. 1983; Loughlin et al. 1986a,b; Saper 1987a). The terminology used here 
corresponds with that of most studies in rats (e.g. Mason and Fibiger 1979; 
Waterhouse et al. 1983; Loughlin et al. 1986a,b). The best documented (both by 
tracer studies and electrophysiological) topographical relationship is that of 
ventrally placed LC and subcoeruleus neurons projecting to the spinal cord in rats 
(Nygren and Olson 1977; Mason and Fibiger 1979; Moore and Bloom 1979; 
Loughlin et al. 1986a), cats (Nakazato 1987) and monkeys (Foote et al. 1983). 
Other targets of ventrally placed neurons are the caudate nucleus and cerebellum 
(Mason andFibiger 1979; Footeetal. 1983;Loughlinetal. 19863^). Anotherwell-
documented projection is that of the dorsally placed cells to the hippocampus and 
septum, preferentially in the caudal half (Mason and Fibiger 1979; Segal 1980a,b; 
Loughlin et al. 1986a,b). Thalamic projections have their origin throughout the LC, 
but cortical projections preferentially originate from dorsal layers (Mason and 
Fibiger 1979; Loughlin et al. 1986a; Nakazato 1987). For an individual neuron 
within the central, compact LC, the probability of projecting to a given critical 
target varies along the dorsal-ventral gradient, as regards occipital, sensorimotor 
and frontal projections, respectively (Waterhouse et al. 1983). Findings in the cat 
(Nakazato 1987) and rat LC (Waterhouse et al. 1983) differ somewhat, in that in 
cats ascending cortical projections are mainly found in the rostral part of the LC and 
preferentially midway-to-caudally in the rat. 
In conclusion, spatial preferences of LC projection neurons do not represent 
complete segregation, whereas possible interspecies variation needs further docu-
mentation. It may be said, however, that dorsally placed neurons preferentially 
project to cortical targets, hippocampus and septum, and ventrally placed neurons 
preferentially descend or reach no further than subcortical structures. 
In contrast to the knowledge of the physiology, pharmacology and efferents 
of the LC system .little is know about neural inputs that regulate its activity (Foote 
et al. 1983; Aston-Jones et al 1986). Many of the afférents suggested in literature 
need further confirmation (Aston-Jones et al. 1986). The bulk of afférents arises 
from medullary nuclei: nucleus prepositus hypoglossi and nucleus paragigantocel-
lularis (Guyenet and Young 1987), whereas other substantial sources of LC 
147 
afférents are paraventricular hypothalamic nuclei (Swanson 1987) and intermedia-
ry grey of the spinal cord (Aston-Jones et al. 1986). The other afferent projections 
that have been described (Foote et al. 1983; Moore and Card 1984) might have been 
directed to adjacent parabrachial nuclei that have similar routes of projection as the 
LC (Saper and Loewy 1980; see also Newman 1985). The spread of dendritic 
ramifications far beyond the cell body region of LC (Ch.II.3.1.) may contribute to 
more widespread afferent inputs, as was already demonstrated for hypothalamic 
projections (Mason and Fibiger 1979). Afférents from nuclei in close proximity of 
the LC could not be excluded by Aston-Jones et al. (1986). 
Anterograde tracers, injected into the VTA produced labeled fibers entering 
the LC, whereas injections into the SNc did not (Beckstead et al. 1979; Swanson 
1982). Details on prefrontal cortical afférents in the primate brain are provided by 
Amsten and Goldman-Rakic (1984), who noted densest terminals at rostral levels 
of the LC, originating mainly in dorsolateral and dorsomedial prefrontal areas. 
They therefore suggested that NA and serotonin containing cells, which 
innervate widespread areas of cortex, receive a selective prefrontal cortical 
projection, whereas the dopamine containing cells, which innervate more 
restricted areas of cortex receive afférents from widespread cortical regions. 
Histochemical studies showed adrenaline, serotonin, substance P, enkephalin and 
neurotensin containing terminals within the boundaries of the LC (Moore and Card 
1984; Amsten and Goldman-Rakic 1984). 
Fig.II.28. gives an account of the extrapolated afferent projections in the human 
brain (Foote et al. 1983; Moore and Card 1984; Nieuwenhuys et al. 1988), with 
dotted lines for more controversial projections (Aston-Jones el al. 1986). 
148 
dm 
Cxpf 
dl 
Fig II 28 
Afferent projections of the human locus coeruleus 
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II.4. NEUROANATOMY OF THE NUCLEUS RAPHE 
DORSALIS 
II.4.1. General morphology of the human nucleus raphe dorsalis (NRd) 
As was noted already for the other monoammergic structures, the phyloge-
netic advance and enlargement of the cerebral cortex also led to a considerable 
increase in the extent and volume of the raphe nuclei (Hubbard and DiCarlo 1974b; 
Parent 1981: Sladek et al. 1982: Feiten and Sladek 1983; Ohm et al. 1989). 
Although the term "raphe" characterizes the position close to the midline, nowa-
days it is most commonly associated with serotonin- histochemistry. Raphe nuclei 
and serotonergic cell groups do not overlap 100% (see Feiten and Sladek 1983)and 
Dahlström and Fuxe (1964) introduced a new classification of the indolamine-
containing cells in the rat brain stem, i.e., nine groups designated В1 through B9. 
The distribution pattern and characteristics of the serotonin groups are essentially 
similar in the rat, cat, monkey and human brain (Dahlström and Fuxe 1964; 
Hubbard and DiCarlo 1974b; Wiklund et al. 1981; Feiten and Sladek 1983; 
Steinbusch and Nieuwenhuys 1983), but there is no generally accepted nomencla-
ture of the related raphe nuclei in different mammalian species (Braak 1970). 
Generally an oral and a caudal group is distinguished, the former including a central 
and a dorsal portion. The central portion is indicated as nucleus centralis superior 
(Olszewski and Baxter 1954; Taber 1960) or nucleus raphe medianus (Crosby and 
Woodbume 1943; Conrad et al. 1974; Azmitia and Segal 1978). Caudal raphe 
nuclei are located throughout the length of the medulla oblongata (Taber 1960; 
Riley 1943; Braak 1970). 
In the monkey (Sladek et al. 1982) and cat (Léger and Wiklund 1982) brains 
their is a "lateralization" and a further degree of mixing of serotonin with other 
monoammergic groups in the brainstem (see also Léger and Wiklund 1982; Feiten 
and Sladek 1983). Steinbusch and Nieuwenhuys (1983) already described seroto-
nin-immunoreactivity in the SN and VTA and actually noted that most of the 
serotonergic elements might be found outside the boundaries of the raphe nuclei in 
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the rat brain. The serotonin group is the first to appear in ontogenesis (Parent 1981) 
and the few serotonin-positive neurons situated in the reticular formation of rats 
might be neurons that during ontogenesis did not complete their migration toward 
the raphe region (Steinbusch and Nieuwenhuys 1983). In the cat the ratio between 
serotonergic and non-serotonergic neurons in the nucleus raphe dorsalis is 70 % 
(Wiklund et al. 1981), whereas in rats only one-third of the NRd neurons seems to 
be serotonergic (Descames et al. 1986). The intermingling of different monami-
nergic elements had been noted to be of particular significance in quantitative 
analysis of age-related changes in specific serotonergic neuron systems in the 
mammalian brain (Sladek et al. 1982). 
Data regarding architectonical and neuronal details of the human nucleus raphe 
dorsalis (NRd), corresponding roughly with cell group B7 of Dahlström and Fuxe 
(1964), mainly stem from Olszewski and Baxter (1954), Braak (1970) and Ohm et 
al. (1989). Serotonergic neurons within the raphe nuclei have no special structural 
characteristics that make identification possible in Nissl stained sections. In the 
human brain the strongly lipofuscin-pigmented nuclei of the raphe system are 
particularly well recognizable in the PFAAF staining of Braak (1980), that was also 
used by Ohm et al. (1989) for description of cytologic details. The dorsal raphe 
nucleus extends for a distance of 20-25 mm from the level of the oculomotor 
nucleus to the level of the caudal pole of the locus coeruleus (Braak 1970; see als 
Figs.II.24,II.25.). It is continuous with the nucleus raphe linearis rostralis and 
nucleus interfascicularis of the VTA, based on pigmento-architecture. The nucleus 
raphe centralisinthenomenclatureofBraak(1970; see als Ohm et al. 1989)greatly 
corresponds with nucleus linearis centralis and caudalis of the VTA, as defined by 
Halliday and Tork (1986) and followed by us (Fig.II.24.). Midline raphe nuclei and 
midline VTA nuclei are continuous, in the pontine tegmentum passing to the 
nucleus centralis superior and nucleus reticularis tegmenü of Bechterew (Olszews-
ki and Baxter 1954; Braak 1970; Ohm et al. 1989) The NRd has its greatest extent 
and densest cellular area dorsomedially bordering the trochlear nucleus (nucleus 
supratrochlear!s pars dorsalis of Olszewski and Baxter 1954). Midway from this 
wing-like formation an unpaired intercalate subnucleus (Ohm et al. 1989) had a 
cellular density and lipofuscin pigmentation that make it hardly distinguishable 
from the surrounding central mesencephalic grey substance. The small neurons 
within this subnucleus might be DAergic (Descarries et al. 1986) as has been 
suggested also for the cat (Wiklund et al. 1981; Léger and Wiklund 1982) and 
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monkey (Tanaka et al. 1982). Few neuromelanin-containing neurons could be 
found here in the human brain (see also Saper and Petito 1982). A possible 
corresponding portion of the dorsal raphe nucleus in other species displays either 
a lesser number or a different kind of serotonin-containing neurons (Hubbard and 
DiCarlo 1974b; Molliver 1987). Both parts contain a high amount of small neurons 
(Ohm et al. 1989). At more caudal levels a similar diffuse transition with the 
nucleus laterodorsalis tegementi stresses the need of histochemical techniques for 
the exact identification of NRd neurons. 
Histochemical studies in the rat brain (for review see Steinbusch and Nieu­
wenhuys 1983; Weissman et al. 1987) and anti-serotonin-immunohistochemistry 
in the human fetus (Takahashi et al. 1986) confirm the preponderance of serotonin 
containing neurons in the traditionally defined boundaries of the NRd, extending 
into the VTA and locus coerulcus complex. Within the cytoarchitectonically 
defined NRd of the human brain Ohm et al. (1989) distinguished five neuronal 
types: 
1) Large ovoid to polygonal neurons with much lipofuscin; 2) Likewise cells, 
displaying more dust-fine and faintly stained pigment granules; 3) Medium-sized, 
ovoid to polygonal neurons with loosely distributed, small pigment granules; 4) 
Small ovoid neurons devoid of pigment or with few intensely stained granules; 5) 
Small spindle shaped nerve cells with various amount of intensely stained 
lipofuscin granules. 
Golgi-Сох studies in monkeys (Feiten and Sladck 1983) revealed the 
presence of small clusters of dendrites oriented vertically in the midline, tangen-
tially around the circumferential edge of the fasciculus longitudinalis medialis that 
also vertically or obliquely spread into the latter. These bundles consisted mainly 
of primary or secondary dendrites of NRd neurons, although shafts of fourth 
ventricular tanycy tes and dendrites of the dorsal tegmental nucleus cells also were 
present. Similar observations in rats have been reviewed by Steinbusch and 
Nieuwenhuys (1983). Like other monoaminergic nuclei, serotonerigc neurons in 
primates provided zones of direct neuronal vascular apposition, as demonstrated 
electronmicroscopically (Chan-Palay 1976; Feiten and Sladek 1983). The attach­
ment of serotonergic dendrites to blood capillaries and the supraependymal plexus 
on the ventricular surface (Richards et al. 1981; Steinbusch and Nieuwenhuys 
1983). derived from NRd and nucleus centralis superior neurons, might have 
implications for AD pathophysiologic considerations (Hardy et al. 1986). 
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II.4.2 Fiber connections of the nucleus raphe dorsalis 
By far the most data on ascending projections of the NRd have been obtained 
from studies in rats (for review Nieuwenhuys et al. 1988). The pattern of terminals 
generally might be derived from studies on cortical serotonergic fiber distribution 
in different species (see Stcinbusch 1981; Köhler and Steinbusch 1982; Morrison 
et al. 1982b; Takeuchi and Sano 1983; Stuart et al. 1986; Molliver 1987; Mulligan 
andTörk 1987,1988; DeLimaetal. 1988), but these terminals might originate from 
other raphe nuclei as well, especially raphe medianus, i.e. nucleus centralis superior 
(see Köhler and Steinbusch 1982; Molliver 1987; Vertes and Martin 1988). 
Besides, projections from basal forebrain serotonergic neurons have to be exclu-
ded, as was already discussed concerning lesion experiments by Andén et al. 
(1966). Specific ascending pathways of the NRd have been studied preferentially 
with tritiated aminoacids in rats (Conrad et al. 1974; Azmitia and Segal 1978) and 
cats (Bobillier et al. 1976), but some detailed topographical principles could also 
be obtained from retrograde labeling studies (Tohyama etal. 1980; O'Heam and 
Molliver 1984; Waterhouse et al. 1986). 
Apart from serotonergic fibers, NRd efferents containing other neurotrans-
mitters, like substance P, thyrotropin-releasing hormone and methionine-ehkepha-
line (for review see Stcinbusch and Nieuwenhuys 1983), have been shown to 
originate from raphe nuclei in rats. The meaning of a particularly large number of 
peptides in the NRd has to be elucidated yet. Because of the lack of data on NRd 
efferents in primates, such fiber systems in the human brain, are mainly based on 
hodological data of the cat brain (Bobillier et al. 1976) and different studies on rats 
(Nieuwenhuys et al. 1988). The highly branched fibers of the NRd together 
innervate virtually the whole central nervous system, thus comprising the most 
exentisive central neuronal network yet described. From the study of Feiten and 
Sladek (1983) on monoamine pathways in monkeys it can be concluded that 
descending projections in primates, like those of non-primates, are mostly derived 
from more caudally located raphe nuclei. There are extensive connections with the 
reticular formation (Steinbusch and Nieuwenhuys 1983) and rctrogradely labeled 
brainstem nuclei including nucleus laterodorsalis tegmenti, locus coeruleus, nuclei 
raphe pontis and raphe magnus, nucleus reticularis tegmenti pontis and substantia 
grisea pontis (Tohyama et al. 1980; Leichnetz et al. 1989). 
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In all mammalian species studied, ascending fibers travel mainly in a para-
median zone through the midbrain ventral tegmental area (Andén et al. 1966b; 
Ungerstedt 1971 a; Azmitia and Segal 1978;Bobillieretal. 1976; Feiten and Sladek 
1983), were serotonergic axon terminals forni axodendritic contacts with both 
DAergic and non-DAergic cells (Hervé et al. 1987). At the level of the mesencep-
halic junction, the main bundle progresses ventrally and laterally to the mamillary 
bodies, but adjacent nucleus interpeduncularis and SNc are more specifically 
projected on by the nucleus centralis superior (Bobillier et al. 1976). After entering 
the medial forebrain bundle, NRd axons course similar to the other diffuse cortical 
projection systems, i.e., a lateral system through the substantia innominata to the 
external capsule and a medial pathway continuing rostrally through the septum. 
(Saper 1987a). The latter divides into a branch that runs back through the fornix to 
the hippocampal formation and another branch that runs overthe genu of the corpus 
callosum and into the frontal cortex and cingulate bundle (see also Tohyama et al. 
1980). Whereas projections from the nucleus centralis superior primarily contribu-
te to the medial pathway (see also Feiten and Sladek 1983), fibers of the NRd 
contribute to both projections, similar to the coeruleo-cortical projection system 
(Saper 1987a). A much smaller dorsal ascending serotonergic pathway courses 
within the fasciculus longitudinalis dorsalis of Schütz and a ventrolateral bundle 
follows the fasciculus longitudinalis medialis before joining the ventral ascending 
system in the VTA, giving off fibers to the SN (Bobillier et al. 1976; Azmitia and 
Segal 1978). Few fibers were seen in the SNc of the rat, cat and monkey, but in the 
SNr these fibers were densely and uniformely distributed in the rat and cat; the pars 
lateralis seems to contain more serotonergic fibers in higher mammals, suggesting 
an essential role of serotonin in extrapyramidal circuitry (Mori et al. 1987). 
Fibers to the medial habenular nucleus and various thalamic centres follow 
the habenulo-interpeduncular tract, but also the stria medullaris. At more rostral 
levels fibers course through the ansa peduncularis to the amygdaloid complex and 
follow the capsula interna to the striatum. DAergic neurons of the NRd projecting 
to the striatum probably are continous with mesostriatal projections of the VTA and 
were observed mainly in a ventral subdivision, bordering the nucleus linearis 
caudalis (Parent et al. 1983a; Descarries et al. 1986). The ratio of DAergic to 
serotonergic fibers projecting to the striatum can not be determined with the current 
state of kwowledge (see also Steinbusch et al. 1981). The concentration of seroton-
in-immunoreactive fibers in the neostriatum was high in ventral, medial and caudal 
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parts and especially the area bounded by the globus pallidus, in rats, cats and 
monkeys (Mori et al. 1985), decreasing progressively from the caudal to the rostral 
plane. In both cat and monkey the distribution pattern of serotonergic fibers is more 
inhomogeneous, especially in the caput nucleus caudaius (Mori et al. 1985). 
Likewise a serotonergic fiber distribution pattern in the rat and cat was more 
uniformely, whereas the lateral pallidal segment in monkeys showed more sparse 
immunoreactivity. Projections to both dorsal and ventral striatum have their origin 
mainly in NRd boudaries, as was demonstrated in cats (Bobillier et al. 1976) and 
rats (Steinbusch et al. 1981 ; Steinbusch and Nieuwenhuys 1983). Projections to the 
nucleus accumbens, probably following the external capsule (Nieuwenhuys et al. 
1988) have been regarded to be involved in the modulatory mechanism of 
nociception (for ref. Li et al. 1989). 
Hypothalamic centres that contain NRd terminals include dorsomedial, ven-
tromedial and infundibular nuclei, but also anterior and lateral hypothalamic areas, 
medial and lateral preoptic areas are innervated by NRd efferents (Nieuwenhuys et 
al 1988). The nucleus suprachiasmaticus might be reached by a specific dorsal 
raphe arcuate tract sending axon terminals also to the ventral corpus geniculatum 
laterale, as described by Azmitia and Segal (1978). The medial and lateral septal 
nuclei are reached through Broca's diagonal band and fibers passing the septum 
course to caudal hippocampal subiculum and comu ammonis, as well as entorhinal 
cortex. The latter projection might originate preferentially from the nucleus cen-
tralis superior. The molecular layerof the gyrus dentatus is mainly reached by fibers 
of the perforant pathway or fornix, originating specifically from NRd neurons 
(Azmitia and Segal 1978). A high density of serotonin radio-ligand receptor 
binding was noted in area CAI and the molecular layer of the dentate gyrus, 
whereas minimal labeling occured in the pyramidal cell layer of the CA2/CA3 
region (Stuart et al. 1986). These data suggest primarily a role for the nucleus 
centralis superior in hippocampal innervation, as was also suggested by Köhler and 
Steinbusch (1982). 
Most of the areas described also contained serotonin receptors in the monkey 
brain (Stuart et al. 1986), correlating particularly well with the distribution as 
reported in cortical and thalamic targets. As regards diencephalic nuclei the highest 
receptor binding was observed in the ventral lateral geniculate nucleus, paraven-
tricular nucleus and parafascicular/central nuclei (Stuart et al. 1986). The relative 
absence of radio-ligand labeling in the hypothalamus, despite high levels of 
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endogeneous serotonin, is indicative of either serotonin cell bodies without 
serotonin receptors or a different subtype of serotonin receptors on hypothalamic 
cells. 
Within the NRd a topographic ordering exists with respect to rostrocaudal-
ly aligned terminal fields in the ipsilateral cortex of rats (Tohyama et al. 1980; 
O'Heam and Molliver 1984; Waterhouse et al. 1986). The rostral part of the NRd 
projects preferentially to reticular formation, SN and thalamic nuclei, shifting 
laterally to ventral parts of the caudate-putamen to enter the capsula externa to 
piriform and entorhinal cortices; the caudal part also provides descending axons 
and fibers innervating hypothalamic nuclei, ascending in the mfb more medially 
to occupy Broca's diagonal band and entering the cingulum (Tohyama et al. 1980), 
thus overlapping allocorücal projections of the nucleus centralis superior, like 
those to the hippocampus (Köhler and Steinbusch 1982). Projections to isocortical 
areas arise mainly from the middle three fifths of the dorsal raphe nucleus (see also 
Saper 1987a for review). 
Neurons projecting to the motor, sensorimotor and visual cortical areas were 
concentrated in dorsal intermediate and ventral portions of the NRd, respectively 
(Waterhouse et al. 1986). Some overlap in hypothalamic with sensorimotor cortex 
projections and caudate-putamen with both motor and sensorimotor cortical 
projections has been suggested, whereas spinal cord projection neurons overlap 
with the position of retrogradely labeled NRd neurons of the occipital cortex 
(Waterhouse et al. 1986). In primates putamen-labeled cells tend to occupy a more 
lateral position relative to caudate-labeled cells of the NRd (Parent et al. 1983). A 
substantial number of NRd neurons provide common input to neocortical and 
cerebellar areas that receive afferent information related to the same sensory or 
motor function (Waterhouse et al. 1986). 
The greatest density of serotonin innervation in the monkey cortex is in the 
primary sensory areas, particularly the visual cortex (Morrison et al. 1982b; 
Takeuchi and Sano 1983; DeLima et al. 1988), with the most fibers distributed in 
layer IV, complementary to the densest NAergic fiber distribution in layers III, V 
and VI. Apparently NRd projections converge with geniculo-cortical input in spiny 
stellate cells of layer IV (DeLima et al. 1988). Generally, however, labeled axons 
and boutons are scattered diffusely, throughout the six layers of the cerebral cortex 
(Takeuchi and Sano 1983; Saper 1987a), whereas highest levels of radio-ligand 
binding to serotonin receptors were observed in cortical layers I-II (Stuart et al. 
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1986). Like NAergic afférents, long non-varicose "tract-fibers" where noted 
preferentially in layers I and VI, in both rats and cats (Takeuchi and Sano 1983; 
Mulligan and Törk 1988). Only minor differences have been noted between 
innervation patterns of other neocortical areas. In the primary motor cortex (area 
4 of Brodmann) the overall number of immunoreactive fibers was small, particu-
larly in layers IV and V, whereas the pattern in sensory and secondary visual cortex 
(i.e. area 18) roughly corresponded with that of the primary visual cortex. The 
basket-like terminal pattern as described in the cat (Mulligan and Törk 1988), 
resembling that formed by enkephalin, substance Ρ and tyrosine-hydroxylase 
containing axons in septum and frontal cortex of rats, might be species-specific and 
thus represents no generalized innervation pattern (Mulligan and Törk 1988). 
Although afférents to the NRd originate in far less widespread regions, they 
provide an important pathway in limbic-midbrain projections, as was suggested by 
Nauta ( 1958). The final relay in a massive hippocampal-raphe conduction route is 
formed by the interpeduncular nucleus, which provides a substantial part of NRd 
afférents (Groenewegen et al. 1986). A similar role is performed by the lateral 
habenular nucleus (Herkcnham andNauta 1977,1979), integrating the raphe nuclei 
into a typical limbic circuitry (Nicuwenhuys et al. 1988). The only neocortical 
region which projects directly to the mesencephalic raphe nuclei is the prefrontal 
cortex (Amsten and Goldman-Rakic 1984). 
157 
158 
III. MORPHOMETRIC SECTION 
"Man wird bemerken können, daß ein guter Kopf nur desto-
mehr Kunst anwendet, je weniger Data vor ihm liegen; daß er, 
gleichsam seine Herrschaft zu zeigen, selbst aus den vorlie-
genden Datis nur wenige Günstlinge herauswählt, die ihm 
nicht geradezu widersprechen, und daß er die feindseligen 
zuletzt so zu verwickeln, zu umspinnen und beiseite zu bringen 
weiß , daß wirUichnunmehr das Ganze nicht mehr einer freiwir-
kenden Republik, sondern einem despotischen Hofe ähnlich 
wird." 
J'.W'.Goethe, Zur Naturwissenschaft, 1793 
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ULI. INTRODUCTORY REMARKS 
In this chapter the results of the morphometric analysis will be presented. 
TTie problems concerning the sampling procedure will be discussed later (Ch.m.5.1.), 
but criteria as to what actually is counted will be dealt with here briefly. Essentially 
the following data have to be obtained: 
1. Cellular size: Necessary not only for the determination of the correction 
formula (Ch.1.3.), but also as an indication of possible age-related changes afterage 
60. Differences in cellular shape may be derived from differences in largest 
diameter (Dm=D-max) as compared to spherical diameter (Dc=D-circle) and 
cellular surface (A=area). All numbers represent micrometers (|am). As regards the 
nucleus raphe dorsalis (NRd) no data of cellular size were collected. The cell 
number of the NRd is based on the counting of nucleoli, and no correction formula 
for splilted elements has to be calculated. 
2. Number of cells counted: The absolute cell-number is determined, 
taking sections throughout the antero-posterior extent of the nucleus and possible 
tissue shrinkage, will not influence counting results. Counted numbers are multi­
plied by a factor to correct for the part of the whole structure that is counted and a 
correction formula as presented in chapter 1.3.2. The data presented in the following 
tables are 'real cell numbers'; i.e. without limitations that are statistically quanti­
fiable. They might be compared with any other ' real cell number' supplied by other 
quantitative studies. Where the mean cell number of different samples has been 
calculated usual statistical procedures for calculation of standard deviation (SD) 
and significance were evaluatedwith Student's t-test. Cytological criteria as to the 
incorporation of cellular elements are based on the data supplied in the anatomical 
section. Neuromelanin pigmented neurons are always identifiable, but cells 
without neuromelanin pigment sometimes are hard to distinguish from glia. 
Practice indicated neurons smaller than about 10 μτη (mostly of typical dark 
spherical appearance) to belong to glial elements. Therefore, neuronal elements 
smaller than half a square of the counting grid (i.e. smaller than 12,5μηι) arc not 
included, unless they contained neuromelanin or other characteristic features of the 
nuclei under consideration. 
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3. Semi-quantitative data on senile plaques and neurofibrillary tangles. 
Typical examples of neurofibrillary tangles and senile plaques as can be found in 
the human brainstem, are shown in Fig.III.l. Criteria as on the identification of 
these neurodegenerative changes are descriptive, but no doubt representative. 
Comparison with criteria (i.e. photomicrographs) of similar changes in the 
neocortex (Broere 1990), the nucleus basalis magnocellularis of Meynert (Vogels 
1990), the hippocampus (De Vries 1990) and the amygdala (Vereecken in 
preparation) revealed common descriptive features of the neurodegenerative 
changes as can be seen in various brain areas. One minor difference might be small 
variation in outer shape of neurofibrillary tangles, seemingly depending on the 
shape and size of cellular elements in the area studied. Thus, whereas cortical 
tangles are typically pyramidal- shaped (Broere 1990) those in various brainstem 
nuclei have a more spherical or polygonal appearance (Fig.III.l.). Generally the 
sizes of plaques and tangles differ to a large extent. Splitted parts of these elements 
often can not be recognized and only the most typical examples can be counted. It 
is often not possible to distinguish tangentially sectioned blood vessels and their 
fibrillary Congo red fluorescence from transsected neurofibrillary tangles. In cases 
of doubt such elements were not counted (for discussion see Ch.1.2.). Because of 
these inaccuracies as regards 'real numbers', the counting of ncurodegerative 
changes will be named 'semi-quantitative'. 
4. Within the graphical representations various points have been inter-
connected, without claiming a continuity of data, but for reasons of clearness. 
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Fig. III. 1a 
Neurofibrillary tangles of ventral tegmental midline structures. Congo-red (x 400) 
Fig. III. l b 
Neuritic plaques of mesencephalic tegmentum. Congo-red (x 400) 
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Abbreviations: 
D-circle = spherical diameter 
D-max = size of greatest cellular diameter 
Area = cellular surface on transsection 
M+ = neuromelanin-containing neurons 
M- = neurons without neuromelanin pigment 
SNmed = medial part of the substantia nigra i.e. subnuclei Am, Ai and Pm 
SNlat = lateral part of the substantia nigra i.e. subnuclei Al, PI, Pm and Ps 
LC = locus coeruleus 
NRd = nucleus raphe dorsalis 
NFT's = neurofibrillary tangles 
SP's = senile plaques = neuritic plaques 
SD = standard deviation 
AD = Alzheimer's disease 
PD = Parkinson's disease 
С = control cases 
NS = no significant difference (statistically) 
R = right (side of brain stem) 
L = left 
TH-ir = tyrosine hydroxylase-immunoreactive neurons 
DBH-ir = dopamine-ß-hydroxylase-immunoreative neurons 
t = t value necessary for the students t-test, calculated as 
t = / x - μ/ in which: 
s /Vñ 
χ = mean number of cells counted in a certain area in Alzheimer or Parkinson brains 
μ = mean number of cells counted in the same defined sub(region) in control brains, 
representing the normally expected cell number in controls 
s = variance of mean values of cell counts in the relevant (sub)region in Alzheimer or 
Parkinson brains 
η = number of Alzheimer or Parkinson brains used to calculate χ and s 
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III.2. CELLULAR SIZES AND NUMBERS OF THE SUB­
STANTIA NIGRA AND VENTRAL TEGMENTAL AREA 
In order to correctly quantify neuron numbers cellular sizes have to be obtained, for 
the correction formula of Abercrombie (1946). Each time 25 samples were 
analysed, using a Kontron MOP-Vidcoplan equipment. Tables on substantia nigra/ 
ventral tegmental area, locus coeruleus and nucleus raphe dorsalis will be presented 
separately. 
TABLE Ш.1. Cellular sizes substantia nigra and ventral tegmental area (μπα) 
Age 
(nr) 
60 
(87029) 
62 
(87177) 
69 
(86179) 
91 
(88184) 
65 
(87068) 
93 
(88221) 
79 
(86204) 
Diagnosis 
Normal 
Nornial 
Normal 
Normal 
AD 
SDAT 
PD 
Melanin con 
Unit 
D-circle 
D-max 
Area 
D-circle 
D-max 
Area 
D-circle 
D-max 
Area 
D-circle 
D-max 
Area 
D-circle 
D-max 
Area 
D-circle 
D-max 
Area 
D-circle 
D-max 
Area 
SNmed. 
(μιη) 
40 
40 
»004 
27 
43.5 
4480 
28 
39 
4650 
29 
43 
5200 
21 
28 
2600 
23.5 
34.5 
3373 
24 
35 
SNlat. 
26 
39.5 
4214 
31 
48 
5780 
27 
39 
4500 
29 
44 
6200 
25 
39 
3900 
17 
39.5 
4568 
25 
39 
tabling neurons 
SNreL 
25 
43.5 
4420 
30 
44 
5300 
26.5 
36 
4300 
32 
50 
3700 
25 
41 
3800 
26 
38 
3915 
28 
42 
VTA 
23 
34 
3231 
25 
40.5 
3700 
25 
40 
3800 
25 
39.5 
2900 
20 
32 
2500 
20 
34 
2314 
20.5 
34 
A8 
24 
39 
3520 
26.5 
40 
4100 
25 
40 
3800 
22 
34 
4300 
24 
37.5 
3500 
20 
31 
2423 
24 
34 
Neurons without 
neuromdanin 
SNc 
23 
37 
3186 
26 
44 
3900 
25 
40 
3650 
26.5 
42 
23 
38 
3300 
24 
40.5 
3450 
24 
44 
SNr 
21 
36 
2705 
22 
40 
3103 
22 
40 
VTA 
18 
30 
1919 
23.5 
40 
3250 
22 
37.5 
3050 
24 
39 
3400 
24 
38 
3300 
20 
36 
2517 
20 
36 
AS 
21 
36 
2624 
20 
36 
2517 
22 
35 
TABLE ΙΠ.2. Mean cellular sizes of SN and VTA 
mean D-circle 
mean D-max 
± S D 
mean D-circle 
mean D-max 
± S D 
mean D-circle 
± S D 
mean D-circle 
mean D-max 
± S D 
mean D-circle 
mean D-max 
± S D 
mean D-circle 
mean D-max 
± S D 
SN(M+) 
29.2 ±3.6 
42.4 ±3.8 
SN(M-) 
24.3 ±2.0 
39.8 ± 3.0 
SNmed(M+) 
31 ±5.2 
VTA(M+) 
24.5 ±0.9 
38.5 ±2.6 
SN(M+) 
29.2 ±3.6 
42.4 ±3.8 
VTA(M+) 
24.5 ±0.9 
38.5 ±2.6 
VTA(+) 
24.5 ±0.9 
38.5 ±2.6 
VTA(M-) 
21.9 ±2.4 
36.6 ±3.9 
SNlat(M+) 
28 ±1.9 
A8(M+) 
24.4 ±2.8 
38.3 ±2.5 
SN(M-) 
24.3 ±2.0 
39.8 ±3.0 
VTA(M-) 
21.9 ±2.4 
36.6 ±3.9 
t 
5.2 
1.5 
t 
1 
0.8 
t 
1.58 
t 
1.58 
1.58 
t 
2.45 
0.8 
t 
1.08 
0.5 
significance 
p < 0 . 2 
ρ = 0.10 
significance 
NS 
NS 
significance 
NS (p<0.2) 
significance 
NS 
NS 
significance 
p < 0 . 1 
NS 
significance 
NS 
NS 
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Table Ш.1. gives an account of the results of the data from Kontron MOP-
Videoplan measurements. These data are summarized in table ΠΙ.2., providing 
mean profile sizes, on which some conclusions can be drawn: 
1. The mean spherical diameter of neuromelanin pigmented nigral cells (29.2 ±3.6 
μπι) does not differ significantly between various nigral subnuclei, but is signifi­
cantly larger than that of VTA neurons (24,5 ± 0.9 μπι). The mean spherical 
diameter of VTA cells is comparable to that of A8 cells, both as regards 
neuromelanin containing cells and those without neuromelanin. 
2. No significant change of cellular sizes related to age could be detected. 
3. The mean spherical diameter of nigral (24.3 ± 2.0 μπι) and VTA (21.9 + 2.4 μπι) 
cells without neuromelanin pigment also showed no age-related change. 
4. Similar results hold for largest profile size (D-max) and cellular surface (Area), 
although the difference between neuromelanin-containing nigral cells and those 
without pigment (mean D-max 42.4 ± 3.8 μτη and 39.8 ± 3.0 μπι, respectively is 
not significant now. 
VTA cells without neuromelanin pigment (D-max = 36.6 + 3.9 μπι) are smaller 
than those of the SN (D-max = 39.8 + 3.0 μτη), but because of the high variability 
in cell sizes, this difference has no statistical relevance. 
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Data from the foregoing tables may be visualized as follows: 
Fig III 2 
Cellular sizes ( D - c i r c l e ) of various subnuclei 
related to age 
years 
Fig III 3 . 
Cellular sizes ( D - c i r c l e ) of various subnuclei 
related to disease-state 
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SN med 
Ш control 
(n=4) 
SN lat SN ret VTA 
Ш Ш і 2 Ь е , т е г ІШгиЪхпш* 
(n=2) (n=2) 
A8 
Whereas figure III.2 provides information on the distribution of cellular sizes 
among control cases of various age, figure III.3 gives information on such findings 
as regards patients with AD and PD, as compared with controls. 
Figure III.3 clearly shows that, generally speaking, no important changes in 
sphencal diameters occur in vanous disease states. The drop in spherical diameter 
of neuromelamn pigmented cells of the VTA in both AD and PD, however, is 
significant. Therefore, this change is incorporated in the correction performed on 
quantitative estimation of cell numbers. Likewise the drop m spherical diameter of 
the medial part of the SN, especially in AD, deserves attention (and is also 
incorporated in further calculations). 
It may be stated that generally there seems to be a trend of neurons to shrink in AD 
and PD, but this trend is not uniform and without statistical significance. For mean 
largest and mean cellular surface of all subnuclei, this trend has grown to a 
significant level as regards neuromelanin pigmented cells. This is shown in table 
III.3. 
Table IIIJ. Differences of mean cellular sizes in disease-states (n=4) as compared to 
controls (n=4) 
Disease state 
Controls 
AD/SDAT 
Controls 
AD/SDAT 
Controls 
AD/SDAT 
Controls 
AD/SDAT/PD 
Controls 
AD/SDAT/PD 
Controls 
AD/SDAT/PD 
Controls 
AD/SDAT 
Controls 
AD/SDAT 
Controls 
AD/SDAT 
Subnudeus 
SNmed(M+) 
TA(M+) 
VTA(M-) 
SN(M+) 
VTA(M+) 
VTA(M-) 
SN(M+) 
VTA(M+) 
VTA(M-) 
Mean size (μιη) 
3 1 0 ± 5 . 2 
22 3 ± 1 3 
2 4 5 ± 0 9 
2 0 + 0 
2 1 9 ± 2 4 
2 2 0 ± 2 0 
424 + 3 8 
373 + 4 0 
385 + 2 0 
3 3 3 ± 0 9 
366 + 51 
366 + 0 9 
4846 + 644 
3693 ± 601 
3608 ±250 
2407 + 93 
2905 + 576 
2909 + 392 
Variable 
D-circle 
D-circle 
D-cirde 
D-max 
D-max 
D-max 
Area 
Area 
Area 
t 
67 
5 
005 
128 
57 
19 
129 
Significance 
p < 0 1 0 
p < 0 1 0 
NS 
p = 010 
p < 0 0 1 
NS 
p = 005 
p = 0025 
NS 
Data on cellular sizes were incorporated in the calculation of real cell numbers, with the aid of Abercrombie's 
(1946) correction formula 
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Table Ш.4. shows corrected neuron numbers as quantified for the three main parts of the SN 
(medial, lateral and pars reticulata), the VTA and the retrorubral area (A8). In this table the left and 
right sides of the brainstem are separately quantified. 
Table Ш.4. Neuron numbers substantia nigra and ventral tegmental area in 
controls, AD and PD brains and corrected according to Abercrombie (1946) 
Age 
Conti 
60 
62 
69 
80 
91 
ADI 
65 
69 
76 
93 
Nr. 
ois 
87029 
87177 
86179* 
88269* 
88184 
»rains 
87068 
87395 
88177 
88221 
VUneuromel. 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
L/R 
R 
R 
L 
L 
R 
R 
L 
L 
R 
R 
R 
R 
R 
R 
L 
L 
R 
R 
L 
L 
R 
R 
L 
L 
R 
R 
L 
L 
R 
R 
L 
L 
SN med 
74510 
10430 
61245 
8046 
95396 
19073 
78179 
16391 
62938 
14901 
58705 
14603 
58987 
19371 
63221 
9238 
65897 
9355 
71970 
11769 
66857 
9752 
82589 
22625 
67415 
14485 
56483 
4526 
46158 
27460 
46158 
14786 
SN lat 
76546 
12363 
80984 
11038 
72941 
13835 
107331 
22665 
103726 
26198 
116761 
25903 
102616 
25020 
75714 
10302 
82053 
11467 
107364 
22029 
94554 
20284 
85766 
13653 
106808 
16899 
89563 
13579 
82887 
34401 
73152 
21123 
SN ret 
47293 
43645 
36707 
33182 
39044 
57995 
40419 
48727 
35195 
74735 
58291 
72045 
43718 
77426 
34645 
44841 
38611 
28026 
48264 
31377 
49062 
58840 
42208 
44228 
43721 
46000 
28391 
42649 
30378 
58185 
25551 
50569 
VTA 
46781 
29868 
39584 
45120 
58776 
85792 
46481 
58148 
61774 
128370 
69571 
101997 
53978 
120109 
77068 
116296 
21503 
20070 
30168 
26656 
41850 
59872 
38891 
48800 
40117 
48607 
39475 
52684 
27601 
62092 
31452 
76831 
Λ8 
11695 
21111 
7047 
11355 
9596 
37424 
12295 
46381 
9596 
31667 
9596 
48300 
8996 
58216 
15893 
54057 
3056 
9721 
11002 
10349 
3172 
21324 
8724 
31167 
12224 
43276 
14058 
48607 
4890 
28224 
4278 
13798 
SN tot 
198349 
66439 
178935 
52267 
207380 
90902 
225929 
87783 
201859 
115834 
233756 
112551 
205322 
121817 
173579 
64382 
186560 
48848 
227598 
65175 
210474 
88876 
210563 
80506 
217944 
77383 
174436 
60755 
159423 
120046 
144862 
86479 
* Left side incomplete. Neuron number of right side also applied for left side when necessary. 
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Age Nr. 
PD brains 
68 
69 
74 
79 
89142 
89141 
87377 
86204 
PD+AD brain 
66 87062 
M=Ncuromel 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
M 
non-M 
L/R 
R 
R 
L 
L 
R 
R 
L 
L 
R 
R 
L 
L 
R 
R 
L 
L 
R 
R 
L 
L 
SN med 
22800 
20672 
36000 
31008 
10500 
21584 
10800 
25232 
23216 
5506 
10834 
5506 
35085 
15791 
25170 
8972 
48367 
17304 
24764 
9045 
SN lat 
14700 
26752 
21462 
34960 
7938 
14896 
14994 
16112 
11334 
13765 
7556 
11012 
35028 
30063 
35150 
9362 
49869 
14158 
37780 
9439 
Sn ret 
11286 
60800 
10602 
54400 
4743 
34880 
4185 
16000 
17993 
68182 
10584 
64815 
10321 
49259 
25613 
28827 
20462 
52610 
25048 
30724 
VTA 
26320 
31584 
34545 
6580 
23118 
58104 
25299 
67788 
35492 
77761 
30437 
34857 
29224 
39176 
31405 
37416 
A8 
4848 
4242 
5454 
3636 
2350 
28248 
392 
42372 
3633 
34520 
5155 
18454 
783 
21601 
5092 
18694 
SN tot 
48786 
108224 
96494 
119968 
23181 
71360 
29979 
57344 
52542 
87453 
28974 
81333 
80435 
95114 
85933 
47161 
118698 
84072 
87592 
49208 
Graphical representations of these data are shown in figures III.4. ad III .5. in which 
neuron numbers of three groups have been arranged. Neuron numbers of both sides 
of the brainstem are taken together in these representations. Cases of AD and SD AT 
are taken together and referred to as "dementia". Figure III.5. is a visualization of 
the graphical representation in figure III.4. 
F i g III U. 
Mean neuron numbers of various subnuclei 
related to disease-state ( left * right together) 
300 
с 
111 
3 
SN med SN lat SN ret VTA 
^ ^ H control ШШШ dementia V//// λ Parkinson 
( π = 5 ) ( η = Α ) ( η = 4 ) 
Fig I I I .5. 
Mean neuron numbers of various subnuclei 
related to disease - state ( left • right together) 
300 -
с 
S 
•з 
£ 
~ zool· 
I 
E 
D 
С 
= too • 
M« 
м-
SNmed 
M-
м* м- м* 
SN lat SN ret 
M-
VTA 
Α8 
• control 
(η = 5 ) 
• dementia 
( η = 4 ) 
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172 
The conclusions that may be drawn from these data are summarized in the tables 
ΠΙ.5 and III.6. Mean cell numbers of controls and PD cases, respectively, have been 
calculated and compared with each other and with AD/SDAT cases ("AD" in table 
ΠΙ.6.). For discussion see Ch.III.5.2. 
Table Ш.5. Mean cell numbers of various nigral subnuclei In PD (n=4) as compared to 
controls (n=5) 
Subnudeus 
SNmed(M+) 
SNmed(M-) 
SNlat(M+) 
SNIat(M-) 
SNret(M+) 
SNret(M-) 
Disease state 
Control 
PD 
Control 
PD 
Control 
PD 
Control 
PD 
Control 
PD 
Control 
PD 
Neuron number 
69,147 
21.800 
14,006 
16.784 
92.077 
18,520 
18.416 
19.615 
41,914 
11,916 
56.574 
47.145 
% cell loss 
68% 
NS 
80% 
NS 
72% 
17% (NS; ρ » 0 . 2 ) 
Table Ш.6. Mean cell numbers of ТЛ, SNtot and A8: differences of AD (n=4) and PD 
(n=4) as related to controls (n=5). 
Subnudeus 
VTA(M+) 
VTA(M-) 
SN-toul(M+) 
SN-toul(M-) 
A8(M+) 
A8(M-) 
Disease state 
Control 
PD 
AD 
Control 
PD 
AD 
Control 
PD 
AD 
Control 
PD 
AD 
Control 
PD 
AD 
Control 
PD 
AD 
Neuron number 
56,752 ± 11,799 
26,672 ± 8,634 
33,882 + 8,019 
91.606 ± 29.764 
59,628 ± 13,235 
49,452 + 17,366 
203,139+ 19,248 
55,791 ± 26,650 
191,483 + 27,941 
88.997 + 24.569 
83.495 + 28,624 
78,509 ± 20.773 
10,589+ 2,508 
3.714 + 1,564 
7,672 + 4.101 
38,564+ 15,313 
30,899 ± 8,756 
25,808+ 15,888 
% cell loes 
53 % 
40.5% 
35.0% 
47.1% 
73 % 
6 % 
6 % 
12 % 
65 % 
28 % 
20 % 
33 % 
t 
3.48 
2.85 
2.42 
2.43 
5.52 
0.40 
0.19 
0.50 
4.40 
0.71 
0.88 
0.80 
significance 
ρ = 0.005 
ρ < 0.025 
ρ < 0.025 
ρ < 0.025 
ρ < 0.0005 
NS 
NS 
NS 
ρ < 0.0025 
NS; ρ » 0 . 2 0 
NS; ρ » 0 . 2 0 
NS; ρ » 0 . 2 0 
The conclusions that might be drawn from these latter tables are as follows: 
1. These data firstly show the relatively greater standard deviation of neurons 
without neuromelanin pigment, especially as regards area A8. Therefore substan-
tial numerical differences may be not-statistically-significant. 
Next, the medial part of the SN appears to contain the greatest relative abundance 
of neuromelanin-containing neurons, as compared to overall cell number. 
2. Both medial and lateral parts of the SN show a significant loss of neurons in 
Parkinson's disease (68% and 80%, respectively). No significant changes in cell 
number of (M-)ncurons have been measured, unless a slight increase in non-
pigmented neurons in PD. 
3.As regards the pars reticulata there is a significant loss of pigmented neurons in 
PD (72%), but not in AD. 
4. A significant loss of neurons of the VTA, both pigmented and those without 
neuromelanin, is apparent both in PD and AD. The most remarkable is the loss of 
cells without neuromelanin in the VTA of Alzheimer's disease patients. 
5. Less significant are the differences concerning neuron loss of A8 and SN-total, 
although again a significant loss of unpigmented cells may be registered for A8 in 
AD-cases. 
6. Neuron numbers of the various subnuclei in the case of combined AD and PD 
are within the realm of what might be expected from the datamentioncd before. I.e., 
a significant loss of both pigmented cells and those without neuromelanin. 
7. There appears to be no change of cell number related to age, neither in controls 
nor in disease cases (Fig.III.6.). Both controls and AD-cases show no clear trend 
among the highly variable data. Because no significant change of cell number in 
the SN for AD relative to controls was noted, controls and AD cases could be taken 
together. This new set of samples, providing a greater number of cases, can be 
correlated to age again (Fig.III.7.). For this figure the mean cell number of the left 
and the right SN, respectively, were taken in each case. Cellular sizes that might 
be expected related to age are represented by the hatched area. 
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Ш.З. CELLULAR SIZES AND COUNTING RESULTS OF 
THE LOCUS COERULEUS AND NUCLEUS RAPHE 
DORSALIS. 
Table III.7. gives an account of cellular sizes of the locus coeruleus i.e. greatest 
section diameter (D-max) and calculated spherical diameter (D-circle) for several 
cases. Data were obtained similar to the procedure used for the SN and VTA. Again, 
these data are of need to correct for possible cellular shrinkage and counting errors 
as a result of splitted elements. 
Table III.7. Cellular sizes locus coeruleus 
Nr. 
87029 
87177 
88221 
87062 
86204 
87029 
87177 
88221 
87062 
86204 
Age 
60 
62 
93 
66 
79 
60 
62 
93 
66 
79 
Diagnosis 
С 
С 
SDAT 
AD/PD 
PD 
С 
С 
SDAT 
AD/PD 
PD 
Variable 
(μιη) 
Dm 
Dm 
Dm 
Dm 
Dm 
Dc 
Dc 
Dc 
Dc 
Dc 
Rostral M+ 
47 
61 
47.4 
45 
44.2 
36.8 
45.4 
36.4 
32.2 
32.8 
Rostral M-
51 
58.5 
39.4 
50.4 
44 
31 
33 
25.6 
26.4 
25.6 
Caudal M+ 
52.8 
59.4 
61.2 
47 
49.2 
35.6 
37.4 
40.6 
33.8 
33.2 
Caudal M-
52.8 
52.2 
57 
48 
45.6 
34.4 
31.4 
32.4 
26.2 
24.2 
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Table Ш.8. summarizes data on cellular sizes, averaged for controls, AD and 
PD patients respectively. 
1. Normally, various cellular sizes may be seen throughout the locus coeruleus. The 
greatest range of section diameters, however, is seen in the rostral part, especially 
as regards neuromelanin containing neurons. Generally, neurons without pigment 
were somewhat smaller than those with neuromelanin. 
Likewise, variation in spherical diameters rostrally is somewhat greater than 
caudally and rostrally the greatest neuromelamn containing neurons have been 
found. 
2. There appears to be a global shrinkage of cellular elements, both pigmented and 
cells without neuromelanin, in cases of AD, SDAT and PD. 
No changes of cellular size related to age in controls or disease cases was 
demonstrable. 
3. The most pertinent finding is a general reduction of cellular size throughout 
the locuscoeruleus in Parkinson's disease, either isolated orin combination with 
AD. 
This reduction in cellular size only concerned the rostral part in the case of 
SDAT. Neuromelanin pigmented cells were reduced to 77% of their normal size, 
whereas neurons withoutneuromelanin showed a shrinkage to 81 % of theiroriginal 
size. 
Table IIL8. 
Variable 
Mean D-max 
Mean D-max 
Mean D-max 
Mean D-max 
Mean D-circle 
Mean D-circle 
Mean D-circle 
Mean D-circle 
Disease state 
Control (n=2) 
А О . Р О ^ З ) 
Control (n=2) 
AD,PD(n=3) 
Control (n=2) 
A D . P D ^ S ) 
Control (
n =
2) 
А О . Р О ^ з ) 
Control
 ( n = 2 ) 
A D
.
P D ( n = 3 ) 
Control
 ( n = 2 ) 
A D . P D ^ s ) 
Control (n=2) 
AD,PD(n=3) 
Control
 ( n = 2 ) 
AD,PD(n=3) 
Part of LC 
Rostral(M+) 
Rostral (M-) 
Caudal(M+) 
Caudal(M-) 
Rostral(M+) 
Rostral(M-) 
Caudal(M+) 
Caudal(M-) 
Hm±SD 
54,0 
45,5 ±2,2 
54,8 
44,6 ±4,3 
56,1 
52.5 + 6.2 
52,5 
50,2 + 4.9 
41.1 
33,8+1,85 
32 
25.9 + 0,38 
36,5 
35,9 ± 3,42 
32,9 
27,6 ±3,49 
t 
3,86 
2,36 
0,58 
0,47 
3.9 
16 
0.18 
1.5 
significance 
ρ < 0,025 
0,10 < p < 0,05 
NS 
NS 
ρ < 0.025 
ρ < 0,0025 
NS 
NS; ρ > 0,1 
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Table Ш.9. gives the counting of neuron numbers in the locus coeruleus. The interpretation of these 
results is visualized in figures Ш.8.а,Ь. The total cell number is calculated, again, after correction 
(Abercrombie, 1946), using cellular sizes as mentioned before. 
Table Ш.9. Counting results Locus coeruleus 
Age 
Controls 
60 
62 
69 
80 
91 
Dementia 
65 (AD) 
69(SDAT) 
76 (SDAT) 
82 (MID) 
93 (SDAT) 
PD brains 
68 
69 
74 
79 
PD/AD brain 
66 
Brain nr. 
87029 
87177 
86179 
88269 
88184 
87068 
87395 
88177 
87368 
88221 
89142 
89141 
87377 
86204 
87062 
Left(M+) 
19313 
22357 
17143 
19488 
19313 
4380 
7152 
4167 
12483 
3723 
21296 
10406 
10132 
5324 
5066 
Right(M+) 
18662 
29729 
17577 
16212 
19964 
5037 
8046 
5037 
5694 
5475 
19602 
6050 
6854 
10406 
8344 
Left(M-) 
8296 
18056 
16348 
16530 
15128 
1315 
3520 
6312 
4734 
3945 
15427 
8866 
2192 
4576 
3520 
Right(M-) 
11224 
14884 
13908 
16910 
11712 
1052 
4928 
5260 
3945 
3682 
15427 
9398 
2929 
5434 
4224 
Table ШЛО. Concluding data on locus coeruleus countings (mean cell numbers) and 
reduction of cell number (%) with statistical significance (n=5) 
Disease state 
Control 
Dementia 
Parkinson's 
disease 
(M+) 
(M-) 
(M+) 
(M-) 
(M+) 
(M-) 
Mean cell number 
19.976 ±3.627 
14.300 + 2.889 
6.119 + 2.466 
3.869+1.562 
11.259 ±5.644 
8.031 ±4.883 
% cell loss 
69,4% 
73,0% 
44,6% 
44,0% 
t 
5,6 
6,68 
1,5 
1.28 
significance 
ρ < 0,0005 
ρ < 0.0005 
ρ < 0,10 
NS (ρ > 0.10) 
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These data suggest that: 
1. There is a significant loss of cells in the LC both in dementia and PD, somewhat 
more pronounced in Dementia. Indeed, one of the PD cases showed a cell number 
within the range of controls, whereas another PD case had an extreme loss of cells, 
beyond the mean of dementia cases. 
2. No significant age-related changes were found. As regards neuromelanin 
containing neurons a trend of smaller cell numbers in older brains can not be 
excluded. 
3. The most striking result, again, is the loss of neurons whithout neuromelanin 
pigment in Dementia, which certainly not would have been detected if only 
pigmented cells had been counted. 
4. An additional reduction of neuron number among cells with D-max smaller than 
12,5 μιη (smaller undefined neuronal elements) has been calculated both in 
dementia (40%) and PD (48%). 
5. From the plotting table sheets a more detailed image of regional cell loss can be 
obtained. Calculation of anterior-posterior differences revealed a global cell loss 
of 70% throughout the rostro-caudal extent. This was different for neurons without 
neuromelanin: a cell loss of 55% for the caudal half contrasts with that of 80% in 
the rostral half of the locus cocruleus in dementia cases. In PD the uniform rostro-
caudal gradient (44% loss both of pigmented cells and neurons without neurome­
lanin) remained. 
6. Among dementia cases, the greatest cell number has been counted in a MID brain 
(male, 82 yrs.).The counting conclusions, mentioned before, do not change signi­
ficantly if controls and PD cases are compared with dementia of Alzheimer's type. 
Table III.l 1. provides data on cell numbers, based on the counting of nucleoli, 
179 
Table III. 11. provides data on cell numbers, based on the counting of nucleoli, 
within the nucleus raphe dorsalis. These data are summarized in table III. 12, 
providing mean cell numbers. The rostral part is defined as one-third of the total 
anterior-posterior length. 
Table Ш.11. Neuron numbers in the nucleus raphe dorsalis for controls, AD and PD cases. 
Age 
Controls 
60 
62 
69 
80 
91 
AD brains 
65 
69 
76 
93 
PD brains 
68 
69 
74 
79 
AD+PD brain 
66 
Brain nr. 
87029 
87177 
86179 
88269 
88184 
87068 
87395 
88177 
88221 
89142 
89141 
87377 
86204 
87062 
Neuron number 
385,280 
443,520 
433,280 
677,120 
663,680 
227,200 
189,440 
434,560 
403,840 
481.920 
661.120 
440,960 
689,280 
245,760 
Rostral one-third 
163,200 
321.280 
273,280 
378.240 
341.760 
129.280 
96.640 
221.440 
228,480 
272,000 
380,160 
240.640 
371.840 
123,520 
Table Ш.12. Mean cell numbers of nucleus raphe dorsalis and cell loss related to controls 
Disease state 
Control (n=5) 
Control 
AD (n=4) 
AD 
PD (n=4) 
PD 
(sub)nudeus 
NRd 
Rostral part 
NRd 
Rostral part 
NRd 
Rostral part 
Neuron number ± SD 
520,576 ±160,000 
295,552 ± 74,360 
313,760+125.000 
168.960 ± 67.714 
568.320+127,000 
316,160+ 60.929 
% loss 
39.7 % 
43 % 
NS 
NS 
t 
1.94 
1.87 
significance 
0.05<p<0.10 
0.05<p<0.10 
NS 
NS 
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Fig III θ a 
Neuron number of locus coeruleus related to age 
(neuromelamn containing cel ls) 
25 -
20 
о 
с 
15 
E 
10 
control 
Dementia 
Parkinson's disease 
60 65 70 75 80 85 90 95 
• Years 
Fig ІІІ Ь 
Neuron number of locus coeruleus related to age 
( c e l l s without neuromelamn) 
control 
Dementia 
Parkinson's disease 
Each point represents left side and right side, respectively, in a single case (see tabel III 9) 
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These data are visualized in figures ІП.9.а and b. The conclusions that might be 
drawn: 
1. The mean neuron number of the nucleus raphe dorsalis, in its largest extent, 
is 520,576 ± 160,000 cells. No significant change of this cell number was shown 
in PD cases. 
2. There is a significant loss of NRd cells in cases of Alzheimer's disease (39,7 %), 
somewhat more pronounced in the rostral one-third of the nucleus (43%), although 
this difference is not statistically significant. 
3. It is remarkable that there is a trend of increasing cell number with age and 
certainly no age-related cell-loss, both in controls and in AD cases. 
Fig III 9 l 
Neuron number of nucleus raphe dorsalis -
related to age 
7 • 
2 3 
COntfDl 
Alzhtimtr s disvas· 
Parkinson s diMast 
Fig 1119 t> 
Neuron number of the rostral one - third of nucleus raphe dorsalis -
related to age 
E 
— Control 
Alzhtimer s diseasr 
Parkinson s discase 
60 65 TO 75 
Each point represents the neuron number of a single case (see tabel 111.11) 
90 85 90 95 
— . Ytars 
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III.4. DISTRIBUTION AND SEMIQUANTITATIVE CAL-
CULATION OF NEUROFIBRILLARY TANGLES AND 
SENILE PLAQUES 
Figures IH.lO.a.b and Ill.ll.a.b give an account of the typical distribution of 
neurodegenerative findings in a case of Alzheimer's disease. The boundaries of the 
monoaminergic nuclei, as defined in the neuroanatomical section (section II), are 
by no means respected by these findings. Nevertheless, an attempt was made to 
quantify the number of neurofibrillary tangles and senile plaques, within the 
monoaminergic nuclei under consideration. Nuclear boundaries were defined by 
using plotter sheets, available after quantification of Nissl-stained sections, as a 
guide. 
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Fig. 10a and 10 b 
Distribution of neurofibrillary tangles (Congo red fluorescence) 
in the human mesencephalon and rostral rhombencephalon 
in Alzheimer's disease 
0-87396 ( · • S40 NFTI 
Fig. 10a 
184 
0-Θ7395 ( · . 640 NFT) 
Fig 10b l i o ' ^ а »<· 
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Fig Ila and 11b 
Distribution of senile plaques (Congo red fluorescence) 
in the human mesencephalon and rostral rhombencephalon 
in Alzheimer's disease 
О Θ73Θ5 
+ • 640 sp 
Fig 11a 
186 
0-87395 ( · - 640 sp) 
Fig 11b 
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Table III. 13. presents data on semi-quantitative estimation of neurofibrillary 
tangles in AD brains, left and right side taken together. The counted numbers, as 
noted here, have to be quantified with χ 16 and χ 40, for the estimation of real 
numbers. 
Table Ш.1Э. Numbers of neurofibrillary tangles, without correction, as counted for 1/40 of 
the rostro-caudal extent (bilaterally) 
Age 
65 
66 
69 
76 
93 
Disease 
AD 
AD+PD 
SDAT 
SDAT 
SDAT 
Brain nr. 
87068 
87062 
87395 
88177 
88221 
Mean + SD 
Extrapolation and calculation 
for 40 sec lions 
SNmed 
2 
14 
12 
6 
4 
7.6 ±4.6 
SNlat 
18 
15 
24 
16 
8 
14.2 + 6.1 
SNtot = 13.952 
VTA 
50 
46 
114 
95 
64 
74 ±26.5 
47.360 
NRd 
178 
81 
93 
147 
74 
111.6 ±40.8 
73.344 
LC 
19 
37 
50 
42 
16 
32.8+12.9 
20.992 
These estimated numbers of neurofibrillary tangles may be compared with cell 
losses using the following data. 
1. Number of neurons in control cases, both M+ and M-, on both sides of the brains. 
2. Number of lost neurons in AD, both M+and Μ-, bilaterally for the various nuclei. 
3. Percentage of cell loss of AD cases as compared to controls. 
Data of 1, 2, and 3. are as follows: 
Neuron numbers of both sides: 
in: Controls (M+/M-) 
(n=5) 
AD brains (M+/M-)(n=4) 
Cell loss in AD 
Number of NFTs as compared 
to number of lost cells 
SNtot 
584.272 
539.984 
44.288 
31.5% 
VTA 
284.928 
166.667 
118.261 
4 0 % 
NRd 
520.576 
313.760 
206.816 
35.5% 
LC 
68.552 
19.976 
48.576 
43.2% 
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In conclusion, the number of neurofibrillary tangles as a percentage of the 
number of lost cells in AD cases seems to be rather uniform, as illustrated in 
fig. ШЛ2. 
Fig.III 12. 
Number of NFT's as compared to number of cell loss 
in AD cases 
number of NFT's 
cell loss in AD 
250 
V) 
С 
1 200 
& 
E 
f 150 
О) 
υ 
II 
_іл 
"3 
" 100 
s 
50 
% of cell loss related to controls 
SN tot 
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The number of senile plaques as estimated for brains of patients dying with 
Alzheimer's disease is shown in table III. 14. 
Table Ш.14. Estimation of the number of senile plaques in monoamlnergic nuclei SN, VTA, 
NRd and LC in Alzheimer's disease 
Age 
65 
66 
69 
76 
93 
Brain nr. 
87068 
87062 
87395 
88177 
88221 
SNmed 
640 
1.280 
1.920 
--
-
SNIat 
„ 
3.840 
6.400 
5.120 
-
VTA 
1.920 
4.480 
18.560 
10.240 
640 
NRd 
„ 
3.200 
9.600 
4.480 
1.280 
LC 
3.200 
7.680 
14.080 
2.560 
1.280 
Senile plaques in the mesencephalon, both of control cases and of Parkinson's 
disease, were exceptional. Generally, it can be said that no senile plaques occurred 
in any of the monoaminergic brainstem nuclei in cases without Alzheimer's 
disease. Besides, the estimated number of senile plaques in cases with AD was 
significantly smaller than the number of neurofibrillary tangles and their greatest 
concentration was seen in the inferior colliculus and adjacent central grey. 
Table HI. 15. gives an estimation of the number of neurofibrillary tangles that 
occurred in the brains of aged control patients. Neurofibrillary tangles now seemed 
to be diffusely spread, rather than occurring exactly within defined nuclear 
boundaries. Therefore the mesencephalon and rostral rhombencephalon has been 
subdivided into five areas and the number of tangles is noted for each distin­
guished area. 
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Table Ш.15. Neurofibrillary tangles within various areas of control brains and brains with 
Parkinson's disease. (For estimation of real number: multiplication with χ 640) 
Age 
60 
62 
69 
80 
91 
74 
79 
Brain number 
87029 
87177 
86179 
88269 
88184 
87377 
86204 
State 
С 
С 
С 
С 
С 
PD 
PD 
Areal 
-
4 
2 
2 
-
7 
2 
Area 2 
8 
6 
АгеаЗ 
-
2 
2 
1 
-
4 
-
Area 4 
6 
3 
1 
3 
12 
1 
NRd 
9 
4 
2 
8 
2 
11 
5 
LC 
6 
4 
-
-
4 
4 
2 
l~Sub5laniia Nigra 
2~Venlral Ttgmmlal Area 
3 — Helicula' formation slructures 
i-Tectum 
It is important to note that the number of neurofibrillary tangles in the areas 3 and 
4, as defined in table III. 15, possibly have been underscored, since these areas were 
not within the scope of primary interest. The conclusion, that there seems to be a 
relative abundance of NFT's within areas 1 and 2 of control brains, has no validity 
therefore. It is remarkable, however, that both SN and VTA of the aged brain at least 
show some neurofibrillary degeneration. 
The greatest number of NFT's occured in the brain of a patient who died with 
Parkinson's disease (case number 87377) in which a remarkable degree of 
congophilic angiopathy was seen. In such a case it is not always possible to 
differentiate between tangentially sectioned (fibrillary) vascularendothelian struc­
tures and transected neurofibrillary tangles. The number of neurofibrillary tangles 
as indicatedhere, will rather be an underestimation than anoverestimation, because 
no fibrillary structures that could not be identified with certainty were included. 
The table (Table III. 15) clearly shows that no clear correlation of quantitative 
neurofibrillary degeneration related to age could be demonstrated for the mesen­
cephalon and rostral rhombencephalon. 
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ΙΠ.5. GENERAL CONCLUSIONS AND DISCUSSION OF 
THE MORPHOMETRIC SECTION 
IIL5.1. Critical evaluation of the counting method. 
Our counting method had to be easily adoptable with a minimum of bias, in 
order to provide a method for routine examination on different brainstem structu­
res. Besides an exact location of the counted elements has to be assured. Recent 
developments in stcrcology (Gundersen 1986) have forced observers to consider 
different approaches in the counting and calculation of neural elemcnts.This is 
especially true for the morphometric analysis in aging and aging disease, which is 
characterized by specific problems, as reviewed by Coleman and Flood (1987). 
Like immunohistochemical stained cellular elements and fluorescent profiles, the 
neuromelanin containing cells can easily be detected by a comparable computeri­
zed plotting system (German et al.1983,1988a; Agnati and Fuxe 1984a,b; Hirsch 
et al. 1988). Differences in transmitter expression, caused by variations in tissue 
processing, age and post-mortem delay, as well as the yet undefined interaction 
between transmitter depletion and cell loss (Coleman and Flood 1987), arque in 
favour of the application of neuromelanin as a marker in cell countings. On the 
other hand melanin obscures other cytologic maricers, such as nuclei and nucleoli 
(Pakkcnberg and Brody 1965; Bogerts et al.1983) that could otherwise help to 
identify various elements. Therefore the rather large neuromelanin containing 
profiles, variable in size and shape, in order to be quantified demand correction by 
calculation (Abercrombie 1946; Bolender 1982). The correction formula as 
proposed by Abercrombie (1946), and used in several studies on the human 
catecholaminergic nuclei (Bondareff 1982; Bondarcff and Mountjoy 1986; Halli-
day and Törk 1986; German et al. 1988a) leads to some overcorrection of the 
counting error, especially for a relatively large mean neuron diameter with much 
variance ("lost caps", Haug 1986). Therefore Floderus' formula (Floderus 1944) 
might be used, compensating for this phenomenon, by taking into account the 
height of the "lost caps" (see presumptions nr. 5). Still some presumptions have to 
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be made and some biassing factors could not be excluded completely for practical 
reasons: 
1. Quantification of CA neurons identified by their pigmentation presents some 
interpretative problems (Bogerts 1981; Saper and Pelilo 1982; Marsden 1983). 
Even though it is accepted that pigmented neurons may have at one time produced 
either DA or NA (see Ch. 1.4.) the question remains whether all CA-producing 
neurons necessarily contain pigment. Therefore investigation in age-related and 
pathological degenerative changes in CA nuclei necessarily also has to include 
non-neuromelanin-pigmentcd neurons. 
2. For a standard morphometric analysis of the substantia nigra and the ventral 
tegmental area it is useful to have eight equidistant sections for extrapolation lo the 
real cell-number, after systematic random sampling, with a reliability of 95 % 
following Cavalieri's principle (Mattveldt 1987; see also Vogels 1990). Our atlas 
provides a matrix for this procedure. Some variation exists, however, in the 
position of different (sub)nuclei, for which this matrix docs not provide sufficient 
information. But this variation is minimal for the different categories: substantia 
nigra medialis, substantia nigra lateralis, substantia nigra pars reticularis, ventral 
tegmental area and area retrorubralis. Each of these entities is sampled in more than 
eight sections (with the exception of the area retrorubralis). The selection of still 
more and smaller entities (i.e. subnuclci), for comparison with each other, would 
be of interest from an anatomical point of view, but had to be ruled out from a 
methodological point of view. Indeed, ihe reliability of countings on area A8 is 
significantly smaller and no conclusions will be drawn from countings of this area. 
3. The neuromelanin-containing neurons have to be considered as spherical 
elements in order to make Floderus' and Abercrombie's correction formula 
(Flodcrus 1944; Abercrombie 1946; Haug 1986) suitable. The Kontron MOP-
Videoplan calculates a "D-circle", representing the diameter of an equivalent 
spherical particle. The effect of these size and shape variations is not to great, as 
has been indicated by Gittes and Bolcnder (1987). 
4. The same counts, to an unacceptable degree, for neurofibrillary tangles and 
senile plaques, of which the profiles are in no way exactly defined. Therefore 
counting results of neuropathologic elements in this study have to be defined 
"semi-quantitative". 
5. Because variation in cellular sizes, although not always significant on statistical 
grounds, still might affect the counting results, some control calculations were 
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done, using Floderus' correction formula (Table III.16. and Fig. III.13.). Because 
of the introduction of 'lost caps' the outcome provides greater cell numbers, closer 
to reality. But in relation to each other the data do not change significantly as can 
be seen in figure III. 13. Abercrombies correction formula is more generally used 
in literature and is therefore chosen as a standard in our calculations. 
'2h' in Floderus' formula (Floderus 1944; see chapter 1.3.2.) is the height of a lost 
cap, derived from its spherical diameter (for discussion Haug 1986; Albers et al. 
1988). The numerical value of D-circle of a lost cap roughly corresponds with '2h' 
and is used in our calculations. 
In conclusion, comparison of these data clearly shows that the use of either 
(uncomplicated) correction according to Abercrombie (1946) or (complicated) 
correction according to Floderus (1944) introduces no significant variation (compare 
Fig. III. 13. with Fig. III.6. and III.7.). 
6. Of the "lost caps", the smallest elements identified, it is impossible to trace their 
origin to either neuromelanin containing cells or other cells, when they do not 
contain neuromelanin. This, however, does not lead to much bias because the size 
of these elements was in the same range for the different categories. 
7. In order to make the counting method uniform throughout the analysed 
structures, also the neurons without neuromelanin were counted as cellular 
profiles, although their nucleoli could well be identified. The comparability 
between the different quantified categories, however, is of importance, in order to 
justify general conclusions (Ch.IV.). 
8. The choice of Congo-red fluorescence for identification and quantification of 
neurofibrillary tangles and senile plaques (Puchtler and Sweat 1962,1965) was 
based on a pilot study, comparing different ways of tissue processing and staining 
procedures. Congo-red fluorescence appeared to demonstrate optimally neurofi-
brillary changes and senne plaques, compared with Thioflavin S and Silver 
staining according to Gallyas (1971). It is now recognized that the Bodian stain 
docs not reveal the density of neurofibrillary tangles and senile plaques seen in 
material stained with the Bielschowsky silver method, thioflavin S or Congo-red 
(Yamamoto and Hirano 1986). Diffuse plaque-like structures (Selkoe 1989; see 
also Vogels 1990), which are not detected by the conventional stains for amyloid, 
Congo-red and thioflavin S, were sometimes seen in Congo-red fluorescence, but 
were not counted as SP's (see also Fig. III. 1). 
9. Perivascular fibriflary deposits or amyloid is difficult to distinguish from real 
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cellular neurofibrillary changes (see also Selkoe 1989). Mostly the appearance of 
blood cells or recognition of endothelial cells could determine the origin of the 
fluorescent material. Besides, lipofuscin has fluorescence properties (Barden 
1981), although its granular appearance made it easy distinguishable from neuro­
fibrillary tangles and senile plaques. The Congo-red fluorescence of Hpofuscine 
could aid in differentiation of this age-dependent cellular pigment from neurome-
lanin granules, which do not excite fluorescence under the mercury arc lamp 
illumination of Congo-red stained sections. 
Table Ш.16. Neuron numbers of various subnuclel, corrected according to Floderus (1944) 
Brain Nr. 
87029 
(C;60yr) 
87177 
(C;62yr) 
86179 
(C;69yr) 
88269 
(C;80yr) 
88184 
(C;91 yr) 
Mean neu 
number (n 
SldeL/R 
R 
L 
R 
L 
R 
L 
R 
L 
R 
L 
ron 
=5) 
M+/M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M 
M+ 
M-
SNmed 
84,696 
12.388 
69,617 
9,557 
104,590 
20,601 
85.714 
17,704 
68,126 
16,482 
63,238 
15,493 
61.393 
16,550 
63,459 
19,252 
61,688 
21,954 
66,116 
10,470 
72,864 
16,045 
SNlat 
87,957 
14.087 
93,056 
12,577 
74,642 
15,129 
109,835 
24.786 
115.729 
29,337 
107,684 
27,360 
124,262 
29,722 
120,425 
24,318 
109.209 
28.709 
80.579 
11.821 
102,338 
21.785 
SNret 
55.928 
52,451 
43,409 
39.877 
41.656 
62.447 
43,123 
52,468 
28,399 
50,763 
26.506 
47,137 
58,777 
81,399 
51,846 
85,114 
44,083 
87,478 
34,934 
50,663 
42.866 
60,980 
VTA 
53,826 
37,256 
45,545 
56,281 
64,608 
91,840 
51,093 
62,247 
66.758 
141,431 
61,573 
130.228 
76.213 
101.289 
88,368 
97,818 
59,131 
119,275 
84,426 
115,488 
65,154 
95,315 
AB 
13,172 
23,980 
7,937 
12,898 
10,097 
39,797 
12.937 
49,322 
10,370 
34.658 
7,454 
24,855 
11,326 
47,647 
20,529 
60,268 
10,618 
57,429 
18,759 
53.327 
12.320 
40.418 
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Brain Nr 
87068 
(AD;65 yr) 
87395 
(AD/SDAT) 
(69 yr) 
88177 
(AD/SDAT) 
(76 yr) 
88221 
(SDAT;93 yr) 
Mean neuron 
number(n=4) 
87062 
(AD+PD) 
(66 yr) 
Side L/R 
R 
L 
R 
L 
R 
L 
R 
L 
R 
L 
M+/M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
M+ 
M-
SNmed 
78.843 
10,620 
86,109 
13.361 
84,915 
11,527 
104,895 
26,744 
75,246 
16,212 
63.044 
5,066 
51.520 
30.736 
51,520 
16,550 
74,512 
16,352 
62.438 
20.288 
31,968 
10,605 
SNlat 
95,600 
13,018 
125.090 
25,008 
115.180 
23,977 
104.476 
16,138 
119,208 
18,914 
99,961 
15,199 
92.510 
38,504 
81,645 
23,643 
104.209 
174.401 
56.520 
16,600 
42.818 
11.066 
SNret 
44.073 
31,517 
55,091 
35.285 
58.232 
68,704 
50,097 
51,643 
49,571 
53,055 
32,189 
49.190 
34,442 
67.109 
28,970 
58.325 
44,083 
51,854 
24,834 
57,637 
30.401 
33.660 
VTA 
24.813 
21,693 
34,812 
28,811 
50,772 
66.364 
47.182 
54,091 
47,204 
57.182 
46.448 
61,978 
32.476 
73.046 
37,008 
90.385 
40,089 
56,694 
34.361 
40.455 
36,925 
38.636 
A8 
3.366 
10,507 
12.117 
11,185 
3,602 
23,636 
9,906 
34,545 
14,814 
50.911 
¡7,036 
57,182 
5.925 
33.203 
5.185 
16.232 
8,994 
29,675 
901 
23,636 
5,854 
20,455 
10. Statistical analysis of differences between controls and cases with AD or PD 
was done according to student's t-test. The presumption has to be made that cell 
numbers are "normally ditributed" among age categories and that disease cases are 
"sampled" in comparison to the mean of the standard population. 
These presumption oblige to consider the levels of significance with restriction. 
11. Florcdus' (1944) and Abcrcrombies (1946) correction cannot rule out all bias 
in the determination of exact cell numbers, in material that has to be sectioned 
(Haug 1986; Williams and Rakic 1988). 
But, evidently, the method's practicality has outweighed its problems and indeed 
it is most often used in literature on our subject. The use of a dissector (Gundersen 
1986) is preferable on theoretical grounds, but its practicle application met with 
many difficulties, of which the indefinite recognition of cellular particles and the 
tracing of exactly similar areas in sectioned brainstem material, were the most 
important. 
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Fig. III.13. 
Neuron numbers of SN and VTA as related to age. Correction 
according to Floderus (1944). (Neuromelanin containing neurons) 
---» control (n=5) 
- SN 
VTA 
Г* 
VTA 
-o Alzheimer's disease 
Alzheimer's disease 
with Parkinson's disease 
(n=l ) 
SN I AD/PD 
4-
i<* 
AD/PD 
j _ 
60 65 70 75 BO 85 90 95 
•Years 
Each point represents left side and right side, respectively of a single case 
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ΙΠ.5.2. Discussion of the counting results. 
No doubt that the pathophysiological backgrounds of aging and aging 
diseases need be considered within the larger context of changes in glia, dendrites, 
axons, synapses, extracellular space, blood vessels as well as within the context of 
changes in neurons. But the estimation of neuron numbers and the quantification 
of neuropathologic findings provides a relative uniformly applicable method for 
grading one essential aspect. The relative few studies on exact numbers of nerve 
cells in the human and animal nervous system, however, seem to be related to 
difficulties inherent in such quantitative preparations (Hanley 1974; Brody 1978; 
Haug 1986; Coleman and Flood 1987). For a comparative analysis of age-related 
changes among species, however, data on neuron numbers and size, although 
highly variable, are most complete (Flood and Coleman 1988). As suggested by 
these authors (Coleman and Flood 1987), however, multivariate descriptors of 
brain morphology and chemistry, in a number of regions, are of need in order to 
provide more accurate distinctions between AD and normal, than is possible with 
any single parameter currently in wide use. The condition of various regions to be 
analysed has been settled more or less by the fact that other regions of the brain used 
fortius study have been analysed in parallel studies (Broere 1990, Vogels 1990, De 
Vries 1990). On the other hand, the number of cases studied here is too small to 
draw far-reaching conclusions. The value of our data rather is gathered from the 
systematic analysis of single cases, as regards main representative nuclei of 
monoaminergic brainstem systems, throughout their neuroanatomical extent. 
A similar approach, although by far less complete, has been carried out by Mann 
and co-workers (Mann et al.l984a,b) and Zweig and co-workers (Zweig et al. 
1988). Like most of the studies that quantify age related changes these authors 
measured either densities of neurons or number of neurons in representative 
sections, rather than total numbers of neurons. For matters of comparison, 
however, such semi-quantitative data have been referred to in the tables that follow. 
Actually the first conclusion that might be drawn is, that variations in cellular 
sizes and numbers of various monoaminergic brainstem nuclei are such that 
major conclusions about cell loss related to aging and age-related disease 
should be based on large series, analysed following a systematic sampling 
procedure throughout the nucleus. 
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The close correlation between the distribution of pathologic changes, the 
degree of cell loss and pre-mortem clinical assesment of disease-state show that 
these morphometric changes are greatly exacerbated in AD and PD, although an 
overlap with the findings in normally aged people is remarkable, especially as 
regards the eldest (Tomlinson et al. 1970; Alvord et al. 1974; McGeer et al. 1977; 
Mann et al. 1984 b; Jcllinger 1987c). This general statement also is applicable to 
most of the data in our study, especially when neuron countings are corrected for 
tissue shrinkage and cellular shrinkage. The cell loss of the VTA in AD, e.g., was 
also counted without correction and the difference between normally aged and AD 
cases was much more pronounced then. On the other hand, because of the limited 
number of cases available, only the most profound effects may be detectable 
(Coleman and Flood 1987; Williams and Rakic 1988) and statistically significant 
differences between mean values of the quantitative data have a particular value in 
this respect (see Fig. III.6. and III.7. on the correlation between cell number and age 
for the substantia nigra). The many questions that have been raised in the literature 
as regards the importance of morphometric changes also involve the regional 
distribution of cell loss within a given nucleus (Zweig et al. 1988; Marcyniuk et al. 
1989; Chan-Palay and Asan 1989a,b), the relation of cellular size to vulnerability 
of cell survival (Mann et al. 1984a; Curdo and Kemper 1984) and the importance 
ofparameters like neuromelanin (Mann and Yates 1974a,b; Hirsch et al. 1988;)and 
changes in monoamine levels (Cross et al. 1983; Mann and Yates 1986; Kaye et 
al. 1988a; Reinikainen et al. 1988). It will be clear that it is hardly possible to 
compare all these parameters in relation to data from literature although tables 
III. 17-III. 19 allow comparison for most of them with the references cited. 
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Substantia nigra and ventral tegmental area 
Table Ш.17. Some data from literature on cell numbers oí substantia nigra and 
ventral tegmental area, in several species 
Authors 
Pakkenberg and 
Brody 1965 
Mann et al. 
1984/1987 
Tabalon et al. 
1985 
McGeer et al. 
1977 
Bogerts et al. 
1983 
Halliday and 
Törk 1986 
Hirsch 
et al. 1988 
Poirier 
et al. 1983 
Halliday and 
Törk 1986 
German et al. 
1988 
Percheron et al. 
1989 
Van Domburg 
1990 
Van Domburg 
1990 
Substantia Nigra 
(M+) 1029/scction 
(M-) 387/section 
494.8 + 17.8/seciion 
1,000- 1,100/section 
450,000-150,000 
(age dependent) 
(M+) 300,000 
(part of VTA) 
436,000 
213,186 + 5,451 
73,508 ±5,583 
71,000 
61,883 + 7,170 
116,000 (SNc) 
18,000 (SNl) 
36,000 (SNr) 
(M+) 203,139 ±19,248 
(M-) 88,997 ±24,569 
(M+) 218,068 
(M-) 98,810 
Ventral Tegmental Area 
28.8 ± 2.2/section 
(M+) 5,000 
690,000 
32,314 
47,000 
14.110± 1,333 
(M+) 56,752 ±11,799 
(M-) 91,606 ±29,764 
(M+) 65,154 
(M-) 95,315 
Correction 
no 
no 
(nucleoli) 
no 
no 
(Haug 1976) 
Abercrombie 
no 
no 
Abercrombie 
Abercrombie 
Abercrombie 
Abercrombie 
Abercrombie 
Floderus 
Floderus 
Species 
human 
human 
human 
human 
human 
human 
human 
monkey 
monkey 
monkey 
Macaca 
mulatta 
human 
human 
human 
human 
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Total neuron numbers of the normal SN and VTA are mainly derived from 
neuroanatomical investigations not directly involved with neuropathology (Table 
III. 17.). The rate of neuronal decrement with age found in several studies (Riederer 
and Wukeüch 1976; McGeer et al. 1977,1978; Mann et al. 1984a; Riederer and 
Kruzik 1987; Calne and Peppard 1987), ranged from continuous lossof about 40% 
throughout life to a decline of 35% that begins mainly after the age of 65 (Mann 
et al. 1984a). Such substantial cell loss could not be confirmed in our study, but it 
neither could be excluded because of the small number of cases studied (Table III.6. 
and III.7.). The degree of cell loss in the SN is highly variable and could not be 
correlated with degrees of dementia (see also Gaspar and Gray 1984) or Parkinso-
nism (Pakkenberg and Brody 1965). The overall relation to Parkinson's disease, 
however, is highly significant, especially as regards the lateral part of the SN pars 
compacta (see also Oppenheimer 1984; Homykiewicz and Kish 1986; Jellinger 
1986b, 1987a; Hirschetal. 1988), where cell loss was about 80% from that of age-
matched controls. Secondly, within each cell group of the PD brains, there is a 
greater relative sparing of non-pigmented than of neuromelanin-containing neu-
rons, as was also shown by several other investigators (Foix and Nicolesco 1925; 
Pakkenberg and Brody 1965; Mann and Yates 1986; Hirsch et al. 1988). Extra 
neuronal pigment and extremely weakly stained pigmented cells were more 
numerous in disease cases, particularly PD. This evidence suggest a selective 
vulnerability of the neuromelanin-pigmented subpopulation of dopamine-contai-
ning mesencephalic neurons in PD (see also Chapter I.4.). Likewise, a more or less 
differential cell loss of unpigmented neurons was seen in AD/SDAT cases. Our 
results as regards nigral cell loss in AD/SDAT (6% of neuromelanin-pigmented 
neurons and 12% of unpigmented cells; both not significant) agrees well with data 
from literature (Mann 1985; Chui et al. 1986; Mann and Yates 1986; Jellinger 
1987b; Gibb et al. 1989b). 
A matter of interest is whether cognitive impairment might be related to cell 
loss in the medial part ofthe SN (Bogerts et al. 1983; Mann 1985; Rinne étal. 1989; 
Gibb et al. 1989b). Such findings have a rather firm neuroanatomical basis (see 
Chapter II.2.6.), although other (non-anatomical) factors might be involved (see 
Javoy-Agid and Agid 1980; Hamill et al. 1988). Generally, the pathological basis 
for intellectual impairment associated with PD is controversial (Hakim and 
Mathieson, 1979; Bogerts et al. 1983; Gaspar and Gray 1984; Chui et al. 1986; 
Rinne et al. 1989). Our material could not settle this question. Patient number 
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87377 had the lowest neuron number of the medial part of the SN (73% cell loss) 
and showed also the most extensive neurofibrillary changes. The second most 
affected was the SN pars medialis of patient number 89141, who had a psychiatric 
history of major depression. Patient number 87062, who had combined AD and 
PD, had a relatively well-preserved medial part of the SN (40% total cell loss) and 
patient number 89142 (with 34% cell loss in the medial part of the SN) was deeply 
imbecile from youth on and only had mild symptoms of Parkinson's disease. Such 
findings suggest that primary cortical degeneration might be independent from 
primary subcortical pathology. Regrettably, no exact information on the degree and 
manifestation of the parkinsonian syndrome of these patients are available. 
Neuronal loss in the ventral tegmental area has been reported both in PD (Javoy-
Agid and Agid 1980; Bogertsetal. 1983; Uhi et al 1985; Jellinger 1987a,b; Hirsch 
et al. 1988) and AD (Mann et al. 1987; Gibb et al. 1989b). We not only could 
confirm these data, but also found more specified loss of neuromelanin-pigmented 
cells in PD(53%) andprimary loss of neurons without neuromelanin pigment (47% 
cell loss) in AD cases. The overall cell loss in the VTA was comparable for both 
AD and PD cases. 
Neurofibrillary changes in both SN and VTA have been described since long 
in AD patients (Hirano and Zimmerman 1962; Ishii 1966; Yamada and Mehraein 
1977; Hunter 1985; German et al. 1987; Gibb et al. 1989b) or patients with 
dementia (GasparandGray 1984; Hunter 1985; Chuietal. 1986; Yoshimura 1988). 
As Gibb and co-workers recently concluded (Gibb et al. 1989b), mild degenerative 
changes accompanied by tangles in the SN and VTA are common in AD, but severe 
cell loss in the SN is rare. The distribution pattern of NFT's throughout the 
mesencephalon and rostral rhombencephalon in our cases (Fig. III. 10. and III. 11.) 
corresponds very well with that described by others (Hirano and Zimmerman 1962; 
Ishii 1966; Tomlinson and Corsellis 1984). The same counts for the destribution 
pattern of senile plaques (Iseki et al. 1989; Ohm and Braak 1989). The prevalence 
of such neurodegenerative changes in the VTA is significantly higher than that in 
the SN, parallel to the difference in total cell loss in AD cases. Generally, the 
distribution pattern of neurodegenerative changes, although preferentially restric-
ted to the most cell-rich areas, was throughout the mesencephalon, without keeping 
to strict nuclear boundaries. Indeed somewhat more NFT's e.g., were found at the 
most rostral boundaries of the VTA (limbic midbrain arca or hypothalamic-ventral 
tegmental transition zone) and the most lateral border of the SN ('nucleus 
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peripeduncularis' and, particularly, the area belonging to the corpus geniculatum 
mediale). At places where blood vessels are most frquently seen, like the substantia 
perforata posterior and near the fourth ventricle and aqueduct, relatively many 
neurofibrillary changes were found, sometimes rather undefinable and not of the 
typical 'tangle' appearance. Such changes (particularly for brain number 87377, 
f,74 yr,PD) were very similar to the congophilic angiopathy as described in AD 
(Tomlinson and Corsellis 1984; Selkoe 1989). 
Locus coeruleus 
Table m.lS.a. Some data from literature on neuron numbers of the human locus coeruleus 
Authors 
Brody 1978 
Vijayashankar and 
Brody 1979 
Репу et al. 1981 
Mann et al. 1983 
Tomonaga 1983 
Iversen et al 
1983 
Bondarcffetal. 
1982 
Mountjoy and 
Bondareff 1986 
Gemían et al 1988 
Baker el al. 1989 
Marcyniuk et 
al. 1989 
Chan-Palay and 
Asan 1989a 
Van Domburg 1990 
Neuron number 
18,950-9.310 
13.378 + 2,145 
66 4 + 6 4/secüon 
20 цт 
120 - 50/ 
section 20μιη 
98.3±4.3/mm2 
17.630/2-11,515/2 
9,642 + 465 
9,426 + 765 
9,55 t - 16,427 
9,500 - 17,000 
23,000 - 8,953 
53,500/2 
49.7 + 45-
196 0 + 1 2 5/section 
(both sides!) 
33.130-19.740 
19.976 + 3,627 
14,300+2,889 
Element·) counted 
neurons with 
nucleoli/M+ 
neurons with 
nucleoli/M+ 
nucleoli 
M+ cells/ 
nucleoli 
neurons with 
nuclei/M+ 
M+ cells 
DBH-ir cells 
total neurons 
total neurons 
M+ cells 
TH-ir/neurons 
M+ neurons 
TH-ir cells 
M+ cells 
cells 
Correction 
no 
no 
no 
no 
no 
no 
no 
no 
Abercrombie 
Abercrombie 
modified 
no 
no 
no 
Abercrombie 
Abercrombie 
Remarks 
age-dependent 
mean number 
60-89 years 
LC might be 
about 
20-25 sections 
age-dependent 
age-dependent 
no significant 
difference M+/ 
DBH-ir 
n=5 
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The locus coeruleus is the most extensively studied catecholaminergic 
nucleus in aging and aging diseases, mainly for two reasons. Diffuse cortical 
projections have been demonstrated both in rodents and primates (see Ch.II.3.3.) 
and reduced levels of noradrenaline in LC projection fields have been showed both 
in PD and AD (Farley and Homykiewicz 1977; Adolfsson et al. 1979; Scatton et 
al. 1983; Gottfiies et al. 1983; Agid et al. 1987). A relationship between noradre-
nergic denervation and dementia, comparable to that of ACh and the nucleus 
basalis of Meynert, has been suggested both in AD and PD (Alvord et al. 1974; 
Perry et al. 1981; Bondareffet al. 1982; Mann and Yates 1983,1986; Gaspar and 
Gray 1984; Mann et al. 1985; Cash et al. 1987). Secondly, the locus coeruleus was 
one of the first subcortical nuclei to be associated with normal aging, and suitable 
for the estimation of neuron numbers related to age (Brody 1978; Tomlinson et al. 
1981). Nowadays computer assisted reconstruction has been shown to be a good 
aid in the rapid morphometric analysis of this brainstem nucleus (Gennan et al. 
1988a; Bakeret al. 1989; Chan-Palay and Asan 1989a,b). Such reconstruction e.g. 
revealed changes in the rostro-caudal length of the nucleus, varying between 
controls (14.9+1.4 mm), SDAT-cases (13+ 2.2 mm) and PD-cases (12.4 +5 mm), 
whereas marked changes in neuronal morphology could be quantified (Chan-Palay 
and Asan 19893^). Counting of neuromelanin pigmented cells in the human LC 
(Tomlinson et al. 1981; Bondareff et al. 1982; Mann et al. 1982, 1983, 1984a; 
German et al. 1988a) seemed accurately to reflect the number of CA cells (Baker 
et al. 1989) and direct comparison could be made between studies in which TH-
immunoreactivity cells were counted (see Table III. 18.). It remains to be settled 
whether pigmentation is associated only with noradrenaline-containing neurons 
and whether neuronal cell loss is the only cause of depigmentation of the LC (Cash 
et al. 1987). Quantitative assessment of immunocytochemically identified CA 
neurons of the LC has been described in various studies now (Iversen et al. 1983; 
Bakeret al. 1989; Chan-Palay and Asan 1989a,b). As can be seen from table III. 18. 
the number of immunoreactive neurons, ranging from 9,426 DBH-posiüve cells 
(Iversen et al. 1983) to 33,130 TH-immunoreactive (Chan-Palay and Asan 1989a,b) 
cells roughly corresponds with our number of neuromelanin-pigmented neurons 
and total number of neurons, after correction for cellular sizes. A reduction in soma 
size occurs in cells of all morphological classes in adult brains (German et al. 
1988a; Chan-Palay and Asan 1989a). We measured a mean D-max of 54,4 μιη and 
a mean D-circle of 35,6 μιη, comparable to the mean soma size of TH-ir cells of 
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37,4 μπι of Baker and co-workers (Baker et al. 1989). Shrinkage of cells 
preferentially occurred in AD and PD cases and was surmised by swelling and 
dendritic arbor reduction of individual neurons (Chan-Palay and Asan 1989b), 
probably due to disintegration of the cytoskeleton (see also Mann 1985). The 
importance of determining both D-cirle and D-max as well as soma areas is clearly 
demonstrated by such findings. 
Although cell loss and neurofibrillary changes in the LC have been most 
extensively documented in AD/SDAT (for reviews Coleman and Flood 1987; 
Chan-Palay and Asan 1989a,b) such findings have been known since long to be 
characteristic of PD also (Greenfield andBosanquet 1953; Beheim-Schwarzbach 
1952,1954). Cell loss in both disease states and in aging shows substantial variation 
as is shown in table III. 18.b. The greatest cell loss, noted by Chan-Palay and Asan 
(1989a) was seen in a patient with chronic depression. The degree of LC 
degeneration was found to be extremely variable, especially in PD cases, ranging 
from 77% (AD-case 88177) to 0% (PD-case 89142), fomeuromelanin containing 
cells. 
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Table Ш.18.Ь. Degree of cell loss in the human locus coeruleus: data from literature 
% Neuron Loss 
24.6 - 87.5 (ΤΗ+) 
30.9 (TH+) 
48.3 (TH+) 
30-50%(M+) 
50 - 80 % 
37.5 - 70 % 
70 - 87 % 
60.3 % 
4 0 % 
3 1 - 7 3 % 
9 0 % 
72 - 85 % 
7 9 % 
4 0 % 
50 - 79 % 
55 % (TH+) 
56 % (M+) 
6 0 % 
58.3 % 
ca. 30 % 
32-47 % 
69.4% 
73.0 % 
44.6% 
44.0% 
Disease/Age 
SDAT 
PD 
PD-dementia 
old age 
AD/SDAT 
ADySDAT 
PD 
AD/SDAT 
old age 
SDAT 
PD 
PD 
PD 
old age 
AD/SDAT 
PD 
dementia 
SDAT 
AD 
old age 
PD/AD 
AD(M+) 
AD(M-) 
PD(M+) 
PD(M-) 
Authors 
Chan-Palay and Asan 1989b 
Chan-Palay and Asan 1989b 
Chan-Palay and Asan 1989b 
Vijayashankirand Brody 1979 
Tomlinson et al. 1981 
Chui et al. 1981 
Chuielal. 1981 
Jellinger 1987b 
Tomonaga 1983 
Tomonaga 1983 
Tomonaga 1983 
Jellinger 1987a 
Mann et al. 1983 
Mannetal. 1984a 
Mannetal. 1982,1983,1986 
Hirsch et al. 1988 
Bondaieff and Mountjoy 1986 
Iversen et al. 1983 
Perry et al. 1981 
Marcyniuk et al. 1989 
Zweigetal. 1989b 
Van Domburg 1990 
Van Domburg 1990 
Van Domburg 1990 
Van Domburg 1990 
Our PD-case (nr. 87377, age 74 yr.), with the most extreme cell loss in the LC (both 
sides) of PD cases, was the same as the one that showed relatively abundant 
neurofibrillary changes in the SN, VTA and NRd. Normally a highly significant 
correlation coefficient for the left and right sides of the brainstem nuclei locus 
coeruleus has been noted (German et al. 1988a; Baker et al. 1989) but laterality 
differences in neuron numbers of disease cases are substantial (see Chan-Palay and 
Asan 1989b). Our results contrasted with those of the latter authors in that we found 
more severe degenerative changes and cell loss in SDAT cases as compared to PD 
cases (see also Cash et al. 1987). Topographical arrangement of cell loss in the LC 
of AD cases (Marcyniuk et al. 1986; Chan-Palay and Asan 1989b) could be 
confirmed by us only for the preferential loss of cells without neuromelanin 
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pigment in the rostral part of the LC. Such findings might very well be correlated 
with neuropathological changes in the projection areas of these neurons in the 
neocortex (Mann et al. 1985; Emson and Lindvall 1986) but also, to neurochemical 
characteristics, like appearance or absence of neuromelanin (Mann and Yates 
1974b; Cash et al. 1987). Both demented and non-demented paricinsonians show-
reducedlevels of NA in LC projection fields, like cerebral cortex and hippocampus 
(Scatton et al. 1983), whereas neuronal loss in these cases is uniformly distributed 
throughout the nucleus. In mentally normal old people cell loss is also uniformly 
distributed throughout the whole nucleus (Marcymuk et al. 1989). Whereas 
neuromelanin might be a risk factor in cellular decrement in PD and aging (Hirsch 
et al. 1988), in AD neuromelanin containing neurons were relatively more 
preserved. Because depigmentation was not related to the loss of noradrenaline, 
Cash and co-workers (Cash et al. 1987) concluded that the correspondence between 
catecholamine- and pigment-containing cells, which seems to hold for DA cells in 
the ventral mesencephalon, may not be true of NA neurons in the LC. 
Neurofibrillary changes (NFT's and SP's) associated with LC cell loss have 
attracted much attention and have been described by many authors (Behcim-
Schwarzbach 1954; Ishii 1966; Yamada andMehraein 1977; Forno 1978; Mann et 
al. 1982; Gaspar and Gray 1984; Tomlinson and Corsellis 1984; German et al. 
1987). Neurofibrillary degeneration seems to be age-related (Tomonaga 1983; 
Mann et al. 1984a) and significantly more abundant in AD than in PD and aged 
controls. The number of nerve cells showing neurofibrillary changes generally is 
only roughly estimated and comparison among data from literature is hardly 
possible. The mean senile plaque count per optical field of the temporal cortex 
correlated with changes in DB H and CAT in normal and demented cases (Perry et 
al. 1981)and with cell loss of the LC (Tomlinson etal. 1981;GasparandGray 1984; 
Mann et al. 1985; Marcyniuk et al. 1986a,b). But dementia selectively associated 
with PD, i.e. of the subcortical type, correlated with severe neuronal loss in 
subcortical nuclei, without significant numbers of plaques or tangles in the 
hippocampus and cerebral cortex (Gaspar and Gray 1984; Chui et al. 1986). 
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Nucleus raphe dorsalis 
Table Ш.19. Some data from literature on neuron numbers of the human nucleus 
raphe dorsalis 
Authors 
Curcio and 
Kemper 1984 
Yamamoto and 
Hirano 1985a,b 
Zweig cl al. 
1988 
Van Domburg 
1990 
Neuron number 
526.9/ 7.40 irmi-
= l\lmnf-
21/mm 2 
10.6 + 3.4 /mm* 
103.2-114.5/ 
section 
520,576 + 160,000 
Elements counted 
total nucleoli 
nucleoli > 
3.51+ 0.22 μπι 
neurons > 25μιη 
nucleoli 
nucleoli 
Correction 
Abercrombie 
Abercrombie 
no 
no 
Remarks 
sections 12μπι 
thickness 
Although biochemical studies of the serotonergic system in aging AD and PD have 
created controversy (Robinson et al. 1972; Gottfries et al. 1973,1983; Adolfsson 
étal. 1979; Bentonetal. 1982; MannandYates 1986;McGeerandMcGeerl987; 
D'Amotoetal. 1987b;Reinikainenetal. 1988a)somemorphometricstudiesofthe 
NRd (Curcio and Kemper 1984; Yamamoto and Hirano 1985a,b; Jellinger 1987b) 
have called attention to this nucleus as another possible important site of abnorma-
lity especially in Alzheimer's disease. No change of serotonergic activity in 
cortical areas of aging rhesus monkeys has been detected (Goldman-Rakic and 
Brown 1981). The fact that no data on the total cell number of the dorsal raphe 
nucleus are available may be related to the fact that there is no clear-cut border 
between the NRd and the surrounding periaqueductal gray matter defined in 
literature. There is no natural marker at hand in the NRd, like neuromelanin in ca-
techolaminergic nuclei. Most NRd cells contain lipofuscin (Ohm et al. 1989) that 
is, however, distributed throughout the brain (Mann and Yates 1974a,b; Braak 
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1980). Neuron numbers are usually defined as neuronal densities or neurons per 
section without definite volumetric data. The mean cell density of neurons in 
controls ranged from about 8 per mm2 (Curdo and Kemper 1984; corrected 
according to Abcrcrombie) to lO.ó + S^permm^amamotoandHirano 1985a,b). 
Zweig et al.(1988) noted 103.2 -114.5 neurons per section of 12 »m thickness at 
three levels. 
Different views on the extent of the exact area captured by the nucleus raphe 
dorsalis also follow from data on its rostro-caudal length, ranging from 4-5 mm 
(Törk and Homung 1986) to 20-25 mm (Ohm et al. 1989). The boundaries of the 
NRd as defined in our study are such that (part of) the nucleus centralis superior, 
as defined by others, might be involved. The total cell number we counted, based 
on the number of nuclcolated cells with lipofuscin, but without restriction to 
neuronal sizes, ranged from 385,280 to 677,120. Remarkably enough an age-
related increase, both in controls and AD/SDAT brains was noted. Such an increase 
perhaps might be explained by shrinkage, and consequently higher densities, of 
nucleoli (Mann et al. 1984a; Curcio and Kemper 1984), without appropriate 
correction for this bias. No significant cell loss was detected in the NRd of PD-
brains, wheras AD-brains showed about 40 % cell loss throughout the rostral-
caudal extent.Neuronal loss of the NRd in AD/SDAT, as registered in literature, 
ranged from 77 % (Yamamoto and Hirano 1985a) to no evidence of overall 
neuronal loss (Curcio and Kemper 1984). Jellinger (1987a,c) also noted a neuronal 
decrement of 44.5 % in PD-cases. Cell loss both in AD and PD seems to be 
preferentially restricted to large polygonal neurons (Curcio and Kemper 1984; 
Yamamoto and Hirano 1985a,b; Jellinger 1987a; Zweig et al. 1988). In AD/SDAT 
an average of 2.25 % of the total NRd population contained NFT's according to 
Curcio and Kemper (1984), compared with 0.35 % in aged controls. We counted 
about 14 % neurofibrillary degenerated cells in AD/SDAT, compared with 2.6 % 
in control cases of similar age. Ishii (1966) observed in six cases with SDAT, with 
a mean age of 75 yrs. a substantially greater number of NFT's in the NRd, noting 
in four of six brains that over 50 % of the neurons contained NFT's. Yamamoto and 
Hirano (1985a) noted a 39-fold increase in NFT number of AD/SDAT-cases as 
compared to controls. They also saw few to several senile plaques in the NRd in 
all cases of AD, with or without amyloid core, less common than in the dorsal part 
of the periaqueductal grey and inferior colliculus (see also Yamada and Mehracin 
1977). Although neuronal loss within the nucleus centralis superior could not be 
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confirmed separately in our study, these cells also clearly showed NFT's, of 
importance concerning their projection to the hippocampus and other brain regions 
severly affected in AD. 
Adjacent brainstem nuclei 
The tegmental pedunculopontine nucleus, pars compacta (NTPP), a putative 
choUnergic nucleus in the dorsolateral mesencephalic reticular formation, has been 
shown to suffer significant neuronal loss in PD, AD/SDAT and progressive supra-
nuclear palsy, with frequent occurence of Lewy bodies and NFT's (Hirsch et al. 
1987; Zweig et al. 1989a; Mufson et al. 1988; JeUinger 1988). Although such 
findings have been disputed (Woolf et al. 1989), we also saw clear accumulation 
of neurofibrillary degeneration within the area of the tegmental pedunculopontine 
nucleus (Fig. III. 10. and III. 11.). Both types of cytoskeletal lesion were infrequent 
in controls (see also Jellinger 1987b) and the degenerative changes apparently are 
more selectively affected in progressive supranuclear palsy and PD than in AD/ 
SDAT, suggesting a stronger correlation of degeneration with functional aspects 
than with biochemical characteristics (Jellinger 1987c). Likewise, the dorsal 
tegmental nucleus, another cholinergic brainstem nucleus, has been shown to be 
involvedin Alzheimer's disease neuropathology (Mannetal. 1985). Such changes 
are continuous with those of adjacent auditory brainstem nuclei (Ohm and Braak 
1989) and nucleus of Edinger-Westphal (Hirano and Zimmerman 1962; Hunter 
1985). It is not at all clear whether NFT's and SP's within such brainstem tegmental 
nuclei are confined to either nuclear boundariess or histochemically defined cell 
areas. Indeed, toourexperience, NFT's and SP's were found very often in transition 
zones, like that of caudal hypothalamus-VTA; LC-NRd; NRd-NLTd; NTPP-CI; 
SN-CGM; VTA-corpus mamillare and so on. 
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IV GENERAL DISCUSSION 
"De ouderdom is voor het leven als het laatste bedrijf 
van een toneelstuk. 
Wij moeten trachten het einde ervan te zien vooraleer 
we het beu zijn, vooral wanneer wij het risico lopen er 
een walg van te krijgen." 
Cicero, De ouderdom; ca. 50 v. Chr. 
Vert. H. Beek, E De Ridder, 1949 
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Early and accurate diagnosis of Alzheimer's disease has a major impact on 
the progress of research on dementia and its eventual therapies. To address the 
problems involved in diagnosing AD in its earliest stage and to differentiate it from 
normal aging and age-related diseases, a research program was started by a "joint 
venture" of the Departments of Anatomy/Embryology and Neurology, emphasi-
zing the importance of longterm studies based on standardized procedures and 
careful controls. An inventory of the most important brain areas involved in the 
dementia syndrome, as well as standardization of procedures for these brain areas, 
were developed. Because various brain areas present their own characteristic 
difficulties as regards morphometric analysis, different projects were directed at 
the neocortex (B roere 1990), the hippocampus (De Vries 1990), the nucleus basalis 
of Meynert (Vogels 1990) and the amygdala (Vereecken, in progress). The present 
study sought to provide detailed information about morphometric changes and 
procedural difficulties of the brainstem monoaminergic nuclei: Substantia Nigra 
(SN), Ventral Tegmental Area (VTA), Locus Coeruleus (LC) and Nucleus Raphe 
dorsalis (NRd). In future research cases also have to be closely observed during 
prolonged hospitalization in order to properly document the relationship between 
these monoaminergic systems and the degree and specific type of dementia. 
Generally, highly variable amounts of neurons and age-related cell loss are 
found (Coleman and Flood 1987; Williams and Herrup 1988), suggesting that cell 
loss in the brain can be quite variable, but also that quantitative moiphometric 
analysis represents a host of problems which may cloud the interpretation of many 
studies. The determination of cell numbers in subcortical structures is less 
uncertain than it is in the cerebral cortex, because of the usually relatively precise 
boundaries of most structures studied, as well as their generally more limited 
extent. On the other hand various monoaminergic brainstem nuclei appeared not 
at all uniformly defined in literature as regards their exact boundaries, their possible 
subnuclei and their connections with other brain areas in the primate brain. For 
these reasons a substantial part of our work has been devoted to the development 
of a practicable counting procedure (adapted to modem stereological principles) 
and extensive neuroanatomical examination of the brainstem monoaminergic 
nuclei under consideration. We are well aware that much about pathophysiology 
in aging diseases can not be captured by morphometry alone, no matter how 
carefully done (Saper 1987b). 
While the clinical criteria of primary degenerative dementia are widely used 
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(McKhann et al. 1984; Khachaturian 1985; Schulte 1989) follow-up studies with 
ncuropathological examination are rare and often retrospective (Todorov et al. 
1975; Tiemey et al. 1988; Chui 1989). The final diagnosis of AD still requires 
ncuropathological confirmation (Todorov et al. 1975; Blessed 1980; Terry and 
Katzman 1983; Tomlinson and Corsellis 1984; Khachaturian 1985; Kellett 1987) 
either by biopsy or autopsy specimen. But clinical aids for differentiation (like the 
scales of Hoehn and Yahr ( 1967) and Webster ( 1968) in PD) are becoming increa-
singly important (Folstein et al. 1975; Sulkava et al. 1983; Flickeret al. 1985; 
Reisberg et al. 1985; Mortimer et al. 1987; Tiemey et al. 1988; Gibb 1989a). A 
tissue bank, housing material representative of the full range of neurologic, clinical, 
pathologic and other data pertinent to the study of AD (Khachaturian 1985) seems 
to be a hardly realizable idea, although in our study support was provided by the 
Dutch Brain Bank. More detailed information, however, was available for patients 
followed at our own University hospital or local nursing homes, and undergoing 
autopsy at the University Institute of Pathological Anatomy. 
The relationship between clinical findings and pathological phenomena has 
been controversial since long, both as regards Alzheimer-like neurofibrillary 
changes and "parkinsonian" Lewy bodies (Tomlinson et al. 1970; Wilcock and 
Esiri 1982; Sulkava et al. 1983; Ball 1984; Ulrich et al. 1986; Jellinger 1987b; 
Crystal et al. 1988). Whereas Lewy bodies might be primary findings of cortical 
pathology in some dementia cases (Sima et al. 1986; Kosaka et al. 1988; Gibb et 
al. 1989a), some 'motor-diseases' like PD (Alvord et al. 1974; Gibb 1989b), 
amyotrophic lateral sclerosis (Meyers et al. 1974) and progressive supranuclear 
palsy (Agid et al. 1986; Jellinger 1988) show significant neurofibrillary changes 
in brainstem nuclei. Our case of PD, number 87377, who had no clinical signs of 
dementia, showed substantial neurofibrillary changes throughout the mesencepha-
lon, reminiscent of the 'idiopathic tangle type of Parkinsonism' as described by 
Alvord et al. (1974). Similar findings were registered in the nucleus basalis (see 
Vogels 1990) of this patient. Non-demented subjects with such Alzheimer patho-
logy might have 'preclinical' AD, but numerous cortical plaques also have been 
seen in some elderly subjects who never developed clinical dementia (Terry et al. 
1981; Wilcock and Esiri 1982; Crystal et al. 1988). Likewise, various brain 
diseases as well as the aging proces per se may be responsible for the typical 
dementia syndrome (Sulkava et al. 1983; Chui et al. 1985,1989; Ulrichetal. 1986; 
Gottfries 1986). Recent immunocytochemical analysis of brain tissue from pa-
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tients with AD and Down's syndrome suggest that the deposition of ß-amyloid 
protein in a nonfibrillary ('preamyloid') form may represent earliest, age-related, 
Alzheimer-like abnormalities, diffusely spread over various brain areas (Hardy 
1988; Selkoe 1989). The significance of this overlap becomes more clear when the 
association between quantifiable measures of neuropathological changes in the 
brain after death is examined. This subject is particularly stressed here as regards 
the dementia syndromes of Alzheimer and cognitive decline related to Parkinson ' s 
disease (JeUinger 1987b; Gibb 1989b). The brainstem is unique in harbouring 
nuclei in close association that might be typically involved in at least one of both 
diseases. Indeed a remarkable overlap in cellular loss of the VTA and Locus 
Coeruleus for both diseases stands against a more selective involvement of the SN 
and the NRd in PD and AD, respectively (see Ch. III.; Jellinger 1987b,c; Hamill 
et al. 1988; Gibb et al. 1989b). The concept of quantitative rather than qualitative 
change (or the principle of 'threshold effects', widely appreciated in the field of 
neuropsychiatry) as the major differentiating feature in aging and age-related 
diseases (for discussion: Tomlinson et al. 1970; McGeer and Mc Geer 1984; 
Coleman and Flood 1987; Brizee 1987; Brody 1987; Saper 1987b; Williams and 
Herrup 1988) thus only holds for certain nuclei, in certain cases. 
In PD decrease of dopamine and homovanillic acid in the SN and striopal-
lidum correlated significantly with the loss of nigral neurons (Bemheimer et al. 
1973; Jellinger 1986c, 1987a;Javoy-Agidetal. 1984; Morgan and Finch 1988). In 
Alzheimer's disease the activity of the cholinergic enzyme choline acetyltransfe-
rase did correlate more significantly with specific aspects of the Alzheimer disease 
process than did the noradrenergic system (Perry et al. 1981; Mann and Yates 
1986). Yet, the concept of specific mono-transmitter-related states had to be 
abandoned: A (biochemical) overlap of various disease states as well as the aging 
proces itself is significant (Rossor 1982; Perry et al. 1985; Quinn et al. 1986; 
Gottfries 1986). The ChAT activity in demented parkinsonian patients is severely 
reduced (Perry et al. 1985,1987), whereas both noradrenergic and the mesolimbic 
dopaminergic projections are affected in AD as well as PD (Javoy- Agjd et al. 1981 ; 
Lees and Smith 1983; Mann and Yates 1986; Quinn et al. 1986; Cash et al. 1987; 
Hamill et al. 1988; Gibb et al. 1989b). But, the (histochemical) meaning of the 
substantial cell loss of neurons without neuromelanin pigment within the VTA 
(47 % in our cases) has to be elucidated yet. It corresponds with the loss of neu-
romelanin-containing, presumed dopaminergic, neurons within this area in PD (50 
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% cell loss in our cases). Likewise, the loss of neurons without pigment in the LC 
mADcases(73% cell loss) was nearly similar to that of pigmented SN pars lateralis 
neurons in PD (80 %). But in this case pigmented cells of the LC in AD cases also 
showed substantial decrement (69,4 % cell loss). It will be of much importance to 
relate such findings to more detailed immunohistochemical analysis, in future 
research. 
Generally, in spite of age-related declines, single chemical markers do not 
fit very well with specific disease states, nor do changes in enzymatic activity 
correlate well with the extent of cell loss in the respective nuclei (Mann et al. 1986). 
Uneven, mosaic-like plaque distribution and morphology in the striatum and 
globus pallidus, with plaque aggregation near and within certain fiber tracts 
(Rudelli et al. 1984), likewise, was more suggestive of a relation with projection-
systems. Therefore a better approach might be the analysis of functional systems, 
in which different nuclei are interconnected and various transmitters might be 
responsible for a rather sensitive equilibrium of quantitative as well as qualitative 
factors. E.g., it is difficult to conceive of a pathogenetic event acting directly on 
dopaminergic cell bodies, that would severely affect those of the VTA, while 
sparing those of the SN. What seems more likely is that the primary damage to these 
neurons occurs within other parts of theirneuroanatomical circuitry, with reduction 
in nuclear volume (atrophy), neurofibrillary degeneration and loss of perikarya 
following as secondary retrograde or anterograde changes. There is growing 
evidence now of multisystem atrophies, providing subtle variation in clinical 
symptomatology, to which specific therapeutical approaches might be, at least 
theoretically, thinkable (e.g. Torch etal. 1977; Jellinger 1986a; Koller 1987; Quinn 
1989; Gibb 1989a). The well known variability in therapeutic approaches of PD, 
might be a characteristic example (for review Birkmayer 1987). 
Dysfunction of at-risk neurons is associated with several types of cytoske-
letal pathology (Tomlinson and Corsellis 1984; Mann 1985; Price et al. 1986; 
Kowall and Kosik 1987; Selkoe 1989). We tried to relate cell loss and neurofibril-
lary degeneration in AD/SDAT cases to neuroanatomical data on hodology of the 
various monoaminergic nuclei. First of all the highly variable results as regards 
normal cell number and pathologic cell loss (see Ch. III.) might well correlate with 
differences in regional influences based on connectivity. Such topographic loss, 
however, needs far more detailed analysis of a much greater number of cases. 
Modem computer-assisted analysis, based on quantifications of immunohistoche-
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mically marked elements or on the sampling of neuromelanin-containing cells 
(Agnati et al.l984a,b; German et al. 1983,1988a; Hirsch et al. 1988; Bakeret al. 
1989; Chan-Palay and Asan 1989a,b) must serve to further confirm such presump-
tive parallels. The differential cell loss of the lateral and medial parts of the SN in 
PD and the rather selective involvement of ventral tegmental area cells without 
neuromelanin pigment in AD, are the most representative examples of localized 
cell loss that might reflect the existence of functional loops throughout basal 
ganglia and cortical circuitry (Ch. II.2.6.). Comparable findings on subsystems 
based on LC connectivity are evolving (Marcyniuk et al. 1986a,b,1989). Altera-
tions in neurotransmitter markers, although partially overlapping in AD and PD, 
might appear to be highly localized, following selective involvement within 
neuronal populations of both subcortical and cortical structures (Emson and 
Lindvall 1986; Price et al.1986; Mann and Yates 1986; Procter et al. 1988; 
Whitehouse 1989). Expanding the neurochemical inventory of the systems affec-
ted and spared, to e.g. the highly characteristically neurochemically defined striatal 
circuitry (Graybiel and Ragsdale 1983; Graybiel 1989; Jiménez-Castellanos and 
Graybiel 1989), might solve many questions on parallels and differences within the 
spectrum ranging from typical motor disease to exclusively cognitive decline. 
Besides, interactions between parallel cholinergic and catecholaminergic subsys-
tems (Terry and Davies 1980; Jones and Friedman 1983; Henderson 1987; 
Graybiel 1989; Sara 1989) in which the nucleus tegmenti pedunculopontinus (see 
Ch. II.3.2.), nucleus basalis of Meynert and ventral pallidum (Alheid and Heimer 
1988; Cools et al. 1989) might play an important role, throw new light on side-
effects of dopaminergic or anü-cholinergic medication. 
Neuronal loss in AD corrected for tissue shrinkage and comprising both 
neuromelanin-containing and unpigmented catecholaminergic neurons had a 
remarkable relationship with neurofibrillary degeneration. For all monoaminergic 
nuclei we calculated the number of NFT's to be about one-third of the cell loss (Fig. 
III. 12.). Thus, the larger brainstem nuclei (like SN and NRd) might show a 
substantial number of NFT's correlating with a relatively small percentage of 
neuronal decrement of such larger brain nuclei. Together with the very marked 
shrinkage of cortical volume, accompanied by a considerable loss of projection 
neurons in our AD/SDAT cases (see also В roere 1990) these data suggest an 
independent and parallel course of degenerative changes, respectively, in PD and 
AD/SDAT, similar to that which has been proposed by various authors (for reviews 
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Peareonetal.l985;Saperetal.l985,1987;MannandYates 1986; Jellinger 1987b). 
Therefore, we follow the hypothesis on anatomical correlates of the distribution of 
the pathological changes in cortical and subcortical structures in Alzheimer's 
disease (Rudelli et al.1984; Pearson et al.1985; Saper et al. 1985,1987b; Mann and 
Yates 1986; Hardy et al. 1986). The basis of the apparent selectivity might be two-
fold. Firstly, there is a chronic attack on nerve endings and secondly, those neurons 
with long projections (including the dopaminergic and serotonergic, but most 
particularly cholinergic and noradrenergic systems) are the least able to withstand 
such an attack. They therefore show corresponding degeneration in Alzheimer's 
disease. Typical signs of Parkinsonism have been shown since long to be primarily 
related to cell loss in the SN (mainly lateral) pars compacta and locus coeruleus 
(Hassler 1938; Greenfield and Bosanquet 1953; Homykiewicz and Kish 1986; 
Jcllinger 1986b), whereas secondary cell loss in the substantia innominata, locus 
coeruleus and cerebral cortex more closely correlated with signs of dementia in PD 
patients (Alvord et al. 1974; Hakim and Mathieson 1979; Whitehouse et al. 1981 ; 
Ball 1984; Perry et al. 1985; Korczyn et al. 1986; Gibb 1989b). 
Neurofibrillary transformation in subcortical nuclei, then, might be an age-
related essential feature of neurons projecting to the cerebral cortex (Wisniewski 
and Iqbal 1980; German et al. 1987), secondary to the structural changes in the 
affected brain. Such structural changes might follow anatomical pathways (Torch 
et al. 1977; Emson and Lindvall 1986), following e.g. an infectious event (Ball 
1982; Roberts 1986; Saper et al. 1987) or otherwise a toxin or autoimmune 
response (for reviews see Toledano-Gasca 1988; Kozlowski and Nilawar 1988; 
Barker and Calm 1988). Uptake of a "neurotoxin" at affected terminals and 
retrograde transport to perikarya causes neurofibrillary tangles to be formed; their 
accumulation leads to perikaryal changes culminating in cell death and cell loss 
(Hardy et al. 1986; Saper et al. 1987; German et al. 1987). As shown by one of our 
colleagues (see Vogels 1990; see also Arendt et al. 1985) degenerative findings in 
our AD/SDAT cases correlated with changes in some basal forebrain nuclei of the 
same brain. The cholinergic, noradrenergic and serotonergic neurons that have 
been implicated in the pathophysiology of AD have their cell bodies in the so-called 
'isodendritic' core system in the brain (Rossor 1981; Cadet 1984,1988) in which 
failing of compensatory, dendritic growth, like that of hippocampal neurons, might 
play a substantial role (Coleman and Flood 1986,1987). The presence of a 
topographical organization within these cortical projection systems (Goldman-
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Rakic and Brown 1981; Saper 1987a; Pamavelas and Papadopoulos 1989) 
suggests that the specific pattern of cognitive deficits in a patient with AD may 
reflect the distribution of the cell loss within the nucleus basalis area and/or 
monoaminergic brainstem nuclei. 
Senile plaques have been shown to be associated with degeneration at the site 
of axon terminals (see Tomlinson and Corsellis 1984; Pearson et al. 1985; Price et 
al. 1986). We found relatively few plaques within the area of the nucleus raphe 
dorsalis, the locus coeruleus and the nucleus tegmenti pedunculopontinus, i.e. 
those nuclei with relatively few cortical afférents. Instead relatively many plaques 
have been found at the dorsal border of the SN/VTA and especially at its most 
lateral site and in the nucleus peripeduncularis. These latter areas have been shown 
to receive substantial afferent projections from basal forebrain nuclei, paralimbic 
regions and the amygdala, areas that have been associated with AD degeneration. 
The highest density of senile plaques has been found in the midbrain roof and 
pretectal area. Corticotectal fibers arise from portions of the frontal, temporal, 
parietal and occipital lobes (Carpenter 1985; Goldman-Rakic 1987b). Besides, the 
superior colliculi are laminated resembling the cerebral cortex in their organiza-
tion, and are also closely related to reticular formation and catecholamine-
containing neurons (Carpenter 1985). Ourinvestigation was not directed at relating 
exactly the distribution of the senile plaques to the organization of the superior and 
inferior colliculus, but the global wealth of amyloid plaques within tectal confines 
is in agreement with the aforementioned concept. Significant loss of neurons in the 
tegmental pedunculopontine nucleus, pars compacta (NTPP), a putative choliner-
gic nucleus of the brainstem, has been demonstrated in progressive supranuclear 
palsy, PD and combined PD/AD, with frequent occurrence of Lewy bodies and 
NFT's (Zweig et al.l989a; Jellinger 1987b,1988). Although we noted substantial 
neurofibrillary degeneration in AD/SD AT cases, cell number was not quantified in 
our study. Putative cholinergic neurons of the NTPP might be more selectively 
affected in PD and much less in AD/SD AT cases as can be expected from its more 
close relationship to the basal ganglia and ascending reticular formation than to the 
cerebral cortex (Vertes and Martin 1988; Spann and Grofová 1989). 
The neuropathological changes in the cortex associated with AD are not 
uniformly distributed. The medial temporal cortex and the amygdala are most 
severely affected; parieto-temporal and certain prefrontal association areas are also 
involved, but there is relatively little pathology in the primary sensory areas and in 
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the motor cortex (Brun 1983; Pearson et al. 1985; VanHoesen and Damasio 1987; 
Broerc 1990). Aside from the arcai distribution of the pathology, the microscopic 
distribution, particularly of neurofibrillary tangles, within affected neocortical 
areas supports the concept of a relationship between the disease process and cortical 
connectivity (Pearson et al. 1985). The arcai distribution, with a progression of 
severity from the medial temporal cortex back towards the primary sensory areas, 
might very well be correlated to connectivity with subcortical nuclei (Ch. 
ΙΙ.2.,ΙΙ.3.,Π.4.), although the exact cortical distribution of terminals of projection 
neurons needs definitive light- and electron-microscopic confirmation. Neurofi­
brillary tangles in the neocortex are particularly abundant in the infragranular and 
supragranular pyramidal cells of layers HI and V and show a patchy distribution 
(Pearson et al. 1985). This patchy distribution is not random and resembles that of 
the pyramidal cells that give rise to the corticocortical association fibers (Pearson 
et al. 1985), but also of the preferentially prefrontal projection sites of brainstem 
nuclei (Emson and Lindvall 1986; Goldman-Rakic 1987b,1988). In the principal 
sulcus of the monkey prefrontal cortex, e.g., CA-containing axons are most 
concentrated in upper layer III and in the deep layers V and VI and are more sparse 
in other layers (Levitt et al. 1984; Goldman-Rakic 1987b). It is likely, therefore, 
that neurofibrillary tangles appear in projection neurons that send their axons to 
pathologically changed cortical areas (German et al.1987). Cortical projections of 
the nucleus raphe dorsalis are mainly complementary to those of the catecholami-
nergic nuclei LC, SN and VTA (Molliver 1987; Bergeretal. 1988),i.e. particularly 
to layer IV and preferentially to the primary sensory cortex (Takeuchi and Sano 
1983). But serotonergic fibers innervate all subportions of the hippocampal 
formation (Emson and Lindvall 1986; Molliver 1987), that might explain the 
abundance of NFT's within the NRd. There is a remarkable small proportion of 
senile plaques as compared to neurofibrillary tangles to be found in the NRd (SP/ 
NFT=0.25) as might be derived from our tables III. 13. and III. 14. This quotient was 
substantially greater for the LC (SP/NFT=1.37) and VTA (SP/NFT=0.75), which 
might correspond roughly to the extent of afferentiation from prefrontal cortical 
structures and the formation of amyloid plaques adjacent to cortical terminals. In 
the SN, where neurodegenerative changes are less well pronounced, a remarkable 
high proportion of SP's as compared to NFT's (SP/NFT=13.76) has been found, 
suggesting rather strong secondary degeneration as compared to relatively few 
primary cytoskeletal changes (NFT's) of cortical projection neurons. In PD 
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neuronal loss of cholinergic and monoaminergic subcortical nuclei is not signifi-
cantly related with neurofibrillary degeneration (Hakim and Mathieson 1979; 
Mann and Yates 1983; Ball 1984; Lees 1985; Perry et al.1985; Cummings 1988). 
Likewise, damage to the nucleus basalis of Meynert and other subcortical nuclei 
has been found without impressive cortical neuronal loss or AD pathology (Gaspar 
and Gray 1984; Nakano and Hirano 1984; Jellinger 1986b,c,1987b). 
In our cases Alzheimer neurofibrillary tangles occurred in the SN of nonpar-
kinsonian patiens with about the same frequency as in parkinsonians and with about 
the same frequency as did Lewy bodies. The somewhat higher frequency of NFT's 
in the LC might be explained by the fact that they also occur much more commonly 
in elderly people, increasing linearly up to the age of 90 years (Alvord et al. 1974) 
and a combination of SDAT with PD win be no uncommon finding in the very old 
(Zweig et al. 1989b). Indeed the number of NFT's and SP's in our case 87062 
(combined PD and AD) was similar to that found in patients with AD/SDAT. 
In summary, in the dementia of PD (and perhaps also that of progressive 
supranuclear palsy and Parkinsonism-demenüa of Guam) the same subcortical 
structures as those in AD (i.e. nucleus basalis, locus coeruleus and perhaps also 
dorsal raphe) show neuropathological changes in addition to SN degeneration, 
although only aspecific cortical pathology has been identified as yet in these 
disorders. Such changes illustrate the concept of "subcortical dementia" (Cum-
mings and Benson 1984; Chui 1989) in which the clinical deficit stems from a 
failure to sufficiently activate the cortex rather than as a result of primary cortical 
degeneration with secondary subcortical involvement. Such a view is very well in 
agreement with data on the functional importance of subcortical-to-cortical (espe-
cially monoaminergic) projections (Saper et al. 1987; Foote and Morrison 1987; 
Goldman-Rakic 1988; Gaspar et al. 1989; Pamavelas and Papadopoulos 1989). 
This distinction can also be recognized clinically since the early prominent aphasia, 
amnesia, agnosia and apraxia of AD (typifying cortical dementias) is largely 
replaced in "purely" subcortical dementias, by changes in mood, arousal, attention 
and motivation, that may underly the cognitive deficits within such patients. The 
concept that a failure of subcortical systems using specific neurotransmitters 
underhes a subpopulation of patients suffering the dementia syndrome is attractive 
because of its obvious therapeutic implications (Fleet et al. 1987; Gotham et al. 
1988). 
Both AD and PD show preponderance for specific neuronal systems in 
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several different regions of the brain. We do not understand why these diseases 
involve those neurons while sparing other cells groups. But the relation between 
cell loss and neurofibrillary degeneration (Fig.III. 12) and the severity of pathologic 
involvement in different areas (Rossori 982; Wilcock and Esiri 1982; Mann 1985; 
Perry et al. 1987; Jellinger 1987b) support the suggestion that the disease process 
in both PD and AD may extend along the connecting fibers (Appel 1981 ; Pearson 
et al.1985; Saper et al. 1987). The dopaminergic cell continuum of the mesencep-
halon might be subdivided in a part mainly related to cognitive and motivational 
functions (VTA) and a more purely motor part (SNc), both related to a common 
output part (SNret). A similar subdivision within the noradrenergic locus coeruleus 
is getting growing interest, its dorsal/rostral part being mainly involved in 
ascending cognition-related projections, whereas more diffuse ventrally and 
caudally placed neurons might have motor and output-related functions. It is 
tempting to speculate on a similar subdivision within the raphe system, its 
pathology being also associated with both motor and cognitive decline, but data on 
this subject are preliminary yet. A systematic methodological approach in the study 
of pathologic changes in major brainstem circuitry of the basal ganglia and the 
brainstem monoaminergic nuclei, might contribute to our understanding of their 
functional role in human cognition and motor function, as well as the very old 
question as regards a possible overlap in motor and cognitive processing. 
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V. SUMMARY AND CONCLUSIONS 
"Die waarlijk allerzotste lieden hebben gemeend met zoveel 
slapeloze uren en zoveel inspanning zich een of andere 
reputatie te moeten verwerven, het meest zinloze wat er 
bestaat. Maar ondertussen hebt U aan de Zotheid toch maar al 
dat voortreffelijk gerief in het leven te danken; en wat het 
allerleukste is, и profiteert van andermans gekheid!" 
Erasmus: Laus Stullitiae, 1508 
Vert. AJJiiensch, 1974 
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Dopamine, noradrenaline (both catecholamines) and serotonin are monoa-
minergic neurotransmitter substances and, together with acetylcholine, make up 
the most essential neurotransmitters of the human central nervous system. They 
seem to be responsible for specific nervous system functions that are typically 
susceptible to age-related decline. A substantial loss of acetylcholine is characte-
ristic for the dementia of Alzheimer, whereas the extrapyramidal signs in Paridn-
son's disease are related to a loss of dopamine. Both monoamines and acetylcholine 
are produced in subcortical nuclei that have widespread projections on forebrain 
structures and the cerebral cortex. An interconnection of such projections is 
suggested by the concept of the "reticular formation", suggesting similarities in 
their pathophysiological manifestations and associated diseases. Themain sources 
of monoamines are three brain stem nuclei: 1 .substantia nigra (dopamine); 2. locus 
coeruleus (noradrenaline) and 3. nucleus raphe dorsalis (serotonin). The most 
important source of acetylcholine is spread over a complex of basal forebrain 
magnocellular structures, known as the nucleus basalis of Meynert. This nucleus 
and its relation to Alzheimer's disease, has been thoroughly examined in recent 
decades, and a pathophysiological concept, which reminds of the "dopamine -
model" in Parkinson's disease, has been suggested. Elaboration of other monoa-
minergic nuclei has been less comprehensive, but changes related to aging disease, 
especially dementia, have been stated for all monoaminergic structures. We 
investigated a possible relationship of the substantia nigra, locus coeruleus and 
nucleus raphe dorsalis with degeneration of both Alzheimer's disease and Parkin-
son's disease. Loss of cells and neurofibrillary changes (as described by Alzheimer 
in 1907 in cortical areas) might substantiate such degeneration. The age-related 
decline of nigro-striatal projections, characteristic in Parkinson's disease, might 
serve as a model. 
Dopaminergic cells of the human mesencephalon show a dark-brown 
appearance, because of a natural pigment: neuromelanin. Accumulation of neuro-
melanin-pigment is related to catecholamine break-down and characterizes both 
substantia nigra and locus coeruleus neurons. A substantial reduction of neurome-
lanin-pigmented neurons can be found in Parkinson's disease, being most pronoun-
ced in the lateral pars compacta of the substantia nigra. This "subnucleus", 
therefore, might be considered to be most typically involved in motor functions of 
the extrapyramidal system. The distribution of tyrosine hydroxylase-immunoreac-
tivity (the enz; matic marker of catecholamines), appears to overlap with neurome-
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lanin pigment distribution. Therefore, cellular decrement of catecholaminergic 
brainstem areas, mostly is denoted as a loss of ncuromelanin-pigmented cells, 
generally quantified only for one or a few sections. Another restriction, which 
might introduce substantial bias in counting results, is the variability in the shape 
of neuromelanin-pigmented cells. Stereological principles might account for such 
bias, as well as for pathological tissue shrinkage. Therefore Floderus' (1944) and 
Abercrombies ( 1946) correction formulas were applied, necessitating exact data on 
cellular shape and sizes in different (disease) states. The nucleus raphe dorsalis 
neurons show an identifiable nucleolus, which might serve as an unequivocal 
counting element. A similar approach, i.e. counting of nucleoli, has been perfor­
med in parallel studies (see Ch. IV), on nucleus basalis, hippocampus, amygdala 
and neocortex. Neurofibrillary tangles and senile plaques, the characteristic 
manifestations of Alzheimer neurofibrillary degeneration, again, are highly varia­
ble in size and shape. Morphometric data on these neuropathological elements are 
only semi-quantitative. 
В ased on modem chemical neuroanatomy some traditional concepts have to 
be questioned: 1. specific brain nuclei have been associated with a single neuro­
transmitter, 2. single neurotransmitters have been related to specific (motor or 
cognitive) functions of the central nervous system. Apart from dopamine and 
acetylcholine other neurotransmitters, like serotonin and noradrenaline might be 
involved in Parkinson's disease and Alzheimer's disease, respectively. Neurode­
generative changes (like senile plaques, neurofibrillary tangles and Lewy bodies) 
appear also to be more widespread throughout the brain, although their high 
numbers in certain brain areas still applies as a neuropathological hallmark. Special 
attention has been directed to neuroanatomical data in order to solve some major 
questions: 1. is there an overlap in Alzheimer's disease and Parkinson's disease as 
regards certain parts of monoaminergic structures ? 2.is there a topographical 
distribution of cell loss and neurodegenerative findings, which accounts for clinical 
symptoms (motor and cognitive) in both disease states ? 3. are common (topograp­
hical) morphometric findings indicative of certain common pathophysiological 
principles and their clinical manifestation, especially cognitive disturbances ? 4. is 
there a correlation with changes in other brain areas functioning within the circuit 
under consideration ? The concept of a purely motor-related dopaminergic substan­
tia nigra, e.g., had to be substituted for a mesencephalic dopaminergic cell-conti­
nuum. The ventral tegmental area, situated dorsally and medially to the pars 
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compacta of the substantia nigra, appears to be a more diffusely spread part of this 
continuum, projecting on forebrain and cortical structures and related to cognitive 
and motivational aspects of behaviour in animal experiments. Many details on both 
nigrostriatal (motor) and mesolimbocortical ("motivational") loops have been 
derived from animal studies, especially rats. Extrapolation of this circuitry to the 
human brain has been aimed for, with the aid of the many data available from 
tracing studies in the literature on primates. 
A correlation of these neuroanatomical data with morphometric analysis of 
post-mortem (human) material, might serve to relate certain functions more 
particularly to certain areas of the monoaminergic brain stem nuclei. Cell number 
and neuropathological changes might serve, then, to estimate the involvement of 
certain circuits in cognitive disturbances of Alzheimer's disease and extrapyrami-
dal functioning in parkinsonism. Morphometric analysis of routinely stained Nissl 
and Congo-red preparations in future research has to confirm these suggestions on 
the involvement of well-defined circuits in specific aspects of both disease states. 
Our study (primarily designed as an inventarization) is only of limited value in 
proving statistically significant changes in cell number as regards different 
subnuclei in Alzheimer's disease, because of the small number of cases and the lack 
of clinical follow-up. Some important suggestions on pathophysiology, however, 
can be stated based on combined neuroanatomical and morphometric analysis. 
Besides, a contribution to the relevance of various manifestations of the dementia 
syndrome, e.g. the so-called "subcortical dementia" (treatable on theoretical 
grounds by monoaminergic or cholinergic substances), might be derived. 
Our findings, based on countings and neuropathological investigations, of a 
small number of cases, might be summarized as follows: 
1. Cell los of dopaminergic cells in the lateral part of the substantia nigra pare 
compacta inParkinson's disease is about 80% and is the greatest cell loss measured 
for monoaminergic structures in both disease states. In Alzheimer's disease a 
statistically significant reduction in cellular size can be seen in the medial part of 
the substantia nigra. As a whole the substantia nigra shows a significant cellular 
decrement only in Parkinson's disease, as compared to Alzheimer's disease and the 
aging process itself, when changes of cellar size are taken into account. 
2. A remarkable loss of cells without neuromelanin pigment can be seen in the 
ventral tegmental area in Alzheimer's disease cases (47%). These neurons need 
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further neurochemical characterization. Catecholaminergic (pigmented) ventral 
tegmental cells show a reduction of about 40% in Alzheimer's disease and about 
50% in Parkinson's disease cases. 
3. The retrorubral area (A8), a less well defined component of mesencephalic 
catecholaminergic neurons, extending dorsally from the caudal substantia nigra, 
also shows a reduction in cell number, both in Paricinson's disease and Alzheimer's 
disease cases. 
4. As regards the locus coeruleus there is a significant shrinkage of cells, 
preferentially in its rostral part (particularly associated with cortical projections). 
Corrected cell-loss of the locus coeruleus is about 70% in Alzheimer's disease and 
about 44% in Paricinson's disease, both concerning pigmented cells and neurons 
without neuromelanin. 
5. The nucleus raphe dorsalis only shows a significant cell loss in Alzheimer's 
disease cases (40%). 
6. Generally stated, the number of neurofibrillary tangles in the monoaminergic 
nuclei is about one-third of the number of lost cells in Alzheimer's disease. 
7. Only few senile (neuritic) plaques can be found in mesencephalic structures. The 
pattern of distribution, like that of neurofibrillary tangles, is more diffusely spread, 
without obeying cellular boundaries. Relatively many neurofibrillary changes 
have been found in the corpus geniculatum mediale, superior and inferior collicu-
lus, nucleus peripeduncularis, nucleus tegmenü pedunculopontinus and in the most 
caudal part of the lateral hypothalamic area. 
8. The pattern of distribution of tangles and plaques in our study corresponds with 
the pattern that might be expected according to the concept of Pearson and co-
workers. They (Pearson et al. 1985) stated that neurofibrillary changes occur in 
perikaryae of neurons that project to certain cortical areas "at risk", in relation to 
aging. Senile plaques might be transformations at the terminal site of cortical 
afferent fibers in the neuropil, preferentially in the neighbourhood of blood-
vessels. 
9. Primary changes in Alzheimer's disease appear in the cerebral cortex, with only 
secondarily, anterograde or retregrade, involvement of subcortical structures. 
Primary pathological changes in Parkinson's disease, however, appear in subcor-
tical nuclei (especially substantia nigra) and their projections. Basal forebrain and 
cortical areas are only secondarily involved, then. 
Based on these relationship an overlap in degenerated structures is very well 
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possible, which might account for the overlap in clinical symptomatology, 
described in several studies. 
10. "Subcortical dementia" is a syndrome of, at least theoretical, importance, 
referring to primary degeneration of subcortical structures, with secondarily 
involvement of cognition-related (cortical) structures. Transsynaptic (transaxonal) 
transport of neorotoxines, along (e.g. monoaminergic) trajectories susceptible to 
aging and neural decrement, might play an important role. Modem investigations, 
based on such concepts, might shed more light on certain kinds of dementia that 
are hard to understand, like dementia in Parkinson's disease and dementia 
following encephalitis. Selective neuron loss of monoaminergic brainstem struc-
tures, related to topographical principles of their projections, might provide an 
additional clue to such considerations in current neuroscience. 
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SAMENVATTING EN CONCLUSIES 
Dopamine en noradrenaline (de catecholaminen) vormen tesamen met sero-
tonine de monoaminerge neurotransmitters en zijn met acetylcholine de meest 
bekende transmitter substanties van het centrale zenuwstelsel. Al velejaren wordt 
aangenomen dat deze stoffen specifieke funkties vervullen, die met name bij de 
normale veroudering een achteruitgang vertonen. In pathologische zin zou vervol-
gens een uitgesproken verlies aan acetylcholine optreden bij de dementie van het 
type Alzheimer, terwijl de extrapiramidale dysfunktie bij de ziekte van Parkinson 
gerelateerd is aan een verlies van dopamine. Zowel de drie monoamines als het 
acetylcholine worden geproduceerd in subcorticale kernen en van daaruit getran-
sporteerd naar wijd verbreide voorhersenstrukturen en de cortex cerebri. De 
betreffende projekties lijken met elkaar verweven, zoals traditioneel in het concept 
van de 'formatio reticularis' aangegeven, en het ligt voor de hand de pathofysio-
logie van deze verschillende projekties en hun oorsprongskemen, als ook de 
daaraan verbonden ziektebeelden, met elkaar te vergelijken. De drie monoaminen 
worden met name geproduceerd in hersenstam kemen: 1. de substantia nigra 
(dopamine); 2. de locus coeruleus (noradrenaline) en 3. de nucleus raphe dorsalis 
(serotonine). De meest bekende cholinerge kern, de nucleus basalis van Meynert, 
is een magnocellulair complex in de basale voorhersenen. De laatste decennia is 
veel onderzoek gedaan naar veranderingen in de nucleus basalis bij de ziekte van 
Alzheimer, in de hoop een vergelijkbaar pathofysiologisch model te kunnen 
ontwikkelen als dat voor de ziekte van Parkinson betreffende de substantia nigra 
en bijhorende dopaminerge projekties op het striatum. De andere monoaminerge 
strukturen zijn daarbij minder uitvoerig onderzocht. Wel is waarschijnlijk gemaakt 
dal alle monoaminerge strukturen veranderingen vertonen als gevolg van patholo-
gische veroudering, in de zin van dementie van het Alzheimer type of anderszins, 
zoals dementie bij parkinsonisme. In het licht van deze kennis hebben wij ons de 
vraag gesteld of nu de substantia nigra, locus coeruleus en nucleus raphe dorsalis 
betrokken zouden kunnen zijn bij zowel de degeneratie van de ziekte van 
Alzheimer als bij die van de ziekte van Parkinson. Daartoe zou eventueel cclverlies 
en de typische neurofibrillaire veranderingen (zoals in 1907 door Alzheimer 
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beschreven voor corticale gebieden) gemeten moeten kunnen worden. De typische 
leefüjdsafhankelijke nigro-striatale degeneratie, zoals beschreven bij de ziekte van 
Parkinson, zou daarbij model kunnen staan. 
Voordeel van deze dopaminerge struktuur in het mesencephalon is ook dat 
zij een 'natuurlijke cel-marker' vertoont, namelijk het neuromelanine. Dit is een 
donkerbruin pigment, als afbraak produkt van catecholaminen aanwezig in de 
substantia nigra en locus coenileus, en karakteristiek goeddeels ontbrekend in de 
hersenstam van patiënten met de ziekte van Parkinson. Het grootste verlies aan 
neuromelanine-houdende cellen bij parkinsonisme wordt beschreven voor het 
laterale deel van de substantia nigra pars compacta en deze "subnucleus" wordt 
daarom beschouwd als het meest met extrapiramidale bewegingsstoomissen 
verbonden dopaminerge kerngebied. Gebleken is dat neuromelanine-houdende 
cellen redelijk overeenkomen met tyrosine hydroxylase (de enzymatische marker 
voor catecholaminerge strukturen)-houdende cellen. In de literatuur wordt celver-
lies van de catecholaminerge hersenstam kemen dan ook vaak aangegeven als 
verlies van aantal neuromelanine houdende cellen, doorgaans echter slechts voor 
enkele doorsneden. Een beperking daarbij is bovendien de onregelmatige configu-
ratie van gepigmenteerde cellen, waarbij men niet weet of men met hele cellen of 
met cel-delen te maken heeft en daardoor tot onjuiste telresultaten komt. Boven-
dien zijn faktoren als pathologische weefsel of cel-krimp van invloed op de 
morfometrische resultaten als men willekeurig gevormde neurale elementen 
kwantificeert. Derhalve is bij de ontwikkelde telmethode rekening gehouden met 
deze zogenaamde stereologische principes en worden correctie formules volgens 
Floderus (1944) en Abercrombie (1946) toegepast. Cellen van de nucleus raphe 
dorsalis zijn heikenbaar aan een met-splijtbare nucleolus en kunnen derhalve 
zonder correctie formules worden gekwantificeerd (net als b.v. cellen van de 
nucleus basalis, hippocampus en cortex in parallel lopende projekten). Neurofibril-
laire elementen, "neurofibrillary tangles"(NFr) en "senile plaques"(SP), zijn weer 
wisselend van vorm en grootte en bieden opnieuw problemen als het gaat om exacte 
kwantificering in verschillende moeilijk begrensbare hersen-arealen. Derhalve is 
de morfometrie van deze elementen altijd slechts semi-kwantitatief. 
In het licht van de huidige kennis van de chemische neuroanatomie neemt 
men steeds meer afstand van het oude concept, dat: 1 .specifieke strukturen geka-
rakteriseerd kunnen worden door enkelvoudige neurotransmitters; 2. enkelvoudige 
neurotransmitters gecorreleerd zijn aan specifieke (motorische of cognitieve) 
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fiinkties. Zo is inmiddels gebleken dat bij de ziekte van Parkinson naast dopamine 
ook acetylcholine, noradrenaline en andere chemische substanties betrokken zijn 
en dat verlies aan cognitieve fiinkties bij de ziekte van Alzheimer niet enkel 
gecorreleerd is aan verlies van cholinerge projekties. Tevens blijken neurodegene-
ratieve verschijnselen (senile plaques en neurofibrillary tangles en Lewy bodies) 
meer diffuus verdeeld over het cerebrum en ook niet beperkt tot een ziektebeeld, 
hoewel ze nog steeds als karakteristieke pathologisch kenmerken gelden. Speciale 
aandacht is dan ook geschonken aan de neuroanatomie van de te onderzoeken 
strukturen om de volgende vragen te kunnen inventariseren: 1. Is er inderdaad een 
zekere overlap in de ziekte van Alzheimer en de ziekte van Parkinson, betreffende 
de pathologie monoaminerge strukturen dan wel gedeelten van deze stukturen? 2. 
Is de topografische verdeling van celveriies en neurodegeneratieve verschijnselen 
zodanig dat dit een herkenbaar substraat vormt voor de klinische Symptomatologie 
bij deze ziekte (т.п. motorisch vs. cognitief)? 3. Zijn er op basis van de overlap in 
morfometrische bevindingen van bepaalde (sub)arealen conclusies te trekken t.a. v. 
de pathofysiologie van beide ziektebeelden en vooral ook betreffende symptomen 
die bij beide ziektebeelden worden aangetroffen, т.п. cognitieve fiinktiestoomis-
sen? 4. Is de neuroanatomische verdeling van de degeneratieve verschijnselen 
zodanig dat deze correleert met andere hersengebieden die binnen een betreffend 
circuit funktioneren? Zo kan bv. de substantia nigra niet meer opgevat worden in 
traditionele zin, maar moet het mesencephale dopaminerge celcontinuum uitge­
breid worden meteen zgn. ventraal tegmentaal areaal (VTA), dat, i.Lt. de substantia 
nigra, meer gerelateerd is aan voorhersenstrukturen en cognitieve en motivatimele 
gedragscomponenten. Dit gebied strekt zich uit juist mediaal en dorsaal van de 
substantia nigra pars compacta. Daarmee is het tevens een gebied waar overlap in 
de pathologie van de ziekte van Parkinson en de ziekte van Alzheimer verwacht kan 
worden, mits inderdaad de corticale projekties in verband gebracht mogen worden 
met cognitieve fiinkties en striatale projekties met motorische fiinkties. Reeds vele 
details t.a.v. de anatomie en fysiologie der monoaminerge hersenstam kernen zijn 
bekend, maar meestal gebaseerd op onderzoek aan de hersenen van de rat. Zeer veel 
aandacht is gegeven aan de extrapolatie van deze gegevens naar het menselijk 
brein, waarbij т.п. de literatuur m.b.t. onderzoek aan primaten is gerefereerd. 
Juist het relateren van deze kennis aan exacte morfometrische analyse van 
post-mortem materiaal kan suggesties t.a.v. de fiinkties der verschillende kem-
arealen op hun waarde toetsen. Het aantal cellen en neuropathologische bevindin-
231 
gen in een belangrijke schakel (in dit geval een monoaminerge hersenstam kem) 
uit een circuit dient als maat voor de betrokkenheid van dat circuit bij (cognitieve) 
stoornissen van het Alzheimer type of (extrapiramidale) verschijnselen van 
parkinsonisme. De morfometrische methode ter snelle analyse van Nissl en Congo-
rood aangekleurd obductie materiaal schept dan de mogelijkheid om gedetaileerde 
klinische observatie te relateren aan gedetaileerde post-mortem analyse. 
Als inventarisatie is ons onderzoek nog niet geschikt gebleken om veel harde 
gegevens omtrent subtiele morphometrische veranderingen in subarealen bij de 
ziekte van Alzheimer te leveren. 
De resultaten van onderzoek aan ons klein aantal breinen suggereren echter wel 
enige verwachtingen ten aanzien van de pathofysiologic van de betreffende 
vcrouderingsziekten en hun neuroanatomisch substraat. 
Daarmee zou vooral een bijdrage geleverd kunnen worden aan de discussie rond 
verschillende vormen van het dementie-syndroom, zoals dat van een zgn. 'subcor-
ticale dementie ', die theoretisch voor medicamenteuze behandeling (suppletie van 
monoaminerge of cholinerge substanties) in aanmerking kan komen. 
De resultaten van de celtellingen en het neuropathologisch onderzoek 
zouden dan als volgt kunnen worden samengevat: 
1. Celverlies van dopaminerge cellen in het laterale deel van de substantia nigra 
pars compacta bij de ziekte van Parkinson bedraagt ca. 80% en is tevens het grootste 
celverlies zoals binnen monoaminerge strukturen kan worden gevonden bij de 
genoemde ziektebeelden. Bij de ziekte van Alzheimer is er in het mediale deel van 
de substantia nigra een statistisch significante reductie in cel grootte. De substantia 
nigra als geheel toont alleen bij de ziekte van Parkinson een significant celverlies. 
Er is rekening gehouden met veranderingen in cel-grootte, hoewel die veranderin-
gen meestal niet statisch significant zijn, bij een der ziektes of bij het veroudering-
sproces zelf. 
2. Opmerkelijk is een celverlies van niet-neuromelanine-houdende cellen in de area 
tegmentalis ventralis (VTA) bij de ziekte van Alzheimer (47%). Deze cellen zijn 
nog niet goed cytochemisch gekarakteriseerd. De catecholaminerge cellen van de 
VTA vertonen een reductie van 50% bij de ziekte van Parkinson en 40% bij de 
ziekte van Alzheimer. 
3. De area retrorubralis (A8), een minder scherp gedefinieerde uitbreiding dorsaal 
van de substantia nigra, vertoont eveneens celverlies zowel bij de ziekte van 
Parkinson als bij de ziekte van Alzheimer. 
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4. Ook t.a.v. de locus coeruleus moet rekening gehouden worden met cel-krimp, 
waarbij opvalt dat deze in het rostrale deel (het meest gerelateerd aan corticale 
projecties) het sterkst is. Het (gecorrigeerde) celverlies van de locus coeruleus is 
ca. 70% bij de ziekte van Alzheimer en 44% bij de ziekte van Parkinson, zowel voor 
melanine-houdende als ongepigmenteerde cellen. 
5.De nucleus raphe dorsalis vertoont alleen bij de ziekte van Alzheimer een 
significant celverlies (40%). 
6. Algemeen gesteld blijkt het aantal neurofibrillaire tangles in alle drie de 
monoaminerge kemen steeds ongeveer 1/3 deel te bedragen van het aantal verloren 
cellen, bij de ziekte van Alzheimer. 
7. Seniele (neuritische) plaques worden slechts weinig aangetroffen binnen de 
monoaminerge strukturen. Het verdelingspatroon van seniele plaques, maar ook 
dat van neurofibrillaire tangles, houdt zich relatief slecht aan de begrenzingen van 
monoaminerge kemen. Er worden т.п. ook relatief veel neurodegeneratieve 
verschijnselen gezien in corpus gcniculatum mediale, tectum mesencephali, 
nucleus peripeduncularis, nucleus tegmenüpedunculopontinus en caudale uitloper 
van de laterale hypothalamus. 
8. Het verdelingspatroon van tangles en plaques is zodanig dat het concept van 
Pearson en medewerkers (Pearson et al. 1985) kan worden uitgebreid voor 
hersenstamstrukturen. Daarbij geldt dat neurofibrillaire tangles degeneraüeve 
veranderingen zijn, binnen cellen die op 'gevoelige' corticale arealen projecteren, 
en gerelateerd aan veroudering. Seniele plaques zouden ontstaan ter plaatse van 
terminalia van corticale afferenten in het neuro-pileem, vooral ook in sterk 
gevasculariseerde gebieden. 
9. De primaire pathologie bij de dementie van het Alzheimer-type is daarbij 
corticaal, met secundaire anterograde en retrograde subcorticale degeneratie. De 
primaire pathologie bij de ziekte van Parkinson is subcorticaal, met eventuele 
secundaire degeneratie van basale voorhersenenen corticale strukturen. T.g.v. deze 
'verdeling' en de relatie daarvan met veroudering, ontstaat er een zekere overlap 
in beide ziektebeelden. 
10. Het begrip 'subcorticale dementie' is, tenminste theoretisch, van waarde. Het 
verwijst naar primaire degeneratie van subcorticale strukturen of van de bijbeho-
rende projecties op de cortex. Transsynaptisch transport van neurotoxinen langs 
sterk vertakkende, gevoelige projecties (zoals die der monoaminerge kemen) zou 
daarbij een rol kunnen spelen. Dit model verdient aandacht binnen het huidige 
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onderzoek naar slecht begrepen demenüële beelden, m .η. die welke gekoppeld zijn 
aan de ziekte van Paricinson, maar ook b.v. bij de encephaliüden. Seleküef 
celverlies binnen monoaminerge kernen, gerelateerd aan de topografie van hun 
projecties, heeft daartoe duidelijk aanknopingspunten geboden. 
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Dankwoord 
Mijn dank gaat uit naar alle medewerk(st)ers van de vakgroep Anatomie en 
Embryologie van de Fakulteit der Geneeskunde en Tandheelkunde, die hebben 
bijgedragen aan het in dit proefschrift beschreven onderzoek. Daarbij mag gezegd 
worden dat ook de niet-strikt-wetenschappelijke bijdragen en de meer informele 
gesprekken op deze afdeling doorgaans zeer stimulerend waren. 
De analisten hebben steeds zorg gedragen voor uitstekend afgewerkt materiaal 
onder leiding van Freek van Woricum, op het Research-Laboratorium voor 
Morfologische Neurologie in het Instituut voor Neurologie, vooral Josine van 
Luy t. Het immunohistochemische onderdeel werd met name verzorgd door Roelie 
de Bocr-van Huizen en Ine Bergervoet-Vemooij, die ook kostennoch moeite spaar-
den om, met medewerking van Marijn van Beers, voor goed foto-materiaal te 
zorgen. De beschikbaarheid van actuele literatuur-gegevens werd met zorg verze-
kerd door Anja Rozendaal-Verburg, via "haar" documentatiecentrum VVZCZS 
(dat moet blijven !). 
Een meer wetenschappelijk geaarde bijdrage werd geleverd door Dave Mier, 
die de tellingen van de locus coeruleus voor zijn rekening nam. Joop Pemot hielp 
één en ander om te zetten in geschikte computer-taal en legde een wonderbaarlijk 
geduld aan de dag bij het bepleiten van het belang hierin ook zelf meer ervaring op 
te doen. Pietcr Wesseling wist op het scherp van de snede nog het nodige materiaal 
aan te dragen voor een onmisbaar deel van het onderzoek. En, over materiaal 
gesproken, de Amsterdamse "Hersenbank" en de verpleeghuizen Joachim en Anna 
(Nijmegen), alsmede het R.K. Kempisch Verpleeghuis (Bladcl) en Stichting Ver-
pleeghuizen gewest Helmond (Bakel), mogen daarbij niet onvermeld blijven. 
Dan werkten er natuurlijk nog een aantal mensen op de achtergrond, die 
niettemin onmisbaar waren en hopelijk weten dat ik ze erkentelijk ben. Dus, Cocky 
en Marjon en Henk (..waar haal je die fraaie antistoffen vandaan...?) en anderen: 
de herhaalde oefeningen van geduld waren niet voor niets. Hetzelfde geldt voor de 
collegae promovendi, waarmee het prettig samenwerken was en die daarvan 
tenminste zelf ook hun vruchten hebben mogen plukken. Zij stonden mij een in-
haalmanoevre toe, vooral door te helpen bij een aantal technische aspecten van de 
morfometrie. 
Tot slot natuurlijk de persoonlijke vrienden, die altijd een meer esoterische 
bijdrage leveren en gelukkig weten dat hun bijdrage nu eens niet te quantifíceren 
is. Jullie weten dat echte dank niet om formalismen vraagt. Vandaar. 
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STELLINGEN 
ι. 
"It is essential, in discussing the physiology of the corpus striatum, to think 
anatomically". 
S. A.K.Wilson, 1914 
IL 
Het onderscheid tussen corticale en subcorticale dementie is zinvol. 
ΠΙ. 
"Eine statistische Korrelation führt zu einer Frage, noch nicht zu einer Erkenntnis 
der Art der Beziehung." 
K. Jaspers, Allgemeine Psychopathologie, 6° druk, 1953 
IV. 
Het veelvuldig gebruik van de zinsnede "Het zou wellicht zo kunnen zijn dat " 
maakt een proefschrift extra dik en Poppers' falsifieerbaarheids-theorie overbodig. 
V. 
"Het feit, dat het postmortaal onderzoek van de hersenen van een aan dementie 
overleden patient de ene keer uitgesproken organisch-structurele veranderingen 
der hersenen en een andere keer nauwelijks hersen-stoomissen aan het licht brengt, 
is slechts veridaarbaar vanuit de opvatting, dat de geaardheid van de gemeenschap 
en van de cultuurwereld, waarmee het individu verbonden is, in hoge mate 
medebepalend zijn voor een al dan niet optreden van een dementeringsproces." 
J.J.G.Prick, 1971 
VI. 
Waardevrije wetenschap is als waardeloze liefde. 
VIL 
Voor de ziekte van Parkinson geldt: Waar een wil is is géén weg. 
VUL 
De totale hoeveelheid domheid onder gezonde mensen overtreft verre het verlies 
aan intellectuele funklics bij gedementeerden. 
IX. 
De Stelling "Do more less well" (Gundersen HJG and Österby R (1981) 
J Microscopy 121: 65-73) is van toepassing op strikt morfometrisch onderzoek, 
maarmoet worden omgekeerd bij de neuro-anatomische interpretatie van de bevin-
dingen. 
Χ. 
De reden om het humane brein met dat van een rat te vergelijken dient enkel van 
praktisch neuro-anatomische aard te zijn. 
XI. 
"The political party which will have the foresight and humanity to introduce into 
its platform an article advocating and supporting the longer and better use of the 
human brain will offer a worthy issue to its electorate." 
M. Critchley, 1956 
ΧΠ. 
Het nerveus-functionele klachtenpatroon is de meest therapie-resistente be­
smetting. Het in cultuur verkregen agens heet "Stigma". 
XIII. 
Het verschil tussen de anthroposofische en de academische geneeskunde zit in de 
balans tussen goede wil en Goodwill; bij beide is deze aan een kant overbelast. 
XIV. 
Publiceren is als vreemdgaan; er is altijd iemand bij betrokken die het níet leuk 
vindt. 
XV. 
Nietzsche dementeerde en God was dood; beide breinen zijn niet meegeteld. 
